Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Gene_full_name.refGene	Function_description.refGene	Disease_description.refGene	Tissue_specificity(Uniprot).refGene	Expression(egenetics).refGene	Expression(GNF/Atlas).refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	cytoBand	cosmic70	ExAC_ALL	ExAC_AFR	ExAC_AMR	ExAC_EAS	ExAC_FIN	ExAC_NFE	ExAC_OTH	ExAC_SAS	gnomAD_genome_ALL	gnomAD_genome_AFR	gnomAD_genome_AMR	gnomAD_genome_ASJ	gnomAD_genome_EAS	gnomAD_genome_FIN	gnomAD_genome_NFE	gnomAD_genome_OTH	avsnp147	CLNALLELEID	CLNDN	CLNDISDB	CLNREVSTAT	CLNSIG	HGMD_pro_2019.1
1	21795289	21795289	-	C	exonic	NBPF3		frameshift insertion	NBPF3:NM_001256416:exon3:c.243dupC:p.Q83Pfs*31,NBPF3:NM_032264:exon3:c.243dupC:p.Q83Pfs*31,NBPF3:NM_001330381:exon7:c.75dupC:p.Q27Pfs*31	1.98380335692613e-11	0.378787941923582	0.621212058056581	neuroblastoma breakpoint family member 3	.	.	TISSUE SPECIFICITY: Expressed in testis and fetal heart, as well as in non small cell lung carcinoma and neuroblastoma cell line. {ECO:0000269|PubMed:16079250}.; 	unclassifiable (Anatomical System);heart;hypothalamus;colon;skin;breast;bile duct;uterus;pancreas;whole body;lung;ganglion;larynx;bone;thyroid;pituitary gland;liver;testis;head and neck;brain;stomach;	.	0.06699	.	3.60019308	99.52819061	1664.61558	7.53254	1p36.12																								
1	21932582	21932582	-	G	exonic	RAP1GAP		frameshift insertion	RAP1GAP:NM_001145658:exon18:c.1596dupC:p.D533Rfs*142,RAP1GAP:NM_002885:exon18:c.1404dupC:p.D469Rfs*142,RAP1GAP:NM_001145657:exon19:c.1404dupC:p.D469Rfs*19,RAP1GAP:NM_001330383:exon19:c.1404dupC:p.D469Rfs*19,RAP1GAP:NM_001350524:exon20:c.1404dupC:p.D469Rfs*19,RAP1GAP:NM_001350525:exon20:c.1404dupC:p.D469Rfs*19,RAP1GAP:NM_001350527:exon20:c.1404dupC:p.D469Rfs*142,RAP1GAP:NM_001350528:exon20:c.1404dupC:p.D469Rfs*142,RAP1GAP:NM_001350526:exon21:c.1404dupC:p.D469Rfs*19	0.974156915163255	0.0258430341562822	5.0680462784698e-08	RAP1 GTPase activating protein	FUNCTION: GTPase activator for the nuclear Ras-related regulatory protein RAP-1A (KREV-1), converting it to the putatively inactive GDP-bound state. {ECO:0000269|PubMed:15141215}.; 	.	TISSUE SPECIFICITY: Significant expression seen in the brain, kidney and pancreas. Abundant in the cerebral cortex and expressed at much lower levels in the spinal cord. Not detected in the lymphoid tissues. {ECO:0000269|PubMed:9346962}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;hypothalamus;sympathetic chain;skin;prostate;lung;frontal lobe;placenta;thyroid;hippocampus;testis;kidney;brain;stomach;cerebellum;	amygdala;whole brain;medulla oblongata;occipital lobe;superior cervical ganglion;temporal lobe;adrenal cortex;caudate nucleus;pons;fetal thyroid;skeletal muscle;subthalamic nucleus;uterus corpus;adrenal gland;thyroid;prefrontal cortex;globus pallidus;kidney;trigeminal ganglion;cingulate cortex;parietal lobe;	0.37356	0.15820	-0.725642751	14.24274593	2918.53299	10.24858	1p36.12																								
1	21932625	21932625	G	A	exonic	RAP1GAP		synonymous SNV	RAP1GAP:NM_001145658:exon18:c.C1554T:p.T518T,RAP1GAP:NM_002885:exon18:c.C1362T:p.T454T,RAP1GAP:NM_001145657:exon19:c.C1362T:p.T454T,RAP1GAP:NM_001330383:exon19:c.C1362T:p.T454T,RAP1GAP:NM_001350524:exon20:c.C1362T:p.T454T,RAP1GAP:NM_001350525:exon20:c.C1362T:p.T454T,RAP1GAP:NM_001350527:exon20:c.C1362T:p.T454T,RAP1GAP:NM_001350528:exon20:c.C1362T:p.T454T,RAP1GAP:NM_001350526:exon21:c.C1362T:p.T454T	0.974156915163255	0.0258430341562822	5.0680462784698e-08	RAP1 GTPase activating protein	FUNCTION: GTPase activator for the nuclear Ras-related regulatory protein RAP-1A (KREV-1), converting it to the putatively inactive GDP-bound state. {ECO:0000269|PubMed:15141215}.; 	.	TISSUE SPECIFICITY: Significant expression seen in the brain, kidney and pancreas. Abundant in the cerebral cortex and expressed at much lower levels in the spinal cord. Not detected in the lymphoid tissues. {ECO:0000269|PubMed:9346962}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;hypothalamus;sympathetic chain;skin;prostate;lung;frontal lobe;placenta;thyroid;hippocampus;testis;kidney;brain;stomach;cerebellum;	amygdala;whole brain;medulla oblongata;occipital lobe;superior cervical ganglion;temporal lobe;adrenal cortex;caudate nucleus;pons;fetal thyroid;skeletal muscle;subthalamic nucleus;uterus corpus;adrenal gland;thyroid;prefrontal cortex;globus pallidus;kidney;trigeminal ganglion;cingulate cortex;parietal lobe;	0.37356	0.15820	-0.725642751	14.24274593	2918.53299	10.24858	1p36.12		0.1991	0.0646	0.4678	0.3124	0.1734	0.1622	0.2044	0.2085	0.0986	0.0490	0.2590	0.0662	0.2481	0.0934	0.1037	0.1074	rs2275365						
1	40315888	40315888	A	T	exonic	TRIT1		nonsynonymous SNV	TRIT1:NM_001312692:exon3:c.T366A:p.F122L,TRIT1:NM_001312691:exon5:c.T606A:p.F202L,TRIT1:NM_017646:exon5:c.T606A:p.F202L	9.42968680674274e-10	0.28367453303875	0.716325466018282	tRNA isopentenyltransferase 1	FUNCTION: Catalyzes the transfer of a dimethylallyl group onto the adenine at position 37 of both cytosolic and mitochondrial tRNAs, leading to the formation of N6-(dimethylallyl)adenosine (i(6)A). {ECO:0000269|PubMed:11111046}.; 	.	.	lymphoreticular;ovary;colon;retina;bone marrow;uterus;prostate;whole body;frontal lobe;cerebral cortex;endometrium;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;blood;skeletal muscle;pancreas;lung;trabecular meshwork;placenta;visual apparatus;liver;kidney;mammary gland;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;appendix;testis;atrioventricular node;	0.23650	0.14415	-0.003562597	53.72729417	1128.84131	6.41211	1p34.2		0.1041	0.1711	0.2057	0.2903	0.1005	0.0560	0.1049	0.0890	0.1085	0.1688	0.1611	0.0629	0.2781	0.0990	0.0564	0.0937	rs3738671						
1	40771432	40771432	C	T	exonic	COL9A2		synonymous SNV	COL9A2:NM_001852:exon21:c.G1062A:p.P354P	0.182801205838876	0.817194565040543	4.22912058107295e-06	collagen type IX alpha 2	FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.; 	DISEASE: Multiple epiphyseal dysplasia 2 (EDM2) [MIM:600204]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:10364514}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:10411504}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Stickler syndrome 5 (STL5) [MIM:614284]: An autosomal recessive form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. STL5 is characterized by high myopia, vitreoretinal degeneration, retinal detachment, mild to moderate sensorineural hearing loss, short stature in childhood, and absence of cleft palate and Pierre Robin sequence. {ECO:0000269|PubMed:21671392}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.10977	0.16297	1.690270544	96.40835103	4219.57468	12.92194	1p34.2		0.0313	0.1073	0.0773	0.1043	0.0131	0.0034	0.0178	0.0341	0.0396	0.1053	0.0694	0	0.0985	0.0106	0.0025	0.0144	rs6676013	249910	Multiple_Epiphyseal_Dysplasia,_Dominant|not_specified|Stickler_Syndrome,_Recessive|not_provided	MedGen:CN043640|MedGen:CN169374|MedGen:CN239473|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
1	43907055	43907056	TG	-	intronic	SZT2				1.51746679777732e-07	0.99999984825332	4.6978326740771e-20	seizure threshold 2 homolog (mouse)	FUNCTION: Involved in oxidative stress. May be involved in superoxide dismutase activity and in neuroprotective effect of peroxisomes, but has no direct dismutase activity when tested in yeast. May enhance epileptogenesis and confer low seizure threshold (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in the brain, predominantly in the parietal and frontal cortex, as well as in dorsal root ganglia. Expressed in peripheral white blood cells. {ECO:0000269|PubMed:20045724, ECO:0000269|PubMed:23932106}.; 	unclassifiable (Anatomical System);prostate;lung;heart;pituitary gland;colon;cervix;	.	.	0.09202	.	.	2151.43823	8.52940	1p34.2																								
1	55060362	55060363	GC	-	exonic	ACOT11		frameshift deletion	ACOT11:NM_015547:exon6:c.605_606del:p.D203Sfs*7,ACOT11:NM_147161:exon6:c.605_606del:p.D203Sfs*7	1.33339142705338e-10	0.53607299380681	0.463927006059851	acyl-CoA thioesterase 11	FUNCTION: Has acyl-CoA thioesterase activity towards medium (C12) and long-chain (C18) fatty acyl-CoA substrates.; 	.	TISSUE SPECIFICITY: Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue.; 	unclassifiable (Anatomical System);lymph node;ovary;lacrimal gland;colon;parathyroid;fovea centralis;choroid;lens;skin;retina;prostate;optic nerve;nasopharynx;thyroid;placenta;macula lutea;pituitary gland;liver;head and neck;spleen;kidney;mammary gland;stomach;	.	0.10496	0.13932	0.720128343	85.85751356	3575.80865	11.56510	1p32.3																								
1	65890990	65890990	C	T	exonic	LEPROT		synonymous SNV	LEPROT:NM_001198683:exon2:c.C21T:p.L7L,LEPROT:NM_017526:exon2:c.C21T:p.L7L,LEPROT:NM_001198681:exon3:c.C48T:p.L16L	0.0947893568489441	0.768843555769765	0.136367087381291	leptin receptor overlapping transcript	FUNCTION: Negatively regulates leptin receptor (LEPR) cell surface expression, and thus decreases response to leptin. Negatively regulates growth hormone (GH) receptor cell surface expression in liver. May play a role in liver resistance to GH during periods of reduced nutrient availability. {ECO:0000269|PubMed:18042720, ECO:0000269|PubMed:19907080}.; 	.	TISSUE SPECIFICITY: Expressed at the highest levels in heart and placenta and at a lesser extent in lung, liver, skeletal muscle, kidney and pancreas.; 	.	.	0.23172	0.87580	-0.009020804	52.8544468	3.87804	0.14449	1p31.3		0.0079	0.0012	0.0010	0.0409	0.0545	0.0028	0.0143	0.0012	0.0116	0.0007	0.0012	0	0.0420	0.0564	0.0049	0.0143	rs13306523	282920	Leptin_receptor_deficiency|Monogenic_Non-Syndromic_Obesity	MedGen:C3554225,OMIM:614963,Orphanet:ORPHA179494|MedGen:CN239457	criteria_provided,_single_submitter	Uncertain_significance	
1	109716431	109716431	C	-	exonic	KIAA1324		frameshift deletion	KIAA1324:NM_001284352:exon6:c.618delC:p.H207Tfs*60,KIAA1324:NM_020775:exon7:c.924delC:p.H309Tfs*60	2.14864520738644e-08	0.998570003732984	0.00142997478056437	KIAA1324	FUNCTION: May protect cells from cell death by inducing cytosolic vacuolization and upregulating the autophagy pathway. {ECO:0000269|PubMed:21072319}.; 	.	TISSUE SPECIFICITY: Expressed in normal endometrium but overexpressed in endometroid tumors. {ECO:0000269|PubMed:16322283}.; 	.	.	0.18892	0.10823	-0.501537595	21.83887709	267.58763	3.50758	1p13.3																								
1	109716437	109716438	GT	-	exonic	KIAA1324		stopgain	KIAA1324:NM_001284352:exon6:c.624_625del:p.C209*,KIAA1324:NM_020775:exon7:c.930_931del:p.C311*	2.14864520738644e-08	0.998570003732984	0.00142997478056437	KIAA1324	FUNCTION: May protect cells from cell death by inducing cytosolic vacuolization and upregulating the autophagy pathway. {ECO:0000269|PubMed:21072319}.; 	.	TISSUE SPECIFICITY: Expressed in normal endometrium but overexpressed in endometroid tumors. {ECO:0000269|PubMed:16322283}.; 	.	.	0.18892	0.10823	-0.501537595	21.83887709	267.58763	3.50758	1p13.3																								
1	115604798	115604798	C	T	exonic	TSPAN2		synonymous SNV	TSPAN2:NM_001308315:exon3:c.G228A:p.G76G,TSPAN2:NM_001308316:exon3:c.G228A:p.G76G,TSPAN2:NM_005725:exon3:c.G228A:p.G76G	0.000100586967317338	0.804850683445572	0.19504872958711	tetraspanin 2	FUNCTION: May play a role in signalling in oligodendrocytes in the early stages of their terminal differentiation into myelin-forming glia and may also function in stabilizing the mature sheath. {ECO:0000250}.; 	.	.	.	.	0.16613	0.12378	-0.007201372	53.19061099	151.97102	2.69598	1p13.2		0.3422	0.3347	0.3918	0.4809	0.3133	0.3500	0.3481	0.2239	0.3112	0.3078	0.3137	0.3	0.4419	0.2130	0.3226	0.3070	rs10776795						
1	154293675	154293675	G	A	exonic	AQP10		nonsynonymous SNV	AQP10:NM_080429:exon1:c.G44A:p.R15Q	0.0152782932027765	0.878522242818559	0.106199463978665	aquaporin 10	FUNCTION: Water channel required to promote glycerol permeability and water transport across cell membranes. May contribute to water transport in the upper portion of small intestine. Isoform 2 is not permeable to urea and glycerol. {ECO:0000269|PubMed:11573934, ECO:0000269|PubMed:12084581}.; 	.	TISSUE SPECIFICITY: Expressed exclusively in duodenum and jejunum. Highest expression in absorptive epithelial cells at the tips of villi in the jejunum.; 	unclassifiable (Anatomical System);lung;liver;testis;spleen;skeletal muscle;	.	0.10780	0.10375	0.104848986	61.49445624	4035.92542	12.59512	1q21.3		0.2921	0.2658	0.2131	0.2251	0.3732	0.2968	0.3102	0.3470	0.2985	0.2700	0.2368	0.1887	0.2246	0.3627	0.3122	0.3238	rs6668968						
1	154293736	154293739	GGTA	-	exonic	AQP10		frameshift deletion	AQP10:NM_080429:exon1:c.105_105del:p.M35Ifs*34	0.0152782932027765	0.878522242818559	0.106199463978665	aquaporin 10	FUNCTION: Water channel required to promote glycerol permeability and water transport across cell membranes. May contribute to water transport in the upper portion of small intestine. Isoform 2 is not permeable to urea and glycerol. {ECO:0000269|PubMed:11573934, ECO:0000269|PubMed:12084581}.; 	.	TISSUE SPECIFICITY: Expressed exclusively in duodenum and jejunum. Highest expression in absorptive epithelial cells at the tips of villi in the jejunum.; 	unclassifiable (Anatomical System);lung;liver;testis;spleen;skeletal muscle;	.	0.10780	0.10375	0.104848986	61.49445624	4035.92542	12.59512	1q21.3																								
1	156814027	156814027	G	A	exonic	INSRR		nonsynonymous SNV	INSRR:NM_014215:exon15:c.C2783T:p.P928L	4.91565760465697e-07	0.999920299072368	7.92093618710879e-05	insulin receptor-related receptor	FUNCTION: Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. {ECO:0000269|PubMed:21641549}.; 	.	.	.	.	0.62339	0.19592	-2.250890405	1.279782968	1815.11428	7.85768	1q23.1		0.1680	0.2461	0.1710	0.1154	0.1141	0.1613	0.1330	0.1953	0.1709	0.2398	0.1722	0.1689	0.1062	0.1149	0.1527	0.1408	rs56252149						
1	156814053	156814053	C	-	exonic	INSRR		frameshift deletion	INSRR:NM_014215:exon15:c.2757delG:p.L920Cfs*37	4.91565760465697e-07	0.999920299072368	7.92093618710879e-05	insulin receptor-related receptor	FUNCTION: Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. {ECO:0000269|PubMed:21641549}.; 	.	.	.	.	0.62339	0.19592	-2.250890405	1.279782968	1815.11428	7.85768	1q23.1	ID=COSM206896,COSM206897;OCCURENCE=1(large_intestine)	8.293e-06	0	0	0	0	1.507e-05	0	0									rs772259106						
1	156814063	156814065	TCC	-	exonic	INSRR		nonframeshift deletion	INSRR:NM_014215:exon15:c.2745_2747del:p.E915Dfs*383	4.91565760465697e-07	0.999920299072368	7.92093618710879e-05	insulin receptor-related receptor	FUNCTION: Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. {ECO:0000269|PubMed:21641549}.; 	.	.	.	.	0.62339	0.19592	-2.250890405	1.279782968	1815.11428	7.85768	1q23.1																								
1	176857309	176857309	-	AG	exonic	ASTN1		frameshift insertion	ASTN1:NM_001286164:exon18:c.2971_2972insCT:p.W991Sfs*37,ASTN1:NM_004319:exon18:c.2971_2972insCT:p.W991Sfs*37,ASTN1:NM_207108:exon18:c.2971_2972insCT:p.W991Sfs*37	0.999415997291979	0.000584002707053689	9.67762336583381e-13	astrotactin 1	FUNCTION: Neuronal adhesion molecule that is required for glial- guided migration of young postmitotic neuroblasts in cortical regions of developing brain, including cerebrum, hippocampus, cerebellum and olfactory bulb.; 	.	.	unclassifiable (Anatomical System);heart;ovary;hypothalamus;sympathetic chain;adrenal cortex;fovea centralis;choroid;lens;skeletal muscle;skin;retina;uterus;optic nerve;whole body;lung;frontal lobe;bone;macula lutea;visual apparatus;hippocampus;testis;brain;	amygdala;dorsal root ganglion;whole brain;medulla oblongata;superior cervical ganglion;thalamus;occipital lobe;cerebellum peduncles;hypothalamus;temporal lobe;pons;caudate nucleus;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.12514	0.11666	-1.095046929	6.97688134	570.07336	4.84399	1q25.2																								
1	211533371	211533371	-	A	exonic	TRAF5		frameshift insertion	TRAF5:NM_001033910:exon5:c.497dupA:p.C168Mfs*17,TRAF5:NM_001319207:exon5:c.530dupA:p.C179Mfs*17,TRAF5:NM_004619:exon5:c.497dupA:p.C168Mfs*17,TRAF5:NM_145759:exon5:c.497dupA:p.C168Mfs*17	8.829041147296e-06	0.925326371922777	0.0746647990360753	TNF receptor associated factor 5	FUNCTION: Adapter protein and signal transducer that links members of the tumor necrosis factor receptor family to different signaling pathways by association with the receptor cytoplasmic domain and kinases. Mediates activation of NF-kappa-B and probably JNK. Seems to be involved in apoptosis. Plays a role in mediating activation of NF-kappa-B by EIF2AK2/PKR. {ECO:0000269|PubMed:15121867}.; 	.	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood.; 	smooth muscle;colon;parathyroid;skin;uterus;prostate;endometrium;larynx;testis;germinal center;brain;artery;unclassifiable (Anatomical System);lymph node;islets of Langerhans;blood;skeletal muscle;breast;pancreas;lung;epididymis;nasopharynx;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;aorta;	.	0.08401	0.16123	-0.045835247	50.34206181	216.64914	3.18150	1q32.3																								
1	215820982	215820983	CC	-	exonic	USH2A		frameshift deletion	USH2A:NM_206933:exon67:c.14672_14673del:p.G4891Afs*62	3.68100336207458e-43	0.999989235571568	1.07644284322941e-05	Usher syndrome 2A (autosomal recessive, mild)	FUNCTION: Involved in hearing and vision.; 	DISEASE: Usher syndrome 2A (USH2A) [MIM:276901]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:10729113, ECO:0000269|PubMed:10738000, ECO:0000269|PubMed:10909849, ECO:0000269|PubMed:11311042, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12525556, ECO:0000269|PubMed:14970843, ECO:0000269|PubMed:15015129, ECO:0000269|PubMed:15025721, ECO:0000269|PubMed:15241801, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:17085681, ECO:0000269|PubMed:17405132, ECO:0000269|PubMed:18273898, ECO:0000269|PubMed:18452394, ECO:0000269|PubMed:19683999, ECO:0000269|PubMed:19737284, ECO:0000269|PubMed:20309401, ECO:0000269|PubMed:20440071, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21593743, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22004887, ECO:0000269|PubMed:23737954, ECO:0000269|PubMed:9624053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 39 (RP39) [MIM:613809]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10775529, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12427073, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:16098008, ECO:0000269|PubMed:17296898, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:24227914}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Present in the basement membrane of many, but not all tissues. Expressed in retina, cochlea, small and large intestine, pancreas, bladder, prostate, esophagus, trachea, thymus, salivary glands, placenta, ovary, fallopian tube, uterus and testis. Absent in many other tissues such as heart, lung, liver, kidney and brain. In the retina, it is present in the basement membranes in the Bruch's layer choroid capillary basement membranes, where it localizes just beneath the retinal pigment epithelial cells (at protein level). Weakly expressed. Isoform 2 is expressed in fetal eye, cochlea and heart, and at very low level in brain, CNS, intestine, skeleton, tongue, kidney and lung. Isoform 2 is not expressed in stomach and liver. In adult tissues, isoform 2 is expressed in neural retina and testis, and at low level in brain, heart, kidney and liver. Isoform 1 displays a similar pattern of expression but is expressed at very low level in fetal cochlea. {ECO:0000269|PubMed:11788194, ECO:0000269|PubMed:12433396, ECO:0000269|PubMed:15015129, ECO:0000269|PubMed:9624053}.; 	unclassifiable (Anatomical System);liver;testis;retina;	dorsal root ganglion;superior cervical ganglion;adrenal gland;temporal lobe;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;cerebellum;	0.15836	.	4.179636958	99.70511913	6401.91635	16.71188	1q41																								
1	215821050	215821050	C	-	exonic	USH2A		frameshift deletion	USH2A:NM_206933:exon67:c.14605delG:p.A4869Lfs*15	3.68100336207458e-43	0.999989235571568	1.07644284322941e-05	Usher syndrome 2A (autosomal recessive, mild)	FUNCTION: Involved in hearing and vision.; 	DISEASE: Usher syndrome 2A (USH2A) [MIM:276901]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses. {ECO:0000269|PubMed:10729113, ECO:0000269|PubMed:10738000, ECO:0000269|PubMed:10909849, ECO:0000269|PubMed:11311042, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12525556, ECO:0000269|PubMed:14970843, ECO:0000269|PubMed:15015129, ECO:0000269|PubMed:15025721, ECO:0000269|PubMed:15241801, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:17085681, ECO:0000269|PubMed:17405132, ECO:0000269|PubMed:18273898, ECO:0000269|PubMed:18452394, ECO:0000269|PubMed:19683999, ECO:0000269|PubMed:19737284, ECO:0000269|PubMed:20309401, ECO:0000269|PubMed:20440071, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21593743, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22004887, ECO:0000269|PubMed:23737954, ECO:0000269|PubMed:9624053}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 39 (RP39) [MIM:613809]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10775529, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:12427073, ECO:0000269|PubMed:15325563, ECO:0000269|PubMed:16098008, ECO:0000269|PubMed:17296898, ECO:0000269|PubMed:20507924, ECO:0000269|PubMed:21686329, ECO:0000269|PubMed:22334370, ECO:0000269|PubMed:24227914}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Present in the basement membrane of many, but not all tissues. Expressed in retina, cochlea, small and large intestine, pancreas, bladder, prostate, esophagus, trachea, thymus, salivary glands, placenta, ovary, fallopian tube, uterus and testis. Absent in many other tissues such as heart, lung, liver, kidney and brain. In the retina, it is present in the basement membranes in the Bruch's layer choroid capillary basement membranes, where it localizes just beneath the retinal pigment epithelial cells (at protein level). Weakly expressed. Isoform 2 is expressed in fetal eye, cochlea and heart, and at very low level in brain, CNS, intestine, skeleton, tongue, kidney and lung. Isoform 2 is not expressed in stomach and liver. In adult tissues, isoform 2 is expressed in neural retina and testis, and at low level in brain, heart, kidney and liver. Isoform 1 displays a similar pattern of expression but is expressed at very low level in fetal cochlea. {ECO:0000269|PubMed:11788194, ECO:0000269|PubMed:12433396, ECO:0000269|PubMed:15015129, ECO:0000269|PubMed:9624053}.; 	unclassifiable (Anatomical System);liver;testis;retina;	dorsal root ganglion;superior cervical ganglion;adrenal gland;temporal lobe;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;cerebellum;	0.15836	.	4.179636958	99.70511913	6401.91635	16.71188	1q41																								
1	220300128	220300128	C	G	exonic	IARS2		nonsynonymous SNV	IARS2:NM_018060:exon14:c.C1780G:p.Q594E	0.472741795319536	0.527258129464453	7.52160107726284e-08	isoleucyl-tRNA synthetase 2, mitochondrial	.	DISEASE: Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia (CAGSSS) [MIM:616007]: An autosomal recessive disorder characterized by cataracts, short-stature secondary to growth hormone deficiency, sensorineural hearing deficit, peripheral sensory neuropathy, skeletal dysplasia, scoliosis, and facial dysmorphism. {ECO:0000269|PubMed:25130867}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;ovary;colon;skin;bone marrow;uterus;prostate;whole body;endometrium;larynx;bone;thyroid;pituitary gland;testis;dura mater;germinal center;spinal ganglion;brain;gall bladder;unclassifiable (Anatomical System);meninges;lymph node;cartilage;heart;tongue;hypothalamus;blood;lens;skeletal muscle;breast;bile duct;pia mater;lung;nasopharynx;trabecular meshwork;placenta;visual apparatus;hypopharynx;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;	amygdala;adipose tissue;testis;parietal lobe;	0.49745	0.12590	-0.929520514	9.683887709	591.48905	4.92950	1q41		0.0001	0	0	0.0021	0	0	0	0	3.231e-05	0	0	0	0.0006	0	0	0	rs151085900						
1	220383756	220383756	G	A	exonic	RAB3GAP2		nonsynonymous SNV	RAB3GAP2:NM_012414:exon7:c.C586T:p.P196S	0.99873648274446	0.00126351725552891	1.06405941098825e-14	RAB3 GTPase activating non-catalytic protein subunit 2	FUNCTION: Regulatory subunit of a GTPase activating protein that has specificity for Rab3 subfamily (RAB3A, RAB3B, RAB3C and RAB3D). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones. Rab3 GTPase-activating complex specifically converts active Rab3-GTP to the inactive form Rab3- GDP. Required for normal eye and brain development. May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non- synaptic vesicular release of neurotransmitters. {ECO:0000269|PubMed:9733780}.; 	DISEASE: Warburg micro syndrome 2 (WARBM2) [MIM:614225]: A rare syndrome characterized by microcephaly, microphthalmia, microcornia, congenital cataracts, optic atrophy, cortical dysplasia, in particular corpus callosum hypoplasia, severe mental retardation, spastic diplegia, and hypogonadism. {ECO:0000269|PubMed:20967465}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9733780}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;endometrium;bone;thyroid;pituitary gland;testis;germinal center;pineal gland;brain;tonsil;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;hypothalamus;adrenal cortex;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	subthalamic nucleus;fetal liver;occipital lobe;superior cervical ganglion;medulla oblongata;prefrontal cortex;globus pallidus;atrioventricular node;trigeminal ganglion;cingulate cortex;skeletal muscle;parietal lobe;	0.63992	0.12109	-1.080231599	7.277659825	2000.41869	8.24160	1q41																								
1	220383822	220383822	G	C	exonic	RAB3GAP2		nonsynonymous SNV	RAB3GAP2:NM_012414:exon7:c.C520G:p.L174V	0.99873648274446	0.00126351725552891	1.06405941098825e-14	RAB3 GTPase activating non-catalytic protein subunit 2	FUNCTION: Regulatory subunit of a GTPase activating protein that has specificity for Rab3 subfamily (RAB3A, RAB3B, RAB3C and RAB3D). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones. Rab3 GTPase-activating complex specifically converts active Rab3-GTP to the inactive form Rab3- GDP. Required for normal eye and brain development. May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non- synaptic vesicular release of neurotransmitters. {ECO:0000269|PubMed:9733780}.; 	DISEASE: Warburg micro syndrome 2 (WARBM2) [MIM:614225]: A rare syndrome characterized by microcephaly, microphthalmia, microcornia, congenital cataracts, optic atrophy, cortical dysplasia, in particular corpus callosum hypoplasia, severe mental retardation, spastic diplegia, and hypogonadism. {ECO:0000269|PubMed:20967465}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:9733780}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;endometrium;bone;thyroid;pituitary gland;testis;germinal center;pineal gland;brain;tonsil;unclassifiable (Anatomical System);lymph node;heart;cartilage;islets of Langerhans;hypothalamus;adrenal cortex;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	subthalamic nucleus;fetal liver;occipital lobe;superior cervical ganglion;medulla oblongata;prefrontal cortex;globus pallidus;atrioventricular node;trigeminal ganglion;cingulate cortex;skeletal muscle;parietal lobe;	0.63992	0.12109	-1.080231599	7.277659825	2000.41869	8.24160	1q41		0.0001	0	0	0.0020	0	0	0	0									rs143415462						
1	225373003	225373004	GT	-	exonic	DNAH14		frameshift deletion	DNAH14:NM_001373:exon36:c.5480_5481del:p.V1828Dfs*62	8.77000190556253e-06	0.3191763133612	0.680814916636895	dynein axonemal heavy chain 14	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);uterus;testis;colon;brain;skeletal muscle;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;globus pallidus;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.32231	0.10036	1.394519284	94.6685539	7454.49367	18.56756	1q42.12																								
1	225373016	225373016	G	-	exonic	DNAH14		frameshift deletion	DNAH14:NM_001373:exon36:c.5493delG:p.G1832Afs*18	8.77000190556253e-06	0.3191763133612	0.680814916636895	dynein axonemal heavy chain 14	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);uterus;testis;colon;brain;skeletal muscle;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;globus pallidus;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.32231	0.10036	1.394519284	94.6685539	7454.49367	18.56756	1q42.12																								
1	225373130	225373130	A	-	intronic	DNAH14				8.77000190556253e-06	0.3191763133612	0.680814916636895	dynein axonemal heavy chain 14	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);uterus;testis;colon;brain;skeletal muscle;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;globus pallidus;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.32231	0.10036	1.394519284	94.6685539	7454.49367	18.56756	1q42.12																								
1	226054323	226054323	C	T	exonic	TMEM63A		nonsynonymous SNV	TMEM63A:NM_014698:exon9:c.G626A:p.G209D	6.10813887296527e-05	0.998806637656999	0.00113228095427175	transmembrane protein 63A	FUNCTION: Acts as an osmosensitive calcium-permeable cation channel. {ECO:0000250}.; 	.	.	.	.	0.07297	.	0.584200036	82.336636	2871.4616	10.14633	1q42.12																								
1	226054333	226054333	G	A	exonic	TMEM63A		nonsynonymous SNV	TMEM63A:NM_014698:exon9:c.C616T:p.L206F	6.10813887296527e-05	0.998806637656999	0.00113228095427175	transmembrane protein 63A	FUNCTION: Acts as an osmosensitive calcium-permeable cation channel. {ECO:0000250}.; 	.	.	.	.	0.07297	.	0.584200036	82.336636	2871.4616	10.14633	1q42.12		0.1795	0.0289	0.2710	0.3244	0.1186	0.1615	0.1608	0.2329	0.1426	0.0357	0.2339	0.1490	0.3366	0.1180	0.1828	0.1673	rs45492299						
1	226054385	226054386	GA	-	intronic	TMEM63A				6.10813887296527e-05	0.998806637656999	0.00113228095427175	transmembrane protein 63A	FUNCTION: Acts as an osmosensitive calcium-permeable cation channel. {ECO:0000250}.; 	.	.	.	.	0.07297	.	0.584200036	82.336636	2871.4616	10.14633	1q42.12																								
1	226054388	226054388	A	-	intronic	TMEM63A				6.10813887296527e-05	0.998806637656999	0.00113228095427175	transmembrane protein 63A	FUNCTION: Acts as an osmosensitive calcium-permeable cation channel. {ECO:0000250}.; 	.	.	.	.	0.07297	.	0.584200036	82.336636	2871.4616	10.14633	1q42.12																								
1	228033258	228033258	T	A	exonic	PRSS38		nonsynonymous SNV	PRSS38:NM_183062:exon4:c.T671A:p.I224N	0.0302666135927824	0.924653770873147	0.0450796155340703	protease, serine 38	.	.	.	.	.	.	.	1.422020658	94.93394669	1792.01767	7.81450	1q42.13		0.0384	0.0449	0.0248	0.0370	0.0453	0.0372	0.0412	0.0466	0.0368	0.0451	0.0227	0.0132	0.0229	0.0441	0.0328	0.0389	rs61741607						
1	228033318	228033318	-	C	intronic	PRSS38				0.0302666135927824	0.924653770873147	0.0450796155340703	protease, serine 38	.	.	.	.	.	.	.	1.422020658	94.93394669	1792.01767	7.81450	1q42.13																								
1	230895258	230895258	G	T	exonic	CAPN9		nonsynonymous SNV	CAPN9:NM_006615:exon3:c.G284T:p.G95V,CAPN9:NM_016452:exon3:c.G284T:p.G95V	1.73327533297539e-11	0.805828751134411	0.194171248848256	calpain 9	FUNCTION: Calcium-regulated non-lysosomal thiol-protease.; 	.	TISSUE SPECIFICITY: Expressed predominantly in stomach.; 	unclassifiable (Anatomical System);prostate;whole body;endometrium;nasopharynx;colon;stomach;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.06312	0.09013	1.120636874	92.10309035	4397.74449	13.25652	1q42.2																								
1	230914857	230914857	-	G	exonic	CAPN9		frameshift insertion	CAPN9:NM_001319676:exon7:c.904dupG:p.C304Lfs*20,CAPN9:NM_016452:exon8:c.1015dupG:p.C341Lfs*20,CAPN9:NM_006615:exon9:c.1093dupG:p.C367Lfs*20	1.73327533297539e-11	0.805828751134411	0.194171248848256	calpain 9	FUNCTION: Calcium-regulated non-lysosomal thiol-protease.; 	.	TISSUE SPECIFICITY: Expressed predominantly in stomach.; 	unclassifiable (Anatomical System);prostate;whole body;endometrium;nasopharynx;colon;stomach;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.06312	0.09013	1.120636874	92.10309035	4397.74449	13.25652	1q42.2																								
2	10784454	10784454	A	T	exonic	NOL10		nonsynonymous SNV	NOL10:NM_001261392:exon12:c.T940A:p.Y314N,NOL10:NM_001261394:exon12:c.T868A:p.Y290N,NOL10:NM_024894:exon13:c.T1018A:p.Y340N	0.80330394780875	0.19669415444774	1.89774350966986e-06	nucleolar protein 10	.	.	.	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;endometrium;bone;thyroid;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;lacrimal gland;tongue;islets of Langerhans;blood;lens;skeletal muscle;bile duct;breast;lung;mesenchyma;nasopharynx;placenta;macula lutea;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;pons;trigeminal ganglion;	0.28400	0.09752	0.308721233	72.59966973	1681.61121	7.55777	2p25.1																								
2	10784501	10784501	A	-	intronic	NOL10				0.80330394780875	0.19669415444774	1.89774350966986e-06	nucleolar protein 10	.	.	.	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;endometrium;bone;thyroid;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;lacrimal gland;tongue;islets of Langerhans;blood;lens;skeletal muscle;bile duct;breast;lung;mesenchyma;nasopharynx;placenta;macula lutea;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;pons;trigeminal ganglion;	0.28400	0.09752	0.308721233	72.59966973	1681.61121	7.55777	2p25.1																								
2	54035508	54035508	G	C	exonic	ERLEC1		nonsynonymous SNV	ERLEC1:NM_001127397:exon9:c.G952C:p.V318L,ERLEC1:NM_015701:exon9:c.G952C:p.V318L	0.000679063416474332	0.995056886922254	0.00426404966127196	endoplasmic reticulum lectin 1	FUNCTION: Probable lectin that binds selectively to improperly folded lumenal proteins. May function in endoplasmic reticulum quality control and endoplasmic reticulum-associated degradation (ERAD) of both non-glycosylated proteins and glycoproteins. {ECO:0000269|PubMed:16531414, ECO:0000269|PubMed:18264092, ECO:0000269|PubMed:18502753}.; 	.	.	medulla oblongata;ovary;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;heart;cartilage;urinary;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;atrium;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;islets of Langerhans;bile duct;pancreas;lung;cornea;adrenal gland;placenta;hippocampus;kidney;stomach;cerebellum;	superior cervical ganglion;testis - interstitial;testis;globus pallidus;ciliary ganglion;skeletal muscle;	0.39225	0.10625	-0.690637458	15.12149092	592.52283	4.93296	2p16.2		0.0927	0.0711	0.1831	0.1872	0.0537	0.0708	0.0883	0.0980	0.0752	0.0668	0.1778	0.0861	0.1843	0.0529	0.0676	0.0733	rs2287345						
2	58316814	58316814	A	G	exonic	VRK2		nonsynonymous SNV	VRK2:NM_001288839:exon6:c.A145G:p.I49V,VRK2:NM_001130480:exon7:c.A499G:p.I167V,VRK2:NM_001130481:exon7:c.A499G:p.I167V,VRK2:NM_001130482:exon7:c.A430G:p.I144V,VRK2:NM_001130483:exon7:c.A499G:p.I167V,VRK2:NM_006296:exon7:c.A499G:p.I167V,VRK2:NM_001288836:exon8:c.A145G:p.I49V,VRK2:NM_001288838:exon9:c.A499G:p.I167V,VRK2:NM_001288837:exon10:c.A499G:p.I167V	1.21621414925507e-08	0.549410088450979	0.450589899386879	vaccinia related kinase 2	FUNCTION: Serine/threonine kinase that regulates several signal transduction pathways. Isoform 1 modulates the stress response to hypoxia and cytokines, such as interleukin-1 beta (IL1B) and this is dependent on its interaction with MAPK8IP1, which assembles mitogen-activated protein kinase (MAPK) complexes. Inhibition of signal transmission mediated by the assembly of MAPK8IP1-MAPK complexes reduces JNK phosphorylation and JUN-dependent transcription. Phosphorylates 'Thr-18' of p53/TP53, histone H3, and may also phosphorylate MAPK8IP1. Phosphorylates BANF1 and disrupts its ability to bind DNA and reduces its binding to LEM domain-containing proteins. Downregulates the transactivation of transcription induced by ERBB2, HRAS, BRAF, and MEK1. Blocks the phosphorylation of ERK in response to ERBB2 and HRAS. Can also phosphorylate the following substrates that are commonly used to establish in vitro kinase activity: casein, MBP and histone H2B, but it is not sure that this is physiologically relevant.; 	.	TISSUE SPECIFICITY: Isoform 1 and isoform 2 are expressed in various tumor cell lines. Expression of isoform 1 inversely correlates with ERBB2 in breast carcinomas (at protein level). Widely expressed. Highly expressed in fetal liver, skeletal muscle, pancreas, heart, peripheral blood leukocytes and testis. {ECO:0000269|PubMed:16704422, ECO:0000269|PubMed:20679487, ECO:0000269|PubMed:9344656}.; 	myocardium;ovary;colon;parathyroid;fovea centralis;skin;bone marrow;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;bone;thyroid;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;hypothalamus;blood;skeletal muscle;pancreas;lung;adrenal gland;nasopharynx;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;stomach;	testis - interstitial;testis - seminiferous tubule;ciliary ganglion;	0.13255	0.09620	0.066214104	58.95848077	3255.28139	10.86391	2p16.1		0.3576	0.1032	0.3303	0.4308	0.3537	0.3975	0.3631	0.3375	0.3098	0.1129	0.3301	0.4497	0.4170	0.3832	0.3886	0.3585	rs1051061						
2	71163191	71163191	-	C	exonic	ATP6V1B1		frameshift insertion	ATP6V1B1:NM_001692:exon1:c.108dupC:p.R38Pfs*45	0.000244050365843846	0.995997233947054	0.00375871568710207	ATPase H+ transporting V1 subunit B1	FUNCTION: Non-catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.; 	DISEASE: Renal tubular acidosis, distal, with progressive nerve deafness (dRTA-D) [MIM:267300]: An autosomal recessive disease characterized by the association of renal distal tubular acidosis with sensorineural hearing loss. Distal renal tubular acidosis is characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. {ECO:0000269|PubMed:12414817, ECO:0000269|PubMed:12579397, ECO:0000269|PubMed:9916796}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in the cochlea and endolymphatic sac. {ECO:0000269|PubMed:9916796}.; 	unclassifiable (Anatomical System);ovary;colon;parathyroid;fovea centralis;choroid;lens;retina;uterus;optic nerve;lung;endometrium;placenta;macula lutea;testis;spleen;kidney;brain;mammary gland;stomach;	superior cervical ganglion;kidney;atrioventricular node;skeletal muscle;	0.16583	0.32362	-0.484940685	22.75300778	4381.39275	13.20978	2p13.3																								
2	96795666	96795666	G	-	exonic	ASTL		frameshift deletion	ASTL:NM_001002036:exon8:c.771delC:p.S258Vfs*10	3.67008336651582e-05	0.822828432995594	0.177134866170741	astacin-like metallo-endopeptidase (M12 family)	FUNCTION: Oocyte-specific oolemmal receptor involved in sperm and egg adhesion and fertilization. Plays a role in the polyspermy inhibition. Probably acts as a protease for the post-fertilization cleavage of ZP2. Cleaves the sperm-binding ZP2 at the surface of the zona pellucida after fertilization and cortical granule exocytosis, rendering the zona pellucida unable to support further sperm binding (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in promyelocytic leukemia HL-60 cells, Burkitt's lymphoma Raji cells, and also in some ovarian carcinomas. Not detected in normal tissues. {ECO:0000269|PubMed:15087446}.; 	uterus;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.08019	0.09622	0.711016566	85.72776598	2406.21675	9.10932	2q11.1																								
2	97613616	97613616	T	C	exonic	FAM178B		synonymous SNV	FAM178B:NM_001122646:exon8:c.A1017G:p.T339T	8.69889482161504e-05	0.330167527293484	0.6697454837583	family with sequence similarity 178 member B	.	.	.	breast;myocardium;ovary;placenta;liver;testis;parathyroid;spleen;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;cerebellum;	.	.	0.839664339	88.29912715	1005.80053	6.10536	2q11.2		0.6310	0.9356	0.5784	0.4984	0.7482	0.7884	0.6486	0.3668	0.7970	0.9309	0.5443	0.79	0.5	0.7162	0.7869	0.7521	rs1624844						
2	98611983	98611984	AG	CA	exonic	TMEM131		nonframeshift substitution	TMEM131:NM_015348:exon1:c.142_143TG:p.L48W	0.999999482162299	5.17837701316274e-07	3.55399032522147e-20	transmembrane protein 131	FUNCTION: May play a role in the immune response to viral infection. {ECO:0000250}.; 	.	.	lymphoreticular;smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;skin;uterus;prostate;whole body;frontal lobe;cochlea;endometrium;bone;thyroid;testis;germinal center;brain;bladder;gall bladder;unclassifiable (Anatomical System);lymph node;cartilage;islets of Langerhans;pharynx;blood;skeletal muscle;breast;bile duct;lung;adrenal gland;nasopharynx;placenta;visual apparatus;alveolus;liver;spleen;head and neck;kidney;stomach;peripheral nerve;thymus;	amygdala;	0.45783	0.10928	-1.050945462	7.62561925	2067.68724	8.37853	2q11.2																								
2	111556639	111556639	A	T	exonic	ACOXL		nonsynonymous SNV	ACOXL:NM_001142807:exon7:c.A509T:p.Y170F	6.28385483611373e-10	0.400098611117413	0.599901388254202	acyl-CoA oxidase-like	.	.	.	unclassifiable (Anatomical System);islets of Langerhans;placenta;	superior cervical ganglion;ciliary ganglion;pons;trigeminal ganglion;fetal thyroid;skeletal muscle;	0.07205	0.07959	1.86668643	97.19863175	3441.02377	11.26674	2q13																								
2	111556649	111556649	C	T	exonic	ACOXL		synonymous SNV	ACOXL:NM_001142807:exon7:c.C519T:p.V173V	6.28385483611373e-10	0.400098611117413	0.599901388254202	acyl-CoA oxidase-like	.	.	.	unclassifiable (Anatomical System);islets of Langerhans;placenta;	superior cervical ganglion;ciliary ganglion;pons;trigeminal ganglion;fetal thyroid;skeletal muscle;	0.07205	0.07959	1.86668643	97.19863175	3441.02377	11.26674	2q13																								
2	111598958	111598958	C	T	exonic	ACOXL		nonsynonymous SNV	ACOXL:NM_001142807:exon10:c.C764T:p.T255M	6.28385483611373e-10	0.400098611117413	0.599901388254202	acyl-CoA oxidase-like	.	.	.	unclassifiable (Anatomical System);islets of Langerhans;placenta;	superior cervical ganglion;ciliary ganglion;pons;trigeminal ganglion;fetal thyroid;skeletal muscle;	0.07205	0.07959	1.86668643	97.19863175	3441.02377	11.26674	2q13		0.2072	0.1655	0.2604	0.1739	0.2314	0.2011	0.1831	0.2292	0.1845	0.1534	0.2100	0.2033	0.1623	0.2234	0.1924	0.2092	rs1554005						
2	120060128	120060128	A	-	intronic	C2orf76				0.00333205633699219	0.609126325636586	0.387541618026422	chromosome 2 open reading frame 76	.	.	.	unclassifiable (Anatomical System);uterus;lung;heart;liver;testis;germinal center;skin;	.	.	0.05220	0.657836546	84.27105449	35.71966	1.07429	2q14.2		0.0012	0.0001	0	0	0	1.671e-05	0.0012	0.0083	6.579e-05	0.0001	0	0	0	0	0	0.0010	rs551303723						
2	120078756	120078758	GGC	-	exonic	C2orf76		nonframeshift deletion	C2orf76:NM_001322330:exon3:c.156_158del:p.P55Ffs*72,C2orf76:NM_001322331:exon3:c.156_158del:p.P55Ffs*72,C2orf76:NM_001017927:exon4:c.156_158del:p.P55Ffs*72,C2orf76:NM_001322329:exon4:c.156_158del:p.P55Ffs*72	0.00333205633699219	0.609126325636586	0.387541618026422	chromosome 2 open reading frame 76	.	.	.	unclassifiable (Anatomical System);uterus;lung;heart;liver;testis;germinal center;skin;	.	.	0.05220	0.657836546	84.27105449	35.71966	1.07429	2q14.2																								
2	121989539	121989539	G	-	exonic	TFCP2L1		frameshift deletion	TFCP2L1:NM_014553:exon13:c.1204delC:p.H402Tfs*8	0.999192586615908	0.000807412112885351	1.27120695004053e-09	transcription factor CP2-like 1	FUNCTION: Transcriptional suppressor. May suppress UBP1-mediated transcriptional activation. Required for normal duct development in the salivary gland and kidney (By similarity). Modulates the placental expression of CYP11A1. {ECO:0000250, ECO:0000269|PubMed:10644752}.; 	.	TISSUE SPECIFICITY: Highly expressed in placental JEG-3 cells and very low levels of expression in non-steroidogenic cells. No expression was seen in adrenal NCI-H295A cells or in adrenal tissue. {ECO:0000269|PubMed:10644752}.; 	unclassifiable (Anatomical System);heart;lacrimal gland;islets of Langerhans;colon;blood;bone marrow;breast;prostate;lung;thyroid;placenta;liver;spleen;kidney;	superior cervical ganglion;ciliary ganglion;kidney;atrioventricular node;	0.12962	0.10362	-0.400392389	26.85185185	222.44013	3.22468	2q14.2																								
2	121989546	121989546	-	G	splicing	TFCP2L1	NM_014553:exon13:c.1199-2->C			0.999192586615908	0.000807412112885351	1.27120695004053e-09	transcription factor CP2-like 1	FUNCTION: Transcriptional suppressor. May suppress UBP1-mediated transcriptional activation. Required for normal duct development in the salivary gland and kidney (By similarity). Modulates the placental expression of CYP11A1. {ECO:0000250, ECO:0000269|PubMed:10644752}.; 	.	TISSUE SPECIFICITY: Highly expressed in placental JEG-3 cells and very low levels of expression in non-steroidogenic cells. No expression was seen in adrenal NCI-H295A cells or in adrenal tissue. {ECO:0000269|PubMed:10644752}.; 	unclassifiable (Anatomical System);heart;lacrimal gland;islets of Langerhans;colon;blood;bone marrow;breast;prostate;lung;thyroid;placenta;liver;spleen;kidney;	superior cervical ganglion;ciliary ganglion;kidney;atrioventricular node;	0.12962	0.10362	-0.400392389	26.85185185	222.44013	3.22468	2q14.2																								
2	138420996	138420996	A	G	exonic	THSD7B		nonsynonymous SNV	THSD7B:NM_001316349:exon26:c.A4502G:p.K1501R	5.65285413355626e-06	0.999994327459527	1.96863388907999e-08	thrombospondin type 1 domain containing 7B	.	.	.	unclassifiable (Anatomical System);lung;muscle;testis;amniotic fluid;skeletal muscle;stomach;aorta;	superior cervical ganglion;ciliary ganglion;atrioventricular node;	0.33549	0.08669	.	.	4772.07743	13.99787	2q22.1		0.6256	0.6603	0.5683	0.6025	0.6282	0.6388	0.6389	0.5921	0.5957	0.6265	0.4640	0.7152	0.5615	0.5641	0.5951	0.5751	rs10206850						
2	138421045	138421045	-	A	exonic	THSD7B		frameshift insertion	THSD7B:NM_001316349:exon26:c.4552dupA:p.A1520Sfs*2	5.65285413355626e-06	0.999994327459527	1.96863388907999e-08	thrombospondin type 1 domain containing 7B	.	.	.	unclassifiable (Anatomical System);lung;muscle;testis;amniotic fluid;skeletal muscle;stomach;aorta;	superior cervical ganglion;ciliary ganglion;atrioventricular node;	0.33549	0.08669	.	.	4772.07743	13.99787	2q22.1		2.917e-05	0	0	0	0	2.71e-05	0	9.367e-05									rs757896998						
2	138421110	138421110	T	-	exonic	THSD7B		frameshift deletion	THSD7B:NM_001316349:exon26:c.4616delT:p.F1540Lfs*15	5.65285413355626e-06	0.999994327459527	1.96863388907999e-08	thrombospondin type 1 domain containing 7B	.	.	.	unclassifiable (Anatomical System);lung;muscle;testis;amniotic fluid;skeletal muscle;stomach;aorta;	superior cervical ganglion;ciliary ganglion;atrioventricular node;	0.33549	0.08669	.	.	4772.07743	13.99787	2q22.1																								
2	165802197	165802198	AG	-	exonic	SLC38A11		frameshift deletion	SLC38A11:NM_001199148:exon3:c.101_102del:p.S34Wfs*11,SLC38A11:NM_173512:exon3:c.101_102del:p.S34Wfs*11,SLC38A11:NM_001351537:exon4:c.269_270del:p.S90Wfs*11,SLC38A11:NM_001351538:exon5:c.101_102del:p.S34Wfs*11	1.9255130084062e-06	0.445662354955709	0.554335719531282	solute carrier family 38 member 11	FUNCTION: Putative sodium-dependent amino acid/proton antiporter. {ECO:0000305}.; 	.	.	prostate;pancreas;iris;lens;brain;retina;bone marrow;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.11450	.	0.018483465	55.44939844	82.94201	1.93443	2q24.3																								
2	216264079	216264080	GA	-	intronic	FN1				0.0644415382988527	0.935558461701147	2.07475663084699e-16	fibronectin 1	FUNCTION: Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. Participates in the regulation of type I collagen deposition by osteoblasts.; 	DISEASE: Glomerulopathy with fibronectin deposits 2 (GFND2) [MIM:601894]: Genetically heterogeneous autosomal dominant disorder characterized clinically by proteinuria, microscopic hematuria, and hypertension that leads to end-stage renal failure in the second to fifth decade of life. {ECO:0000269|PubMed:18268355}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Plasma FN (soluble dimeric form) is secreted by hepatocytes. Cellular FN (dimeric or cross-linked multimeric forms), made by fibroblasts, epithelial and other cell types, is deposited as fibrils in the extracellular matrix. Ugl-Y1, Ugl-Y2 and Ugl-Y3 are found in urine. {ECO:0000269|PubMed:17614963, ECO:0000269|PubMed:3584091}.; 	ovary;colon;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cochlea;thyroid;bone;amniotic fluid;brain;unclassifiable (Anatomical System);heart;cartilage;tongue;islets of Langerhans;spinal cord;lens;skeletal muscle;breast;pancreas;lung;cornea;epididymis;placenta;trabecular meshwork;macula lutea;visual apparatus;amnion;liver;alveolus;head and neck;mammary gland;aorta;	dorsal root ganglion;superior cervical ganglion;adipose tissue;olfactory bulb;smooth muscle;heart;fetal liver;lung;trachea;placenta;liver;ciliary ganglion;fetal lung;trigeminal ganglion;	0.92203	0.99216	-2.323170444	1.18542109	825.54252	5.63214	2q35																								
2	219903200	219903201	GT	-	exonic	CFAP65		frameshift deletion	CFAP65:NM_001278296:exon3:c.58_59del:p.T20Rfs*61,CFAP65:NM_152389:exon3:c.58_59del:p.T20Rfs*61,CFAP65:NM_001278295:exon4:c.220_221del:p.T74Rfs*61,CFAP65:NM_194302:exon4:c.253_254del:p.T85Rfs*61	.	.	.	cilia and flagella associated protein 65	.	.	.	.	.	0.07665	.	-1.85098044	2.040575607	.	.	2q35																								
2	219903258	219903258	T	G	exonic	CFAP65		nonsynonymous SNV	CFAP65:NM_001278296:exon3:c.A1C:p.M1L,CFAP65:NM_152389:exon3:c.A1C:p.M1L,CFAP65:NM_001278295:exon4:c.A163C:p.M55L,CFAP65:NM_194302:exon4:c.A196C:p.M66L	.	.	.	cilia and flagella associated protein 65	.	.	.	.	.	0.07665	.	-1.85098044	2.040575607	.	.	2q35		0.6993	0.5650	0.6071	0.4350	0.8392	0.7697	0.7190	0.6442	0.6976	0.5656	0.6627	0.7053	0.4478	0.8307	0.7694	0.7383	rs6736922						
2	227968772	227968775	AAAA	-	intronic	COL4A4				1.68977859995688e-08	0.999999295867498	6.87234715642658e-07	collagen type IV alpha 4	FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen.; 	DISEASE: Alport syndrome, autosomal recessive (APSAR) [MIM:203780]: A syndrome characterized by progressive glomerulonephritis, glomerular basement membrane defects, renal failure, sensorineural deafness and specific eye abnormalities (lenticonous and macular flecks). The disorder shows considerable heterogeneity in that families differ in the age of end-stage renal disease and the occurrence of deafness. {ECO:0000269|PubMed:7987396, ECO:0000269|PubMed:9792860}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hematuria, benign familial (BFH) [MIM:141200]: An autosomal dominant condition characterized by non-progressive isolated microscopic hematuria that does not result in renal failure. It is characterized pathologically by thinning of the glomerular basement membrane. {ECO:0000269|PubMed:11961012, ECO:0000269|PubMed:12631110, ECO:0000269|PubMed:8787673}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Alpha 3 and alpha 4 type IV collagens are colocalized and present in kidney, eye, basement membranes of lens capsule, cochlea, lung, skeletal muscle, aorta, synaptic fibers, fetal kidney and fetal lung. PubMed:8083201 reports similar levels of expression of alpha 3 and alpha 4 type IV collagens in kidney, but PubMed:7523402 reports that in kidney levels of alpha 3 type IV collagen are significantly lower than those of alpha 4 type IV collagen. Highest levels of expression of alpha 4 type IV collagen are detected in kidney, calvaria, neuroretina and cardiac muscle. Lower levels of expression are observed in brain, lung and thymus, and no expression is detected in choroid plexus, liver, adrenal, pancreas, ileum or skin. {ECO:0000269|PubMed:7523402, ECO:0000269|PubMed:8083201}.; 	unclassifiable (Anatomical System);pancreas;lung;nasopharynx;macula lutea;visual apparatus;pituitary gland;liver;spleen;blood;fovea centralis;kidney;germinal center;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;medulla oblongata;appendix;globus pallidus;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.09807	0.24901	1.041609675	91.26562869	4900.23196	14.26220	2q36.3																								
2	228230836	228230836	T	C	exonic	TM4SF20		nonsynonymous SNV	TM4SF20:NM_024795:exon3:c.A374G:p.N125S	2.18814392829867e-06	0.153947019827756	0.846050792028315	transmembrane 4 L six family member 20	.	.	TISSUE SPECIFICITY: Expressed in the brain, with high levels in the parietal lobe, hippocampus, pons, white matter and cerebellum. {ECO:0000269|PubMed:23810381}.; 	colon;blood;kidney;skeletal muscle;stomach;	superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.11504	0.08353	0.705562627	85.52724699	96.59184	2.12324	2q36.3		0.0286	0.1163	0.0093	0.1410	0.0429	0.0045	0.0200	0.0201	0.0462	0.1109	0.0143	0.0099	0.1452	0.0341	0.0047	0.0244	rs80305648						
2	231149062	231149063	AA	-	exonic	SP140		frameshift deletion	SP140:NM_001278453:exon13:c.1158_1159del:p.K388Efs*20,SP140:NM_001278452:exon14:c.1320_1321del:p.K442Efs*20,SP140:NM_001278451:exon15:c.1419_1420del:p.K475Efs*20,SP140:NM_007237:exon16:c.1500_1501del:p.K502Efs*20	1.99687363350876e-08	0.998412016087812	0.00158796394345159	SP140 nuclear body protein	FUNCTION: Component of the nuclear body, also known as nuclear domain 10, PML oncogenic domain, and KR body (PubMed:8910577). May be involved in the pathogenesis of acute promyelocytic leukemia and viral infection (PubMed:8910577). May play a role in chromatin-mediated regulation of gene expression although it does not bind to histone H3 tails (PubMed:24267382). {ECO:0000269|PubMed:24267382, ECO:0000269|PubMed:8910577, ECO:0000303|PubMed:8910577}.; 	.	TISSUE SPECIFICITY: High levels in spleen and peripheral blood leukocytes, much lower levels in tonsils, thymus, prostate, ovary, small intestine, and colon (PubMed:8695863, PubMed:8910577.) Very low levels in heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas (PubMed:8910577). Not detected in brain, liver and muscle (PubMed:8695863). {ECO:0000269|PubMed:8695863, ECO:0000269|PubMed:8910577}.; 	unclassifiable (Anatomical System);lymph node;ovary;salivary gland;intestine;pharynx;colon;blood;skin;bone marrow;breast;prostate;lung;nasopharynx;visual apparatus;liver;testis;spleen;germinal center;kidney;mammary gland;brain;bladder;tonsil;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.02782	0.06218	0.316000233	72.80018872	737.24204	5.38969	2q37.1																								
2	231149087	231149092	AGAATG	-	exonic	SP140		nonframeshift deletion	SP140:NM_001278453:exon13:c.1183_1188del:p.M398Rfs*355,SP140:NM_001278452:exon14:c.1345_1350del:p.M452Rfs*355,SP140:NM_001278451:exon15:c.1444_1449del:p.M485Rfs*355,SP140:NM_007237:exon16:c.1525_1530del:p.M512Rfs*355	1.99687363350876e-08	0.998412016087812	0.00158796394345159	SP140 nuclear body protein	FUNCTION: Component of the nuclear body, also known as nuclear domain 10, PML oncogenic domain, and KR body (PubMed:8910577). May be involved in the pathogenesis of acute promyelocytic leukemia and viral infection (PubMed:8910577). May play a role in chromatin-mediated regulation of gene expression although it does not bind to histone H3 tails (PubMed:24267382). {ECO:0000269|PubMed:24267382, ECO:0000269|PubMed:8910577, ECO:0000303|PubMed:8910577}.; 	.	TISSUE SPECIFICITY: High levels in spleen and peripheral blood leukocytes, much lower levels in tonsils, thymus, prostate, ovary, small intestine, and colon (PubMed:8695863, PubMed:8910577.) Very low levels in heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas (PubMed:8910577). Not detected in brain, liver and muscle (PubMed:8695863). {ECO:0000269|PubMed:8695863, ECO:0000269|PubMed:8910577}.; 	unclassifiable (Anatomical System);lymph node;ovary;salivary gland;intestine;pharynx;colon;blood;skin;bone marrow;breast;prostate;lung;nasopharynx;visual apparatus;liver;testis;spleen;germinal center;kidney;mammary gland;brain;bladder;tonsil;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.02782	0.06218	0.316000233	72.80018872	737.24204	5.38969	2q37.1																								
2	231406680	231406680	T	C	exonic	SP100		nonsynonymous SNV	SP100:NM_001080391:exon28:c.T2477C:p.M826T	8.71376355676682e-07	0.999964307615292	3.48210083517976e-05	SP100 nuclear antigen	FUNCTION: Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to PubMed:11909962. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to PubMed:15247905. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53- mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation. {ECO:0000269|PubMed:11909962, ECO:0000269|PubMed:14647468, ECO:0000269|PubMed:15247905, ECO:0000269|PubMed:15592518, ECO:0000269|PubMed:15767676, ECO:0000269|PubMed:16177824, ECO:0000269|PubMed:17245429, ECO:0000269|PubMed:21274506, ECO:0000269|PubMed:21880768}.; 	.	TISSUE SPECIFICITY: Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.; 	smooth muscle;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;larynx;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;pharynx;blood;lens;breast;bile duct;lung;cornea;nasopharynx;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	testis - interstitial;superior cervical ganglion;smooth muscle;lymph node;appendix;ciliary ganglion;white blood cells;atrioventricular node;whole blood;skeletal muscle;tonsil;	0.76267	.	0.229636184	68.56569946	106.53399	2.24030	2q37.1		0.7995	0.7510	0.6459	0.4564	0.8341	0.8561	0.8167	0.8714	0.7966	0.7464	0.6874	0.8974	0.4437	0.8331	0.8580	0.8186	rs836237						
2	231406741	231406741	-	T	exonic	SP100		frameshift insertion	SP100:NM_001080391:exon28:c.2539dupT:p.Y848Lfs*5	8.71376355676682e-07	0.999964307615292	3.48210083517976e-05	SP100 nuclear antigen	FUNCTION: Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to PubMed:11909962. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to PubMed:15247905. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53- mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation. {ECO:0000269|PubMed:11909962, ECO:0000269|PubMed:14647468, ECO:0000269|PubMed:15247905, ECO:0000269|PubMed:15592518, ECO:0000269|PubMed:15767676, ECO:0000269|PubMed:16177824, ECO:0000269|PubMed:17245429, ECO:0000269|PubMed:21274506, ECO:0000269|PubMed:21880768}.; 	.	TISSUE SPECIFICITY: Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.; 	smooth muscle;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;larynx;bone;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;pharynx;blood;lens;breast;bile duct;lung;cornea;nasopharynx;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	testis - interstitial;superior cervical ganglion;smooth muscle;lymph node;appendix;ciliary ganglion;white blood cells;atrioventricular node;whole blood;skeletal muscle;tonsil;	0.76267	.	0.229636184	68.56569946	106.53399	2.24030	2q37.1																								
2	233659621	233659623	TGA	-	exonic	GIGYF2		nonframeshift deletion	GIGYF2:NM_001103148:exon12:c.1428_1430del:p.D478Efs*816,GIGYF2:NM_001103146:exon13:c.1446_1448del:p.D484Efs*816,GIGYF2:NM_001103147:exon15:c.1509_1511del:p.D505Efs*816,GIGYF2:NM_015575:exon15:c.1446_1448del:p.D484Efs*816	0.99999999997935	2.06501034539141e-11	4.07829157222728e-28	GRB10 interacting GYF protein 2	FUNCTION: May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling, including IGF1 and insulin receptors. {ECO:0000269|PubMed:12771153}.; 	DISEASE: Parkinson disease 11 (PARK11) [MIM:607688]: A complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:18358451}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	.	.	.	0.69759	0.11014	-1.146380093	6.334041047	981.73564	6.04956	2q37.1																								
2	238427194	238427194	T	C	exonic	MLPH		nonsynonymous SNV	MLPH:NM_001042467:exon5:c.T458C:p.L153P,MLPH:NM_001281473:exon5:c.T458C:p.L153P,MLPH:NM_024101:exon5:c.T458C:p.L153P,MLPH:NM_001281474:exon6:c.T458C:p.L153P	0.00125354964830075	0.9969698425912	0.00177660776049879	melanophilin	FUNCTION: Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor protein MYO5A. {ECO:0000269|PubMed:12062444}.; 	DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;parathyroid;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;prostate;trachea;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.49203	0.18515	0.494191824	79.62373201	636.84728	5.07635	2q37.3		0.1664	0.3664	0.0690	0.0743	0.1615	0.1715	0.1416	0.1347	0.1977	0.3394	0.0728	0.0927	0.0754	0.1383	0.1540	0.1619	rs3751109						
2	238427251	238427251	G	A	exonic	MLPH		nonsynonymous SNV	MLPH:NM_001042467:exon5:c.G515A:p.G172D,MLPH:NM_001281473:exon5:c.G515A:p.G172D,MLPH:NM_024101:exon5:c.G515A:p.G172D,MLPH:NM_001281474:exon6:c.G515A:p.G172D	0.00125354964830075	0.9969698425912	0.00177660776049879	melanophilin	FUNCTION: Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor protein MYO5A. {ECO:0000269|PubMed:12062444}.; 	DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;parathyroid;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;prostate;trachea;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.49203	0.18515	0.494191824	79.62373201	636.84728	5.07635	2q37.3		0.1566	0.3531	0.0633	0.0693	0.1481	0.1623	0.1334	0.1257	0.1977	0.3392	0.0728	0.0927	0.0753	0.1386	0.1539	0.1619	rs3751107						
2	238449096	238449098	GAG	-	exonic	MLPH		nonframeshift deletion	MLPH:NM_001281473:exon8:c.1006_1008del:p.E339Afs*142,MLPH:NM_001281474:exon8:c.781_783del:p.E264Afs*194,MLPH:NM_001042467:exon9:c.1126_1128del:p.E379Afs*194,MLPH:NM_024101:exon10:c.1210_1212del:p.E407Afs*194	0.00125354964830075	0.9969698425912	0.00177660776049879	melanophilin	FUNCTION: Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor protein MYO5A. {ECO:0000269|PubMed:12062444}.; 	DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;parathyroid;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;prostate;trachea;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.49203	0.18515	0.494191824	79.62373201	636.84728	5.07635	2q37.3																								
2	238449164	238449164	G	A	exonic	MLPH		synonymous SNV	MLPH:NM_001281473:exon8:c.G1074A:p.Q358Q,MLPH:NM_001281474:exon8:c.G849A:p.Q283Q,MLPH:NM_001042467:exon9:c.G1194A:p.Q398Q,MLPH:NM_024101:exon10:c.G1278A:p.Q426Q	0.00125354964830075	0.9969698425912	0.00177660776049879	melanophilin	FUNCTION: Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor protein MYO5A. {ECO:0000269|PubMed:12062444}.; 	DISEASE: Griscelli syndrome 3 (GS3) [MIM:609227]: Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations. {ECO:0000269|PubMed:12897212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;parathyroid;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;prostate;trachea;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.49203	0.18515	0.494191824	79.62373201	636.84728	5.07635	2q37.3																								
2	242007272	242007272	T	C	exonic	SNED1		nonsynonymous SNV	SNED1:NM_001080437:exon22:c.T3104C:p.V1035A	0.983762810114589	0.0162371897519464	1.33464568364101e-10	sushi, nidogen and EGF like domains 1	.	.	.	lymphoreticular;smooth muscle;ovary;salivary gland;sympathetic chain;colon;parathyroid;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;thyroid;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;blood;skeletal muscle;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;cerebellum;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;adipose tissue;olfactory bulb;temporal lobe;caudate nucleus;pons;atrioventricular node;fetal thyroid;skeletal muscle;skin;uterus corpus;subthalamic nucleus;globus pallidus;ciliary ganglion;trigeminal ganglion;cerebellum;	0.22403	0.13286	-1.379925048	4.364236848	4194.17391	12.86144	2q37.3																								
3	38271924	38271924	A	-	intronic	OXSR1				0.989117555735273	0.0108824144587223	2.98060046457564e-08	oxidative stress responsive 1	FUNCTION: Regulates downstream kinases in response to environmental stress. May also have a function in regulating the actin cytoskeleton. {ECO:0000269|PubMed:14707132, ECO:0000303|PubMed:14707132}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed in all tissue examined. {ECO:0000269|PubMed:10083736}.; 	ovary;sympathetic chain;colon;parathyroid;skin;uterus;prostate;frontal lobe;cochlea;endometrium;larynx;thyroid;bone;iris;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;blood;skeletal muscle;breast;pancreas;lung;placenta;liver;spleen;head and neck;cervix;kidney;stomach;peripheral nerve;cerebellum;	dorsal root ganglion;trigeminal ganglion;	0.52576	0.14445	-0.293801652	32.93819297	1902.58992	8.02351	3p22.2																								
3	52407041	52407041	C	T	exonic	DNAH1		synonymous SNV	DNAH1:NM_015512:exon44:c.C6957T:p.H2319H	4.42227332517076e-20	0.999999999998172	1.82836286627503e-12	dynein axonemal heavy chain 1	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed primarily in trachea and testis, 2 tissues containing axonemal structures. Also expressed in brain. {ECO:0000269|PubMed:11175280, ECO:0000269|PubMed:9256245}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;parathyroid;blood;skin;breast;bile duct;prostate;pancreas;optic nerve;whole body;lung;frontal lobe;thyroid;placenta;liver;testis;germinal center;kidney;brain;bladder;stomach;	superior cervical ganglion;occipital lobe;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.10314	0.12173	-0.361375728	28.63882991	4201.19407	12.89158	3p21.1		0.2896	0.0551	0.2441	0.1727	0.3555	0.3465	0.3265	0.2614	0.2452	0.0577	0.2685	0.3609	0.1556	0.3176	0.3405	0.2939	rs1546737	389641	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
3	52540804	52540804	C	-	exonic	STAB1		frameshift deletion	STAB1:NM_015136:exon18:c.1927delC:p.P644Rfs*29	2.79798765369336e-25	0.999997818126492	2.18187350760166e-06	stabilin 1	FUNCTION: Acts as a scavenger receptor for acetylated low density lipoprotein. Binds to both Gram-positive and Gram-negative bacteria and may play a role in defense against bacterial infection. When inhibited in endothelial tube formation assays, there is a marked decrease in cell-cell interactions, suggesting a role in angiogenesis. Involved in the delivery of newly synthesized CHID1/SI-CLP from the biosynthetic compartment to the endosomal/lysosomal system. {ECO:0000269|PubMed:12077138, ECO:0000269|PubMed:16357325}.; 	.	TISSUE SPECIFICITY: High levels found in spleen, lymph node, liver and placenta. Also expressed in endothelial cells. {ECO:0000269|PubMed:11829752, ECO:0000269|PubMed:12077138}.; 	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;adrenal cortex;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;aorta;	.	0.27083	0.14313	-4.124226635	0.159235669	3007.38266	10.41148	3p21.1																								
3	52540811	52540819	CCATCCTGC	-	exonic	STAB1		nonframeshift deletion	STAB1:NM_015136:exon18:c.1934_1942del:p.I649Kfs*1920	2.79798765369336e-25	0.999997818126492	2.18187350760166e-06	stabilin 1	FUNCTION: Acts as a scavenger receptor for acetylated low density lipoprotein. Binds to both Gram-positive and Gram-negative bacteria and may play a role in defense against bacterial infection. When inhibited in endothelial tube formation assays, there is a marked decrease in cell-cell interactions, suggesting a role in angiogenesis. Involved in the delivery of newly synthesized CHID1/SI-CLP from the biosynthetic compartment to the endosomal/lysosomal system. {ECO:0000269|PubMed:12077138, ECO:0000269|PubMed:16357325}.; 	.	TISSUE SPECIFICITY: High levels found in spleen, lymph node, liver and placenta. Also expressed in endothelial cells. {ECO:0000269|PubMed:11829752, ECO:0000269|PubMed:12077138}.; 	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;vein;skin;retina;bone marrow;uterus;prostate;optic nerve;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;adrenal cortex;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;aorta;	.	0.27083	0.14313	-4.124226635	0.159235669	3007.38266	10.41148	3p21.1																								
3	53164394	53164394	C	T	exonic	RFT1		nonsynonymous SNV	RFT1:NM_052859:exon1:c.G23A:p.G8D	3.17066987972078e-06	0.932935318963993	0.0670615103661272	RFT1 homolog	FUNCTION: May be involved in N-linked oligosaccharide assembly. May participate in the translocation of oligosaccharide from the cytoplasmic side to the lumenal side of the endoplasmic reticulum membrane. {ECO:0000269|PubMed:18313027}.; 	DISEASE: Congenital disorder of glycosylation 1N (CDG1N) [MIM:612015]: A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N- glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:18313027, ECO:0000269|PubMed:19701946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;ovary;sympathetic chain;colon;parathyroid;skin;uterus;prostate;endometrium;larynx;thyroid;bone;testis;germinal center;unclassifiable (Anatomical System);lymph node;cartilage;heart;blood;skeletal muscle;pancreas;lung;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;cervix;kidney;stomach;	ciliary ganglion;atrioventricular node;	0.12756	0.09586	0.088260113	60.56853031	604.63702	4.97744	3p21.1		0.0006	0	0	0.0124	0	0	0.0054	0									rs151322409						
3	56771251	56771251	A	C	exonic	ARHGEF3		nonsynonymous SNV	ARHGEF3:NM_001128616:exon8:c.T1021G:p.L341V,ARHGEF3:NM_019555:exon8:c.T1003G:p.L335V,ARHGEF3:NM_001289698:exon9:c.T1021G:p.L341V,ARHGEF3:NM_001128615:exon11:c.T1099G:p.L367V	0.991271357501421	0.00872855668707193	8.58115069685777e-08	Rho guanine nucleotide exchange factor 3	FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for RhoA and RhoB GTPases. {ECO:0000269|PubMed:12221096}.; 	.	TISSUE SPECIFICITY: Widely expressed. Highest levels are found in adult brain and skeletal muscle. Lower levels are found in heart and kidney. {ECO:0000269|PubMed:10873612, ECO:0000269|PubMed:12221096}.; 	smooth muscle;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;cerebral cortex;endometrium;bone;thyroid;testis;brain;pineal gland;tonsil;unclassifiable (Anatomical System);cartilage;heart;lacrimal gland;islets of Langerhans;spinal cord;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;hippocampus;liver;spleen;cervix;kidney;mammary gland;stomach;aorta;cerebellum;	subthalamic nucleus;globus pallidus;cingulate cortex;	0.32682	0.12378	-0.290161348	33.33923095	2959.45549	10.30538	3p14.3		0.3413	0.5243	0.5248	0.4295	0.2845	0.2913	0.3106	0.2775	0.3757	0.5190	0.5060	0.2682	0.4620	0.2870	0.3033	0.3053	rs3772219						ID=CM167853;CLASS=DP;MUT=ALT;GENE=ARHGEF3;STRAND=-;DNA=NM_001128615.1:c.1099T>G;PROT=NP_001122087.1:p.L367V;DB=rs3772219;PHEN="Reduced_aemoglobin_and_haematocrit_levels";RANKSCORE=0.1
3	122646828	122646828	A	G	exonic	SEMA5B		nonsynonymous SNV	SEMA5B:NM_001256348:exon7:c.T485C:p.I162T,SEMA5B:NM_001031702:exon8:c.T659C:p.I220T,SEMA5B:NM_001256346:exon8:c.T659C:p.I220T,SEMA5B:NM_001256347:exon8:c.T821C:p.I274T	0.00033149979824729	0.999648260065092	2.02401366607334e-05	semaphorin 5B	FUNCTION: May act as positive axonal guidance cues. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);ovary;tongue;colon;parathyroid;fovea centralis;choroid;lens;retina;uterus;breast;optic nerve;lung;frontal lobe;placenta;macula lutea;visual apparatus;testis;head and neck;kidney;brain;	.	0.71231	0.10725	-0.453812624	23.73201227	2905.53502	10.22279	3q21.1		0.1403	0.1585	0.1170	0.0565	0.0936	0.1563	0.1618	0.1451	0.1350	0.1619	0.1232	0.1433	0.0512	0.0914	0.1396	0.1286	rs2276774						
3	122646845	122646845	C	-	exonic	SEMA5B		frameshift deletion	SEMA5B:NM_001256348:exon7:c.468delG:p.N157Tfs*126,SEMA5B:NM_001031702:exon8:c.642delG:p.N215Tfs*126,SEMA5B:NM_001256346:exon8:c.642delG:p.N215Tfs*126,SEMA5B:NM_001256347:exon8:c.804delG:p.N269Tfs*126	0.00033149979824729	0.999648260065092	2.02401366607334e-05	semaphorin 5B	FUNCTION: May act as positive axonal guidance cues. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);ovary;tongue;colon;parathyroid;fovea centralis;choroid;lens;retina;uterus;breast;optic nerve;lung;frontal lobe;placenta;macula lutea;visual apparatus;testis;head and neck;kidney;brain;	.	0.71231	0.10725	-0.453812624	23.73201227	2905.53502	10.22279	3q21.1		9.041e-06	0	0	0	0	1.569e-05	0	0									rs779113397						
3	123946836	123946836	G	T	splicing	KALRN	NM_001322992:exon2:c.68-1G>T;NM_001322988:exon2:c.68-1G>T;NM_001322990:exon2:c.68-1G>T;NM_001322991:exon2:c.68-1G>T;NM_003947:exon2:c.68-1G>T;NM_001322989:exon2:c.68-1G>T;NM_001024660:exon2:c.68-1G>T			0.999996915329978	3.08467002159339e-06	5.55409347529539e-19	kalirin, RhoGEF kinase	FUNCTION: Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity. {ECO:0000269|PubMed:10023074}.; 	DISEASE: Coronary heart disease 5 (CHDS5) [MIM:608901]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:17357071}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform 2 is brain specific. Highly expressed in cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus. Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed in skeletal muscle. {ECO:0000269|PubMed:10023074}.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;optic nerve;frontal lobe;cochlea;oesophagus;endometrium;thyroid;pituitary gland;iris;testis;ciliary body;brain;amygdala;unclassifiable (Anatomical System);heart;tongue;hypothalamus;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;head and neck;spleen;kidney;mammary gland;stomach;	whole brain;amygdala;superior cervical ganglion;medulla oblongata;occipital lobe;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;	0.66718	.	-3.651326374	0.271290399	881.44733	5.78506	3q21.2																								
3	123946837	123946837	G	T	exonic	KALRN		nonsynonymous SNV	KALRN:NM_001024660:exon2:c.G68T:p.G23V,KALRN:NM_001322988:exon2:c.G68T:p.G23V,KALRN:NM_001322989:exon2:c.G68T:p.G23V,KALRN:NM_001322990:exon2:c.G68T:p.G23V,KALRN:NM_001322991:exon2:c.G68T:p.G23V,KALRN:NM_001322992:exon2:c.G68T:p.G23V,KALRN:NM_003947:exon2:c.G68T:p.G23V	0.999996915329978	3.08467002159339e-06	5.55409347529539e-19	kalirin, RhoGEF kinase	FUNCTION: Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity. {ECO:0000269|PubMed:10023074}.; 	DISEASE: Coronary heart disease 5 (CHDS5) [MIM:608901]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:17357071}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform 2 is brain specific. Highly expressed in cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus. Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed in skeletal muscle. {ECO:0000269|PubMed:10023074}.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;optic nerve;frontal lobe;cochlea;oesophagus;endometrium;thyroid;pituitary gland;iris;testis;ciliary body;brain;amygdala;unclassifiable (Anatomical System);heart;tongue;hypothalamus;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;head and neck;spleen;kidney;mammary gland;stomach;	whole brain;amygdala;superior cervical ganglion;medulla oblongata;occipital lobe;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;	0.66718	.	-3.651326374	0.271290399	881.44733	5.78506	3q21.2																								
3	123946840	123946840	C	T	exonic	KALRN		nonsynonymous SNV	KALRN:NM_001024660:exon2:c.C71T:p.S24F,KALRN:NM_001322988:exon2:c.C71T:p.S24F,KALRN:NM_001322989:exon2:c.C71T:p.S24F,KALRN:NM_001322990:exon2:c.C71T:p.S24F,KALRN:NM_001322991:exon2:c.C71T:p.S24F,KALRN:NM_001322992:exon2:c.C71T:p.S24F,KALRN:NM_003947:exon2:c.C71T:p.S24F	0.999996915329978	3.08467002159339e-06	5.55409347529539e-19	kalirin, RhoGEF kinase	FUNCTION: Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity. {ECO:0000269|PubMed:10023074}.; 	DISEASE: Coronary heart disease 5 (CHDS5) [MIM:608901]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:17357071}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform 2 is brain specific. Highly expressed in cerebral cortex, putamen, amygdala, hippocampus and caudate nucleus. Weakly expressed in brain stem and cerebellum. Isoform 4 is expressed in skeletal muscle. {ECO:0000269|PubMed:10023074}.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;optic nerve;frontal lobe;cochlea;oesophagus;endometrium;thyroid;pituitary gland;iris;testis;ciliary body;brain;amygdala;unclassifiable (Anatomical System);heart;tongue;hypothalamus;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;head and neck;spleen;kidney;mammary gland;stomach;	whole brain;amygdala;superior cervical ganglion;medulla oblongata;occipital lobe;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;subthalamic nucleus;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;	0.66718	.	-3.651326374	0.271290399	881.44733	5.78506	3q21.2																								
3	125856775	125856776	CA	-	exonic	ALDH1L1		stopgain	ALDH1L1:NM_001270365:exon8:c.801_802del:p.C267*,ALDH1L1:NM_001270364:exon10:c.1134_1135del:p.C378*,ALDH1L1:NM_012190:exon10:c.1104_1105del:p.C368*	9.61783695417292e-06	0.999330570126497	0.000659812036549155	aldehyde dehydrogenase 1 family member L1	.	.	TISSUE SPECIFICITY: Highly expressed in liver, pancreas and kidney. {ECO:0000269|PubMed:20498374}.; 	medulla oblongata;ovary;colon;fovea centralis;choroid;retina;prostate;optic nerve;thyroid;bone;testis;spinal ganglion;bladder;brain;unclassifiable (Anatomical System);hypothalamus;adrenal cortex;lens;skeletal muscle;lung;nasopharynx;macula lutea;hippocampus;visual apparatus;liver;spleen;kidney;mammary gland;stomach;	superior cervical ganglion;adipose tissue;liver;kidney;trigeminal ganglion;	0.13532	0.19904	-0.163564105	40.68176457	5265.95607	14.98933	3q21.3																								
3	125856796	125856796	C	-	exonic	ALDH1L1		frameshift deletion	ALDH1L1:NM_001270365:exon8:c.781delG:p.E261Rfs*3,ALDH1L1:NM_001270364:exon10:c.1114delG:p.E372Rfs*3,ALDH1L1:NM_012190:exon10:c.1084delG:p.E362Rfs*3	9.61783695417292e-06	0.999330570126497	0.000659812036549155	aldehyde dehydrogenase 1 family member L1	.	.	TISSUE SPECIFICITY: Highly expressed in liver, pancreas and kidney. {ECO:0000269|PubMed:20498374}.; 	medulla oblongata;ovary;colon;fovea centralis;choroid;retina;prostate;optic nerve;thyroid;bone;testis;spinal ganglion;bladder;brain;unclassifiable (Anatomical System);hypothalamus;adrenal cortex;lens;skeletal muscle;lung;nasopharynx;macula lutea;hippocampus;visual apparatus;liver;spleen;kidney;mammary gland;stomach;	superior cervical ganglion;adipose tissue;liver;kidney;trigeminal ganglion;	0.13532	0.19904	-0.163564105	40.68176457	5265.95607	14.98933	3q21.3																								
3	129297258	129297258	G	-	exonic	PLXND1		frameshift deletion	PLXND1:NM_015103:exon9:c.2260delC:p.R754Gfs*48	0.999989724505468	1.02754945324598e-05	5.14607321368707e-17	plexin D1	FUNCTION: Cell surface receptor for SEMA4A and for class 3 semaphorins, such as SEMA3A, SEMA3C and SEMA3E. Plays an important role in cell-cell signaling, and in regulating the migration of a wide spectrum of cell types. Regulates the migration of thymocytes in the medulla. Regulates endothelial cell migration. Plays an important role in ensuring the specificity of synapse formation. Required for normal development of the heart and vasculature (By similarity). Mediates anti-angiogenic signaling in response to SEMA3E. {ECO:0000250, ECO:0000269|PubMed:20385769}.; 	.	TISSUE SPECIFICITY: Detected at low levels in heart, placenta, lung, skeletal muscle, kidney, thymus and liver. Detected at very low levels in brain, colon, spleen, small intestine and peripheral blood leukocytes. {ECO:0000269|PubMed:12412018}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cerebral cortex;endometrium;bone;thyroid;pituitary gland;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;muscle;blood;lens;breast;pancreas;lung;epididymis;placenta;macula lutea;visual apparatus;liver;hypopharynx;alveolus;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;thymus;	placenta;	0.15642	0.12590	-1.306585655	4.883227176	2739.76702	9.86834	3q22.1																								
3	129694857	129694857	G	-	exonic	TRH		frameshift deletion	TRH:NM_007117:exon2:c.198delG:p.G67Vfs*63	0.0108069146502521	0.834946658331332	0.154246427018416	thyrotropin releasing hormone	FUNCTION: Functions as a regulator of the biosynthesis of TSH in the anterior pituitary gland and as a neurotransmitter/ neuromodulator in the central and peripheral nervous systems. May promote hair shaft elongation, prolonge the hair cycle growth phase (anagen) and antagonized its termination by TGFB2. May also increase proliferation and inhibited apoptosis of hair matrix keratinocytes. {ECO:0000269|PubMed:19825978}.; 	.	TISSUE SPECIFICITY: Hypothalamus. Expressed in the hair follicle epithelium (at protein level). {ECO:0000269|PubMed:19825978}.; 	unclassifiable (Anatomical System);optic nerve;lung;macula lutea;visual apparatus;fovea centralis;brain;pineal gland;	superior cervical ganglion;hypothalamus;ciliary ganglion;trigeminal ganglion;cingulate cortex;skeletal muscle;	0.17607	0.27198	0.018483465	55.44939844	1442.66377	7.08353	3q22.1																								
3	183432983	183432983	C	T	exonic	YEATS2		synonymous SNV	YEATS2:NM_001351369:exon2:c.C33T:p.T11T,YEATS2:NM_001351370:exon2:c.C33T:p.T11T,YEATS2:NM_001351371:exon2:c.C33T:p.T11T,YEATS2:NM_018023:exon2:c.C33T:p.T11T	0.999977828893892	2.21711061079428e-05	3.34975296171863e-16	YEATS domain containing 2	FUNCTION: Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. {ECO:0000269|PubMed:19103755}.; 	.	.	myocardium;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;heart;muscle;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;visual apparatus;head and neck;aorta;stomach;peripheral nerve;	.	0.11833	0.10042	-1.076610636	7.324840764	4718.02584	13.86609	3q27.1		0.1759	0.1554	0.3295	0.3089	0.1543	0.1525	0.1878	0.1130	0.1758	0.1644	0.2947	0.1490	0.3149	0.1590	0.1649	0.1786	rs3736535						
3	183754625	183754625	-	A	exonic	HTR3D		frameshift insertion	HTR3D:NM_001145143:exon5:c.458dupA:p.R155Kfs*10,HTR3D:NM_001163646:exon5:c.602dupA:p.R203Kfs*10	2.59130296079301e-06	0.168847484971448	0.831149923725591	5-hydroxytryptamine receptor 3D	FUNCTION: This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor is a ligand-gated ion channel, which when activated causes fast, depolarizing responses. It is a cation-specific, but otherwise relatively nonselective, ion channel.; 	.	TISSUE SPECIFICITY: Expressed in liver, as well as fetal and adult colon and kidney. {ECO:0000269|PubMed:12801637}.; 	.	.	0.15779	.	2.50993317	98.66124086	1802.49556	7.83334	3q27.1																								
3	183953972	183953972	G	A	exonic	VWA5B2		synonymous SNV	VWA5B2:NM_001320373:exon6:c.G477A:p.P159P,VWA5B2:NM_138345:exon8:c.G1134A:p.P378P	0.354623648336578	0.48351541635271	0.161860935310712	von Willebrand factor A domain containing 5B2	.	.	.	lung;frontal lobe;adrenal gland;islets of Langerhans;hypothalamus;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;trigeminal ganglion;	.	0.09778	1.372468937	94.48572777	4139.22838	12.76384	3q27.1		0.2102	0.1536	0.1675	0.2572	0.35	0.2089	0.25	0.2219	0.1951	0.1586	0.1862	0.1589	0.1815	0.1957	0.2189	0.1945	rs1709657						
4	7857230	7857230	C	T	exonic	AFAP1		synonymous SNV	AFAP1:NM_001134647:exon4:c.G297A:p.P99P,AFAP1:NM_198595:exon4:c.G297A:p.P99P	0.376071779661091	0.623909220708965	1.89996299440042e-05	actin filament associated protein 1	FUNCTION: Can cross-link actin filaments into both network and bundle structures (By similarity). May modulate changes in actin filament integrity and induce lamellipodia formation. May function as an adapter molecule that links other proteins, such as SRC and PKC to the actin cytoskeleton. Seems to play a role in the development and progression of prostate adenocarcinoma by regulating cell-matrix adhesions and migration in the cancer cells. {ECO:0000250, ECO:0000269|PubMed:15485829}.; 	.	TISSUE SPECIFICITY: Low expression in normal breast epithelial cell line MCF-10A and in tumorigenic breast cancer cell lines MCF- 7, T-47D and ZR-75-1. Highly expressed in the invasive breast cancer cell lines MDA-MB-231 and MDA-MB-435. Overexpressed in prostate carcinoma. {ECO:0000269|PubMed:17520695, ECO:0000269|PubMed:17885682}.; 	medulla oblongata;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;placenta;visual apparatus;hippocampus;liver;amnion;head and neck;cervix;kidney;mammary gland;stomach;aorta;cerebellum;	trigeminal ganglion;	0.14735	.	-1.964136947	1.840056617	1928.06896	8.08165	4p16.1		0.3248	0.0939	0.1904	0.0707	0.4131	0.4421	0.3322	0.1825	0.3133	0.0984	0.2339	0.4139	0.0667	0.4164	0.4403	0.3612	rs61742221						
4	7857258	7857261	GGGA	-	exonic	AFAP1		frameshift deletion	AFAP1:NM_001134647:exon4:c.266_269del:p.L89Qfs*11,AFAP1:NM_198595:exon4:c.266_269del:p.L89Qfs*11	0.376071779661091	0.623909220708965	1.89996299440042e-05	actin filament associated protein 1	FUNCTION: Can cross-link actin filaments into both network and bundle structures (By similarity). May modulate changes in actin filament integrity and induce lamellipodia formation. May function as an adapter molecule that links other proteins, such as SRC and PKC to the actin cytoskeleton. Seems to play a role in the development and progression of prostate adenocarcinoma by regulating cell-matrix adhesions and migration in the cancer cells. {ECO:0000250, ECO:0000269|PubMed:15485829}.; 	.	TISSUE SPECIFICITY: Low expression in normal breast epithelial cell line MCF-10A and in tumorigenic breast cancer cell lines MCF- 7, T-47D and ZR-75-1. Highly expressed in the invasive breast cancer cell lines MDA-MB-231 and MDA-MB-435. Overexpressed in prostate carcinoma. {ECO:0000269|PubMed:17520695, ECO:0000269|PubMed:17885682}.; 	medulla oblongata;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;placenta;visual apparatus;hippocampus;liver;amnion;head and neck;cervix;kidney;mammary gland;stomach;aorta;cerebellum;	trigeminal ganglion;	0.14735	.	-1.964136947	1.840056617	1928.06896	8.08165	4p16.1																								
4	8454712	8454712	-	G	exonic	TRMT44		frameshift insertion	TRMT44:NM_001350233:exon5:c.405dupG:p.H137Afs*7,TRMT44:NM_152544:exon5:c.1128dupG:p.H378Afs*7	1.47758486898954e-13	0.00688575851656005	0.993114241483292	tRNA methyltransferase 44 homolog (S. cerevisiae)	FUNCTION: Probable adenosyl-L-methionine (AdoMet)-dependent tRNA (uracil-O(2)-)-methyltransferase. {ECO:0000250}.; 	.	.	.	.	0.11127	0.07994	.	.	301.17928	3.69794	4p16.1																								
4	56847443	56847443	-	C	exonic	CEP135		frameshift insertion	CEP135:NM_025009:exon13:c.1678dupC:p.H561Pfs*2	4.85411343707254e-17	0.972516179714832	0.0274838202851676	centrosomal protein 135kDa	FUNCTION: Centrosomal protein involved in centriole biogenesis. Acts as a scaffolding protein during early centriole biogenesis. Also required for centriole-centriole cohesion during interphase by acting as a platform protein for CEP250 at the centriole. {ECO:0000269|PubMed:17681131, ECO:0000269|PubMed:18851962}.; 	DISEASE: Microcephaly 8, primary, autosomal recessive (MCPH8) [MIM:614673]: A disease defined as a head circumference more than 3 standard deviations below the age-related mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. Despite this marked reduction in size, the gyral pattern is relatively well preserved, with no major abnormality in cortical architecture. Affected individuals are mentally retarded. Primary microcephaly is further defined by the absence of other syndromic features or significant neurological deficits due to degenerative brain disorder. {ECO:0000269|PubMed:22521416}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);cartilage;heart;ovary;fovea centralis;vein;skin;skeletal muscle;breast;uterus;lung;cochlea;mesenchyma;bone;thyroid;placenta;macula lutea;liver;testis;head and neck;spleen;germinal center;peripheral nerve;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;temporal lobe;globus pallidus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.65762	0.11694	0.433520496	77.34725171	248.14339	3.39550	4q12																								
4	68497629	68497629	A	-	intronic	UBA6				0.932317516582033	0.0676824832269061	1.91060637703788e-10	ubiquitin like modifier activating enzyme 6	FUNCTION: Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin- E1 thioester and free AMP. Specific for ubiquitin, does not activate ubiquitin-like peptides. Differs from UBE1 in its specificity for substrate E2 charging. Does not charge cell cycle E2s, such as CDC34. Essential for embryonic development. Required for UBD/FAT10 conjugation. Isoform 2 may play a key role in ubiquitin system and may influence spermatogenesis and male fertility. {ECO:0000269|PubMed:15202508, ECO:0000269|PubMed:17597759, ECO:0000269|PubMed:17889673}.; 	.	TISSUE SPECIFICITY: Widely expressed. Isoform 2 is predominantly expressed in testis with higher expression in adult testis than in fetal testis. {ECO:0000269|PubMed:15202508, ECO:0000269|PubMed:17597759}.; 	medulla oblongata;ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;ganglion;endometrium;larynx;bone;thyroid;testis;germinal center;ciliary body;brain;bladder;unclassifiable (Anatomical System);lymph node;tongue;islets of Langerhans;spinal cord;pharynx;blood;skeletal muscle;breast;pancreas;lung;adrenal gland;placenta;hypopharynx;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.41355	0.11164	-0.973616687	8.8995046	1758.06312	7.73733	4q13.2																								
4	79284800	79284801	AG	-	exonic	FRAS1		frameshift deletion	FRAS1:NM_001166133:exon21:c.2556_2557del:p.G855Sfs*3,FRAS1:NM_025074:exon21:c.2556_2557del:p.G855Sfs*3	2.28997696302965e-23	0.999999999208951	7.91049436331022e-10	Fraser extracellular matrix complex subunit 1	.	DISEASE: Fraser syndrome (FRASS) [MIM:219000]: Multisystem malformation usually comprising cryptophthalmos, cutaneous syndactyly, ear abnormalities, renal agenesis and congenital heart defects. {ECO:0000269|PubMed:23473829}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in many adult tissues, with highest levels in kidney, pancreas and thalamus. Relatively high expression was also detected in fetal kidney and heart. {ECO:0000269|PubMed:12766769}.; 	unclassifiable (Anatomical System);cartilage;heart;muscle;colon;skin;skeletal muscle;lung;frontal lobe;endometrium;adrenal gland;larynx;bone;placenta;thyroid;visual apparatus;liver;testis;head and neck;spleen;kidney;brain;mammary gland;stomach;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;pancreas;globus pallidus;ciliary ganglion;atrioventricular node;caudate nucleus;pons;trigeminal ganglion;skeletal muscle;cerebellum;	0.59318	0.10946	4.646228703	99.76999292	7813.79024	19.03935	4q21.21																								
4	84364751	84364751	A	G	exonic	HELQ		synonymous SNV	HELQ:NM_001297755:exon5:c.T1281C:p.I427I,HELQ:NM_133636:exon6:c.T1482C:p.I494I	4.80499059166513e-11	0.789098827052868	0.210901172899082	helicase, POLQ-like	FUNCTION: DNA-dependent ATPase and 5' to 3' DNA helicase. {ECO:0000269|PubMed:11751861}.; 	.	.	unclassifiable (Anatomical System);heart;islets of Langerhans;spinal cord;blood;skin;skeletal muscle;retina;bone marrow;uterus;prostate;lung;cochlea;endometrium;thyroid;liver;testis;spleen;cervix;germinal center;kidney;brain;thymus;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;appendix;globus pallidus;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;cerebellum;	.	.	1.783955458	96.85656995	1460.39054	7.12685	4q21.23		0.4668	0.4528	0.6393	0.6643	0.4669	0.4077	0.4581	0.4820	0.4518	0.4436	0.5513	0.2715	0.6749	0.4522	0.4286	0.4817	rs7665103						
4	90848955	90848955	A	-	exonic	MMRN1		stopgain	MMRN1:NM_007351:exon5:c.965delA:p.M324*	9.35082142599867e-17	0.00883523144061894	0.991164768559381	multimerin 1	FUNCTION: Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. {ECO:0000269|PubMed:16363244, ECO:0000269|PubMed:19132231, ECO:0000269|PubMed:7629143}.; 	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	TISSUE SPECIFICITY: Synthesized by endothelial cells and megakaryocytes. Stored in platelet alpha granules and endothelial cell Weibel-Palade bodies, following activation of these cells, it is released and attached to megakaryocytes, platelets, endothelium and subendothelium of blood vessels. Not found in plasma. Found in vascular tissues such as placenta, lung, and liver. {ECO:0000269|PubMed:7629143, ECO:0000269|PubMed:8514871}.; 	unclassifiable (Anatomical System);cartilage;heart;small intestine;islets of Langerhans;vein;skin;skeletal muscle;uterus;prostate;optic nerve;whole body;lung;nasopharynx;visual apparatus;duodenum;liver;testis;spleen;spinal ganglion;brain;aorta;tonsil;gall bladder;	appendix;skeletal muscle;	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	4q22.1																								
4	90848990	90848990	A	-	exonic	MMRN1		frameshift deletion	MMRN1:NM_007351:exon5:c.1000delA:p.K334Nfs*2	9.35082142599867e-17	0.00883523144061894	0.991164768559381	multimerin 1	FUNCTION: Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. {ECO:0000269|PubMed:16363244, ECO:0000269|PubMed:19132231, ECO:0000269|PubMed:7629143}.; 	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	TISSUE SPECIFICITY: Synthesized by endothelial cells and megakaryocytes. Stored in platelet alpha granules and endothelial cell Weibel-Palade bodies, following activation of these cells, it is released and attached to megakaryocytes, platelets, endothelium and subendothelium of blood vessels. Not found in plasma. Found in vascular tissues such as placenta, lung, and liver. {ECO:0000269|PubMed:7629143, ECO:0000269|PubMed:8514871}.; 	unclassifiable (Anatomical System);cartilage;heart;small intestine;islets of Langerhans;vein;skin;skeletal muscle;uterus;prostate;optic nerve;whole body;lung;nasopharynx;visual apparatus;duodenum;liver;testis;spleen;spinal ganglion;brain;aorta;tonsil;gall bladder;	appendix;skeletal muscle;	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	4q22.1																								
4	90849006	90849008	AGA	-	exonic	MMRN1		nonframeshift deletion	MMRN1:NM_007351:exon5:c.1016_1018del:p.K341Ifs*888	9.35082142599867e-17	0.00883523144061894	0.991164768559381	multimerin 1	FUNCTION: Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. {ECO:0000269|PubMed:16363244, ECO:0000269|PubMed:19132231, ECO:0000269|PubMed:7629143}.; 	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	TISSUE SPECIFICITY: Synthesized by endothelial cells and megakaryocytes. Stored in platelet alpha granules and endothelial cell Weibel-Palade bodies, following activation of these cells, it is released and attached to megakaryocytes, platelets, endothelium and subendothelium of blood vessels. Not found in plasma. Found in vascular tissues such as placenta, lung, and liver. {ECO:0000269|PubMed:7629143, ECO:0000269|PubMed:8514871}.; 	unclassifiable (Anatomical System);cartilage;heart;small intestine;islets of Langerhans;vein;skin;skeletal muscle;uterus;prostate;optic nerve;whole body;lung;nasopharynx;visual apparatus;duodenum;liver;testis;spleen;spinal ganglion;brain;aorta;tonsil;gall bladder;	appendix;skeletal muscle;	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	4q22.1																								
4	90849043	90849043	-	CGCGAATTTCGACGATC	exonic	MMRN1		frameshift insertion	MMRN1:NM_007351:exon5:c.1053_1054insCGCGAATTTCGACGATC:p.V352Rfs*7	9.35082142599867e-17	0.00883523144061894	0.991164768559381	multimerin 1	FUNCTION: Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. {ECO:0000269|PubMed:16363244, ECO:0000269|PubMed:19132231, ECO:0000269|PubMed:7629143}.; 	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	TISSUE SPECIFICITY: Synthesized by endothelial cells and megakaryocytes. Stored in platelet alpha granules and endothelial cell Weibel-Palade bodies, following activation of these cells, it is released and attached to megakaryocytes, platelets, endothelium and subendothelium of blood vessels. Not found in plasma. Found in vascular tissues such as placenta, lung, and liver. {ECO:0000269|PubMed:7629143, ECO:0000269|PubMed:8514871}.; 	unclassifiable (Anatomical System);cartilage;heart;small intestine;islets of Langerhans;vein;skin;skeletal muscle;uterus;prostate;optic nerve;whole body;lung;nasopharynx;visual apparatus;duodenum;liver;testis;spleen;spinal ganglion;brain;aorta;tonsil;gall bladder;	appendix;skeletal muscle;	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	4q22.1																								
4	90849045	90849045	-	TGC	exonic	MMRN1		nonframeshift insertion	MMRN1:NM_007351:exon5:c.1055_1056insTGC:p.V352_R353insA	9.35082142599867e-17	0.00883523144061894	0.991164768559381	multimerin 1	FUNCTION: Carrier protein for platelet (but not plasma) factor V/Va. Plays a role in the storage and stabilization of factor V in platelets. Upon release following platelet activation, may limit platelet and plasma factor Va-dependent thrombin generation. Ligand for integrin alpha-IIb/beta-3 and integrin alpha-V/beta-3 on activated platelets, and may function as an extracellular matrix or adhesive protein. {ECO:0000269|PubMed:16363244, ECO:0000269|PubMed:19132231, ECO:0000269|PubMed:7629143}.; 	DISEASE: Note=Deficiency in multimerin-1 due to proteolytic degradation within the platelet alpha granules is associated with an autosomal dominant bleeding disorder (factor V Quebec). {ECO:0000269|PubMed:8652809}.; 	TISSUE SPECIFICITY: Synthesized by endothelial cells and megakaryocytes. Stored in platelet alpha granules and endothelial cell Weibel-Palade bodies, following activation of these cells, it is released and attached to megakaryocytes, platelets, endothelium and subendothelium of blood vessels. Not found in plasma. Found in vascular tissues such as placenta, lung, and liver. {ECO:0000269|PubMed:7629143, ECO:0000269|PubMed:8514871}.; 	unclassifiable (Anatomical System);cartilage;heart;small intestine;islets of Langerhans;vein;skin;skeletal muscle;uterus;prostate;optic nerve;whole body;lung;nasopharynx;visual apparatus;duodenum;liver;testis;spleen;spinal ganglion;brain;aorta;tonsil;gall bladder;	appendix;skeletal muscle;	0.13885	0.16819	0.347157132	73.79688606	483.52708	4.52727	4q22.1																								
4	98893594	98893594	A	-	intronic	STPG2				1.00566542470556e-12	0.0211995660002018	0.978800433998793	sperm tail PG-rich repeat containing 2	.	.	.	.	.	0.13597	.	1.221756288	93.21184242	5857.7505	15.87174	4q23																								
4	119944713	119944714	CT	-	exonic	SYNPO2		frameshift deletion	SYNPO2:NM_001128933:exon2:c.234_235del:p.L80Pfs*13,SYNPO2:NM_001128934:exon2:c.234_235del:p.L80Pfs*13,SYNPO2:NM_001286754:exon2:c.141_142del:p.L49Pfs*13,SYNPO2:NM_001286755:exon2:c.234_235del:p.L80Pfs*183,SYNPO2:NM_133477:exon2:c.234_235del:p.L80Pfs*13	0.737066032210172	0.262933086667439	8.8112238893063e-07	synaptopodin 2	FUNCTION: Has an actin-binding and actin-bundling activity. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Skeletal muscle specific. {ECO:0000269|PubMed:11297942}.; 	smooth muscle;ovary;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;atrium;whole body;endometrium;larynx;thyroid;testis;spinal ganglion;brain;unclassifiable (Anatomical System);cartilage;heart;tongue;spinal cord;blood;lens;skeletal muscle;breast;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;alveolus;liver;spleen;head and neck;kidney;stomach;	superior cervical ganglion;skeletal muscle;	0.25557	0.10741	-0.231522913	36.36470866	5388.5703	15.14623	4q26																								
4	119944739	119944739	A	G	intronic	SYNPO2				0.737066032210172	0.262933086667439	8.8112238893063e-07	synaptopodin 2	FUNCTION: Has an actin-binding and actin-bundling activity. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Skeletal muscle specific. {ECO:0000269|PubMed:11297942}.; 	smooth muscle;ovary;developmental;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;atrium;whole body;endometrium;larynx;thyroid;testis;spinal ganglion;brain;unclassifiable (Anatomical System);cartilage;heart;tongue;spinal cord;blood;lens;skeletal muscle;breast;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;alveolus;liver;spleen;head and neck;kidney;stomach;	superior cervical ganglion;skeletal muscle;	0.25557	0.10741	-0.231522913	36.36470866	5388.5703	15.14623	4q26																								
4	134076088	134076088	G	T	exonic	PCDH10		nonsynonymous SNV	PCDH10:NM_032961:exon3:c.G2707T:p.A903S	0.894430213447045	0.105568021181273	1.76537168218335e-06	protocadherin 10	FUNCTION: Potential calcium-dependent cell-adhesion protein.; 	.	TISSUE SPECIFICITY: Moderately expressed in all regions of the brain examined, as well as in testis and ovary, and low expression in all other tissues tested. {ECO:0000269|PubMed:11549318}.; 	unclassifiable (Anatomical System);smooth muscle;spinal cord;choroid;fovea centralis;lens;retina;breast;optic nerve;placenta;macula lutea;kidney;brain;	amygdala;whole brain;subthalamic nucleus;occipital lobe;medulla oblongata;heart;globus pallidus;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;parietal lobe;	0.58985	0.10504	-1.240018202	5.461193678	95.22371	2.10590	4q28.3																								
4	153874652	153874652	T	-	exonic	FHDC1		frameshift deletion	FHDC1:NM_033393:exon2:c.500delT:p.T168Lfs*9	0.024454126798477	0.975428957891545	0.000116915309977695	FH2 domain containing 1	.	.	.	unclassifiable (Anatomical System);heart;ovary;lacrimal gland;colon;parathyroid;skin;skeletal muscle;retina;bone marrow;breast;uterus;prostate;whole body;lung;placenta;visual apparatus;liver;testis;spleen;brain;stomach;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.39667	0.08948	0.969962249	90.20995518	6091.11428	16.31408	4q31.3																								
4	186336370	186336370	T	-	exonic	UFSP2		frameshift deletion	UFSP2:NM_018359:exon6:c.623delA:p.N208Ifs*3	6.10971263298467e-06	0.886025925468131	0.113967964819236	UFM1-specific peptidase 2	FUNCTION: Thiol protease which recognizes and hydrolyzes the peptide bond at the C-terminal Gly of UFM1, a ubiquitin-like modifier protein bound to a number of target proteins. Does not hydrolyze SUMO1 or ISG15 ubiquitin-like proteins. Through TRIP4 deufmylation may regulate intracellular nuclear receptors transactivation and thereby regulate cell proliferation and differentiation. {ECO:0000269|PubMed:25219498}.; 	DISEASE: Beukes familial hip dysplasia (BFHD) [MIM:142669]: A severe progressive degenerative osteoarthritis of the hip joint with underlying dysplasia confined to that region. Affected individuals are of normal stature and have no associated health problems. {ECO:0000269|PubMed:26428751}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;medulla oblongata;ovary;colon;parathyroid;skin;retina;uterus;prostate;whole body;endometrium;oesophagus;larynx;bone;thyroid;testis;amniotic fluid;germinal center;brain;pineal gland;artery;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;hypothalamus;muscle;adrenal cortex;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;placenta;duodenum;spleen;head and neck;kidney;mammary gland;aorta;stomach;	occipital lobe;testis - seminiferous tubule;testis;parietal lobe;skeletal muscle;cingulate cortex;	0.22830	0.10715	-0.025608647	51.91672564	255.71192	3.43940	4q35.1	ID=COSM1428889;OCCURENCE=1(large_intestine)																							
4	186336506	186336506	G	-	intronic	UFSP2				6.10971263298467e-06	0.886025925468131	0.113967964819236	UFM1-specific peptidase 2	FUNCTION: Thiol protease which recognizes and hydrolyzes the peptide bond at the C-terminal Gly of UFM1, a ubiquitin-like modifier protein bound to a number of target proteins. Does not hydrolyze SUMO1 or ISG15 ubiquitin-like proteins. Through TRIP4 deufmylation may regulate intracellular nuclear receptors transactivation and thereby regulate cell proliferation and differentiation. {ECO:0000269|PubMed:25219498}.; 	DISEASE: Beukes familial hip dysplasia (BFHD) [MIM:142669]: A severe progressive degenerative osteoarthritis of the hip joint with underlying dysplasia confined to that region. Affected individuals are of normal stature and have no associated health problems. {ECO:0000269|PubMed:26428751}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;medulla oblongata;ovary;colon;parathyroid;skin;retina;uterus;prostate;whole body;endometrium;oesophagus;larynx;bone;thyroid;testis;amniotic fluid;germinal center;brain;pineal gland;artery;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;hypothalamus;muscle;adrenal cortex;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;placenta;duodenum;spleen;head and neck;kidney;mammary gland;aorta;stomach;	occipital lobe;testis - seminiferous tubule;testis;parietal lobe;skeletal muscle;cingulate cortex;	0.22830	0.10715	-0.025608647	51.91672564	255.71192	3.43940	4q35.1																								
5	635627	635627	C	A	exonic	CEP72		nonsynonymous SNV	CEP72:NM_018140:exon6:c.C832A:p.P278T	1.05831804132716e-09	0.300665456320541	0.69933454262114	centrosomal protein 72kDa	FUNCTION: Involved in the recruitment of key centrosomal proteins to the centrosome. Provides centrosomal microtubule-nucleation activity on the gamma-tubulin ring complexes (gamma-TuRCs) and has critical roles in forming a focused bipolar spindle, which is needed for proper tension generation between sister chromatids. Required for localization of KIZ, AKAP9 and gamma-tubulin ring complexes (gamma-TuRCs) (PubMed:19536135). Involved in centriole duplication. Required for CDK5RAP22, CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). {ECO:0000269|PubMed:19536135, ECO:0000269|PubMed:26297806}.; 	.	.	unclassifiable (Anatomical System);lymph node;islets of Langerhans;colon;retina;optic nerve;lung;frontal lobe;placenta;bone;testis;germinal center;brain;stomach;	ciliary ganglion;skeletal muscle;	0.08108	0.11633	-0.169017544	40.67586695	848.24275	5.69267	5p15.33																								
5	635643	635643	C	T	exonic	CEP72		nonsynonymous SNV	CEP72:NM_018140:exon6:c.C848T:p.A283V	1.05831804132716e-09	0.300665456320541	0.69933454262114	centrosomal protein 72kDa	FUNCTION: Involved in the recruitment of key centrosomal proteins to the centrosome. Provides centrosomal microtubule-nucleation activity on the gamma-tubulin ring complexes (gamma-TuRCs) and has critical roles in forming a focused bipolar spindle, which is needed for proper tension generation between sister chromatids. Required for localization of KIZ, AKAP9 and gamma-tubulin ring complexes (gamma-TuRCs) (PubMed:19536135). Involved in centriole duplication. Required for CDK5RAP22, CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). {ECO:0000269|PubMed:19536135, ECO:0000269|PubMed:26297806}.; 	.	.	unclassifiable (Anatomical System);lymph node;islets of Langerhans;colon;retina;optic nerve;lung;frontal lobe;placenta;bone;testis;germinal center;brain;stomach;	ciliary ganglion;skeletal muscle;	0.08108	0.11633	-0.169017544	40.67586695	848.24275	5.69267	5p15.33		1.652e-05	0	0	0	0	3.006e-05	0	0									rs376290648						
5	635663	635663	-	C	exonic	CEP72		frameshift insertion	CEP72:NM_018140:exon6:c.869dupC:p.R292Qfs*94	1.05831804132716e-09	0.300665456320541	0.69933454262114	centrosomal protein 72kDa	FUNCTION: Involved in the recruitment of key centrosomal proteins to the centrosome. Provides centrosomal microtubule-nucleation activity on the gamma-tubulin ring complexes (gamma-TuRCs) and has critical roles in forming a focused bipolar spindle, which is needed for proper tension generation between sister chromatids. Required for localization of KIZ, AKAP9 and gamma-tubulin ring complexes (gamma-TuRCs) (PubMed:19536135). Involved in centriole duplication. Required for CDK5RAP22, CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). {ECO:0000269|PubMed:19536135, ECO:0000269|PubMed:26297806}.; 	.	.	unclassifiable (Anatomical System);lymph node;islets of Langerhans;colon;retina;optic nerve;lung;frontal lobe;placenta;bone;testis;germinal center;brain;stomach;	ciliary ganglion;skeletal muscle;	0.08108	0.11633	-0.169017544	40.67586695	848.24275	5.69267	5p15.33																								
5	41000835	41000835	T	-	exonic	MROH2B		frameshift deletion	MROH2B:NM_173489:exon38:c.4295delA:p.K1432Rfs*3	1.28868466121395e-26	0.0250058459524975	0.974994154047502	maestro heat like repeat family member 2B	.	.	.	.	.	.	0.08456	1.598375034	95.87756546	6887.10584	17.68880	5p13.1																								
5	41000852	41000853	AA	-	exonic	MROH2B		frameshift deletion	MROH2B:NM_173489:exon38:c.4277_4278del:p.F1426Cfs*2	1.28868466121395e-26	0.0250058459524975	0.974994154047502	maestro heat like repeat family member 2B	.	.	.	.	.	.	0.08456	1.598375034	95.87756546	6887.10584	17.68880	5p13.1																								
5	112929061	112929061	A	-	exonic	YTHDC2		frameshift deletion	YTHDC2:NM_001345976:exon27:c.3374delA:p.N1127Tfs*9,YTHDC2:NM_001345975:exon28:c.3788delA:p.N1265Tfs*9,YTHDC2:NM_022828:exon29:c.4274delA:p.N1427Tfs*9	0.999999571704339	4.28295661406565e-07	2.23811354771163e-20	YTH domain containing 2	FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:26318451). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:26318451). {ECO:0000269|PubMed:26318451}.; 	.	.	ovary;salivary gland;sympathetic chain;intestine;colon;parathyroid;skin;uterus;prostate;whole body;cochlea;endometrium;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;muscle;pharynx;blood;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;hypopharynx;liver;spleen;head and neck;cervix;kidney;stomach;thymus;	amygdala;dorsal root ganglion;medulla oblongata;superior cervical ganglion;testis;globus pallidus;atrioventricular node;	0.41393	0.09698	-0.275617382	33.58693088	3059.0798	10.51775	5q22.2																								
5	118500291	118500291	C	-	exonic	DMXL1		frameshift deletion	DMXL1:NM_001290321:exon20:c.4792delC:p.T1599Lfs*5,DMXL1:NM_001290322:exon20:c.4273delC:p.T1426Lfs*5,DMXL1:NM_005509:exon20:c.4792delC:p.T1599Lfs*5,DMXL1:NM_001349239:exon21:c.4792delC:p.T1599Lfs*5,DMXL1:NM_001349240:exon21:c.4792delC:p.T1599Lfs*5	0.999998843167901	1.15683209865886e-06	3.49660717260196e-24	Dmx like 1	.	.	TISSUE SPECIFICITY: Expressed in bone, breast, eye, foreskin, heart, parathyroid, small intestine, testis, tonsils, placenta and uterus. {ECO:0000269|PubMed:10708522}.; 	sympathetic chain;colon;parathyroid;skin;retina;uterus;prostate;whole body;endometrium;larynx;bone;thyroid;testis;germinal center;brain;pineal gland;unclassifiable (Anatomical System);lymph node;small intestine;heart;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;placenta;hippocampus;liver;spleen;head and neck;kidney;mammary gland;stomach;	amygdala;medulla oblongata;prostate;hypothalamus;thyroid;spinal cord;prefrontal cortex;caudate nucleus;	0.71329	0.11984	-0.820119436	11.8895966	2325.86474	8.93384	5q23.1																								
5	127638776	127638778	CAA	-	exonic	FBN2		nonframeshift deletion	FBN2:NM_001999:exon46:c.5804_5806del:p.V1935Dfs*978	0.999999991794472	8.20552780336503e-09	4.11852941699783e-30	fibrillin 2	FUNCTION: Fibrillins are structural components of 10-12 nm extracellular calcium-binding microfibrils, which occur either in association with elastin or in elastin-free bundles. Fibrillin-2- containing microfibrils regulate the early process of elastic fiber assembly. Regulates osteoblast maturation by controlling TGF-beta bioavailability and calibrating TGF-beta and BMP levels, respectively (By similarity). {ECO:0000250|UniProtKB:Q61555}.; 	DISEASE: Macular degeneration, early-onset (EOMD) [MIM:616118]: An ocular disorder characterized by macular changes resulting in progressive loss of visual acuity. {ECO:0000269|PubMed:24899048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in fetal eye (18 weeks)in the retinal pigment epithelium (RPE), the choroid, Bruch's membrane and in the sclera. Not expressed in the neural retina. {ECO:0000269|PubMed:24899048}.; 	smooth muscle;ovary;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;endometrium;larynx;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;blood;lens;skeletal muscle;bile duct;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;stomach;	superior cervical ganglion;adipose tissue;placenta;testis;appendix;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;	0.65403	0.22936	-1.867776262	2.016985138	3419.53483	11.21650	5q23.3																			454751	Congenital_contractural_arachnodactyly	MedGen:C0220668,OMIM:121050,Orphanet:ORPHA115,SNOMED_CT:205821003	criteria_provided,_single_submitter	Uncertain_significance	
5	141014494	141014494	T	C	exonic	HDAC3		synonymous SNV	HDAC3:NM_003883:exon3:c.A165G:p.Q55Q	0.955038023763879	0.044960983331965	9.92904155755059e-07	histone deacetylase 3	FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4), and some other non-histone substrates. Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Participates in the BCL6 transcriptional repressor activity by deacetylating the H3 'Lys- 27' (H3K27) on enhancer elements, antagonizing EP300 acetyltransferase activity and repressing proximal gene expression. Probably participates in the regulation of transcription through its binding to the zinc-finger transcription factor YY1; increases YY1 repression activity. Required to repress transcription of the POU1F1 transcription factor. Acts as a molecular chaperone for shuttling phosphorylated NR2C1 to PML bodies for sumoylation (PubMed:21444723, PubMed:23911289). Contributes, together with XBP1 isoform 1, to the activation of NFE2L2-mediated HMOX1 transcription factor gene expression in a PI(3)K/mTORC2/Akt-dependent signaling pathway leading to endothelial cell (EC) survival under disturbed flow/oxidative stress (PubMed:25190803). {ECO:0000269|PubMed:21444723, ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:25190803}.; 	.	TISSUE SPECIFICITY: Widely expressed.; 	ovary;sympathetic chain;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;optic nerve;cochlea;endometrium;bone;thyroid;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;muscle;blood;skeletal muscle;pancreas;lung;epididymis;placenta;visual apparatus;duodenum;alveolus;liver;spleen;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;globus pallidus;trigeminal ganglion;parietal lobe;cerebellum;	0.96555	0.64888	-0.029247611	51.40363293	98.72035	2.14866	5q31.3		0.6253	0.8462	0.7832	0.3071	0.6022	0.5989	0.5817	0.6597	0.6716	0.8538	0.7303	0.5927	0.3067	0.6067	0.6193	0.6582	rs2530223						
5	148996133	148996133	G	T	exonic	ARHGEF37		synonymous SNV	ARHGEF37:NM_001001669:exon5:c.G462T:p.P154P	1.08240046485854e-13	0.0211567222284534	0.978843277771438	Rho guanine nucleotide exchange factor 37	FUNCTION: May act as a guanine nucleotide exchange factor (GEF). {ECO:0000250}.; 	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;prostate;optic nerve;endometrium;cerebral cortex;bone;pituitary gland;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;spinal cord;lens;breast;lung;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	.	.	1.183126933	92.82849729	8667.38708	20.12571	5q32		8.642e-06	0	0	0	0	1.527e-05	0	0									rs577680335						
5	148996275	148996275	-	C	exonic	ARHGEF37		frameshift insertion	ARHGEF37:NM_001001669:exon5:c.605dupC:p.L203Pfs*10	1.08240046485854e-13	0.0211567222284534	0.978843277771438	Rho guanine nucleotide exchange factor 37	FUNCTION: May act as a guanine nucleotide exchange factor (GEF). {ECO:0000250}.; 	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;prostate;optic nerve;endometrium;cerebral cortex;bone;pituitary gland;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;spinal cord;lens;breast;lung;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	.	.	1.183126933	92.82849729	8667.38708	20.12571	5q32																								
5	148996278	148996279	CT	-	exonic	ARHGEF37		frameshift deletion	ARHGEF37:NM_001001669:exon5:c.607_608del:p.L203Pfs*9	1.08240046485854e-13	0.0211567222284534	0.978843277771438	Rho guanine nucleotide exchange factor 37	FUNCTION: May act as a guanine nucleotide exchange factor (GEF). {ECO:0000250}.; 	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;prostate;optic nerve;endometrium;cerebral cortex;bone;pituitary gland;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;spinal cord;lens;breast;lung;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	.	.	1.183126933	92.82849729	8667.38708	20.12571	5q32																								
5	148996327	148996327	-	G	exonic	ARHGEF37		frameshift insertion	ARHGEF37:NM_001001669:exon5:c.657dupG:p.A220Gfs*51	1.08240046485854e-13	0.0211567222284534	0.978843277771438	Rho guanine nucleotide exchange factor 37	FUNCTION: May act as a guanine nucleotide exchange factor (GEF). {ECO:0000250}.; 	.	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;prostate;optic nerve;endometrium;cerebral cortex;bone;pituitary gland;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;spinal cord;lens;breast;lung;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	.	.	1.183126933	92.82849729	8667.38708	20.12571	5q32																								
5	149460476	149460476	G	-	exonic	CSF1R		frameshift deletion	CSF1R:NM_001288705:exon2:c.161delC:p.P54Hfs*58,CSF1R:NM_005211:exon3:c.161delC:p.P54Hfs*58,CSF1R:NM_001349736:exon4:c.161delC:p.P54Hfs*58	0.993497648111379	0.00650235017917715	1.70944343508137e-09	colony stimulating factor 1 receptor	FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for CSF1 and IL34 and plays an essential role in the regulation of survival, proliferation and differentiation of hematopoietic precursor cells, especially mononuclear phagocytes, such as macrophages and monocytes. Promotes the release of proinflammatory chemokines in response to IL34 and CSF1, and thereby plays an important role in innate immunity and in inflammatory processes. Plays an important role in the regulation of osteoclast proliferation and differentiation, the regulation of bone resorption, and is required for normal bone and tooth development. Required for normal male and female fertility, and for normal development of milk ducts and acinar structures in the mammary gland during pregnancy. Promotes reorganization of the actin cytoskeleton, regulates formation of membrane ruffles, cell adhesion and cell migration, and promotes cancer cell invasion. Activates several signaling pathways in response to ligand binding. Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of PLCG2 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5- trisphosphate, that then lead to the activation of protein kinase C family members, especially PRKCD. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to activation of the AKT1 signaling pathway. Activated CSF1R also mediates activation of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family kinases SRC, FYN and YES1. Activated CSF1R transmits signals both via proteins that directly interact with phosphorylated tyrosine residues in its intracellular domain, or via adapter proteins, such as GRB2. Promotes activation of STAT family members STAT3, STAT5A and/or STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP- 1. Receptor signaling is down-regulated by protein phosphatases, such as INPP5D/SHIP-1, that dephosphorylate the receptor and its downstream effectors, and by rapid internalization of the activated receptor. {ECO:0000269|PubMed:12882960, ECO:0000269|PubMed:15117969, ECO:0000269|PubMed:16170366, ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:16648572, ECO:0000269|PubMed:17121910, ECO:0000269|PubMed:18467591, ECO:0000269|PubMed:18814279, ECO:0000269|PubMed:19193011, ECO:0000269|PubMed:19934330, ECO:0000269|PubMed:20489731, ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061, ECO:0000269|PubMed:7683918}.; 	DISEASE: Note=Aberrant expression of CSF1 or CSF1R can promote cancer cell proliferation, invasion and formation of metastases. Overexpression of CSF1 or CSF1R is observed in a significant percentage of breast, ovarian, prostate, and endometrial cancers.; DISEASE: Note=Aberrant expression of CSF1 or CSF1R may play a role in inflammatory diseases, such as rheumatoid arthritis, glomerulonephritis, atherosclerosis, and allograft rejection.; DISEASE: Leukoencephalopathy, diffuse hereditary, with spheroids (HDLS) [MIM:221820]: An autosomal dominant adult-onset rapidly progressive neurodegenerative disorder characterized by variable behavioral, cognitive, and motor changes. Patients often die of dementia within 6 years of onset. Brain imaging shows patchy abnormalities in the cerebral white matter, predominantly affecting the frontal and parietal lobes. {ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:24532199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in bone marrow and in differentiated blood mononuclear cells.; 	lymphoreticular;myocardium;ovary;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;tongue;islets of Langerhans;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;alveolus;liver;spleen;head and neck;kidney;mammary gland;stomach;	placenta;	0.42433	0.52469	0.609894095	82.95588582	987.59415	6.06031	5q32																								
5	176383025	176383025	A	-	exonic	UIMC1		stopgain	UIMC1:NM_001199298:exon8:c.1274delT:p.L425*,UIMC1:NM_001317961:exon8:c.776delT:p.L259*,UIMC1:NM_016290:exon8:c.1274delT:p.L425*,UIMC1:NM_001199297:exon9:c.1274delT:p.L425*	0.0326458625692234	0.967278483257136	7.5654173641012e-05	ubiquitin interaction motif containing 1	FUNCTION: Ubiquitin-binding protein (PubMed:24627472). Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed:19328070, Ref.35). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1. {ECO:0000269|PubMed:12080054, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:17525341, ECO:0000269|PubMed:17525342, ECO:0000269|PubMed:17621610, ECO:0000269|PubMed:17643121, ECO:0000269|PubMed:19015238, ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19328070, ECO:0000269|PubMed:24627472, ECO:0000269|Ref.35}.; 	.	TISSUE SPECIFICITY: Expressed in testis, ovary, thymus and heart. Expressed in germ cells of the testis. {ECO:0000269|PubMed:12080054}.; 	colon;fovea centralis;choroid;retina;uterus;optic nerve;whole body;frontal lobe;endometrium;thyroid;bone;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;medulla oblongata;testis - seminiferous tubule;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.28387	0.17850	0.069852974	59.10592121	1332.8819	6.85589	5q35.2																								
5	178581923	178581923	G	-	intronic	ADAMTS2				0.992213475206961	0.00778652425549657	5.37542634593037e-10	ADAM metallopeptidase with thrombospondin type 1 motif 2	FUNCTION: Cleaves the propeptides of type I and II collagen prior to fibril assembly. Does not act on type III collagen. May also play a role in development that is independent of its role in collagen biosynthesis.; 	DISEASE: Ehlers-Danlos syndrome 7C (EDS7C) [MIM:225410]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by extremely fragile tissues, hyperextensible skin and easy bruising. Facial skin contains numerous folds, as in the cutis laxa syndrome. {ECO:0000269|PubMed:10417273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed at high level in skin, bone, tendon and aorta and at low levels in thymus and brain.; 	unclassifiable (Anatomical System);smooth muscle;heart;ovary;cartilage;islets of Langerhans;parathyroid;fovea centralis;choroid;lens;skin;retina;uterus;breast;pancreas;optic nerve;cerebral cortex;placenta;bone;macula lutea;kidney;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.33346	0.31484	-1.800772772	2.217504128	5065.97781	14.58177	5q35.3																								
6	7577240	7577240	-	A	exonic	DSP		frameshift insertion	DSP:NM_001008844:exon20:c.2843dupA:p.I950Nfs*3,DSP:NM_001319034:exon20:c.2843dupA:p.I950Nfs*3,DSP:NM_004415:exon20:c.2843dupA:p.I950Nfs*3	0.999901542789998	9.84572100025319e-05	7.19423015500153e-21	desmoplakin	FUNCTION: Major high molecular weight protein of desmosomes. Involved in the organization of the desmosomal cadherin- plakoglobin complexes into discrete plasma membrane domains and in the anchoring of intermediate filaments to the desmosomes.; 	DISEASE: Keratoderma, palmoplantar, striate 2 (SPPK2) [MIM:612908]: A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present. {ECO:0000269|PubMed:9887343}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated, with woolly hair and keratoderma (DCWHK) [MIM:605676]: An autosomal recessive cardiocutaneous syndrome characterized by a generalized striate keratoderma particularly affecting the palmoplantar epidermis, woolly hair, and dilated left ventricular cardiomyopathy. {ECO:0000269|PubMed:11063735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 8 (ARVD8) [MIM:607450]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:12373648, ECO:0000269|PubMed:15941723, ECO:0000269|PubMed:20031617}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Skin fragility-woolly hair syndrome (SFWHS) [MIM:607655]: An autosomal recessive genodermatosis characterized by skin fragility with blistering, focal and diffuse palmoplantar keratoderma, hyperkeratotic plaques on the trunk and limbs, and woolly hair with varying degrees of alopecia. {ECO:0000269|PubMed:11841538}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa, lethal acantholytic (EBLA) [MIM:609638]: A form of epidermolysis bullosa characterized by severe fragility of skin and mucous membranes. The phenotype is lethal in the neonatal period because of immense transcutaneous fluid loss. Typical features include universal alopecia, neonatal teeth, and nail loss. Histopathology of the skin shows suprabasal clefting and acantholysis throughout the spinous layer, mimicking pemphigus. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis (DCWHKTA) [MIM:615821]: A cardiocutaneous syndrome characterized by biventricular dilated cardiomyopathy, hyperkeratosis, woolly hair, palmoplantar keratoderma, and hypo/oligodontia. {ECO:0000269|PubMed:16628197, ECO:0000269|PubMed:20940358, ECO:0000269|PubMed:22795705}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoform DPI is apparently an obligate constituent of all desmosomes. Isoform DPII resides predominantly in tissues and cells of stratified origin.; 	.	.	0.67242	0.36963	-2.227884388	1.321066289	4755.60752	13.95902	6p24.3																		rs397516927	54052	Primary_dilated_cardiomyopathy	EFO:EFO_0000407,Human_Phenotype_Ontology:HP:0001644,MedGen:C0007193,Orphanet:ORPHA217604,SNOMED_CT:195021004	criteria_provided,_single_submitter	Likely_pathogenic	ID=CI1410882;CLASS=DM?;MUT=ALT;GENE=DSP;STRAND=+;DNA=NM_004415.3:c.2848dupA;DB=rs397516927;PHEN="Cardiomyopathy_dilated"
6	32333955	32333955	T	C	exonic	C6orf10		nonsynonymous SNV	C6orf10:NM_001286474:exon6:c.A206G:p.Y69C,C6orf10:NM_006781:exon6:c.A206G:p.Y69C	1.22806574585252e-13	0.470531124965607	0.52946887503427	chromosome 6 open reading frame 10	.	.	.	unclassifiable (Anatomical System);lung;testis;	.	0.07590	0.07442	4.266124392	99.7287096	12835.27934	24.33992	6p21.32		0.4204	0.1754	0.5745	0.3827	0.3219	0.4279	0.4117	0.4662	0.3202	0.1573	0.5444	0.5695	0.3747	0.2952	0.3950	0.3591	rs9268368						
6	32784712	32784715	ACCC	-	exonic	HLA-DOB		frameshift deletion	HLA-DOB:NM_002120:exon1:c.14_17del:p.W5Sfs*8	9.08751665004379e-05	0.552954446504831	0.446954678328669	major histocompatibility complex, class II, DO beta	FUNCTION: Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM.; 	.	.	.	.	0.11913	0.12310	0.72761005	86.08162302	1166.25764	6.49652	6p21.32																								
6	38800164	38800164	G	A	exonic	DNAH8		nonsynonymous SNV	DNAH8:NM_001206927:exon31:c.G4255A:p.E1419K	2.09466493164173e-37	0.999999999144842	8.55157874037014e-10	dynein axonemal heavy chain 8	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	.	prostate;lung;hypothalamus;testis;germinal center;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.33816	0.09678	.	.	14314.45201	26.19227	6p21.2		0.1518	0.1503	0.1385	0.3584	0.1090	0.1290	0.1145	0.1657	0.1433	0.1572	0.1360	0.1258	0.3690	0.0982	0.1231	0.1293	rs9357283						
6	38800167	38800167	-	T	exonic	DNAH8		frameshift insertion	DNAH8:NM_001206927:exon31:c.4259dupT:p.R1422Sfs*2	2.09466493164173e-37	0.999999999144842	8.55157874037014e-10	dynein axonemal heavy chain 8	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Involved in sperm motility; implicated in sperm flagellar assembly (By similarity). {ECO:0000250}.; 	.	.	prostate;lung;hypothalamus;testis;germinal center;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.33816	0.09678	.	.	14314.45201	26.19227	6p21.2																								
6	40998222	40998223	AA	-	exonic	UNC5CL		stopgain	UNC5CL:NM_173561:exon8:c.1238_1239del:p.F413*	1.666644191506e-07	0.40318084399274	0.596818989342841	unc-5 family C-terminal like	FUNCTION: Inhibits NF-kappa-B-dependent transcription by impairing NF-kappa-B binding to its targets. {ECO:0000269|PubMed:14769797}.; 	.	TISSUE SPECIFICITY: Expressed in pancreas, liver and kidney. {ECO:0000269|PubMed:14769797}.; 	unclassifiable (Anatomical System);pancreas;lung;cartilage;islets of Langerhans;liver;colon;kidney;brain;	dorsal root ganglion;superior cervical ganglion;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;skin;uterus corpus;subthalamic nucleus;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;	0.60201	0.09442	1.512041961	95.47062987	535.67038	4.71781	6p21.1																								
6	40998232	40998233	GG	-	exonic	UNC5CL		frameshift deletion	UNC5CL:NM_173561:exon8:c.1228_1229del:p.P410Rfs*4	1.666644191506e-07	0.40318084399274	0.596818989342841	unc-5 family C-terminal like	FUNCTION: Inhibits NF-kappa-B-dependent transcription by impairing NF-kappa-B binding to its targets. {ECO:0000269|PubMed:14769797}.; 	.	TISSUE SPECIFICITY: Expressed in pancreas, liver and kidney. {ECO:0000269|PubMed:14769797}.; 	unclassifiable (Anatomical System);pancreas;lung;cartilage;islets of Langerhans;liver;colon;kidney;brain;	dorsal root ganglion;superior cervical ganglion;temporal lobe;atrioventricular node;caudate nucleus;pons;skeletal muscle;skin;uterus corpus;subthalamic nucleus;globus pallidus;ciliary ganglion;trigeminal ganglion;cingulate cortex;	0.60201	0.09442	1.512041961	95.47062987	535.67038	4.71781	6p21.1																								
6	43969830	43969830	A	G	exonic	C6orf223		nonsynonymous SNV	C6orf223:NM_001171992:exon3:c.A292G:p.R98G	0.0204906742338502	0.747307931055855	0.232201394710294	chromosome 6 open reading frame 223	.	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;fovea centralis;choroid;lens;skin;retina;optic nerve;lung;cornea;macula lutea;visual apparatus;liver;cervix;kidney;brain;mammary gland;stomach;	.	0.04575	.	1.550689283	95.62396792	872.70364	5.75071	6p21.1																								
6	43969839	43969839	C	A	exonic	C6orf223		nonsynonymous SNV	C6orf223:NM_001171992:exon3:c.C301A:p.P101T	0.0204906742338502	0.747307931055855	0.232201394710294	chromosome 6 open reading frame 223	.	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;fovea centralis;choroid;lens;skin;retina;optic nerve;lung;cornea;macula lutea;visual apparatus;liver;cervix;kidney;brain;mammary gland;stomach;	.	0.04575	.	1.550689283	95.62396792	872.70364	5.75071	6p21.1		0.0046	0	0.0030	0.0962	0	0	0.0096	0.0003	0.0030	0.0002	0	0	0.0549	0	0	0.0010	rs80169011						
6	45909364	45909364	C	T	exonic	CLIC5		nonsynonymous SNV	CLIC5:NM_001114086:exon4:c.G803A:p.R268Q,CLIC5:NM_001256023:exon4:c.G326A:p.R109Q,CLIC5:NM_016929:exon4:c.G326A:p.R109Q	0.00187685115916181	0.724933929762025	0.273189219078813	chloride intracellular channel 5	FUNCTION: Required for normal hearing (PubMed:24781754). It is necessary for the formation of stereocilia in the inner ear and normal development of the organ of Corti (By similarity). Can insert into membranes and form poorly selective ion channels that may also transport chloride ions. May play a role in the regulation of transepithelial ion absorption and secretion. Is required for the development and/or maintenance of the proper glomerular endothelial cell and podocyte architecture (PubMed:15184393, PubMed:18028448, PubMed:20335315). {ECO:0000250|UniProtKB:Q8BXK9, ECO:0000269|PubMed:15184393, ECO:0000269|PubMed:18028448, ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	DISEASE: Deafness, autosomal recessive, 103 (DFNB103) [MIM:616042]: A form of sensorineural deafness with onset in early childhood. Hearing impairment progresses from mild to severe or even profound before the second decade, and is accompanied by vestibular areflexia. {ECO:0000269|PubMed:24781754}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed in both fetal and adult human tissues (PubMed:24781754). Isoform 1 is expressed in renal glomeruli endothelial cells and podocytes (at protein level). {ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	unclassifiable (Anatomical System);ovary;spinal cord;colon;fovea centralis;choroid;lens;retina;uterus;lung;optic nerve;whole body;placenta;macula lutea;liver;testis;kidney;brain;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;kidney;trigeminal ganglion;skeletal muscle;	0.25637	0.09418	1.019682101	90.97664544	213.77513	3.15479	6p21.1		0.0013	0.0003	0.0016	0.0065	0.0032	0.0008	0.0011	0.0004	0.0018	0.0006	0.0024	0	0.0043	0.0026	0.0018	0.0051	rs117204561	588806	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Likely_benign	
6	45909383	45909383	-	G	exonic	CLIC5		frameshift insertion	CLIC5:NM_001114086:exon4:c.783dupC:p.K262Qfs*36,CLIC5:NM_001256023:exon4:c.306dupC:p.K103Qfs*36,CLIC5:NM_016929:exon4:c.306dupC:p.K103Qfs*36	0.00187685115916181	0.724933929762025	0.273189219078813	chloride intracellular channel 5	FUNCTION: Required for normal hearing (PubMed:24781754). It is necessary for the formation of stereocilia in the inner ear and normal development of the organ of Corti (By similarity). Can insert into membranes and form poorly selective ion channels that may also transport chloride ions. May play a role in the regulation of transepithelial ion absorption and secretion. Is required for the development and/or maintenance of the proper glomerular endothelial cell and podocyte architecture (PubMed:15184393, PubMed:18028448, PubMed:20335315). {ECO:0000250|UniProtKB:Q8BXK9, ECO:0000269|PubMed:15184393, ECO:0000269|PubMed:18028448, ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	DISEASE: Deafness, autosomal recessive, 103 (DFNB103) [MIM:616042]: A form of sensorineural deafness with onset in early childhood. Hearing impairment progresses from mild to severe or even profound before the second decade, and is accompanied by vestibular areflexia. {ECO:0000269|PubMed:24781754}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed in both fetal and adult human tissues (PubMed:24781754). Isoform 1 is expressed in renal glomeruli endothelial cells and podocytes (at protein level). {ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	unclassifiable (Anatomical System);ovary;spinal cord;colon;fovea centralis;choroid;lens;retina;uterus;lung;optic nerve;whole body;placenta;macula lutea;liver;testis;kidney;brain;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;kidney;trigeminal ganglion;skeletal muscle;	0.25637	0.09418	1.019682101	90.97664544	213.77513	3.15479	6p21.1																								
6	45909393	45909393	G	-	intronic	CLIC5				0.00187685115916181	0.724933929762025	0.273189219078813	chloride intracellular channel 5	FUNCTION: Required for normal hearing (PubMed:24781754). It is necessary for the formation of stereocilia in the inner ear and normal development of the organ of Corti (By similarity). Can insert into membranes and form poorly selective ion channels that may also transport chloride ions. May play a role in the regulation of transepithelial ion absorption and secretion. Is required for the development and/or maintenance of the proper glomerular endothelial cell and podocyte architecture (PubMed:15184393, PubMed:18028448, PubMed:20335315). {ECO:0000250|UniProtKB:Q8BXK9, ECO:0000269|PubMed:15184393, ECO:0000269|PubMed:18028448, ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	DISEASE: Deafness, autosomal recessive, 103 (DFNB103) [MIM:616042]: A form of sensorineural deafness with onset in early childhood. Hearing impairment progresses from mild to severe or even profound before the second decade, and is accompanied by vestibular areflexia. {ECO:0000269|PubMed:24781754}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed in both fetal and adult human tissues (PubMed:24781754). Isoform 1 is expressed in renal glomeruli endothelial cells and podocytes (at protein level). {ECO:0000269|PubMed:20335315, ECO:0000269|PubMed:24781754}.; 	unclassifiable (Anatomical System);ovary;spinal cord;colon;fovea centralis;choroid;lens;retina;uterus;lung;optic nerve;whole body;placenta;macula lutea;liver;testis;kidney;brain;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;kidney;trigeminal ganglion;skeletal muscle;	0.25637	0.09418	1.019682101	90.97664544	213.77513	3.15479	6p21.1																								
6	46563862	46563862	A	-	intronic	CYP39A1				2.01302072315531e-12	0.0317724970287148	0.968227502969272	cytochrome P450 family 39 subfamily A member 1	FUNCTION: Involved in the bile acid metabolism. Has a preference for 24-hydroxycholesterol, and converts it into a 7-alpha- hydroxylated product.; 	.	TISSUE SPECIFICITY: Liver specific.; 	unclassifiable (Anatomical System);colon;parathyroid;skin;retina;uterus;lung;endometrium;liver;testis;spleen;kidney;stomach;	parietal lobe;	0.28519	0.14711	2.175443036	98.06558151	2037.14445	8.31630	6p12.3																		rs34861937						
6	70981771	70981771	G	A	exonic	COL9A1		synonymous SNV	COL9A1:NM_078485:exon7:c.C357T:p.P119P,COL9A1:NM_001851:exon13:c.C1086T:p.P362P	4.77422931673328e-15	0.977172691861338	0.0228273081386574	collagen type IX alpha 1	FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.; 	DISEASE: Multiple epiphyseal dysplasia 6 (EDM6) [MIM:614135]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:11565064}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stickler syndrome 4 (STL4) [MIM:614134]: An autosomal recessive form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:16909383}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;whole body;optic nerve;endometrium;cochlea;bone;amniotic fluid;middle ear;bladder;brain;unclassifiable (Anatomical System);cartilage;heart;hypothalamus;spinal cord;lens;lung;placenta;internal ear;visual apparatus;macula lutea;head and neck;kidney;mammary gland;	superior cervical ganglion;hypothalamus;ciliary ganglion;caudate nucleus;trigeminal ganglion;skeletal muscle;cingulate cortex;skin;	0.49846	0.17535	-0.856118029	10.95777306	7049.10534	17.93014	6q13																								
6	70981775	70981775	-	AGACGGGCCAGCTGA	exonic	COL9A1		stopgain	COL9A1:NM_078485:exon7:c.352_353insTCAGCTGGCCCGTCT:p.G118_P123delinsVSWPV*,COL9A1:NM_001851:exon13:c.1081_1082insTCAGCTGGCCCGTCT:p.G361_P366delinsVSWPV*	4.77422931673328e-15	0.977172691861338	0.0228273081386574	collagen type IX alpha 1	FUNCTION: Structural component of hyaline cartilage and vitreous of the eye.; 	DISEASE: Multiple epiphyseal dysplasia 6 (EDM6) [MIM:614135]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. {ECO:0000269|PubMed:11565064}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Stickler syndrome 4 (STL4) [MIM:614134]: An autosomal recessive form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:16909383}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;whole body;optic nerve;endometrium;cochlea;bone;amniotic fluid;middle ear;bladder;brain;unclassifiable (Anatomical System);cartilage;heart;hypothalamus;spinal cord;lens;lung;placenta;internal ear;visual apparatus;macula lutea;head and neck;kidney;mammary gland;	superior cervical ganglion;hypothalamus;ciliary ganglion;caudate nucleus;trigeminal ganglion;skeletal muscle;cingulate cortex;skin;	0.49846	0.17535	-0.856118029	10.95777306	7049.10534	17.93014	6q13																								
6	71508370	71508370	A	-	exonic	SMAP1		frameshift deletion	SMAP1:NM_001281439:exon5:c.425delA:p.K145Rfs*48,SMAP1:NM_021940:exon5:c.425delA:p.K145Rfs*48,SMAP1:NM_001044305:exon6:c.506delA:p.K172Rfs*48,SMAP1:NM_001281440:exon6:c.476delA:p.K162Rfs*48	0.983689233136559	0.0163088011507588	1.96571268226952e-06	small ArfGAP 1	FUNCTION: GTPase activating protein that acts on ARF6. Plays a role in clathrin-dependent endocytosis. May play a role in erythropoiesis (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Detected in bone marrow, adrenal gland, trachea, lymph node, spinal cord, peripheral blood leukocytes, thyroid and stomach. {ECO:0000269|PubMed:12119110}.; 	ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;amniotic fluid;germinal center;brain;heart;cartilage;pineal body;blood;lens;skeletal muscle;breast;trabecular meshwork;visual apparatus;macula lutea;liver;cervix;spleen;mammary gland;colon;choroid;fovea centralis;vein;uterus;whole body;larynx;bone;testis;dura mater;pineal gland;unclassifiable (Anatomical System);meninges;lymph node;islets of Langerhans;hypothalamus;pancreas;lung;pia mater;mesenchyma;placenta;head and neck;kidney;stomach;	amygdala;occipital lobe;hypothalamus;	0.25151	.	-0.071520315	48.34866714	1636.02834	7.47505	6q13	ID=COSM247459,COSM1445713;OCCURENCE=1(prostate),1(large_intestine)	0.0712	0.0550	0.1129	0.1118	0.0152	0.1063	0.0625	0.0286	0.0005	0.0003	0.0018	0	0	0.0054	8.892e-05	0	rs770216950						
6	74331589	74331589	A	-	exonic	SLC17A5		frameshift deletion	SLC17A5:NM_012434:exon7:c.916delT:p.Y306Ifs*4	0.0221961749395672	0.974529484014269	0.00327434104616425	solute carrier family 17 member 5	FUNCTION: Transports glucuronic acid and free sialic acid out of the lysosome after it is cleaved from sialoglycoconjugates undergoing degradation, this is required for normal CNS myelination. Mediates aspartate and glutamate membrane potential- dependent uptake into synaptic vesicles and synaptic-like microvesicles. Also functions as an electrogenic 2NO(3)(-)/H+ cotransporter in the plasma membrane of salivary gland acinar cells, mediating the physiological nitrate efflux, 25% of the circulating nitrate ions is typically removed and secreted in saliva. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:11751519, ECO:0000269|PubMed:15510212, ECO:0000269|PubMed:21781115, ECO:0000269|PubMed:22778404}.; 	DISEASE: Infantile sialic acid storage disorder (ISSD) [MIM:269920]: Severe form of sialic acid storage disease. Affected newborns exhibit visceromegaly, coarse features and failure to thrive immediately after birth. These patients have a shortened life span, usually less than 2 years. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:10947946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in fetal lung and small intestine, and at lower level in fetal skin and muscle. In the adult, detected in placenta, kidney and pancreas. Abundant in the endothelial cells of tumors from ovary, colon, breast and lung, but is not detected in endothelial cells from the corresponding normal tissues. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:11751519}.; 	unclassifiable (Anatomical System);cartilage;colon;mammary gland;stomach;	superior cervical ganglion;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.18702	0.25647	0.064394823	58.84642604	5503.64627	15.29397	6q13																								
6	74331647	74331647	-	A	exonic	SLC17A5		frameshift insertion	SLC17A5:NM_012434:exon7:c.857dupT:p.L286Ffs*65	0.0221961749395672	0.974529484014269	0.00327434104616425	solute carrier family 17 member 5	FUNCTION: Transports glucuronic acid and free sialic acid out of the lysosome after it is cleaved from sialoglycoconjugates undergoing degradation, this is required for normal CNS myelination. Mediates aspartate and glutamate membrane potential- dependent uptake into synaptic vesicles and synaptic-like microvesicles. Also functions as an electrogenic 2NO(3)(-)/H+ cotransporter in the plasma membrane of salivary gland acinar cells, mediating the physiological nitrate efflux, 25% of the circulating nitrate ions is typically removed and secreted in saliva. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:11751519, ECO:0000269|PubMed:15510212, ECO:0000269|PubMed:21781115, ECO:0000269|PubMed:22778404}.; 	DISEASE: Infantile sialic acid storage disorder (ISSD) [MIM:269920]: Severe form of sialic acid storage disease. Affected newborns exhibit visceromegaly, coarse features and failure to thrive immediately after birth. These patients have a shortened life span, usually less than 2 years. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:10947946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in fetal lung and small intestine, and at lower level in fetal skin and muscle. In the adult, detected in placenta, kidney and pancreas. Abundant in the endothelial cells of tumors from ovary, colon, breast and lung, but is not detected in endothelial cells from the corresponding normal tissues. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:11751519}.; 	unclassifiable (Anatomical System);cartilage;colon;mammary gland;stomach;	superior cervical ganglion;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.18702	0.25647	0.064394823	58.84642604	5503.64627	15.29397	6q13																								
6	74331657	74331660	ACCC	-	exonic	SLC17A5		frameshift deletion	SLC17A5:NM_012434:exon7:c.845_848del:p.W282Yfs*4	0.0221961749395672	0.974529484014269	0.00327434104616425	solute carrier family 17 member 5	FUNCTION: Transports glucuronic acid and free sialic acid out of the lysosome after it is cleaved from sialoglycoconjugates undergoing degradation, this is required for normal CNS myelination. Mediates aspartate and glutamate membrane potential- dependent uptake into synaptic vesicles and synaptic-like microvesicles. Also functions as an electrogenic 2NO(3)(-)/H+ cotransporter in the plasma membrane of salivary gland acinar cells, mediating the physiological nitrate efflux, 25% of the circulating nitrate ions is typically removed and secreted in saliva. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:11751519, ECO:0000269|PubMed:15510212, ECO:0000269|PubMed:21781115, ECO:0000269|PubMed:22778404}.; 	DISEASE: Infantile sialic acid storage disorder (ISSD) [MIM:269920]: Severe form of sialic acid storage disease. Affected newborns exhibit visceromegaly, coarse features and failure to thrive immediately after birth. These patients have a shortened life span, usually less than 2 years. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:10947946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Found in fetal lung and small intestine, and at lower level in fetal skin and muscle. In the adult, detected in placenta, kidney and pancreas. Abundant in the endothelial cells of tumors from ovary, colon, breast and lung, but is not detected in endothelial cells from the corresponding normal tissues. {ECO:0000269|PubMed:10581036, ECO:0000269|PubMed:11751519}.; 	unclassifiable (Anatomical System);cartilage;colon;mammary gland;stomach;	superior cervical ganglion;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.18702	0.25647	0.064394823	58.84642604	5503.64627	15.29397	6q13																								
6	100868747	100868747	G	-	exonic	SIM1		frameshift deletion	SIM1:NM_005068:exon9:c.1086delC:p.T363Pfs*2	0.99693618254279	0.00306381081261866	6.64459118091292e-09	single-minded family bHLH transcription factor 1	FUNCTION: Transcriptional factor that may have pleiotropic effects during embryogenesis and in the adult.; 	.	.	unclassifiable (Anatomical System);pancreas;islets of Langerhans;liver;kidney;	uterus corpus;superior cervical ganglion;ciliary ganglion;pons;atrioventricular node;skeletal muscle;	0.86069	0.17145	-0.821100135	11.88369899	2822.33817	10.01958	6q16.3																								
6	108233929	108233929	G	A	exonic	SEC63		synonymous SNV	SEC63:NM_007214:exon6:c.C564T:p.N188N	1.24261908060209e-05	0.999895027797944	9.254601125033e-05	SEC63 homolog, protein translocation regulator	FUNCTION: Required for integral membrane and secreted preprotein translocation across the endoplasmic reticulum membrane.; 	.	TISSUE SPECIFICITY: Widely expressed, with high levels in the liver. {ECO:0000269|PubMed:15133510}.; 	.	.	0.26756	0.15588	-0.578583623	18.71903751	221.36898	3.21909	6q21		0.8589	0.9068	0.9097	0.7208	0.8310	0.8536	0.8522	0.8986	0.8638	0.9073	0.8852	0.8874	0.7379	0.8278	0.8588	0.8633	rs675117	101373	Polycystic_liver_disease_1|not_specified	MedGen:C0887850,OMIM:174050|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
6	109762575	109762575	G	T	exonic	SMPD2		nonsynonymous SNV	SMPD2:NM_003080:exon2:c.G66T:p.L22F	8.11572389971647e-11	0.0742456282088369	0.925754371710006	sphingomyelin phosphodiesterase 2	FUNCTION: Converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2- lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso- sn-glycero-3-phosphocholine (lyso-platelet-activating factor). The physiological substrate seems to be Lyso-PAF.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;endometrium;bone;iris;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;hypothalamus;blood;lung;placenta;macula lutea;liver;duodenum;spleen;kidney;stomach;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;trigeminal ganglion;skeletal muscle;	0.07175	0.29293	-0.111973265	45.35857514	1417.90373	7.03838	6q21																								
6	109762654	109762654	G	T	exonic	SMPD2		stopgain	SMPD2:NM_003080:exon2:c.G145T:p.E49X	8.11572389971647e-11	0.0742456282088369	0.925754371710006	sphingomyelin phosphodiesterase 2	FUNCTION: Converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2- lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso- sn-glycero-3-phosphocholine (lyso-platelet-activating factor). The physiological substrate seems to be Lyso-PAF.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;endometrium;bone;iris;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;hypothalamus;blood;lung;placenta;macula lutea;liver;duodenum;spleen;kidney;stomach;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;trigeminal ganglion;skeletal muscle;	0.07175	0.29293	-0.111973265	45.35857514	1417.90373	7.03838	6q21																								
6	110112779	110112779	G	-	intronic	FIG4				6.58630936583289e-27	0.000172410793897148	0.999827589206103	FIG4 phosphoinositide 5-phosphatase	FUNCTION: The PI(3,5)P2 regulatory complex regulates both the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). In vitro, hydrolyzes all three D5-phosphorylated polyphosphoinositide substrates in the order PtdIns(4,5)P2 > PtdIns(3,5)P2 > PtdIns(3,4,5)P3. Plays a role in the biogenesis of endosome carrier vesicles (ECV) / multivesicular bodies (MVB) transport intermediates from early endosomes. {ECO:0000269|PubMed:17556371}.; 	DISEASE: Charcot-Marie-Tooth disease 4J (CMT4J) [MIM:611228]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. {ECO:0000269|PubMed:17572665, ECO:0000269|PubMed:21705420}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 11 (ALS11) [MIM:612577]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269|PubMed:19118816}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Yunis-Varon syndrome (YVS) [MIM:216340]: A severe autosomal recessive disorder characterized by skeletal defects, including cleidocranial dysplasia and digital anomalies, and severe neurologic involvement with neuronal loss. Enlarged cytoplasmic vacuoles are found in neurons, muscle, and cartilage. The disorder is usually lethal in infancy. {ECO:0000269|PubMed:23623387}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polymicrogyria, bilateral temporooccipital (BTOP) [MIM:612691]: A disease characterized by temporo-occipital polymicrogyria, psychiatric manifestations, and epilepsy. {ECO:0000269|PubMed:24598713}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;sympathetic chain;colon;parathyroid;fovea centralis;skin;bone marrow;uterus;prostate;whole body;frontal lobe;larynx;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;blood;lens;skeletal muscle;bile duct;pancreas;lung;cornea;nasopharynx;placenta;macula lutea;liver;head and neck;kidney;mammary gland;stomach;aorta;	dorsal root ganglion;medulla oblongata;subthalamic nucleus;superior cervical ganglion;temporal lobe;globus pallidus;ciliary ganglion;atrioventricular node;caudate nucleus;pons;cingulate cortex;parietal lobe;	0.10577	0.13228	-0.308569083	32.17150271	2517.20331	9.35490	6q21																								
6	117860485	117860485	-	A	exonic	DCBLD1		frameshift insertion	DCBLD1:NM_173674:exon9:c.1045dupA:p.N350Kfs*3	8.21257411364962e-05	0.996282235364536	0.0036356388943279	discoidin, CUB and LCCL domain containing 1	.	.	.	unclassifiable (Anatomical System);islets of Langerhans;colon;parathyroid;uterus;larynx;thyroid;placenta;duodenum;alveolus;testis;head and neck;cervix;brain;mammary gland;stomach;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.17327	0.10218	-0.512444034	21.55579146	1314.8222	6.81517	6q22.1																								
6	121642874	121642876	TTC	-	exonic	TBC1D32		nonframeshift deletion	TBC1D32:NM_152730:exon2:c.220_222del:p.E74Mfs*1184	1.35030437532423e-12	0.99912157643649	0.000878423562160185	TBC1 domain family member 32	FUNCTION: Required for high-level Shh responses in the developing neural tube. Together with CDK20, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to Shh signaling (By similarity). {ECO:0000250}.; 	.	.	.	.	0.07698	.	1.697582556	96.4319415	3597.81877	11.61312	6q22.31																								
6	125379188	125379188	T	A	exonic	RNF217		stopgain	RNF217:NM_001286398:exon3:c.T1217A:p.L406X,RNF217:NM_152553:exon5:c.T341A:p.L114X	0.0299836634081045	0.959889099325529	0.0101272372663666	ring finger protein 217	FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);ovary;cartilage;adrenal cortex;colon;blood;parathyroid;skin;bone marrow;frontal lobe;endometrium;adrenal gland;placenta;thyroid;testis;pineal gland;stomach;	superior cervical ganglion;atrioventricular node;	0.02856	.	0.328949044	73.41354093	336.83992	3.89812	6q22.31																								
6	125379194	125379194	A	C	exonic	RNF217		nonsynonymous SNV	RNF217:NM_001286398:exon3:c.A1223C:p.H408P,RNF217:NM_152553:exon5:c.A347C:p.H116P	0.0299836634081045	0.959889099325529	0.0101272372663666	ring finger protein 217	FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);ovary;cartilage;adrenal cortex;colon;blood;parathyroid;skin;bone marrow;frontal lobe;endometrium;adrenal gland;placenta;thyroid;testis;pineal gland;stomach;	superior cervical ganglion;atrioventricular node;	0.02856	.	0.328949044	73.41354093	336.83992	3.89812	6q22.31																								
6	125379197	125379199	GGG	TTC	exonic	RNF217		nonframeshift substitution	RNF217:NM_001286398:exon3:c.1226_1228TTC:p.W409Ffs*2,RNF217:NM_152553:exon5:c.350_352TTC:p.W117Ffs*2	0.0299836634081045	0.959889099325529	0.0101272372663666	ring finger protein 217	FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from E2 ubiquitin-conjugating enzymes in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);ovary;cartilage;adrenal cortex;colon;blood;parathyroid;skin;bone marrow;frontal lobe;endometrium;adrenal gland;placenta;thyroid;testis;pineal gland;stomach;	superior cervical ganglion;atrioventricular node;	0.02856	.	0.328949044	73.41354093	336.83992	3.89812	6q22.31																								
6	137338212	137338212	T	-	exonic	IL20RA		frameshift deletion	IL20RA:NM_014432:exon2:c.117delA:p.K39Nfs*12	0.00757531716048163	0.977001983699394	0.015422699140124	interleukin 20 receptor subunit alpha	FUNCTION: The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL20RA/IL10RB dimer is a receptor for IL26.; 	.	TISSUE SPECIFICITY: Widely expressed with highest levels in skin and testis and high levels in brain. Highly expressed in psoriatic skin. {ECO:0000269|PubMed:11163236, ECO:0000269|PubMed:14764663}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;larynx;pituitary gland;testis;brain;unclassifiable (Anatomical System);heart;islets of Langerhans;blood;lens;skeletal muscle;lung;placenta;macula lutea;liver;head and neck;kidney;	ciliary ganglion;atrioventricular node;	0.13796	0.11768	0.376678994	75.50719509	564.20193	4.82236	6q23.3																								
6	137338227	137338228	AG	-	exonic	IL20RA		frameshift deletion	IL20RA:NM_014432:exon2:c.101_102del:p.S34Wfs*5	0.00757531716048163	0.977001983699394	0.015422699140124	interleukin 20 receptor subunit alpha	FUNCTION: The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL20RA/IL10RB dimer is a receptor for IL26.; 	.	TISSUE SPECIFICITY: Widely expressed with highest levels in skin and testis and high levels in brain. Highly expressed in psoriatic skin. {ECO:0000269|PubMed:11163236, ECO:0000269|PubMed:14764663}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;larynx;pituitary gland;testis;brain;unclassifiable (Anatomical System);heart;islets of Langerhans;blood;lens;skeletal muscle;lung;placenta;macula lutea;liver;head and neck;kidney;	ciliary ganglion;atrioventricular node;	0.13796	0.11768	0.376678994	75.50719509	564.20193	4.82236	6q23.3																								
6	155485554	155485554	G	A	exonic	TIAM2		synonymous SNV	TIAM2:NM_012454:exon7:c.G2034A:p.Q678Q	0.124829516016011	0.87517048105258	2.93140865080266e-09	T-cell lymphoma invasion and metastasis 2	FUNCTION: Modulates the activity of RHO-like proteins and connects extracellular signals to cytoskeletal activities. Acts as a GDP- dissociation stimulator protein that stimulates the GDP-GTP exchange activity of RHO-like GTPases and activates them. Mediates extracellular laminin signals to activate Rac1, contributing to neurite growth. Involved in lamellipodial formation and advancement of the growth cone of embryonic hippocampal neurons. Promotes migration of neurons in the cerebral cortex. When overexpressed, induces membrane ruffling accompanied by the accumulation of actin filaments along the altered plasma membrane (By similarity). Activates specifically RAC1, but not CDC42 and RHOA. {ECO:0000250, ECO:0000269|PubMed:10512681}.; 	.	TISSUE SPECIFICITY: Expressed in the occipital, frontal and temporal lobes, cerebellum, putamen and testis. {ECO:0000269|PubMed:10512681}.; 	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;prostate;whole body;optic nerve;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;lens;skeletal muscle;pancreas;lung;placenta;visual apparatus;macula lutea;liver;spleen;head and neck;kidney;mammary gland;aorta;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;	0.18572	0.13396	-0.281335604	33.53974994	5362.09394	15.11728	6q25.2		0.6270	0.4230	0.8047	0.5775	0.5981	0.6176	0.6148	0.7045	0.5625	0.4259	0.7482	0.68	0.5894	0.6025	0.6145	0.6033	rs1032141						
6	155485661	155485667	CAGCCGC	-	exonic	TIAM2		frameshift deletion	TIAM2:NM_012454:exon7:c.2141_2147del:p.S717Pfs*36	0.124829516016011	0.87517048105258	2.93140865080266e-09	T-cell lymphoma invasion and metastasis 2	FUNCTION: Modulates the activity of RHO-like proteins and connects extracellular signals to cytoskeletal activities. Acts as a GDP- dissociation stimulator protein that stimulates the GDP-GTP exchange activity of RHO-like GTPases and activates them. Mediates extracellular laminin signals to activate Rac1, contributing to neurite growth. Involved in lamellipodial formation and advancement of the growth cone of embryonic hippocampal neurons. Promotes migration of neurons in the cerebral cortex. When overexpressed, induces membrane ruffling accompanied by the accumulation of actin filaments along the altered plasma membrane (By similarity). Activates specifically RAC1, but not CDC42 and RHOA. {ECO:0000250, ECO:0000269|PubMed:10512681}.; 	.	TISSUE SPECIFICITY: Expressed in the occipital, frontal and temporal lobes, cerebellum, putamen and testis. {ECO:0000269|PubMed:10512681}.; 	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;prostate;whole body;optic nerve;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;lens;skeletal muscle;pancreas;lung;placenta;visual apparatus;macula lutea;liver;spleen;head and neck;kidney;mammary gland;aorta;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;	0.18572	0.13396	-0.281335604	33.53974994	5362.09394	15.11728	6q25.2																								
6	155485667	155485667	C	-	exonic	TIAM2		frameshift deletion	TIAM2:NM_012454:exon7:c.2147delC:p.S717Afs*38	0.124829516016011	0.87517048105258	2.93140865080266e-09	T-cell lymphoma invasion and metastasis 2	FUNCTION: Modulates the activity of RHO-like proteins and connects extracellular signals to cytoskeletal activities. Acts as a GDP- dissociation stimulator protein that stimulates the GDP-GTP exchange activity of RHO-like GTPases and activates them. Mediates extracellular laminin signals to activate Rac1, contributing to neurite growth. Involved in lamellipodial formation and advancement of the growth cone of embryonic hippocampal neurons. Promotes migration of neurons in the cerebral cortex. When overexpressed, induces membrane ruffling accompanied by the accumulation of actin filaments along the altered plasma membrane (By similarity). Activates specifically RAC1, but not CDC42 and RHOA. {ECO:0000250, ECO:0000269|PubMed:10512681}.; 	.	TISSUE SPECIFICITY: Expressed in the occipital, frontal and temporal lobes, cerebellum, putamen and testis. {ECO:0000269|PubMed:10512681}.; 	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;prostate;whole body;optic nerve;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;lens;skeletal muscle;pancreas;lung;placenta;visual apparatus;macula lutea;liver;spleen;head and neck;kidney;mammary gland;aorta;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;	0.18572	0.13396	-0.281335604	33.53974994	5362.09394	15.11728	6q25.2																								
6	160448254	160448254	T	C	exonic	IGF2R		synonymous SNV	IGF2R:NM_000876:exon6:c.T684C:p.C228C	0.999999196216303	8.03783697431275e-07	3.51790096912114e-23	insulin like growth factor 2 receptor	FUNCTION: Transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes. Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6- phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelyosomal compartment where the low pH mediates the dissociation of the complex. This receptor also binds IGF2. Acts as a positive regulator of T-cell coactivation, by binding DPP4. {ECO:0000269|PubMed:10900005}.; 	.	.	myocardium;lymphoreticular;ovary;sympathetic chain;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;endometrium;thyroid;iris;germinal center;bladder;brain;amygdala;heart;cartilage;tongue;urinary;spinal cord;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;larynx;bone;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;islets of Langerhans;muscle;pancreas;lung;cornea;adrenal gland;placenta;duodenum;hypopharynx;head and neck;kidney;stomach;	whole blood;skeletal muscle;	0.14522	0.70508	-1.928748556	1.904930408	3396.75143	11.16393	6q25.3																								
6	160448267	160448267	G	T	exonic	IGF2R		nonsynonymous SNV	IGF2R:NM_000876:exon6:c.G697T:p.A233S	0.999999196216303	8.03783697431275e-07	3.51790096912114e-23	insulin like growth factor 2 receptor	FUNCTION: Transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes. Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6- phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelyosomal compartment where the low pH mediates the dissociation of the complex. This receptor also binds IGF2. Acts as a positive regulator of T-cell coactivation, by binding DPP4. {ECO:0000269|PubMed:10900005}.; 	.	.	myocardium;lymphoreticular;ovary;sympathetic chain;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;endometrium;thyroid;iris;germinal center;bladder;brain;amygdala;heart;cartilage;tongue;urinary;spinal cord;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;alveolus;spleen;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;larynx;bone;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;islets of Langerhans;muscle;pancreas;lung;cornea;adrenal gland;placenta;duodenum;hypopharynx;head and neck;kidney;stomach;	whole blood;skeletal muscle;	0.14522	0.70508	-1.928748556	1.904930408	3396.75143	11.16393	6q25.3																								
6	160969633	160969633	-	A	exonic	LPA		frameshift insertion	LPA:NM_005577:exon32:c.5031dupT:p.T1678Yfs*40	2.4422277924849e-32	0.00753098838146121	0.992469011618539	lipoprotein, Lp(a)	FUNCTION: Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330. {ECO:0000269|PubMed:2531657}.; 	.	.	lung;frontal lobe;adrenal cortex;liver;testis;spleen;kidney;	superior cervical ganglion;liver;trigeminal ganglion;	0.07571	.	.	.	3944.17186	12.41719	6q25.3																								
6	168442765	168442765	G	A	exonic	KIF25		nonsynonymous SNV	KIF25:NM_005355:exon7:c.G763A:p.A255T,KIF25:NM_030615:exon7:c.G763A:p.A255T	3.75351002915501e-09	0.0983683725406008	0.901631623705889	kinesin family member 25	FUNCTION: Negative regulator of amino acid starvation-induced autophagy. {ECO:0000269|PubMed:22354037}.; 	.	.	lung;frontal lobe;testis;	superior cervical ganglion;cerebellum peduncles;testis;globus pallidus;ciliary ganglion;atrioventricular node;skeletal muscle;skin;	0.04864	0.08777	1.936492053	97.50530786	587.48576	4.91639	6q27		0.1256	0.0230	0.1037	0.2385	0.1429	0.0985	0.1111	0.1814	0.0700	0.0220	0.0776	0.1358	0.2197	0.0435	0.0853	0.0847	rs2073634						
6	168842061	168842061	C	T	exonic	SMOC2		nonsynonymous SNV	SMOC2:NM_001166412:exon1:c.C11T:p.P4L,SMOC2:NM_022138:exon1:c.C11T:p.P4L	0.0129697790449358	0.979853407114573	0.00717681384049101	SPARC related modular calcium binding 2	FUNCTION: Promotes matrix assembly and cell adhesiveness (By similarity). Can stimulate endothelial cell proliferation, migration, as well as angiogenesis. {ECO:0000250, ECO:0000269|PubMed:16774925}.; 	DISEASE: Dentin dysplasia 1 (DTDP1) [MIM:125400]: A dental defect in which both primary and secondary dentitions are affected. The clinical crowns of both permanent and deciduous teeth are of normal shape, form and color in most cases, although they may be slightly opalescent and blue or brown. Teeth may be very mobile and exfoliate spontaneously because of inadequate root formation. On radiographs, the roots are short and may be more pointed than normal. Pulp chambers are usually absent except for a chevron- shaped remnant in the crown. Root canals are usually absent. {ECO:0000269|PubMed:22152679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	medulla oblongata;smooth muscle;ovary;sympathetic chain;colon;fovea centralis;choroid;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;synovium;bone;iris;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;urinary;lens;breast;pancreas;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	uterus;testis - interstitial;adipose tissue;testis - seminiferous tubule;thyroid;testis;	0.09715	0.10694	-0.530852121	20.82448691	113.09937	2.31458	6q27																								
6	168842113	168842113	T	G	exonic	SMOC2		synonymous SNV	SMOC2:NM_001166412:exon1:c.T63G:p.A21A,SMOC2:NM_022138:exon1:c.T63G:p.A21A	0.0129697790449358	0.979853407114573	0.00717681384049101	SPARC related modular calcium binding 2	FUNCTION: Promotes matrix assembly and cell adhesiveness (By similarity). Can stimulate endothelial cell proliferation, migration, as well as angiogenesis. {ECO:0000250, ECO:0000269|PubMed:16774925}.; 	DISEASE: Dentin dysplasia 1 (DTDP1) [MIM:125400]: A dental defect in which both primary and secondary dentitions are affected. The clinical crowns of both permanent and deciduous teeth are of normal shape, form and color in most cases, although they may be slightly opalescent and blue or brown. Teeth may be very mobile and exfoliate spontaneously because of inadequate root formation. On radiographs, the roots are short and may be more pointed than normal. Pulp chambers are usually absent except for a chevron- shaped remnant in the crown. Root canals are usually absent. {ECO:0000269|PubMed:22152679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	medulla oblongata;smooth muscle;ovary;sympathetic chain;colon;fovea centralis;choroid;retina;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;synovium;bone;iris;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;urinary;lens;breast;pancreas;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;spleen;kidney;mammary gland;stomach;peripheral nerve;	uterus;testis - interstitial;adipose tissue;testis - seminiferous tubule;thyroid;testis;	0.09715	0.10694	-0.530852121	20.82448691	113.09937	2.31458	6q27		0.3162	0.5681	0.2958	0.4902	0	0.1736	0.2344	0.3611	0.2801	0.5248	0.3176	0.1887	0.4409	0.1295	0.1601	0.2062	rs73270928						
7	6547824	6547824	C	A	exonic	GRID2IP		nonsynonymous SNV	GRID2IP:NM_001145118:exon13:c.G2336T:p.G779V	0.314734427863365	0.488396554797204	0.196869017339431	Grid2 interacting protein	FUNCTION: Postsynaptic scaffolding protein at the parallel fiber- Purkinje cell synapse, where it may serve to link GRID2 with actin cytoskeleton and various signaling molecules. {ECO:0000250}.; 	.	.	.	.	0.17067	.	.	.	4147.16671	12.78487	7p22.1																								
7	12419153	12419154	GA	-	exonic	VWDE		frameshift deletion	VWDE:NM_001135924:exon6:c.828_829del:p.H277Cfs*16,VWDE:NM_001346972:exon6:c.828_829del:p.H277Cfs*16,VWDE:NM_001346973:exon6:c.363_364del:p.H122Cfs*16	.	.	.	von Willebrand factor D and EGF domains	.	.	.	unclassifiable (Anatomical System);whole body;umbilical cord;islets of Langerhans;urinary;blood;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;	.	.	7.749518299	99.93512621	13190.99889	24.71781	7p21.3																								
7	15405216	15405216	G	A	exonic	AGMO		nonsynonymous SNV	AGMO:NM_001004320:exon12:c.C1186T:p.R396C	3.25792688425734e-07	0.774065265660049	0.225934408547263	alkylglycerol monooxygenase	FUNCTION: Glyceryl-ether monooxygenase that cleaves the O-alkyl bond of ether lipids. Ether lipids are essential components of brain membranes. {ECO:0000269|PubMed:20643956}.; 	.	.	unclassifiable (Anatomical System);colon;kidney;skeletal muscle;stomach;	.	0.05711	0.12273	0.402364592	76.45081387	546.90919	4.75481	7p21.2		0.0009	9.724e-05	0	0.0118	0	0	0	0	0.0006	0.0001	0	0	0.0105	0	6.687e-05	0	rs200555224						
7	16460759	16460759	G	-	exonic	ISPD		frameshift deletion	ISPD:NM_001101417:exon1:c.189delC:p.T64Pfs*27,ISPD:NM_001101426:exon1:c.189delC:p.T64Pfs*27	0.00243660167412645	0.928181613521859	0.0693817848040143	isoprenoid synthase domain containing	FUNCTION: Required for protein O-linked mannosylation. Probably acts as a nucleotidyltransferase involved in synthesis of a nucleotide sugar. Required for dystroglycan O-mannosylation. {ECO:0000269|PubMed:22522420, ECO:0000269|PubMed:22522421}.; 	DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C7 (MDDGC7) [MIM:616052]: A form of muscular dystrophy resulting from defective glycosylation of alpha-dystroglycan, and characterized by a limb-girdle phenotype with muscular weakness apparent after ambulation is achieved. MDDGC7 individuals do not show epilepsy, mental retardation, structural eye/brain abnormalities, or white matter changes. {ECO:0000269|PubMed:23390185}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Ubiquitously expressed, with high expression in brain. {ECO:0000269|PubMed:22522420}.; 	.	.	.	.	.	.	1279.20707	6.73590	7p21.2																								
7	42088137	42088137	G	T	exonic	GLI3		nonsynonymous SNV	GLI3:NM_000168:exon5:c.C632A:p.P211Q	0.999994739435503	5.26056449062654e-06	6.00953250163151e-15	GLI family zinc finger 3	FUNCTION: Has a dual function as a transcriptional activator and a repressor of the sonic hedgehog (Shh) pathway, and plays a role in limb development. The full-length GLI3 form (GLI3FL) after phosphorylation and nuclear translocation, acts as an activator (GLI3A) while GLI3R, its C-terminally truncated form, acts as a repressor. A proper balance between the GLI3 activator and the repressor GLI3R, rather than the repressor gradient itself or the activator/repressor ratio gradient, specifies limb digit number and identity. In concert with TRPS1, plays a role in regulating the size of the zone of distal chondrocytes, in restricting the zone of PTHLH expression in distal cells and in activating chondrocyte proliferation. Binds to the minimal GLI-consensus sequence 5'-GGGTGGTC-3'. {ECO:0000269|PubMed:10693759, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:17764085}.; 	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Is expressed in a wide variety of normal adult tissues, including lung, colon, spleen, placenta, testis, and myometrium.; 	.	.	0.99640	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	7p14.1																								
7	42088298	42088298	G	-	intronic	GLI3				0.999994739435503	5.26056449062654e-06	6.00953250163151e-15	GLI family zinc finger 3	FUNCTION: Has a dual function as a transcriptional activator and a repressor of the sonic hedgehog (Shh) pathway, and plays a role in limb development. The full-length GLI3 form (GLI3FL) after phosphorylation and nuclear translocation, acts as an activator (GLI3A) while GLI3R, its C-terminally truncated form, acts as a repressor. A proper balance between the GLI3 activator and the repressor GLI3R, rather than the repressor gradient itself or the activator/repressor ratio gradient, specifies limb digit number and identity. In concert with TRPS1, plays a role in regulating the size of the zone of distal chondrocytes, in restricting the zone of PTHLH expression in distal cells and in activating chondrocyte proliferation. Binds to the minimal GLI-consensus sequence 5'-GGGTGGTC-3'. {ECO:0000269|PubMed:10693759, ECO:0000269|PubMed:11238441, ECO:0000269|PubMed:17764085}.; 	DISEASE: Greig cephalo-poly-syndactyly syndrome (GCPS) [MIM:175700]: Autosomal dominant disorder affecting limb and craniofacial development. It is characterized by pre- and postaxial polydactyly, syndactyly of fingers and toes, macrocephaly and hypertelorism. {ECO:0000269|PubMed:10441342, ECO:0000269|PubMed:12414818, ECO:0000269|PubMed:12794692, ECO:0000269|PubMed:9302279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pallister-Hall syndrome (PHS) [MIM:146510]: An autosomal dominant disorder characterized by a wide range of clinical manifestations. Clinical features include hypothalamic hamartoma, pituitary dysfunction, central or postaxial polydactyly, and syndactyly. Malformations are frequent in the viscera, e.g. anal atresia, bifid uvula, congenital heart malformations, pulmonary or renal dysplasia. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial A1 (PAPA1) [MIM:174200]: A condition characterized by the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type A, the extra digit is well-formed and articulates with the fifth or a sixth metacarpal/metatarsal. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly, postaxial B (PAPB) [MIM:174200]: A condition characterized by an extra digit in the occurrence of supernumerary digits in the upper and/or lower extremities. In postaxial polydactyly type B the extra digit is not well formed and is frequently in the form of a skin. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Polydactyly preaxial 4 (POP4) [MIM:174700]: Preaxial polydactyly (i.e., polydactyly on the radial/tibial side of the hand/foot) covers a heterogeneous group of entities. In preaxial polydactyly type IV, the thumb shows only the mildest degree of duplication, and syndactyly of various degrees affects fingers 3 and 4. {ECO:0000269|PubMed:10441570}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Is expressed in a wide variety of normal adult tissues, including lung, colon, spleen, placenta, testis, and myometrium.; 	.	.	0.99640	0.10708	-1.310171316	4.83014862	2831.41391	10.04419	7p14.1																								
7	50180970	50180970	T	C	exonic	C7orf72		synonymous SNV	C7orf72:NM_001161834:exon7:c.T1071C:p.Y357Y	.	.	.	chromosome 7 open reading frame 72	.	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;skin;lung;cornea;visual apparatus;liver;testis;kidney;brain;mammary gland;	.	.	.	1.170393003	92.68105685	2390.96845	9.07689	7p12.2		0.0007	0	0	0.0241	0	0	0	0	0.0013	0.0001	0	0	0.0240	0	0	0	rs183919075						
7	50180972	50180972	C	T	exonic	C7orf72		nonsynonymous SNV	C7orf72:NM_001161834:exon7:c.C1073T:p.T358I	.	.	.	chromosome 7 open reading frame 72	.	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;skin;lung;cornea;visual apparatus;liver;testis;kidney;brain;mammary gland;	.	.	.	1.170393003	92.68105685	2390.96845	9.07689	7p12.2		0.3888	0.3511	0.3486	0.2074	0.2657	0.3997	0.3252	0.4310	0.3508	0.3465	0.2936	0.32	0.1922	0.2857	0.3899	0.3432	rs1456908						
7	80427555	80427555	A	-	intronic	SEMA3C				0.296856253558956	0.70313652214893	7.22429211477407e-06	semaphorin 3C	FUNCTION: Binds to plexin family members and plays an important role in the regulation of developmental processes. Required for normal cardiovascular development during embryogenesis. Functions as attractant for growing axons, and thereby plays an important role in axon growth and axon guidance (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed intensely in the heart, skeletal muscle, colon, small intestine, ovary, testis, and prostate. Faint expression ubiquitously among other organs, including brain.; 	medulla oblongata;smooth muscle;sympathetic chain;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;endometrium;bone;testis;dura mater;brain;bladder;unclassifiable (Anatomical System);amygdala;meninges;heart;cartilage;hypothalamus;blood;skeletal muscle;bile duct;breast;pancreas;pia mater;lung;adrenal gland;visual apparatus;liver;duodenum;spleen;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;fetal brain;appendix;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.23302	0.18797	-0.619039275	17.39797122	657.84766	5.14333	7q21.11																								
7	129688915	129688915	A	G	exonic	ZC3HC1		synonymous SNV	ZC3HC1:NM_001282191:exon2:c.T216C:p.S72S,ZC3HC1:NM_016478:exon2:c.T216C:p.S72S,ZC3HC1:NM_001282190:exon3:c.T153C:p.S51S	0.000510516198199949	0.998179913302684	0.00130957049911596	zinc finger C3HC-type containing 1	FUNCTION: Essential component of an SCF-type E3 ligase complex, SCF(NIPA), a complex that controls mitotic entry by mediating ubiquitination and subsequent degradation of cyclin B1 (CCNB1). Its cell-cycle-dependent phosphorylation regulates the assembly of the SCF(NIPA) complex, restricting CCNB1 ubiquitination activity to interphase. Its inactivation results in nuclear accumulation of CCNB1 in interphase and premature mitotic entry. May have an antiapoptotic role in NPM-ALK-mediated signaling events. {ECO:0000269|PubMed:16009132}.; 	.	TISSUE SPECIFICITY: Widely expressed. Highly expressed in heart, skeletal muscle and testis. Expressed in brain, placenta, lung, kidney, liver, pancreas, spleen, thymus, prostate, ovary small intestine and colon. Weakly or not expressed in leukocytes. {ECO:0000269|PubMed:12748172}.; 	lymphoreticular;medulla oblongata;umbilical cord;ovary;skin;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;bladder;brain;heart;cartilage;urinary;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;macula lutea;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;choroid;fovea centralis;vein;uterus;whole body;bone;testis;pineal gland;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;muscle;pancreas;lung;nasopharynx;placenta;head and neck;kidney;stomach;	superior cervical ganglion;testis - interstitial;testis;ciliary ganglion;	0.18560	.	0.242582624	69.45623968	3942.67551	12.41332	7q32.2		0.0003	0	0	0.0046	0	0	0	6.104e-05	0.0002	0	0	0	0.0043	0	0	0	rs141185149						
7	138595981	138595981	T	-	exonic	KIAA1549		frameshift deletion	KIAA1549:NM_001164665:exon4:c.3056delA:p.N1019Tfs*11,KIAA1549:NM_020910:exon4:c.3056delA:p.N1019Tfs*11	0.998645789892966	0.00135421009951753	7.51601382700902e-12	KIAA1549	.	DISEASE: Note=A chromosomal aberration involving KIAA1549 is found in pilocytic astrocytoma. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation. {ECO:0000269|PubMed:18974108}.; 	.	unclassifiable (Anatomical System);heart;muscle;colon;fovea centralis;choroid;lens;skin;retina;uterus;breast;pancreas;prostate;optic nerve;lung;frontal lobe;placenta;bone;macula lutea;kidney;brain;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;trigeminal ganglion;	0.46006	0.10368	1.659220063	96.23732012	8982.64039	20.55796	7q34																								
7	139138856	139138856	C	T	splicing	KLRG2	NM_198508:exon4:c.1109+1G>A			4.20606730807966e-07	0.114348465991639	0.88565111340163	killer cell lectin like receptor G2	.	.	.	unclassifiable (Anatomical System);lung;	.	0.08890	.	.	.	2966.04741	10.32209	7q34		5.866e-05	0	0	0	0	0.0002	0	0									rs774037434						
7	139138950	139138950	C	G	exonic	KLRG2		nonsynonymous SNV	KLRG2:NM_198508:exon4:c.G1016C:p.G339A	4.20606730807966e-07	0.114348465991639	0.88565111340163	killer cell lectin like receptor G2	.	.	.	unclassifiable (Anatomical System);lung;	.	0.08890	.	.	.	2966.04741	10.32209	7q34		0.1516	0.2089	0.1728	0.2099	0	0.1314	0.1463	0.1506	0.1436	0.1876	0.1208	0.1291	0.2081	0.0929	0.1254	0.1296	rs17160911						
7	156801695	156801695	G	C	exonic	MNX1		nonsynonymous SNV	MNX1:NM_001165255:exon1:c.C52G:p.Q18E	.	.	.	motor neuron and pancreas homeobox 1	FUNCTION: Putative transcription factor involved in pancreas development and function.; 	.	TISSUE SPECIFICITY: Expressed in lymphoid and pancreatic tissues.; 	unclassifiable (Anatomical System);pancreas;lung;islets of Langerhans;colon;stomach;	beta cell islets;ciliary ganglion;	0.36239	.	.	.	18.67801	0.64518	7q36.3																								
8	1806159	1806159	-	GG	exonic	ARHGEF10		frameshift insertion	ARHGEF10:NM_001308152:exon3:c.71_72insGG:p.E26Rfs*63,ARHGEF10:NM_014629:exon3:c.71_72insGG:p.E26Rfs*63,ARHGEF10:NM_001308153:exon4:c.143_144insGG:p.E50Rfs*63	1.10804741351534e-13	0.993645093874128	0.00635490612576131	Rho guanine nucleotide exchange factor 10	FUNCTION: May play a role in developmental myelination of peripheral nerves. {ECO:0000269|PubMed:14508709}.; 	DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]: Affected individuals present a reduction in nerve conduction velocities without any clinical signs of peripheral or central nervous system dysfunction. SNCV inheritance is autosomal dominant. {ECO:0000269|PubMed:14508709}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;cochlea;cerebral cortex;larynx;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;lung;adrenal gland;nasopharynx;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;thymus;	dorsal root ganglion;testis - interstitial;olfactory bulb;spinal cord;testis;atrioventricular node;trigeminal ganglion;	0.21968	.	-1.016286421	8.109223874	709.76209	5.29246	8p23.3																								
8	1806161	1806161	-	TCCC	exonic	ARHGEF10		frameshift insertion	ARHGEF10:NM_001308152:exon3:c.73_74insTCCC:p.E25Vfs*11,ARHGEF10:NM_014629:exon3:c.73_74insTCCC:p.E25Vfs*11,ARHGEF10:NM_001308153:exon4:c.145_146insTCCC:p.E49Vfs*11	1.10804741351534e-13	0.993645093874128	0.00635490612576131	Rho guanine nucleotide exchange factor 10	FUNCTION: May play a role in developmental myelination of peripheral nerves. {ECO:0000269|PubMed:14508709}.; 	DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]: Affected individuals present a reduction in nerve conduction velocities without any clinical signs of peripheral or central nervous system dysfunction. SNCV inheritance is autosomal dominant. {ECO:0000269|PubMed:14508709}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;cochlea;cerebral cortex;larynx;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;lung;adrenal gland;nasopharynx;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;thymus;	dorsal root ganglion;testis - interstitial;olfactory bulb;spinal cord;testis;atrioventricular node;trigeminal ganglion;	0.21968	.	-1.016286421	8.109223874	709.76209	5.29246	8p23.3																								
8	1806164	1806164	-	GCTGAGC	exonic	ARHGEF10		stopgain	ARHGEF10:NM_001308152:exon3:c.76_77insGCTGAGC:p.E26Gfs*2,ARHGEF10:NM_014629:exon3:c.76_77insGCTGAGC:p.E26Gfs*2,ARHGEF10:NM_001308153:exon4:c.148_149insGCTGAGC:p.E50Gfs*2	1.10804741351534e-13	0.993645093874128	0.00635490612576131	Rho guanine nucleotide exchange factor 10	FUNCTION: May play a role in developmental myelination of peripheral nerves. {ECO:0000269|PubMed:14508709}.; 	DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]: Affected individuals present a reduction in nerve conduction velocities without any clinical signs of peripheral or central nervous system dysfunction. SNCV inheritance is autosomal dominant. {ECO:0000269|PubMed:14508709}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;cochlea;cerebral cortex;larynx;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;lung;adrenal gland;nasopharynx;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;thymus;	dorsal root ganglion;testis - interstitial;olfactory bulb;spinal cord;testis;atrioventricular node;trigeminal ganglion;	0.21968	.	-1.016286421	8.109223874	709.76209	5.29246	8p23.3																								
8	1806229	1806229	A	C	exonic	ARHGEF10		synonymous SNV	ARHGEF10:NM_001308152:exon3:c.A141C:p.P47P,ARHGEF10:NM_014629:exon3:c.A141C:p.P47P,ARHGEF10:NM_001308153:exon4:c.A213C:p.P71P	1.10804741351534e-13	0.993645093874128	0.00635490612576131	Rho guanine nucleotide exchange factor 10	FUNCTION: May play a role in developmental myelination of peripheral nerves. {ECO:0000269|PubMed:14508709}.; 	DISEASE: Slowed nerve conduction velocity (SNCV) [MIM:608236]: Affected individuals present a reduction in nerve conduction velocities without any clinical signs of peripheral or central nervous system dysfunction. SNCV inheritance is autosomal dominant. {ECO:0000269|PubMed:14508709}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;cochlea;cerebral cortex;larynx;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;lung;adrenal gland;nasopharynx;placenta;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;thymus;	dorsal root ganglion;testis - interstitial;olfactory bulb;spinal cord;testis;atrioventricular node;trigeminal ganglion;	0.21968	.	-1.016286421	8.109223874	709.76209	5.29246	8p23.3		0.3039	0.3282	0.2820	0.2620	0.2621	0.2835	0.2867	0.4257	0.2969	0.3245	0.3242	0.1987	0.2299	0.2693	0.2949	0.2982	rs4875950	512831	Slowed_nerve_conduction_velocity,_autosomal_dominant	MedGen:C1842357,OMIM:608236,Orphanet:ORPHA140481	criteria_provided,_single_submitter	Benign	
8	2046785	2046786	GT	-	exonic	MYOM2		stopgain	MYOM2:NM_003970:exon19:c.2412_2413del:p.C805*	1.48718449693549e-55	7.78222893875632e-11	0.999999999922178	myomesin 2	FUNCTION: Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent.; 	.	.	myocardium;colon;choroid;fovea centralis;skin;retina;uterus;optic nerve;atrium;frontal lobe;larynx;testis;germinal center;brain;unclassifiable (Anatomical System);heart;spinal cord;lens;skeletal muscle;lung;placenta;macula lutea;liver;alveolus;head and neck;kidney;peripheral nerve;	skeletal muscle;	0.22436	0.11601	-0.500487825	21.84477471	8300.21663	19.71178	8p23.3																								
8	2057288	2057290	TTA	-	exonic	MYOM2		nonframeshift deletion	MYOM2:NM_003970:exon25:c.3146_3148del:p.I1051Nfs*415	1.48718449693549e-55	7.78222893875632e-11	0.999999999922178	myomesin 2	FUNCTION: Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent.; 	.	.	myocardium;colon;choroid;fovea centralis;skin;retina;uterus;optic nerve;atrium;frontal lobe;larynx;testis;germinal center;brain;unclassifiable (Anatomical System);heart;spinal cord;lens;skeletal muscle;lung;placenta;macula lutea;liver;alveolus;head and neck;kidney;peripheral nerve;	skeletal muscle;	0.22436	0.11601	-0.500487825	21.84477471	8300.21663	19.71178	8p23.3																								
8	6913031	6913031	G	A	exonic	DEFA5		synonymous SNV	DEFA5:NM_021010:exon2:c.C207T:p.T69T	0.000100681038440857	0.200800243834708	0.799099075126851	defensin alpha 5	FUNCTION: Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane. All DEFA5 peptides exert antimicrobial activities, but their potency is affected by peptide processing. {ECO:0000269|PubMed:12021776, ECO:0000269|PubMed:15616305, ECO:0000269|PubMed:17088326}.; 	.	TISSUE SPECIFICITY: Paneth cells of the small intestine (at protein level). {ECO:0000269|PubMed:12021776}.; 	optic nerve;small intestine;macula lutea;fovea centralis;choroid;lens;stomach;retina;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;parietal lobe;	0.10730	0.03412	-0.005381972	53.50908233	9.08816	0.33262	8p23.1		0.3737	0.1933	0.3552	0.3106	0.4310	0.4083	0.3499	0.3689	0.3278	0.1830	0.3266	0.4007	0.2890	0.4115	0.3930	0.3653	rs2272719						
8	17820622	17820622	A	T	exonic	PCM1		nonsynonymous SNV	PCM1:NM_001315507:exon17:c.A2476T:p.M826L,PCM1:NM_001315508:exon17:c.A2479T:p.M827L,PCM1:NM_006197:exon17:c.A2476T:p.M826L	.	.	.	pericentriolar material 1	FUNCTION: Required for centrosome assembly and function. Essential for the correct localization of several centrosomal proteins including CEP250, CETN3, PCNT and NEK2. Required to anchor microtubules to the centrosome. Involved in the biogenesis of cilia. {ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:15659651, ECO:0000269|PubMed:16943179, ECO:0000269|PubMed:20551181, ECO:0000269|PubMed:24121310}.; 	DISEASE: Note=A chromosomal aberration involving PCM1 is found in papillary thyroid carcinomas (PTCs). Translocation t(8;10)(p21.3;q11.2) with RET links the protein kinase domain of RET to the major portion of PCM1. {ECO:0000269|PubMed:10980597}.; DISEASE: Note=A chromosomal aberration involving PCM1 is found in a variety of hematological malignancies including atypical chronic myeloid leukemia (atypical CML) and T-cell lymphoma. Translocation t(8;9)(p22;p24) with JAK2 links the protein kinase domain of JAK2 to the major portion of PCM1.; 	TISSUE SPECIFICITY: Expressed in blood, bone marrow, breast, lymph node, ovary and thyroid. {ECO:0000269|PubMed:10980597, ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321, ECO:0000269|PubMed:16424865}.; 	myocardium;lymphoreticular;smooth muscle;ovary;skin;bone marrow;retina;prostate;frontal lobe;endometrium;cochlea;thyroid;amniotic fluid;germinal center;brain;amygdala;heart;cartilage;tongue;pharynx;blood;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;colon;parathyroid;fovea centralis;uterus;whole body;larynx;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;nasopharynx;placenta;head and neck;kidney;stomach;aorta;thymus;cerebellum;	testis - interstitial;superior cervical ganglion;occipital lobe;testis - seminiferous tubule;prefrontal cortex;testis;caudate nucleus;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;skeletal muscle;	0.52458	0.13544	-0.323627113	30.93300307	3402.14478	11.17265	8p22																								
8	17820646	17820646	G	T	exonic	PCM1		stopgain	PCM1:NM_001315507:exon17:c.G2500T:p.E834X,PCM1:NM_001315508:exon17:c.G2503T:p.E835X,PCM1:NM_006197:exon17:c.G2500T:p.E834X	.	.	.	pericentriolar material 1	FUNCTION: Required for centrosome assembly and function. Essential for the correct localization of several centrosomal proteins including CEP250, CETN3, PCNT and NEK2. Required to anchor microtubules to the centrosome. Involved in the biogenesis of cilia. {ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:15659651, ECO:0000269|PubMed:16943179, ECO:0000269|PubMed:20551181, ECO:0000269|PubMed:24121310}.; 	DISEASE: Note=A chromosomal aberration involving PCM1 is found in papillary thyroid carcinomas (PTCs). Translocation t(8;10)(p21.3;q11.2) with RET links the protein kinase domain of RET to the major portion of PCM1. {ECO:0000269|PubMed:10980597}.; DISEASE: Note=A chromosomal aberration involving PCM1 is found in a variety of hematological malignancies including atypical chronic myeloid leukemia (atypical CML) and T-cell lymphoma. Translocation t(8;9)(p22;p24) with JAK2 links the protein kinase domain of JAK2 to the major portion of PCM1.; 	TISSUE SPECIFICITY: Expressed in blood, bone marrow, breast, lymph node, ovary and thyroid. {ECO:0000269|PubMed:10980597, ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321, ECO:0000269|PubMed:16424865}.; 	myocardium;lymphoreticular;smooth muscle;ovary;skin;bone marrow;retina;prostate;frontal lobe;endometrium;cochlea;thyroid;amniotic fluid;germinal center;brain;amygdala;heart;cartilage;tongue;pharynx;blood;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;colon;parathyroid;fovea centralis;uterus;whole body;larynx;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;nasopharynx;placenta;head and neck;kidney;stomach;aorta;thymus;cerebellum;	testis - interstitial;superior cervical ganglion;occipital lobe;testis - seminiferous tubule;prefrontal cortex;testis;caudate nucleus;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;skeletal muscle;	0.52458	0.13544	-0.323627113	30.93300307	3402.14478	11.17265	8p22																								
8	17820738	17820739	TG	-	exonic	PCM1		frameshift deletion	PCM1:NM_001315507:exon17:c.2592_2593del:p.S866Ifs*4,PCM1:NM_001315508:exon17:c.2595_2596del:p.S867Ifs*4,PCM1:NM_006197:exon17:c.2592_2593del:p.S866Ifs*4	.	.	.	pericentriolar material 1	FUNCTION: Required for centrosome assembly and function. Essential for the correct localization of several centrosomal proteins including CEP250, CETN3, PCNT and NEK2. Required to anchor microtubules to the centrosome. Involved in the biogenesis of cilia. {ECO:0000269|PubMed:12403812, ECO:0000269|PubMed:15659651, ECO:0000269|PubMed:16943179, ECO:0000269|PubMed:20551181, ECO:0000269|PubMed:24121310}.; 	DISEASE: Note=A chromosomal aberration involving PCM1 is found in papillary thyroid carcinomas (PTCs). Translocation t(8;10)(p21.3;q11.2) with RET links the protein kinase domain of RET to the major portion of PCM1. {ECO:0000269|PubMed:10980597}.; DISEASE: Note=A chromosomal aberration involving PCM1 is found in a variety of hematological malignancies including atypical chronic myeloid leukemia (atypical CML) and T-cell lymphoma. Translocation t(8;9)(p22;p24) with JAK2 links the protein kinase domain of JAK2 to the major portion of PCM1.; 	TISSUE SPECIFICITY: Expressed in blood, bone marrow, breast, lymph node, ovary and thyroid. {ECO:0000269|PubMed:10980597, ECO:0000269|PubMed:15184884, ECO:0000269|PubMed:16270321, ECO:0000269|PubMed:16424865}.; 	myocardium;lymphoreticular;smooth muscle;ovary;skin;bone marrow;retina;prostate;frontal lobe;endometrium;cochlea;thyroid;amniotic fluid;germinal center;brain;amygdala;heart;cartilage;tongue;pharynx;blood;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;colon;parathyroid;fovea centralis;uterus;whole body;larynx;bone;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);lymph node;lacrimal gland;islets of Langerhans;bile duct;pancreas;lung;adrenal gland;nasopharynx;placenta;head and neck;kidney;stomach;aorta;thymus;cerebellum;	testis - interstitial;superior cervical ganglion;occipital lobe;testis - seminiferous tubule;prefrontal cortex;testis;caudate nucleus;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;skeletal muscle;	0.52458	0.13544	-0.323627113	30.93300307	3402.14478	11.17265	8p22																								
8	17927393	17927396	AAAT	-	intronic	ASAH1				5.35814510968979e-11	0.110203595268477	0.889796404677942	N-acylsphingosine amidohydrolase (acid ceramidase) 1	FUNCTION: Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid.; 	DISEASE: Spinal muscular atrophy with progressive myoclonic epilepsy (SMAPME) [MIM:159950]: An autosomal recessive neuromuscular disorder characterized by childhood onset of motor deficits and progressive myoclonic seizures, after normal developmental milestones. Proximal muscle weakness and generalized muscular atrophy are due to degeneration of spinal motor neurons. Myoclonic epilepsy is generally resistant to conventional therapy. The disease course is progressive and leads to respiratory muscle involvement and severe handicap or early death from respiratory insufficiency. {ECO:0000269|PubMed:22703880, ECO:0000269|PubMed:24164096}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Broadly expressed with highest expression in heart.; 	lymphoreticular;ovary;sympathetic chain;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;bladder;brain;heart;cartilage;urinary;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;trabecular meshwork;macula lutea;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;atrium;bone;pituitary gland;testis;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;pancreas;lung;adrenal gland;nasopharynx;placenta;head and neck;kidney;stomach;aorta;thymus;	amygdala;superior cervical ganglion;thyroid;spinal cord;kidney;whole blood;	0.16517	0.28903	0.514416907	80.31375324	457.27798	4.44122	8p22																								
8	28321247	28321247	C	T	exonic	FBXO16		nonsynonymous SNV	FBXO16:NM_001258211:exon3:c.G188A:p.R63Q,FBXO16:NM_172366:exon4:c.G224A:p.R75Q	6.61703415087813e-07	0.454532249196479	0.545467089100105	F-box protein 16	FUNCTION: Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation.; 	.	TISSUE SPECIFICITY: Expressed in heart, spleen and colon. {ECO:0000269|PubMed:12243353}.; 	unclassifiable (Anatomical System);smooth muscle;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;retina;bone marrow;prostate;lung;nasopharynx;liver;testis;kidney;brain;	.	0.04035	.	0.262810045	70.43524416	4498.3269	13.47336	8p21.1		0.0053	0.0007	0.0036	0.0292	0.0011	0.0035	0.0055	0.0056	0.0035	0.0007	0.0048	0.0099	0.0308	0.0003	0.0029	0.0010	rs3735726						
8	28321294	28321295	TG	-	exonic	FBXO16		frameshift deletion	FBXO16:NM_001258211:exon3:c.140_141del:p.T47Rfs*65,FBXO16:NM_172366:exon4:c.176_177del:p.T59Rfs*65	6.61703415087813e-07	0.454532249196479	0.545467089100105	F-box protein 16	FUNCTION: Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation.; 	.	TISSUE SPECIFICITY: Expressed in heart, spleen and colon. {ECO:0000269|PubMed:12243353}.; 	unclassifiable (Anatomical System);smooth muscle;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;retina;bone marrow;prostate;lung;nasopharynx;liver;testis;kidney;brain;	.	0.04035	.	0.262810045	70.43524416	4498.3269	13.47336	8p21.1																								
8	28321302	28321304	TTC	-	exonic	FBXO16		nonframeshift deletion	FBXO16:NM_001258211:exon3:c.131_133del:p.R44Ifs*237,FBXO16:NM_172366:exon4:c.167_169del:p.R56Ifs*237	6.61703415087813e-07	0.454532249196479	0.545467089100105	F-box protein 16	FUNCTION: Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation.; 	.	TISSUE SPECIFICITY: Expressed in heart, spleen and colon. {ECO:0000269|PubMed:12243353}.; 	unclassifiable (Anatomical System);smooth muscle;islets of Langerhans;colon;parathyroid;skin;skeletal muscle;retina;bone marrow;prostate;lung;nasopharynx;liver;testis;kidney;brain;	.	0.04035	.	0.262810045	70.43524416	4498.3269	13.47336	8p21.1		7.476e-05	0	0	0.0011	0	0	0	0	6.455e-05	0	0	0	0.0012	0	0	0	rs777110306						
8	52366266	52366267	TG	-	exonic	PXDNL		frameshift deletion	PXDNL:NM_144651:exon10:c.1061_1062del:p.T354Rfs*49	1.93677107008286e-27	0.000599485814575364	0.999400514185425	peroxidasin like	FUNCTION: Isoform PMR1: Endonuclease selectively degrading some target mRNAs while they are engaged by translating ribosomes, among which albumin and beta-globin mRNAs. {ECO:0000269|PubMed:22543864}.; 	.	TISSUE SPECIFICITY: the 57 kDa isoform PMR1 is the only form detected at protein levels in human cell lines. {ECO:0000269|PubMed:22543864}.; 	unclassifiable (Anatomical System);lung;heart;testis;	dorsal root ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	.	2.732433216	98.95022411	6585.72871	17.14983	8q11.22																								
8	98725999	98725999	-	A	splicing	MTDH	NM_178812:exon9:c.1380+2->A			0.721809341419168	0.278165221279176	2.54373016567053e-05	metadherin	FUNCTION: Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF- kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance. {ECO:0000269|PubMed:15927426, ECO:0000269|PubMed:16452207, ECO:0000269|PubMed:18316612, ECO:0000269|PubMed:19111877}.; 	.	TISSUE SPECIFICITY: Widely expressed with highest levels in muscle-dominating organs such as skeletal muscle, heart, tongue and small intestine and in endocrine glands such as thyroid and adrenal gland. Overexpressed in various cancers including breast, brain, prostate, melanoma and glioblastoma multiforme. {ECO:0000269|PubMed:15927426}.; 	myocardium;lymphoreticular;ovary;skin;bone marrow;retina;prostate;frontal lobe;cochlea;endometrium;thyroid;germinal center;bladder;brain;heart;tongue;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;uterus;whole body;larynx;bone;pituitary gland;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;bile duct;pancreas;lung;placenta;head and neck;kidney;stomach;thymus;	amygdala;superior cervical ganglion;medulla oblongata;prefrontal cortex;white blood cells;trigeminal ganglion;cingulate cortex;parietal lobe;	0.42250	0.14254	-0.424258538	25.56027365	333.467	3.87963	8q22.1																								
8	124525483	124525483	C	T	exonic	FBXO32		synonymous SNV	FBXO32:NM_148177:exon3:c.G171A:p.T57T,FBXO32:NM_058229:exon6:c.G606A:p.T202T	0.972568188048745	0.027424725547911	7.08640334382677e-06	F-box protein 32	FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins during skeletal muscle atrophy. Recognizes TERF1. {ECO:0000269|PubMed:15531760}.; 	.	TISSUE SPECIFICITY: Specifically expressed in cardiac and skeletal muscle.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;endometrium;bone;testis;brain;gall bladder;unclassifiable (Anatomical System);heart;cartilage;lacrimal gland;tongue;islets of Langerhans;lens;skeletal muscle;breast;lung;nasopharynx;placenta;macula lutea;liver;kidney;mammary gland;stomach;	superior cervical ganglion;skeletal muscle;	0.50082	0.22697	-0.049474214	50.01179523	503.32869	4.60351	8q24.13		0.1340	0.1774	0.1829	0.4609	0.1104	0.0912	0.1192	0.0848	0.1434	0.1735	0.1563	0.0762	0.4882	0.1100	0.0974	0.1418	rs3739287						
8	144658692	144658692	C	-	exonic	NAPRT		frameshift deletion	NAPRT:NM_001286829:exon7:c.932delG:p.G311Afs*7,NAPRT:NM_145201:exon7:c.932delG:p.G311Afs*7	.	.	.	nicotinate phosphoribosyltransferase	FUNCTION: Catalyzes the conversion of nicotinic acid (NA) to NA mononucleotide (NaMN). Essential for NA to increase cellular NAD levels and prevent oxidative stress of the cells. {ECO:0000269|PubMed:17604275}.; 	.	.	.	.	0.06027	0.11356	-1.017713296	8.103326256	.	.	8q24.3																								
9	6984236	6984236	G	A	exonic	KDM4C		nonsynonymous SNV	KDM4C:NM_001304340:exon9:c.G643A:p.D215N,KDM4C:NM_001146695:exon10:c.G1186A:p.D396N,KDM4C:NM_001146696:exon10:c.G1252A:p.D418N,KDM4C:NM_001304339:exon10:c.G1186A:p.D396N,KDM4C:NM_015061:exon10:c.G1186A:p.D396N	0.000758734602622751	0.999235107356564	6.15804081338881e-06	lysine demethylase 4C	FUNCTION: Histone demethylase that specifically demethylates 'Lys- 9' and 'Lys-36' residues of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-4', H3 'Lys-27' nor H4 'Lys-20'. Demethylates trimethylated H3 'Lys-9' and H3 'Lys-36' residue, while it has no activity on mono- and dimethylated residues. Demethylation of Lys residue generates formaldehyde and succinate. {ECO:0000269|PubMed:16603238}.; 	.	TISSUE SPECIFICITY: Overexpressed in several esophageal squamous cell carcinomas (ESCs). {ECO:0000269|PubMed:10987278}.; 	.	.	0.70659	.	-0.343575389	29.62373201	5314.03953	15.06707	9p24.1		0.2737	0.2047	0.3738	0.4142	0.1919	0.2163	0.2406	0.4402	0.2242	0.2142	0.3457	0.1767	0.3967	0.1924	0.2125	0.2311	rs2296067						ID=CM091846;CLASS=DP;MUT=ALT;GENE=KDM4C;STRAND=+;DNA=NM_015061.4:c.1186G>A;PROT=NP_055876.2:p.D396N;DB=rs2296067;PHEN="Upper_aerodigestive_tract_cancer_association_with";RANKSCORE=0.1
9	19076667	19076667	C	T	exonic	HAUS6		synonymous SNV	HAUS6:NM_001270890:exon11:c.G1122A:p.S374S,HAUS6:NM_017645:exon11:c.G1227A:p.S409S	6.60892812829788e-10	0.854816357735651	0.145183641603456	HAUS augmin like complex subunit 6	FUNCTION: Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. Promotes the nucleation of microtubules from the spindle through recruitment of NEDD1 and gamma-tubulin. {ECO:0000269|PubMed:19029337, ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}.; 	.	.	.	.	0.37338	0.07679	1.032445072	91.12408587	1600.47359	7.40118	9p22.1		0.0005	0	0	0.0064	0	4.509e-05	0	0	0.0004	0	0	0	0.0074	0	0	0	rs185819380						
9	35102743	35102743	C	T	exonic	STOML2		synonymous SNV	STOML2:NM_001287031:exon2:c.G123A:p.V41V,STOML2:NM_013442:exon2:c.G123A:p.V41V	0.529200678276011	0.470656310644159	0.000143011079829444	stomatin like 2	FUNCTION: Mitochondrial protein that probably regulates the biogenesis and the activity of mitochondria. Stimulates cardiolipin biosynthesis, binds cardiolipin-enriched membranes where it recruits and stabilizes some proteins including prohibitin and may therefore act in the organization of functional microdomains in mitochondrial membranes. Through regulation of the mitochondrial function may play a role into several biological processes including cell migration, cell proliferation, T-cell activation, calcium homeostasis and cellular response to stress. May play a role in calcium homeostasis through negative regulation of calcium efflux from mitochondria. Required for mitochondrial hyperfusion a pro-survival cellular response to stress which results in increased ATP production by mitochondria. May also regulate the organization of functional domains at the plasma membrane and play a role in T-cell activation through association with the T-cell receptor signaling complex and its regulation. {ECO:0000269|PubMed:17121834, ECO:0000269|PubMed:18641330, ECO:0000269|PubMed:19597348, ECO:0000269|PubMed:19944461, ECO:0000269|PubMed:21746876, ECO:0000269|PubMed:22623988}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed at low levels. Expressed in lymphoid tissues (at protein level). {ECO:0000269|PubMed:10713127, ECO:0000269|PubMed:11435687, ECO:0000269|PubMed:18641330}.; 	myocardium;lymphoreticular;ovary;skin;retina;bone marrow;prostate;frontal lobe;cochlea;endometrium;gum;thyroid;germinal center;bladder;brain;gall bladder;heart;tongue;pharynx;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;vein;uterus;whole body;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;muscle;bile duct;pancreas;lung;placenta;amnion;head and neck;kidney;stomach;	heart;tumor;	0.87655	0.14979	-0.471992905	23.03609342	30.66945	0.97588	9p13.3		0.0030	9.739e-05	0	0.0401	0	3.018e-05	0.0011	0.0007	0.0026	0	0	0	0.0487	0	0	0	rs2298309						
9	72897504	72897504	T	-	intronic	SMC5				0.980364885210913	0.0196351147459722	4.31147357842747e-11	structural maintenance of chromosomes 5	FUNCTION: Core component of the SMC5-SMC6 complex, a complex involved in repair of DNA double-strand breaks by homologous recombination. The complex may promote sister chromatid homologous recombination by recruiting the SMC1-SMC3 cohesin complex to double-strand breaks. The complex is required for telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines and mediates sumoylation of shelterin complex (telosome) components which is proposed to lead to shelterin complex disassembly in ALT-associated PML bodies (APBs). Required for recruitment of telomeres to PML nuclear bodies. Required for sister chromatid cohesion during prometaphase and mitotic progression; the function seems to be independent of SMC6. {ECO:0000269|PubMed:16810316, ECO:0000269|PubMed:17589526, ECO:0000269|PubMed:19502785}.; 	.	TISSUE SPECIFICITY: Widely expressed (PubMed:11408570). Strongly expressed in testis (PubMed:11408570). {ECO:0000269|PubMed:11408570}.; 	ovary;colon;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;lacrimal gland;tongue;islets of Langerhans;hypothalamus;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;liver;spleen;head and neck;kidney;mammary gland;stomach;aorta;	superior cervical ganglion;trigeminal ganglion;skeletal muscle;	0.35486	0.11584	-0.282886048	33.53385232	892.18859	5.82054	9q21.12																								
9	86900407	86900407	T	C	exonic	SLC28A3		synonymous SNV	SLC28A3:NM_001199633:exon14:c.A1500G:p.E500E,SLC28A3:NM_022127:exon15:c.A1500G:p.E500E	1.9648660260768e-17	0.00679344594423578	0.993206554055764	solute carrier family 28 member 3	FUNCTION: Sodium-dependent, pyrimidine- and purine-selective. Involved in the homeostasis of endogenous nucleosides. Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine). Employs a 2:1 sodium/nucleoside ratio. Also able to transport gemcitabine, 3'-azido-3'-deoxythymidine (AZT), ribavirin and 3-deazauridine. {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:16446384, ECO:0000269|PubMed:17140564}.; 	.	TISSUE SPECIFICITY: Expressed in pancreas, bone marrow, trachea, mammary gland, liver, prostate, and regions of intestine, brain, lung, placenta, testis, kidney, and heart. {ECO:0000269|PubMed:11032837}.; 	.	.	0.17401	0.11684	0.846940207	88.47605567	2204.23741	8.64325	9q21.33																								
9	96052295	96052295	C	G	exonic	WNK2		synonymous SNV	WNK2:NM_006648:exon20:c.C4902G:p.A1634A,WNK2:NM_001282394:exon21:c.C5013G:p.A1671A	0.792762080315492	0.207237918939483	7.45024642649355e-10	WNK lysine deficient protein kinase 2	FUNCTION: Serine/threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively. Activates SLC12A2, SCNN1A, SCNN1B, SCNN1D and SGK1 and inhibits SLC12A5. Negatively regulates the EGF-induced activation of the ERK/MAPK-pathway and the downstream cell cycle progression. Affects MAPK3/MAPK1 activity by modulating the activity of MAP2K1 and this modulation depends on phosphorylation of MAP2K1 by PAK1. WNK2 acts by interfering with the activity of PAK1 by controlling the balance of the activity of upstream regulators of PAK1 activity, RHOA and RAC1, which display reciprocal activity. {ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:18593598, ECO:0000269|PubMed:21733846}.; 	.	TISSUE SPECIFICITY: Expressed in various cancer cell lines (at protein level). Predominantly expressed in heart, brain, skeletal muscle and colon. {ECO:0000269|PubMed:11571656, ECO:0000269|PubMed:17667937, ECO:0000269|PubMed:21733846}.; 	myocardium;ovary;colon;skin;retina;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;iris;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;lacrimal gland;islets of Langerhans;lens;pancreas;lung;placenta;visual apparatus;alveolus;head and neck;mammary gland;peripheral nerve;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;adrenal gland;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;cerebellum;	0.14056	0.12240	.	.	3878.51059	12.27991	9q22.31		0.1783	0.0926	0.3300	0.1570	0.3512	0.2253	0.2185	0.0577	0.1127	0.0606	0.1754	0.15	0.0660	0.1604	0.1308	0.1411	rs4744216						
9	97369188	97369188	T	-	exonic	FBP1		frameshift deletion	FBP1:NM_000507:exon5:c.614delA:p.K205Rfs*72,FBP1:NM_001127628:exon6:c.614delA:p.K205Rfs*72	0.0985907926556028	0.866512033387524	0.0348971739568735	fructose-bisphosphatase 1	FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain. {ECO:0000269|PubMed:16497803, ECO:0000269|PubMed:18375435, ECO:0000269|PubMed:22517657}.; 	DISEASE: Fructose-1,6-bisphosphatase deficiency (FBP1D) [MIM:229700]: An autosomal recessive metabolic disorder characterized by impaired gluconeogenesis, and episodes of hypoglycemia and metabolic acidosis that can be lethal in newborn infants or young children. {ECO:0000269|PubMed:12126934, ECO:0000269|PubMed:9382095}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in pancreatic islets. {ECO:0000269|PubMed:18375435}.; 	.	.	0.37365	0.50695	-0.005381972	53.50908233	143.00069	2.60725	9q22.32																								
9	101056159	101056159	-	T	exonic	GABBR2		frameshift insertion	GABBR2:NM_005458:exon18:c.2567dupA:p.N856Kfs*98	0.999790262521872	0.000209737468490762	9.63726054104311e-12	gamma-aminobutyric acid type B receptor subunit 2	FUNCTION: Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase, stimulates phospholipase A2, activates potassium channels, inactivates voltage-dependent calcium-channels and modulates inositol phospholipid hydrolysis. Plays a critical role in the fine-tuning of inhibitory synaptic transmission. Pre-synaptic GABA receptor inhibits neurotransmitter release by down-regulating high-voltage activated calcium channels, whereas postsynaptic GABA receptor decreases neuronal excitability by activating a prominent inwardly rectifying potassium (Kir) conductance that underlies the late inhibitory postsynaptic potentials. Not only implicated in synaptic inhibition but also in hippocampal long-term potentiation, slow wave sleep, muscle relaxation and antinociception. {ECO:0000269|PubMed:10328880, ECO:0000269|PubMed:18165688, ECO:0000269|PubMed:22660477, ECO:0000269|PubMed:24305054, ECO:0000269|PubMed:9872316}.; 	.	TISSUE SPECIFICITY: Highly expressed in brain, especially in cerebral cortex, thalamus, hippocampus, frontal, occipital and temporal lobe, occipital pole and cerebellum, followed by corpus callosum, caudate nucleus, spinal cord, amygdala and medulla. Weakly expressed in heart, testis and skeletal muscle. {ECO:0000269|PubMed:10087195, ECO:0000269|PubMed:10328880, ECO:0000269|PubMed:10727622}.; 	unclassifiable (Anatomical System);amygdala;ovary;hypothalamus;adrenal cortex;parathyroid;fovea centralis;skeletal muscle;optic nerve;whole body;lung;frontal lobe;placenta;macula lutea;visual apparatus;liver;spleen;pineal gland;brain;cerebellum;	amygdala;whole brain;thalamus;medulla oblongata;superior cervical ganglion;occipital lobe;cerebellum peduncles;hypothalamus;temporal lobe;pons;atrioventricular node;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;ciliary ganglion;parietal lobe;cingulate cortex;cerebellum;	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	9q22.33		8.238e-06	0	0	0	0	1.499e-05	0	0									rs763141501						
9	113191529	113191530	CA	-	exonic	SVEP1		stopgain	SVEP1:NM_153366:exon35:c.5700_5701del:p.C1900*	0.589007650495336	0.410992349504664	1.40850230409457e-16	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1	FUNCTION: May play a role in the cell attachment process. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Present in mesenchymal primary cultured cell lysates (at protein level). Highly expressed in placenta. Also expressed in marrow stromal cell. Weakly or not expressed in other tissues. {ECO:0000269|PubMed:11062057, ECO:0000269|PubMed:16206243}.; 	ovary;colon;parathyroid;choroid;skin;uterus;whole body;frontal lobe;cerebral cortex;larynx;bone;testis;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;skeletal muscle;breast;pancreas;lung;epididymis;nasopharynx;trabecular meshwork;placenta;visual apparatus;liver;hypopharynx;spleen;head and neck;kidney;mammary gland;	superior cervical ganglion;adipose tissue;placenta;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.75699	.	4.588666937	99.75819769	15016.94079	26.57856	9q31.3																								
9	123725953	123725953	C	T	exonic	C5		synonymous SNV	C5:NM_001317163:exon34:c.G4302A:p.L1434L,C5:NM_001735:exon34:c.G4284A:p.L1428L	5.61068968015523e-11	0.999999829018884	1.70925009246444e-07	complement component 5	FUNCTION: Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.; 	DISEASE: Complement component 5 deficiency (C5D) [MIM:609536]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=An association study of C5 haplotypes and genotypes in individuals with chronic hepatitis C virus infection shows that individuals homozygous for the C5_1 haplotype have a significantly higher stage of liver fibrosis than individuals carrying at least 1 other allele. {ECO:0000269|PubMed:15995705}.; 	.	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;optic nerve;whole body;bone;testis;germinal center;brain;unclassifiable (Anatomical System);heart;hypothalamus;lens;skeletal muscle;lung;placenta;macula lutea;liver;cervix;spleen;kidney;	superior cervical ganglion;fetal liver;	0.25448	0.15814	-0.051509809	49.39254541	5639.16587	15.54132	9q33.2																								
9	123725968	123725968	C	T	exonic	C5		synonymous SNV	C5:NM_001317163:exon34:c.G4287A:p.V1429V,C5:NM_001735:exon34:c.G4269A:p.V1423V	5.61068968015523e-11	0.999999829018884	1.70925009246444e-07	complement component 5	FUNCTION: Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.; 	DISEASE: Complement component 5 deficiency (C5D) [MIM:609536]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=An association study of C5 haplotypes and genotypes in individuals with chronic hepatitis C virus infection shows that individuals homozygous for the C5_1 haplotype have a significantly higher stage of liver fibrosis than individuals carrying at least 1 other allele. {ECO:0000269|PubMed:15995705}.; 	.	ovary;colon;parathyroid;choroid;fovea centralis;skin;retina;uterus;optic nerve;whole body;bone;testis;germinal center;brain;unclassifiable (Anatomical System);heart;hypothalamus;lens;skeletal muscle;lung;placenta;macula lutea;liver;cervix;spleen;kidney;	superior cervical ganglion;fetal liver;	0.25448	0.15814	-0.051509809	49.39254541	5639.16587	15.54132	9q33.2																								
9	131360750	131360750	C	T	exonic	SPTAN1		synonymous SNV	SPTAN1:NM_001195532:exon24:c.C3426T:p.L1142L,SPTAN1:NM_001130438:exon25:c.C3486T:p.L1162L,SPTAN1:NM_003127:exon25:c.C3486T:p.L1162L	0.999999999999786	2.14126644281593e-13	1.00356698801876e-35	spectrin alpha, non-erythrocytic 1	FUNCTION: Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus candidate for the calcium-dependent movement of the cytoskeleton at the membrane.; 	DISEASE: Epileptic encephalopathy, early infantile, 5 (EIEE5) [MIM:613477]: A disorder characterized by seizures associated with hypsarrhythmia, profound mental retardation with lack of visual attention and speech development, as well as spastic quadriplegia. {ECO:0000269|PubMed:20493457}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;ovary;sympathetic chain;skin;retina;bone marrow;prostate;optic nerve;frontal lobe;cochlea;endometrium;thyroid;amniotic fluid;germinal center;bladder;brain;gall bladder;tonsil;heart;cartilage;tongue;urinary;adrenal cortex;blood;lens;skeletal muscle;breast;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;colon;fovea centralis;choroid;uterus;cerebral cortex;larynx;bone;testis;spinal ganglion;unclassifiable (Anatomical System);lacrimal gland;islets of Langerhans;hypothalamus;bile duct;pancreas;lung;placenta;amnion;head and neck;kidney;stomach;thymus;cerebellum;	whole brain;amygdala;dorsal root ganglion;occipital lobe;superior cervical ganglion;thalamus;medulla oblongata;cerebellum peduncles;temporal lobe;spinal cord;pons;atrioventricular node;caudate nucleus;skin;subthalamic nucleus;fetal brain;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;cerebellum;	0.60251	0.39112	-3.530899533	0.31257372	104.65947	2.21139	9q34.11		0.8064	0.4910	0.7891	0.5170	0.8249	0.8963	0.8175	0.7815	0.7491	0.4777	0.7828	0.9172	0.5161	0.8242	0.9048	0.8160	rs2227864	168774	Seizures|not_specified|Early_Infantile_Epileptic_Encephalopathy,_Autosomal_Dominant|not_provided	Human_Phenotype_Ontology:HP:0001250,MedGen:C0036572|MedGen:CN169374|MedGen:CN239232|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
9	134497321	134497321	C	T	exonic	RAPGEF1		synonymous SNV	RAPGEF1:NM_001304275:exon11:c.G1767A:p.T589T,RAPGEF1:NM_005312:exon11:c.G1716A:p.T572T,RAPGEF1:NM_198679:exon11:c.G1770A:p.T590T	0.999914749689066	8.5250310716412e-05	2.17573889204483e-13	Rap guanine nucleotide exchange factor 1	FUNCTION: Guanine nucleotide-releasing protein that binds to SH3 domain of CRK and GRB2/ASH. Transduces signals from CRK to activate RAS. Plays a role in the establishment of basal endothelial barrier function. Plays a role in nerve growth factor (NGF)-induced sustained activation of Rap1 and neurite outgrowth. {ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:7806500}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed in adult and fetus. Expression is high in adult skeletal muscle and placenta and in fetal brain and heart. Low levels of expression in adult and fetal liver.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;placenta;macula lutea;visual apparatus;hypopharynx;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;cerebellum;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.17146	0.19882	-1.767443354	2.317763623	77.63729	1.85508	9q34.13		0.0381	0.0889	0.1071	0.0832	0.0145	0.0040	0.0417	0.0851	0.0355	0.0850	0.0919	0.01	0.1	0.0123	0.0039	0.0133	rs2274600						
9	134497362	134497362	C	-	exonic	RAPGEF1		frameshift deletion	RAPGEF1:NM_001304275:exon11:c.1726delG:p.E576Rfs*122,RAPGEF1:NM_005312:exon11:c.1675delG:p.E559Rfs*122,RAPGEF1:NM_198679:exon11:c.1729delG:p.E577Rfs*122	0.999914749689066	8.5250310716412e-05	2.17573889204483e-13	Rap guanine nucleotide exchange factor 1	FUNCTION: Guanine nucleotide-releasing protein that binds to SH3 domain of CRK and GRB2/ASH. Transduces signals from CRK to activate RAS. Plays a role in the establishment of basal endothelial barrier function. Plays a role in nerve growth factor (NGF)-induced sustained activation of Rap1 and neurite outgrowth. {ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:7806500}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed in adult and fetus. Expression is high in adult skeletal muscle and placenta and in fetal brain and heart. Low levels of expression in adult and fetal liver.; 	ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;placenta;macula lutea;visual apparatus;hypopharynx;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;aorta;stomach;cerebellum;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.17146	0.19882	-1.767443354	2.317763623	77.63729	1.85508	9q34.13																								
9	137775166	137775166	G	T	exonic	FCN2		nonsynonymous SNV	FCN2:NM_015837:exon2:c.G119T:p.G40V,FCN2:NM_004108:exon3:c.G233T:p.G78V	1.93230355683024e-09	0.126502910314143	0.873497087753553	ficolin 2	FUNCTION: May function in innate immunity through activation of the lectin complement pathway. Calcium-dependent and GlcNAc- binding lectin. Enhances phagocytosis of S.typhimurium by neutrophils, suggesting an opsonic effect via the collagen region. {ECO:0000269|PubMed:10679061, ECO:0000269|PubMed:17215869}.; 	.	TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.; 	liver;spleen;blood;bone marrow;	liver;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.09798	0.09630	0.578735925	82.29535268	4032.47143	12.58303	9q34.3																								
9	140372570	140372570	G	A	exonic	PNPLA7		nonsynonymous SNV	PNPLA7:NM_152286:exon24:c.C2723T:p.P908L,PNPLA7:NM_001098537:exon25:c.C2798T:p.P933L	6.22823670158545e-27	0.00229814683804157	0.997701853161958	patatin like phospholipase domain containing 7	FUNCTION: Serine hydrolase, whose specific chemical modification by certain organophosphorus (OP) compounds leads to distal axonopathy. {ECO:0000250}.; 	.	.	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;retina;uterus;pancreas;prostate;lung;endometrium;bone;alveolus;testis;germinal center;kidney;brain;stomach;thymus;	superior cervical ganglion;ciliary ganglion;caudate nucleus;trigeminal ganglion;skeletal muscle;skin;parietal lobe;	0.10273	0.09780	0.163315215	64.96815287	2633.02271	9.62537	9q34.3		0.0158	0.0016	0	0.2107	0	0.0015	0.0128	0.0085	0.0065	0.0021	0.0012	0	0.1001	0.0017	0.0006	0.0061	rs3812499						
10	13178766	13178766	G	A	exonic	OPTN		nonsynonymous SNV	OPTN:NM_021980:exon14:c.G1634A:p.R545Q,OPTN:NM_001008212:exon15:c.G1634A:p.R545Q,OPTN:NM_001008211:exon16:c.G1634A:p.R545Q,OPTN:NM_001008213:exon16:c.G1634A:p.R545Q	4.99023423032989e-07	0.847327296999855	0.152672203976722	optineurin	FUNCTION: Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8. Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation. Negatively regulates the induction of IFNB in response to RNA virus infection. Plays a neuroprotective role in the eye and optic nerve. Probably part of the TNF-alpha signaling pathway that can shift the equilibrium toward induction of cell death. May act by regulating membrane trafficking and cellular morphogenesis via a complex that contains Rab8 and hungtingtin (HD). Mediates the interaction of Rab8 with the probable GTPase-activating protein TBC1D17 during Rab8-mediated endocytic trafficking, such as of transferrin receptor (TFRC/TfR); regulates Rab8 recruitnment to tubules emanating from the endocytic recycling compartment. Autophagy receptor that interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family; targets ubiquitin-coated bacteria (xenophagy), such as cytoplasmic Salmonella enterica, and appears to function in the same pathway as SQSTM1 and CALCOCO2/NDP52. May constitute a cellular target for adenovirus E3 14.7, an inhibitor of TNF-alpha functions, thereby affecting cell death. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:15837803, ECO:0000269|PubMed:20085643, ECO:0000269|PubMed:20174559, ECO:0000269|PubMed:21617041, ECO:0000269|PubMed:22854040}.; 	DISEASE: Glaucoma 1, open angle, E (GLC1E) [MIM:137760]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:12939304, ECO:0000269|PubMed:14597044, ECO:0000269|PubMed:15226658, ECO:0000269|PubMed:15326130, ECO:0000269|PubMed:15557444}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glaucoma, normal pressure (NPG) [MIM:606657]: A primary glaucoma characterized by intraocular pression consistently within the statistically normal population range. {ECO:0000269|PubMed:15370540}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 12 (ALS12) [MIM:613435]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269|PubMed:20428114}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Present in aqueous humor of the eye (at protein level). Highly expressed in trabecular meshwork. Expressed nonpigmented ciliary epithelium, retina, brain, adrenal cortex, fetus, lymphocyte, fibroblast, skeletal muscle, heart, liver, brain and placenta. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:9488477}.; 	ovary;colon;substantia nigra;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;thyroid;iris;pituitary gland;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;cerebellum cortex;blood;lens;skeletal muscle;breast;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;alveolus;amnion;spleen;head and neck;kidney;mammary gland;stomach;	amygdala;occipital lobe;subthalamic nucleus;spinal cord;prefrontal cortex;ciliary ganglion;pons;caudate nucleus;parietal lobe;skeletal muscle;cingulate cortex;	0.12825	0.21998	-0.578583623	18.71903751	339.76712	3.91067	10p13		0.0029	0	0.0002	0.0335	0.0002	0.0004	0.0044	0.0016	0.0021	0	0	0.0033	0.0377	0	0.0002	0.0010	rs75654767	22137	Primary_open_angle_glaucoma|Glaucoma_1,_open_angle,_e|Amyotrophic_lateral_sclerosis_type_12|Amyotrophic_Lateral_Sclerosis,_Recessive	Human_Phenotype_Ontology:HP:0012108,MedGen:C0339573,OMIM:137760,SNOMED_CT:77075001|MedGen:C1842026|MedGen:C3150692,OMIM:613435|MedGen:CN239196	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	ID=CM020164;CLASS=DM?;MUT=ALT;GENE=OPTN;STRAND=+;DNA=NM_021980.4:c.1634G>A;PROT=NP_068815.2:p.R545Q;DB=rs75654767;PHEN="Glaucoma_1_open_angle";RANKSCORE=0.1
10	13178789	13178789	C	T	exonic	OPTN		nonsynonymous SNV	OPTN:NM_021980:exon14:c.C1657T:p.H553Y,OPTN:NM_001008212:exon15:c.C1657T:p.H553Y,OPTN:NM_001008211:exon16:c.C1657T:p.H553Y,OPTN:NM_001008213:exon16:c.C1657T:p.H553Y	4.99023423032989e-07	0.847327296999855	0.152672203976722	optineurin	FUNCTION: Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8. Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation. Negatively regulates the induction of IFNB in response to RNA virus infection. Plays a neuroprotective role in the eye and optic nerve. Probably part of the TNF-alpha signaling pathway that can shift the equilibrium toward induction of cell death. May act by regulating membrane trafficking and cellular morphogenesis via a complex that contains Rab8 and hungtingtin (HD). Mediates the interaction of Rab8 with the probable GTPase-activating protein TBC1D17 during Rab8-mediated endocytic trafficking, such as of transferrin receptor (TFRC/TfR); regulates Rab8 recruitnment to tubules emanating from the endocytic recycling compartment. Autophagy receptor that interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family; targets ubiquitin-coated bacteria (xenophagy), such as cytoplasmic Salmonella enterica, and appears to function in the same pathway as SQSTM1 and CALCOCO2/NDP52. May constitute a cellular target for adenovirus E3 14.7, an inhibitor of TNF-alpha functions, thereby affecting cell death. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:15837803, ECO:0000269|PubMed:20085643, ECO:0000269|PubMed:20174559, ECO:0000269|PubMed:21617041, ECO:0000269|PubMed:22854040}.; 	DISEASE: Glaucoma 1, open angle, E (GLC1E) [MIM:137760]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:12939304, ECO:0000269|PubMed:14597044, ECO:0000269|PubMed:15226658, ECO:0000269|PubMed:15326130, ECO:0000269|PubMed:15557444}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glaucoma, normal pressure (NPG) [MIM:606657]: A primary glaucoma characterized by intraocular pression consistently within the statistically normal population range. {ECO:0000269|PubMed:15370540}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 12 (ALS12) [MIM:613435]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269|PubMed:20428114}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Present in aqueous humor of the eye (at protein level). Highly expressed in trabecular meshwork. Expressed nonpigmented ciliary epithelium, retina, brain, adrenal cortex, fetus, lymphocyte, fibroblast, skeletal muscle, heart, liver, brain and placenta. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:9488477}.; 	ovary;colon;substantia nigra;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;thyroid;iris;pituitary gland;testis;amniotic fluid;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;cerebellum cortex;blood;lens;skeletal muscle;breast;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;alveolus;amnion;spleen;head and neck;kidney;mammary gland;stomach;	amygdala;occipital lobe;subthalamic nucleus;spinal cord;prefrontal cortex;ciliary ganglion;pons;caudate nucleus;parietal lobe;skeletal muscle;cingulate cortex;	0.12825	0.21998	-0.578583623	18.71903751	339.76712	3.91067	10p13																								
10	16979789	16979832	CATAAAAACAGATAATAGAGCATTGTATTATCTATATTTTTCTT	-	intronic	CUBN				3.03432572949695e-28	0.9999999775831	2.24169003645547e-08	cubilin	FUNCTION: Cotransporter which plays a role in lipoprotein, vitamin and iron metabolism, by facilitating their uptake. Binds to ALB, MB, Kappa and lambda-light chains, TF, hemoglobin, GC, SCGB1A1, APOA1, high density lipoprotein, and the GIF-cobalamin complex. The binding of all ligands requires calcium. Serves as important transporter in several absorptive epithelia, including intestine, renal proximal tubules and embryonic yolk sac. Interaction with LRP2 mediates its trafficking throughout vesicles and facilitates the uptake of specific ligands like GC, hemoglobin, ALB, TF and SCGB1A1. Interaction with AMN controls its trafficking to the plasma membrane and facilitates endocytosis of ligands. May play an important role in the development of the peri-implantation embryo through internalization of APOA1 and cholesterol. Binds to LGALS3 at the maternal-fetal interface. {ECO:0000269|PubMed:10371504, ECO:0000269|PubMed:11606717, ECO:0000269|PubMed:11717447, ECO:0000269|PubMed:14576052, ECO:0000269|PubMed:9572993}.; 	DISEASE: Recessive hereditary megaloblastic anemia 1 (RH-MGA1) [MIM:261100]: Due to selective malabsorption of vitamin B12. Defects in vitamin B12 absorption lead to impaired function of thymidine synthase. As a consequence DNA synthesis is interrupted. Rapidly dividing cells involved in erythropoiesis are particularly affected. {ECO:0000269|PubMed:10080186, ECO:0000269|PubMed:10887099}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in kidney proximal tubule cells, placenta, visceral yolk-sac cells and in absorptive intestinal cells. Expressed in the epithelium of intestine and kidney.; 	.	.	0.16009	0.31630	1.257700362	93.49492805	6532.49526	17.00260	10p13																								
10	43678844	43678844	-	C	exonic	CSGALNACT2		frameshift insertion	CSGALNACT2:NM_018590:exon8:c.1484dupC:p.E497Rfs*10	0.451240634927787	0.548498353594189	0.00026101147802408	chondroitin sulfate N-acetylgalactosaminyltransferase 2	FUNCTION: Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP- GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. {ECO:0000269|PubMed:12433924, ECO:0000269|PubMed:12446672}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:12433924, ECO:0000269|PubMed:12446672}.; 	.	.	0.32999	0.11194	-0.268115223	34.70747818	1778.77208	7.78907	10q11.21																								
10	50681008	50681008	C	-	exonic	ERCC6		frameshift deletion	ERCC6:NM_000124:exon15:c.2776delG:p.A926Qfs*26,ERCC6:NM_001346440:exon15:c.2776delG:p.A926Qfs*26	5.00691675988158e-13	0.9992610992513	0.000738900748198946	excision repair cross-complementation group 6	FUNCTION: Essential factor involved in transcription-coupled nucleotide excision repair which allows RNA polymerase II-blocking lesions to be rapidly removed from the transcribed strand of active genes. Upon DNA-binding, it locally modifies DNA conformation by wrapping the DNA around itself, thereby modifying the interface between stalled RNA polymerase II and DNA. It is required for transcription-coupled repair complex formation. It recruits the CSA complex (DCX(ERCC8) complex), nucleotide excision repair proteins and EP300 to the at sites of RNA polymerase II- blocking lesions. {ECO:0000269|PubMed:15548521, ECO:0000269|PubMed:16916636, ECO:0000269|PubMed:20541997}.; 	DISEASE: Cockayne syndrome B (CSB) [MIM:133540]: A rare disorder characterized by cutaneous sensitivity to sunlight, abnormal and slow growth, cachectic dwarfism, progeroid appearance, progressive pigmentary retinopathy and sensorineural deafness. There is delayed neural development and severe progressive neurologic degeneration resulting in mental retardation. Two clinical forms are recognized: in the classical form or Cockayne syndrome type 1, the symptoms are progressive and typically become apparent within the first few years or life; the less common Cockayne syndrome type 2 is characterized by more severe symptoms that manifest prenatally. Cockayne syndrome shows some overlap with certain forms of xeroderma pigmentosum. Unlike xeroderma pigmentosum, patients with Cockayne syndrome do not manifest increased freckling and other pigmentation abnormalities in the skin and have no significant increase in skin cancer. {ECO:0000269|PubMed:19894250, ECO:0000269|PubMed:9443879}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cerebro-oculo-facio-skeletal syndrome 1 (COFS1) [MIM:214150]: A disorder of prenatal onset characterized by microcephaly, congenital cataracts, facial dysmorphism, neurogenic arthrogryposis, growth failure and severe psychomotor retardation. COFS is considered to be part of the nucleotide-excision repair disorders spectrum that include also xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome. {ECO:0000269|PubMed:19894250}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: De Sanctis-Cacchione syndrome (DSC) [MIM:278800]: An autosomal recessive syndrome consisting of xeroderma pigmentosum associated with severe neurological and developmental involvement. In addition to the clinical signs of xeroderma pigmentosum, patients present with mental retardation, dwarfism, gonadal hypoplasia, microcephaly and various neurologic complications of early onset. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, age-related, 5 (ARMD5) [MIM:613761]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:16754848}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: UV-sensitive syndrome 1 (UVSS1) [MIM:600630]: An autosomal recessive disorder characterized by cutaneous photosensitivity and mild freckling in the absence of neurological abnormalities or skin tumors. {ECO:0000269|PubMed:15486090}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);lymphoreticular;lung;testis;colon;blood;skeletal muscle;bone marrow;	superior cervical ganglion;ciliary ganglion;pons;trigeminal ganglion;skeletal muscle;skin;	.	0.46867	1.486276519	95.32318943	3542.12652	11.48622	10q11.23	ID=COSM1348074;OCCURENCE=1(large_intestine)																							
10	95121307	95121307	T	C	exonic	MYOF		nonsynonymous SNV	MYOF:NM_133337:exon27:c.A2837G:p.D946G,MYOF:NM_013451:exon28:c.A2876G:p.D959G	2.08401244116976e-36	0.259659118287117	0.740340881712883	myoferlin	FUNCTION: Calcium/phospholipid-binding protein that plays a role in the plasmalemma repair mechanism of endothelial cells that permits rapid resealing of membranes disrupted by mechanical stress. Involved in endocytic recycling. Implicated in VEGF signal transduction by regulating the levels of the receptor KDR (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in myoblast and endothelial cells (at protein level). Highly expressed in cardiac and skeletal muscles. Also present in lung, and at very low levels in kidney, placenta and brain. {ECO:0000269|PubMed:11959863, ECO:0000269|PubMed:17702744, ECO:0000269|PubMed:18502764}.; 	smooth muscle;ovary;salivary gland;intestine;colon;skin;bone marrow;uterus;prostate;endometrium;larynx;bone;thyroid;iris;testis;spinal ganglion;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;urinary;pharynx;blood;skeletal muscle;breast;pancreas;lung;cornea;placenta;visual apparatus;amnion;alveolus;hypopharynx;liver;cervix;head and neck;kidney;mammary gland;aorta;stomach;	superior cervical ganglion;	0.19502	0.13376	-0.435697896	24.68152866	2094.22471	8.43082	10q23.33																								
10	100195123	100195124	CG	-	exonic	HPS1		frameshift deletion	HPS1:NM_000195:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322476:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322477:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322478:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322479:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322490:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322491:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_001322492:exon5:c.303_304del:p.S101Rfs*16,HPS1:NM_182639:exon5:c.303_304del:p.S101Rfs*16	5.9907099496673e-07	0.96719882033045	0.0328005805985547	HPS1, biogenesis of lysosomal organelles complex 3 subunit 1	FUNCTION: Component of multiple cytoplasmic organelles. Apparently crucial for their normal development and function. May be involved in intracellular protein sorting.; 	.	TISSUE SPECIFICITY: Ubiquitous.; 	lymphoreticular;medulla oblongata;ovary;salivary gland;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;bone;thyroid;iris;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;small intestine;heart;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;bile duct;breast;pancreas;lung;placenta;macula lutea;liver;cervix;spleen;kidney;mammary gland;stomach;peripheral nerve;cerebellum;	dorsal root ganglion;superior cervical ganglion;testis - seminiferous tubule;testis;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;bone marrow;	0.56605	0.15893	0.850585932	88.49374853	2245.61435	8.74351	10q24.2																								
10	121579040	121579040	T	C	exonic	INPP5F		synonymous SNV	INPP5F:NM_001243194:exon1:c.T45C:p.F15F	0.00146883108535103	0.998530687106157	4.81808491868399e-07	inositol polyphosphate-5-phosphatase F	FUNCTION: Inositol 5-phosphatase which acts on phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. Hydrolyzes phosphatidylinositol 4,5- bisphosphate most effectively. Modulates AKT/GSK3B pathway by decreasing AKT and GSK3B phosphorylation. {ECO:0000269|PubMed:11274189, ECO:0000269|PubMed:17322895}.; 	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11274189}.; 	ovary;sympathetic chain;developmental;substantia nigra;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;cochlea;endometrium;larynx;thyroid;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;heart;cerebellum cortex;nervous;islets of Langerhans;hypothalamus;spinal cord;blood;lens;skeletal muscle;lung;placenta;macula lutea;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	whole brain;amygdala;thalamus;occipital lobe;medulla oblongata;superior cervical ganglion;hypothalamus;temporal lobe;pons;caudate nucleus;subthalamic nucleus;prefrontal cortex;globus pallidus;cingulate cortex;parietal lobe;cerebellum;	0.16289	.	-0.793601146	12.57372022	536.63529	4.72241	10q26.11		0.1010	0.0104	0.0599	0.1987	0.0979	0.0594	0.0714	0.2817	0.0582	0.0103	0.0526	0.0497	0.1869	0.0929	0.0628	0.0857	rs17099318						
10	123810060	123810060	G	A	exonic	TACC2		synonymous SNV	TACC2:NM_001291876:exon3:c.G141A:p.A47A,TACC2:NM_001291877:exon3:c.G141A:p.A47A,TACC2:NM_206861:exon3:c.G141A:p.A47A,TACC2:NM_206862:exon3:c.G141A:p.A47A	3.52232783639013e-19	0.948831744942938	0.0511682550570616	transforming acidic coiled-coil containing protein 2	FUNCTION: Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). May play a role in organizing centrosomal microtubules. May act as a tumor suppressor protein. May represent a tumor progression marker. {ECO:0000250, ECO:0000269|PubMed:10749935}.; 	.	TISSUE SPECIFICITY: Strongly expressed in heart, skeletal muscle, brain, prostate, thyroid and trachea. {ECO:0000269|PubMed:11161455, ECO:0000269|PubMed:12620397}.; 	ovary;colon;parathyroid;skin;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;gum;bone;thyroid;pituitary gland;testis;brain;unclassifiable (Anatomical System);cartilage;tongue;islets of Langerhans;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;hypopharynx;spleen;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;placenta;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.16116	0.08314	4.102912459	99.68152866	4233.01874	12.93938	10q26.13		0.1193	0.1684	0.3010	0.1481	0.1133	0.0777	0.1159	0.1170	0.1165	0.1689	0.2578	0.0433	0.1628	0.1203	0.0740	0.1151	rs11200367						
10	124742811	124742812	TT	-	exonic	PSTK		frameshift deletion	PSTK:NM_153336:exon3:c.532_533del:p.L179Rfs*5	0.00411002353042562	0.960308594057246	0.0355813824123287	phosphoseryl-tRNA kinase	FUNCTION: Specifically phosphorylates seryl-tRNA(Sec) to O- phosphoseryl-tRNA(Sec), an activated intermediate for selenocysteine biosynthesis. {ECO:0000250}.; 	.	.	.	.	0.25378	0.09590	0.527368849	80.73248408	.	.	10q26.13																								
10	124742860	124742861	CA	-	exonic	PSTK		frameshift deletion	PSTK:NM_153336:exon3:c.581_582del:p.Q195Gfs*5	0.00411002353042562	0.960308594057246	0.0355813824123287	phosphoseryl-tRNA kinase	FUNCTION: Specifically phosphorylates seryl-tRNA(Sec) to O- phosphoseryl-tRNA(Sec), an activated intermediate for selenocysteine biosynthesis. {ECO:0000250}.; 	.	.	.	.	0.25378	0.09590	0.527368849	80.73248408	.	.	10q26.13																								
10	124742913	124742913	C	G	exonic	PSTK		nonsynonymous SNV	PSTK:NM_153336:exon3:c.C634G:p.P212A	0.00411002353042562	0.960308594057246	0.0355813824123287	phosphoseryl-tRNA kinase	FUNCTION: Specifically phosphorylates seryl-tRNA(Sec) to O- phosphoseryl-tRNA(Sec), an activated intermediate for selenocysteine biosynthesis. {ECO:0000250}.; 	.	.	.	.	0.25378	0.09590	0.527368849	80.73248408	.	.	10q26.13																								
10	124742914	124742914	-	GAATTT	exonic	PSTK		nonframeshift insertion	PSTK:NM_153336:exon3:c.635_636insGAATTT:p.N213_P214insFN	0.00411002353042562	0.960308594057246	0.0355813824123287	phosphoseryl-tRNA kinase	FUNCTION: Specifically phosphorylates seryl-tRNA(Sec) to O- phosphoseryl-tRNA(Sec), an activated intermediate for selenocysteine biosynthesis. {ECO:0000250}.; 	.	.	.	.	0.25378	0.09590	0.527368849	80.73248408	.	.	10q26.13																								
10	124742915	124742915	-	GACGATCGTTGCATT	exonic	PSTK		nonframeshift insertion	PSTK:NM_153336:exon3:c.636_637insGACGATCGTTGCATT:p.P212_N213insDDRCI	0.00411002353042562	0.960308594057246	0.0355813824123287	phosphoseryl-tRNA kinase	FUNCTION: Specifically phosphorylates seryl-tRNA(Sec) to O- phosphoseryl-tRNA(Sec), an activated intermediate for selenocysteine biosynthesis. {ECO:0000250}.; 	.	.	.	.	0.25378	0.09590	0.527368849	80.73248408	.	.	10q26.13																								
10	126670381	126670382	CT	-	exonic	ZRANB1		frameshift deletion	ZRANB1:NM_017580:exon6:c.1531_1532del:p.L513Cfs*2	0.99983984952777	0.000160150350222119	1.22007703690613e-10	zinc finger RANBP2-type containing 1	FUNCTION: Specifically hydrolyzes 'Lys-29'-linked and 'Lys-33'- linked diubiquitin. Also cleaves 'Lys-63'-linked chains, but with 40-fold less efficiency compared to 'Lys-29'-linked ones. Positive regulator of the Wnt signaling pathway that deubiquitinates APC protein, a negative regulator of Wnt-mediated transcription. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the stress fiber dynamics and cell migration. May also modulate TNF-alpha signaling. {ECO:0000269|PubMed:18281465, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22157957, ECO:0000269|PubMed:23827681}.; 	.	TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:11463333}.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;blood;lens;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;kidney;mammary gland;stomach;	.	0.15947	0.12378	-0.247889024	35.98726115	305.44181	3.72142	10q26.13																								
11	720130	720130	G	-	exonic	EPS8L2		frameshift deletion	EPS8L2:NM_022772:exon5:c.234delG:p.V79Cfs*3	0.00182700802996643	0.997138159400746	0.00103483256928805	EPS8 like 2	FUNCTION: Stimulates guanine exchange activity of SOS1. May play a role in membrane ruffling and remodeling of the actin cytoskeleton. {ECO:0000269|PubMed:14565974}.; 	.	TISSUE SPECIFICITY: Detected in fibroblasts and placenta. {ECO:0000269|PubMed:14565974}.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;larynx;bone;thyroid;testis;brain;bladder;unclassifiable (Anatomical System);cartilage;heart;lacrimal gland;epidermis;tongue;islets of Langerhans;muscle;pharynx;blood;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;peripheral nerve;	superior cervical ganglion;kidney;	0.20869	0.13493	-1.262067713	5.284265157	298.71169	3.68547	11p15.5																								
11	8061189	8061189	C	T	intronic	TUB				0.471428314326012	0.528526372810899	4.53128630892771e-05	tubby bipartite transcription factor	FUNCTION: Functions in signal transduction from heterotrimeric G protein-coupled receptors. Binds to membranes containing phosphatidylinositol 4,5-bisphosphate. Can bind DNA (in vitro). May contribute to the regulation of transcription in the nucleus. Could be involved in the hypothalamic regulation of body weight (By similarity). Contribute to stimulation of phagocytosis of apoptotic retinal pigment epithelium (RPE) cells and macrophages. {ECO:0000250, ECO:0000269|PubMed:19837063}.; 	DISEASE: Retinal dystrophy and obesity (RDOB) [MIM:616188]: A disease characterized by obesity, night blindness, decreased visual acuity, and electrophysiological features of a rod cone dystrophy. {ECO:0000269|PubMed:24375934}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	smooth muscle;colon;choroid;fovea centralis;retina;uterus;optic nerve;whole body;endometrium;bone;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);cartilage;lens;skeletal muscle;lung;adrenal gland;placenta;hippocampus;visual apparatus;macula lutea;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;cerebellum;	0.28211	0.25332	-0.905656269	10.12031139	201.17736	3.06482	11p15.4																								
11	22283684	22283684	G	A	exonic	ANO5		nonsynonymous SNV	ANO5:NM_001142649:exon16:c.G1637A:p.R546Q,ANO5:NM_213599:exon16:c.G1640A:p.R547Q	9.89423115964736e-16	0.629566310679112	0.370433689320887	anoctamin 5	FUNCTION: Does not exhibit calcium-activated chloride channel (CaCC) activity.; 	DISEASE: Limb-girdle muscular dystrophy 2L (LGMD2L) [MIM:611307]: An autosomal recessive degenerative myopathy characterized by proximal weakness, weakness of the hip and shoulder girdles and prominent asymmetrical quadriceps femoris and biceps brachii atrophy. {ECO:0000269|PubMed:20096397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Miyoshi muscular dystrophy 3 (MMD3) [MIM:613319]: A late- onset muscular dystrophy characterized by distal muscle weakness of the lower limbs, calf muscle discomfort and weakness, quadriceps atrophy. Muscle weakness and atrophy may be asymmetric. {ECO:0000269|PubMed:20096397, ECO:0000269|PubMed:22499103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Highly expressed in brain, heart, kidney, lung, and skeletal muscle. Weakly expressed in bone marrow, fetal liver, placenta, spleen, thymus, osteoblasts and periodontal ligament cells. {ECO:0000269|PubMed:15067359, ECO:0000269|PubMed:15124103}.; 	unclassifiable (Anatomical System);heart;ovary;islets of Langerhans;parathyroid;skin;skeletal muscle;retina;prostate;whole body;lung;cochlea;endometrium;placenta;visual apparatus;liver;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;cerebellum;	0.11025	0.11663	0.584200036	82.336636	354.17365	3.98229	11p14.3		0.0002	0.0007	8.663e-05	0.0015	0	1.5e-05	0	6.057e-05	3.231e-05	0.0001	0	0	0	0	0	0	rs139618850	266631	Limb-girdle_muscular_dystrophy,_type_2L|Miyoshi_muscular_dystrophy_3|not_provided	MedGen:C1969785,OMIM:611307,Orphanet:ORPHA206549|MedGen:C2750076,OMIM:613319,Orphanet:ORPHA399096|MedGen:CN517202	criteria_provided,_single_submitter	Uncertain_significance	ID=CM136006;CLASS=DM;MUT=ALT;GENE=ANO5;STRAND=+;DNA=NM_213599.2:c.1640G>A;PROT=NP_998764.1:p.R547Q;DB=rs139618850;PHEN="Muscular_dystrophy_limb_girdle_2L";RANKSCORE=0.72
11	46717284	46717284	G	T	exonic	ARHGAP1		nonsynonymous SNV	ARHGAP1:NM_004308:exon3:c.C155A:p.P52Q	0.185564722294501	0.812004260072597	0.00243101763290249	Rho GTPase activating protein 1	FUNCTION: GTPase activator for the Rho, Rac and Cdc42 proteins, converting them to the putatively inactive GDP-bound state. Cdc42 seems to be the preferred substrate.; 	.	TISSUE SPECIFICITY: Ubiquitous.; 	myocardium;ovary;salivary gland;colon;parathyroid;choroid;skin;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;bone;thyroid;testis;amniotic fluid;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;muscle;blood;skeletal muscle;pancreas;lung;placenta;visual apparatus;hippocampus;hypopharynx;liver;head and neck;kidney;mammary gland;stomach;	superior cervical ganglion;occipital lobe;placenta;ciliary ganglion;caudate nucleus;trigeminal ganglion;parietal lobe;skeletal muscle;	0.38242	0.30784	-0.137658575	43.57159707	82.23058	1.92404	11p11.2		0	0	0	0	0	0	0	0									rs189963672						
11	46917812	46917812	C	T	exonic	LRP4		nonsynonymous SNV	LRP4:NM_002334:exon9:c.G997A:p.G333R	0.10020880429216	0.899791195700632	7.20751508801609e-12	LDL receptor related protein 4	FUNCTION: Mediates SOST-dependent inhibition of bone formation. Functions as a specific facilitator of SOST-mediated inhibition of Wnt signaling. Plays a key role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between motor neuron and skeletal muscle. Directly binds AGRIN and recruits it to the MUSK signaling complex. Mediates the AGRIN- induced phosphorylation of MUSK, the kinase of the complex. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Alternatively, may be involved in the negative regulation of the canonical Wnt signaling pathway, being able to antagonize the LRP6-mediated activation of this pathway. More generally, has been proposed to function as a cell surface endocytic receptor binding and internalizing extracellular ligands for degradation by lysosomes. {ECO:0000269|PubMed:20381006, ECO:0000269|PubMed:21471202}.; 	DISEASE: Sclerosteosis 2 (SOST2) [MIM:614305]: A sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients. {ECO:0000269|PubMed:21471202, ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. {ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in bone; present in osteoblasts and osteocytes. No expression is observed in osteoclast. Expressed in several regions of the brain. {ECO:0000269|PubMed:21471202}.; 	.	.	0.57115	0.17022	-1.328641279	4.694503421	9909.87734	21.64220	11p11.2	ID=COSM147183;OCCURENCE=1(stomach)	0.0036	0.0193	0.0004	0.0268	0	3.009e-05	0.0033	0	0.0072	0.0203	0.0012	0	0.0247	0	6.662e-05	0.0041	rs61744209	196235	Syndactyly_Cenani_Lenz_type|Sclerosteosis_2|Myasthenic_syndrome,_congenital,_17|not_specified	MedGen:C1859309,OMIM:212780,Orphanet:ORPHA3258|MedGen:C3280402,OMIM:614305|MedGen:C4225377,OMIM:616304|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
11	46917819	46917819	C	T	exonic	LRP4		synonymous SNV	LRP4:NM_002334:exon9:c.G990A:p.L330L	0.10020880429216	0.899791195700632	7.20751508801609e-12	LDL receptor related protein 4	FUNCTION: Mediates SOST-dependent inhibition of bone formation. Functions as a specific facilitator of SOST-mediated inhibition of Wnt signaling. Plays a key role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between motor neuron and skeletal muscle. Directly binds AGRIN and recruits it to the MUSK signaling complex. Mediates the AGRIN- induced phosphorylation of MUSK, the kinase of the complex. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Alternatively, may be involved in the negative regulation of the canonical Wnt signaling pathway, being able to antagonize the LRP6-mediated activation of this pathway. More generally, has been proposed to function as a cell surface endocytic receptor binding and internalizing extracellular ligands for degradation by lysosomes. {ECO:0000269|PubMed:20381006, ECO:0000269|PubMed:21471202}.; 	DISEASE: Sclerosteosis 2 (SOST2) [MIM:614305]: A sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients. {ECO:0000269|PubMed:21471202, ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. {ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in bone; present in osteoblasts and osteocytes. No expression is observed in osteoclast. Expressed in several regions of the brain. {ECO:0000269|PubMed:21471202}.; 	.	.	0.57115	0.17022	-1.328641279	4.694503421	9909.87734	21.64220	11p11.2																								
11	46917878	46917878	G	-	exonic	LRP4		frameshift deletion	LRP4:NM_002334:exon9:c.931delC:p.Q311Nfs*86	0.10020880429216	0.899791195700632	7.20751508801609e-12	LDL receptor related protein 4	FUNCTION: Mediates SOST-dependent inhibition of bone formation. Functions as a specific facilitator of SOST-mediated inhibition of Wnt signaling. Plays a key role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between motor neuron and skeletal muscle. Directly binds AGRIN and recruits it to the MUSK signaling complex. Mediates the AGRIN- induced phosphorylation of MUSK, the kinase of the complex. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Alternatively, may be involved in the negative regulation of the canonical Wnt signaling pathway, being able to antagonize the LRP6-mediated activation of this pathway. More generally, has been proposed to function as a cell surface endocytic receptor binding and internalizing extracellular ligands for degradation by lysosomes. {ECO:0000269|PubMed:20381006, ECO:0000269|PubMed:21471202}.; 	DISEASE: Sclerosteosis 2 (SOST2) [MIM:614305]: A sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients. {ECO:0000269|PubMed:21471202, ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. {ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in bone; present in osteoblasts and osteocytes. No expression is observed in osteoclast. Expressed in several regions of the brain. {ECO:0000269|PubMed:21471202}.; 	.	.	0.57115	0.17022	-1.328641279	4.694503421	9909.87734	21.64220	11p11.2																								
11	46917889	46917890	AG	-	intronic	LRP4				0.10020880429216	0.899791195700632	7.20751508801609e-12	LDL receptor related protein 4	FUNCTION: Mediates SOST-dependent inhibition of bone formation. Functions as a specific facilitator of SOST-mediated inhibition of Wnt signaling. Plays a key role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between motor neuron and skeletal muscle. Directly binds AGRIN and recruits it to the MUSK signaling complex. Mediates the AGRIN- induced phosphorylation of MUSK, the kinase of the complex. The activation of MUSK in myotubes induces the formation of NMJ by regulating different processes including the transcription of specific genes and the clustering of AChR in the postsynaptic membrane. Alternatively, may be involved in the negative regulation of the canonical Wnt signaling pathway, being able to antagonize the LRP6-mediated activation of this pathway. More generally, has been proposed to function as a cell surface endocytic receptor binding and internalizing extracellular ligands for degradation by lysosomes. {ECO:0000269|PubMed:20381006, ECO:0000269|PubMed:21471202}.; 	DISEASE: Sclerosteosis 2 (SOST2) [MIM:614305]: A sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients. {ECO:0000269|PubMed:21471202, ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myasthenic syndrome, congenital, 17 (CMS17) [MIM:616304]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features are easy fatigability and muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. {ECO:0000269|PubMed:24234652}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in bone; present in osteoblasts and osteocytes. No expression is observed in osteoclast. Expressed in several regions of the brain. {ECO:0000269|PubMed:21471202}.; 	.	.	0.57115	0.17022	-1.328641279	4.694503421	9909.87734	21.64220	11p11.2																								
11	47185680	47185680	G	A	exonic	C11orf49		synonymous SNV	C11orf49:NM_001003678:exon9:c.G858A:p.Q286Q	5.45467879227827e-07	0.650818143221783	0.349181311310338	chromosome 11 open reading frame 49	.	.	.	lymphoreticular;ovary;salivary gland;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;endometrium;synovium;bone;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;hypothalamus;blood;lens;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;mammary gland;stomach;	whole brain;amygdala;occipital lobe;medulla oblongata;thalamus;cerebellum peduncles;hypothalamus;temporal lobe;caudate nucleus;subthalamic nucleus;testis - seminiferous tubule;prefrontal cortex;globus pallidus;testis;parietal lobe;cingulate cortex;cerebellum;	0.25098	0.10416	-0.532670911	20.78320359	53.14985	1.44731	11p11.2		0.2011	0.0432	0.1168	0.0775	0.1560	0.2273	0.1956	0.3372	0.1512	0.0467	0.1340	0.2219	0.0791	0.1502	0.2160	0.2082	rs11039114						
11	47185794	47185794	-	AG	exonic	C11orf49		stoploss	C11orf49:NM_001003678:exon9:c.972_973insAG:p.*327SEARGRHWAGRQDPEDTASLRPTGSQALQGLYFDTTLFQYKQSR	5.45467879227827e-07	0.650818143221783	0.349181311310338	chromosome 11 open reading frame 49	.	.	.	lymphoreticular;ovary;salivary gland;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;endometrium;synovium;bone;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;hypothalamus;blood;lens;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;mammary gland;stomach;	whole brain;amygdala;occipital lobe;medulla oblongata;thalamus;cerebellum peduncles;hypothalamus;temporal lobe;caudate nucleus;subthalamic nucleus;testis - seminiferous tubule;prefrontal cortex;globus pallidus;testis;parietal lobe;cingulate cortex;cerebellum;	0.25098	0.10416	-0.532670911	20.78320359	53.14985	1.44731	11p11.2																								
11	47185800	47185801	GT	-	exonic	C11orf49		stoploss	C11orf49:NM_001003678:exon9:c.978_979del:p.*327RPGAGTGQGGRIQRTLLHSDQQGARPCRGFILTPLCFNTNSPE	5.45467879227827e-07	0.650818143221783	0.349181311310338	chromosome 11 open reading frame 49	.	.	.	lymphoreticular;ovary;salivary gland;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;whole body;cochlea;endometrium;synovium;bone;testis;germinal center;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;hypothalamus;blood;lens;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;mammary gland;stomach;	whole brain;amygdala;occipital lobe;medulla oblongata;thalamus;cerebellum peduncles;hypothalamus;temporal lobe;caudate nucleus;subthalamic nucleus;testis - seminiferous tubule;prefrontal cortex;globus pallidus;testis;parietal lobe;cingulate cortex;cerebellum;	0.25098	0.10416	-0.532670911	20.78320359	53.14985	1.44731	11p11.2																								
11	72415293	72415295	GCT	-	exonic	ARAP1		nonframeshift deletion	ARAP1:NM_015242:exon12:c.1159_1161del:p.S387Pfs*819,ARAP1:NM_001040118:exon14:c.1894_1896del:p.S632Pfs*819	1.50377669733894e-05	0.999984379090857	5.83142169592711e-07	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1	FUNCTION: Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity). {ECO:0000250, ECO:0000269|PubMed:11804590}.; 	.	TISSUE SPECIFICITY: Detected in heart, skeletal muscle, spleen, kidney, liver, placenta, lung, peripheral blood leukocytes, adrenal gland, bone marrow, brain, lymph node, mammary gland, prostate, spinal cord, stomach, thyroid and trachea. {ECO:0000269|PubMed:11804590}.; 	lymphoreticular;myocardium;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;bone;thyroid;pituitary gland;testis;germinal center;pineal gland;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;small intestine;islets of Langerhans;adrenal cortex;blood;lens;breast;pancreas;lung;epididymis;placenta;macula lutea;visual apparatus;alveolus;liver;spleen;kidney;mammary gland;stomach;thymus;	prostate;testis - interstitial;testis - seminiferous tubule;adrenal gland;liver;testis;	0.24613	0.17391	-1.446087194	3.933710781	2533.75935	9.39142	11q13.4																								
11	72415320	72415320	G	-	exonic	ARAP1		frameshift deletion	ARAP1:NM_015242:exon12:c.1134delC:p.S379Vfs*107,ARAP1:NM_001040118:exon14:c.1869delC:p.S624Vfs*107	1.50377669733894e-05	0.999984379090857	5.83142169592711e-07	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1	FUNCTION: Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity). {ECO:0000250, ECO:0000269|PubMed:11804590}.; 	.	TISSUE SPECIFICITY: Detected in heart, skeletal muscle, spleen, kidney, liver, placenta, lung, peripheral blood leukocytes, adrenal gland, bone marrow, brain, lymph node, mammary gland, prostate, spinal cord, stomach, thyroid and trachea. {ECO:0000269|PubMed:11804590}.; 	lymphoreticular;myocardium;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;bone;thyroid;pituitary gland;testis;germinal center;pineal gland;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;small intestine;islets of Langerhans;adrenal cortex;blood;lens;breast;pancreas;lung;epididymis;placenta;macula lutea;visual apparatus;alveolus;liver;spleen;kidney;mammary gland;stomach;thymus;	prostate;testis - interstitial;testis - seminiferous tubule;adrenal gland;liver;testis;	0.24613	0.17391	-1.446087194	3.933710781	2533.75935	9.39142	11q13.4	ID=COSM1356831,COSM1356832;OCCURENCE=1(large_intestine)	9.038e-06	0	0	0	0	0	0	6.656e-05									rs751080362						
11	72415321	72415321	G	T	exonic	ARAP1		nonsynonymous SNV	ARAP1:NM_015242:exon12:c.C1133A:p.P378H,ARAP1:NM_001040118:exon14:c.C1868A:p.P623H	1.50377669733894e-05	0.999984379090857	5.83142169592711e-07	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1	FUNCTION: Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity). {ECO:0000250, ECO:0000269|PubMed:11804590}.; 	.	TISSUE SPECIFICITY: Detected in heart, skeletal muscle, spleen, kidney, liver, placenta, lung, peripheral blood leukocytes, adrenal gland, bone marrow, brain, lymph node, mammary gland, prostate, spinal cord, stomach, thyroid and trachea. {ECO:0000269|PubMed:11804590}.; 	lymphoreticular;myocardium;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;endometrium;bone;thyroid;pituitary gland;testis;germinal center;pineal gland;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;small intestine;islets of Langerhans;adrenal cortex;blood;lens;breast;pancreas;lung;epididymis;placenta;macula lutea;visual apparatus;alveolus;liver;spleen;kidney;mammary gland;stomach;thymus;	prostate;testis - interstitial;testis - seminiferous tubule;adrenal gland;liver;testis;	0.24613	0.17391	-1.446087194	3.933710781	2533.75935	9.39142	11q13.4																								
11	72415384	72415384	G	-	ncRNA_exonic	ARAP1-AS2				.	.	.	ARAP1 antisense RNA 2	.	.	.	.	.	.	.	.	.	.	.	11q13.4		5.485e-05	0	0	0	0	9.311e-05	0	0									rs754612983						
11	73670645	73670645	T	C	exonic	DNAJB13		synonymous SNV	DNAJB13:NM_153614:exon3:c.T279C:p.H93H	0.121954826569755	0.872750328214636	0.00529484521560875	DnaJ heat shock protein family (Hsp40) member B13	FUNCTION: May be involved in inhibiting testis spermatogenesis apoptosis.; 	.	TISSUE SPECIFICITY: Specifically expressed in testis.; 	prostate;lung;cartilage;ovary;endometrium;placenta;urinary;liver;testis;parathyroid;	superior cervical ganglion;testis - seminiferous tubule;atrioventricular node;cerebellum;	0.13751	0.13274	0.396906589	76.30927105	2202.42808	8.64001	11q13.4		0.5102	0.8207	0.5527	0.4773	0.4876	0.4604	0.4967	0.5128	0.5712	0.8205	0.5407	0.4536	0.4696	0.4937	0.4632	0.5081	rs653263						
11	73670656	73670656	A	-	exonic	DNAJB13		frameshift deletion	DNAJB13:NM_153614:exon3:c.290delA:p.K98Rfs*24	0.121954826569755	0.872750328214636	0.00529484521560875	DnaJ heat shock protein family (Hsp40) member B13	FUNCTION: May be involved in inhibiting testis spermatogenesis apoptosis.; 	.	TISSUE SPECIFICITY: Specifically expressed in testis.; 	prostate;lung;cartilage;ovary;endometrium;placenta;urinary;liver;testis;parathyroid;	superior cervical ganglion;testis - seminiferous tubule;atrioventricular node;cerebellum;	0.13751	0.13274	0.396906589	76.30927105	2202.42808	8.64001	11q13.4																								
11	73715542	73715542	G	A	exonic	UCP3		synonymous SNV	UCP3:NM_003356:exon5:c.C630T:p.Y210Y,UCP3:NM_022803:exon5:c.C630T:p.Y210Y	1.07071142074629e-05	0.351846038148766	0.648143254737027	uncoupling protein 3 (mitochondrial, proton carrier)	FUNCTION: UCP are mitochondrial transporter proteins that create proton leaks across the inner mitochondrial membrane, thus uncoupling oxidative phosphorylation. As a result, energy is dissipated in the form of heat. May play a role in the modulation of tissue respiratory control. Participates in thermogenesis and energy balance.; 	.	TISSUE SPECIFICITY: Only in skeletal muscle and heart. Is more expressed in glycolytic than in oxidative skeletal muscles. {ECO:0000269|PubMed:9196039}.; 	unclassifiable (Anatomical System);cartilage;spinal cord;blood;fovea centralis;choroid;lens;skeletal muscle;retina;optic nerve;whole body;bone;macula lutea;testis;brain;aorta;	superior cervical ganglion;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.08932	0.32882	0.332586472	73.61405992	876.27254	5.75990	11q13.4		0.5655	0.8143	0.5287	0.4160	0.6401	0.5554	0.5442	0.5244	0.6346	0.8181	0.5468	0.5563	0.4196	0.6432	0.5599	0.5665	rs2075577						
11	100792307	100792307	A	-	exonic	ARHGAP42		frameshift deletion	ARHGAP42:NM_152432:exon6:c.569delA:p.K192Rfs*55	.	.	.	Rho GTPase activating protein 42	FUNCTION: May influence blood pressure by functioning as a GTPase- activating protein for RHOA in vascular smooth muscle. {ECO:0000269|PubMed:24335996}.; 	.	.	unclassifiable (Anatomical System);hypothalamus;sympathetic chain;colon;	superior cervical ganglion;globus pallidus;ciliary ganglion;skeletal muscle;	.	.	.	.	2146.95556	8.52466	11q22.1																								
11	100792335	100792335	G	A	exonic	ARHGAP42		synonymous SNV	ARHGAP42:NM_152432:exon6:c.G597A:p.P199P	.	.	.	Rho GTPase activating protein 42	FUNCTION: May influence blood pressure by functioning as a GTPase- activating protein for RHOA in vascular smooth muscle. {ECO:0000269|PubMed:24335996}.; 	.	.	unclassifiable (Anatomical System);hypothalamus;sympathetic chain;colon;	superior cervical ganglion;globus pallidus;ciliary ganglion;skeletal muscle;	.	.	.	.	2146.95556	8.52466	11q22.1		0.0447	0.0141	0.0846	0.2534	0.0179	0.0498	0.1033	0.0332	0.0440	0.0116	0.0880	0.0662	0.2531	0.0204	0.0430	0.0408	rs75746929						
11	102201832	102201832	-	A	exonic	BIRC3		frameshift insertion	BIRC3:NM_001165:exon6:c.1185dupA:p.Q397Tfs*15,BIRC3:NM_182962:exon7:c.1185dupA:p.Q397Tfs*15	0.886667092506474	0.113281064924801	5.18425687250095e-05	baculoviral IAP repeat containing 3	FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin- protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin- protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase- independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. {ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969}.; 	DISEASE: Note=A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.; 	TISSUE SPECIFICITY: Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;uterus;prostate;cerebral cortex;endometrium;oesophagus;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pharynx;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;visual apparatus;amnion;liver;spleen;head and neck;kidney;aorta;stomach;thymus;	.	0.36052	0.28580	-0.534490515	20.70063694	76.6367	1.83741	11q22.2																								
11	102201850	102201850	-	A	exonic	BIRC3		frameshift insertion	BIRC3:NM_001165:exon6:c.1203dupA:p.I403Nfs*9,BIRC3:NM_182962:exon7:c.1203dupA:p.I403Nfs*9	0.886667092506474	0.113281064924801	5.18425687250095e-05	baculoviral IAP repeat containing 3	FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin- protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin- protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase- independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. {ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969}.; 	DISEASE: Note=A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.; 	TISSUE SPECIFICITY: Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;uterus;prostate;cerebral cortex;endometrium;oesophagus;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pharynx;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;visual apparatus;amnion;liver;spleen;head and neck;kidney;aorta;stomach;thymus;	.	0.36052	0.28580	-0.534490515	20.70063694	76.6367	1.83741	11q22.2																								
11	102201946	102201946	-	GCG	exonic	BIRC3		nonframeshift insertion	BIRC3:NM_001165:exon6:c.1298_1299insGCG:p.R434_A435insR,BIRC3:NM_182962:exon7:c.1298_1299insGCG:p.R434_A435insR	0.886667092506474	0.113281064924801	5.18425687250095e-05	baculoviral IAP repeat containing 3	FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin- protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin- protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase- independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. {ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969}.; 	DISEASE: Note=A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.; 	TISSUE SPECIFICITY: Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;uterus;prostate;cerebral cortex;endometrium;oesophagus;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pharynx;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;visual apparatus;amnion;liver;spleen;head and neck;kidney;aorta;stomach;thymus;	.	0.36052	0.28580	-0.534490515	20.70063694	76.6367	1.83741	11q22.2																								
11	102201948	102201948	-	TTTC	exonic	BIRC3		frameshift insertion	BIRC3:NM_001165:exon6:c.1300_1301insTTTC:p.R434Ifs*5,BIRC3:NM_182962:exon7:c.1300_1301insTTTC:p.R434Ifs*5	0.886667092506474	0.113281064924801	5.18425687250095e-05	baculoviral IAP repeat containing 3	FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin- protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin- protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase- independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. {ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969}.; 	DISEASE: Note=A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.; 	TISSUE SPECIFICITY: Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;uterus;prostate;cerebral cortex;endometrium;oesophagus;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pharynx;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;visual apparatus;amnion;liver;spleen;head and neck;kidney;aorta;stomach;thymus;	.	0.36052	0.28580	-0.534490515	20.70063694	76.6367	1.83741	11q22.2																								
11	102201950	102201950	-	CGATCGTT	exonic	BIRC3		frameshift insertion	BIRC3:NM_001165:exon6:c.1302_1303insCGATCGTT:p.A435Rfs*15,BIRC3:NM_182962:exon7:c.1302_1303insCGATCGTT:p.A435Rfs*15	0.886667092506474	0.113281064924801	5.18425687250095e-05	baculoviral IAP repeat containing 3	FUNCTION: Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin- protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin- protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase- independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. {ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:23453969}.; 	DISEASE: Note=A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.; 	TISSUE SPECIFICITY: Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;uterus;prostate;cerebral cortex;endometrium;oesophagus;bone;thyroid;testis;germinal center;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pharynx;blood;skeletal muscle;breast;bile duct;pancreas;lung;nasopharynx;visual apparatus;amnion;liver;spleen;head and neck;kidney;aorta;stomach;thymus;	.	0.36052	0.28580	-0.534490515	20.70063694	76.6367	1.83741	11q22.2																								
11	102649415	102649415	G	C	exonic	MMP10		nonsynonymous SNV	MMP10:NM_002425:exon4:c.C562G:p.P188A	1.98053112611486e-13	0.00817930161176316	0.991820698388039	matrix metallopeptidase 10	FUNCTION: Can degrade fibronectin, gelatins of type I, III, IV, and V; weakly collagens III, IV, and V. Activates procollagenase.; 	.	.	unclassifiable (Anatomical System);heart;ovary;tongue;colon;vein;skin;skeletal muscle;uterus;lung;endometrium;larynx;epididymis;alveolus;hypopharynx;duodenum;head and neck;	uterus corpus;testis - interstitial;	0.09719	0.63407	1.13538281	92.30360934	779.07324	5.52465	11q22.2		8.246e-06	0	0	0.0001	0	0	0	0									rs200519348						
11	120340100	120340100	A	-	intronic	ARHGEF12				0.99999892582633	1.07417367028587e-06	8.6053136673698e-21	Rho guanine nucleotide exchange factor 12	FUNCTION: May play a role in the regulation of RhoA GTPase by guanine nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as GTPase-activating protein (GAP) for GNA12 and GNA13. {ECO:0000269|PubMed:11094164}.; 	.	TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is found in jejunum and testis.; 	myocardium;ovary;skin;retina;prostate;optic nerve;ganglion;frontal lobe;cochlea;endometrium;gum;thyroid;iris;germinal center;bladder;brain;heart;cartilage;tongue;pharynx;blood;lens;skeletal muscle;breast;trabecular meshwork;macula lutea;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;cerebral cortex;larynx;bone;testis;artery;pineal gland;unclassifiable (Anatomical System);islets of Langerhans;hypothalamus;bile duct;pancreas;lung;cornea;placenta;head and neck;kidney;stomach;aorta;	superior cervical ganglion;skeletal muscle;	0.47120	.	-0.323344668	30.9447983	743.24174	5.41202	11q23.3																								
12	332362	332362	C	T	exonic	SLC6A13		synonymous SNV	SLC6A13:NM_001190997:exon10:c.G1074A:p.A358A,SLC6A13:NM_016615:exon12:c.G1350A:p.A450A	1.85726644531532e-08	0.641770503703225	0.35822947772411	solute carrier family 6 member 13	FUNCTION: Sodium-dependent GABA and taurine transporter. In presynaptic terminals, regulates GABA signaling termination through GABA uptake. May also be involved in beta-alanine transport. {ECO:0000269|PubMed:17502375, ECO:0000269|PubMed:22932902}.; 	.	TISSUE SPECIFICITY: Expressed in brain, kidney, lung, liver and testis. {ECO:0000269|PubMed:11824941, ECO:0000269|PubMed:17502375}.; 	unclassifiable (Anatomical System);optic nerve;lung;macula lutea;colon;fovea centralis;choroid;kidney;lens;brain;stomach;retina;	superior cervical ganglion;globus pallidus;kidney;trigeminal ganglion;skeletal muscle;	0.08446	0.14271	-0.527216948	20.8893607	398.80138	4.19401	12p13.33		0.1897	0.2337	0.1065	0.1718	0.1943	0.2021	0.1663	0.1787	0.2062	0.2360	0.1134	0.2450	0.1710	0.2111	0.1969	0.1929	rs2289954						
12	3728501	3728501	C	T	exonic	CRACR2A		nonsynonymous SNV	CRACR2A:NM_001144958:exon18:c.G1970A:p.G657D	.	.	.	calcium release activated channel regulator 2A	FUNCTION: Ca(2+)-binding protein that plays a key role in store- operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation. Acts as a cytoplasmic calcium-sensor that facilitates the clustering of ORAI1 and STIM1 at the junctional regions between the plasma membrane and the endoplasmic reticulum upon low Ca(2+) concentration. It thereby regulates CRAC channel activation, including translocation and clustering of ORAI1 and STIM1. Upon increase of cytoplasmic Ca(2+) resulting from opening of CRAC channels, dissociates from ORAI1 and STIM1, thereby destabilizing the ORAI1-STIM1 complex. {ECO:0000269|PubMed:20418871}.; 	.	.	.	.	0.10919	0.10015	1.846456612	97.11606511	.	.	12p13.32																								
12	3728523	3728523	G	A	exonic	CRACR2A		nonsynonymous SNV	CRACR2A:NM_001144958:exon18:c.C1948T:p.R650W	.	.	.	calcium release activated channel regulator 2A	FUNCTION: Ca(2+)-binding protein that plays a key role in store- operated Ca(2+) entry (SOCE) in T-cells by regulating CRAC channel activation. Acts as a cytoplasmic calcium-sensor that facilitates the clustering of ORAI1 and STIM1 at the junctional regions between the plasma membrane and the endoplasmic reticulum upon low Ca(2+) concentration. It thereby regulates CRAC channel activation, including translocation and clustering of ORAI1 and STIM1. Upon increase of cytoplasmic Ca(2+) resulting from opening of CRAC channels, dissociates from ORAI1 and STIM1, thereby destabilizing the ORAI1-STIM1 complex. {ECO:0000269|PubMed:20418871}.; 	.	.	.	.	0.10919	0.10015	1.846456612	97.11606511	.	.	12p13.32		4.651e-05	0	0	0.0017	0	0	0	0									rs149484553						
12	6172202	6172202	T	C	exonic	VWF		nonsynonymous SNV	VWF:NM_000552:exon13:c.A1451G:p.H484R	1.52411378256046e-11	0.999999999608107	3.76651636761949e-10	von Willebrand factor	FUNCTION: Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma.; 	DISEASE: von Willebrand disease 1 (VWD1) [MIM:193400]: A common hemorrhagic disorder due to defects in von Willebrand factor protein and resulting in impaired platelet aggregation. Von Willebrand disease type 1 is characterized by partial quantitative deficiency of circulating von Willebrand factor, that is otherwise structurally and functionally normal. Clinical manifestations are mucocutaneous bleeding, such as epistaxis and menorrhagia, and prolonged bleeding after surgery or trauma. {ECO:0000269|PubMed:10887119, ECO:0000269|PubMed:11698279}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: von Willebrand disease 2 (VWD2) [MIM:613554]: A hemorrhagic disorder due to defects in von Willebrand factor protein and resulting in altered platelet aggregation. Von Willebrand disease type 2 is characterized by qualitative deficiency and functional anomalies of von Willebrand factor. It is divided in different subtypes including 2A, 2B, 2M and 2N (Normandy variant). The mutant VWF protein in types 2A, 2B and 2M are defective in their platelet-dependent function, whereas the mutant protein in type 2N is defective in its ability to bind factor VIII. Clinical manifestations are mucocutaneous bleeding, such as epistaxis and menorrhagia, and prolonged bleeding after surgery or trauma. {ECO:0000269|PubMed:12406074, ECO:0000269|PubMed:1409710, ECO:0000269|PubMed:1419803, ECO:0000269|PubMed:1419804, ECO:0000269|PubMed:1420817, ECO:0000269|PubMed:1429668, ECO:0000269|PubMed:1672694, ECO:0000269|PubMed:1673047, ECO:0000269|PubMed:1729889, ECO:0000269|PubMed:1761120, ECO:0000269|PubMed:1832934, ECO:0000269|PubMed:1906179, ECO:0000269|PubMed:2010538, ECO:0000269|PubMed:2011604, ECO:0000269|PubMed:21592258, ECO:0000269|PubMed:2786201, ECO:0000269|PubMed:7620154, ECO:0000269|PubMed:7734373, ECO:0000269|PubMed:7789955, ECO:0000269|PubMed:8011991, ECO:0000269|PubMed:8123843, ECO:0000269|PubMed:8123844, ECO:0000269|PubMed:8338947, ECO:0000269|PubMed:8348943, ECO:0000269|PubMed:8376405, ECO:0000269|PubMed:8435341, ECO:0000269|PubMed:8486782, ECO:0000269|PubMed:8547152, ECO:0000269|PubMed:8622978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: von Willebrand disease 3 (VWD3) [MIM:277480]: A severe hemorrhagic disorder due to a total or near total absence of von Willebrand factor in the plasma and cellular compartments, also leading to a profound deficiency of plasmatic factor VIII. Bleeding usually starts in infancy and can include epistaxis, recurrent mucocutaneous bleeding, excessive bleeding after minor trauma, and hemarthroses. {ECO:0000269|PubMed:10887119, ECO:0000269|PubMed:7989040, ECO:0000269|PubMed:8088787}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Plasma.; 	myocardium;smooth muscle;ovary;sympathetic chain;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;thyroid;brain;tonsil;amygdala;heart;cartilage;adrenal cortex;blood;lens;skeletal muscle;breast;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;vein;uterus;oesophagus;larynx;bone;testis;spinal ganglion;unclassifiable (Anatomical System);islets of Langerhans;muscle;pancreas;lung;nasopharynx;placenta;hypopharynx;head and neck;kidney;stomach;aorta;thymus;cerebellum;	.	0.23835	0.80848	1.036444045	91.14177872	8614.16756	20.10291	12p13.31		0.6212	0.2116	0.5224	0.7081	0.6678	0.6610	0.6848	0.7140	0.5247	0.2122	0.5299	0.6987	0.7258	0.6709	0.6403	0.6255	rs1800378	254694	von_Willebrand_disorder|not_specified	MedGen:C0042974,Orphanet:ORPHA903,SNOMED_CT:128105004|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
12	10034237	10034237	C	T	exonic	KLRF2		nonsynonymous SNV	KLRF2:NM_001190765:exon1:c.C43T:p.R15C	.	.	.	killer cell lectin like receptor F2	FUNCTION: C-type lectin-like receptor involved in natural killer cell mediated cytotoxicity and cytokine secretion in keratinocytes via its interaction with CLEC2A. {ECO:0000269|PubMed:20194751}.; 	.	.	.	.	.	.	.	.	81.20681	1.90851	12p13.31		0.0013	0	0	0.0211	0	0.0008	0.0076	0.0011	0.0018	0	0	0	0.0284	0	0.0006	0	rs74614163						
12	21711231	21711231	G	-	exonic	GYS2		frameshift deletion	GYS2:NM_021957:exon11:c.1325delC:p.P442Qfs*2	1.21631815172674e-14	0.146486871159475	0.853513128840512	glycogen synthase 2	FUNCTION: Transfers the glycosyl residue from UDP-Glc to the non- reducing end of alpha-1,4-glucan.; 	DISEASE: Glycogen storage disease 0 (GSD0) [MIM:240600]: A metabolic disorder characterized by fasting hypoglycemia presenting in infancy or early childhood, high blood ketones and low alanine and lactate concentrations. Although feeding relieves symptoms, it often results in postprandial hyperglycemia and hyperlactatemia. {ECO:0000269|PubMed:9691087}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);whole body;liver;spleen;kidney;	superior cervical ganglion;fetal liver;liver;	0.13195	0.57267	0.316000233	72.80018872	423.9852	4.29969	12p12.1																								
12	52709885	52709885	C	-	exonic	KRT83		frameshift deletion	KRT83:NM_002282:exon7:c.1054delG:p.E352Kfs*39	1.70400143344448e-10	0.0600346734241968	0.939965326405403	keratin 83	.	.	TISSUE SPECIFICITY: Synthesis begins in the cortex 10-15 cell layers above the apex of the dermal papilla and ends abruptly in the middle of the cortex. {ECO:0000269|PubMed:9084137}.; 	unclassifiable (Anatomical System);breast;bile duct;pancreas;lung;	dorsal root ganglion;superior cervical ganglion;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.27404	0.15921	0.75875178	86.82472281	3619.74667	11.66820	12q13.13																								
12	52966391	52966393	GCT	-	exonic	KRT74		nonframeshift deletion	KRT74:NM_175053:exon2:c.530_532del:p.Q177Lfs*353	8.39640673732565e-09	0.154029266434043	0.84597072516955	keratin 74	FUNCTION: Has a role in hair formation. Specific component of keratin intermediate filaments in the inner root sheath (IRS) of the hair follicle (Probable). {ECO:0000305}.; 	DISEASE: Hypotrichosis 3 (HYPT3) [MIM:613981]: A condition characterized by the presence of less than the normal amount of hair. Affected individuals have normal hair in early childhood but experience progressive hair loss limited to the scalp beginning in the middle of the first decade and almost complete baldness by the third decade. Body hair, beard, eyebrows, axillary hair, teeth, and nails develop normally. {ECO:0000269|PubMed:21188418}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectodermal dysplasia 7, hair/nail type (ECTD7) [MIM:614929]: A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. Ectodermal dysplasia of the hair/nail type is characterized by hypotrichosis and nail dystrophy without non- ectodermal or other ectodermal manifestations. {ECO:0000269|PubMed:24714551}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Highly expressed in hair follicles from scalp. In hair, it is specifically present in the inner root sheath (IRS) of the hair follicle. Present in the IRS Huxley layer, but not in Henle layer or cuticle of the IRS. In the IRS Huxley layer, it is expressed in specialized Huxley cells, termed 'Fluegelzellen, along the area of differentiated Henle cells (at protein level). {ECO:0000269|PubMed:12648212, ECO:0000269|PubMed:16874310, ECO:0000269|PubMed:24714551}.; 	lung;heart;testis;	.	0.14828	0.11210	2.384902558	98.47841472	4847.27432	14.14529	12q13.13																								
12	52966397	52966399	GCA	-	exonic	KRT74		nonframeshift deletion	KRT74:NM_175053:exon2:c.524_526del:p.L175Qfs*355	8.39640673732565e-09	0.154029266434043	0.84597072516955	keratin 74	FUNCTION: Has a role in hair formation. Specific component of keratin intermediate filaments in the inner root sheath (IRS) of the hair follicle (Probable). {ECO:0000305}.; 	DISEASE: Hypotrichosis 3 (HYPT3) [MIM:613981]: A condition characterized by the presence of less than the normal amount of hair. Affected individuals have normal hair in early childhood but experience progressive hair loss limited to the scalp beginning in the middle of the first decade and almost complete baldness by the third decade. Body hair, beard, eyebrows, axillary hair, teeth, and nails develop normally. {ECO:0000269|PubMed:21188418}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ectodermal dysplasia 7, hair/nail type (ECTD7) [MIM:614929]: A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. Ectodermal dysplasia of the hair/nail type is characterized by hypotrichosis and nail dystrophy without non- ectodermal or other ectodermal manifestations. {ECO:0000269|PubMed:24714551}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Highly expressed in hair follicles from scalp. In hair, it is specifically present in the inner root sheath (IRS) of the hair follicle. Present in the IRS Huxley layer, but not in Henle layer or cuticle of the IRS. In the IRS Huxley layer, it is expressed in specialized Huxley cells, termed 'Fluegelzellen, along the area of differentiated Henle cells (at protein level). {ECO:0000269|PubMed:12648212, ECO:0000269|PubMed:16874310, ECO:0000269|PubMed:24714551}.; 	lung;heart;testis;	.	0.14828	0.11210	2.384902558	98.47841472	4847.27432	14.14529	12q13.13																								
12	54741814	54741814	G	C	exonic	COPZ1		synonymous SNV	COPZ1:NM_001271734:exon6:c.G357C:p.V119V,COPZ1:NM_001271735:exon7:c.G426C:p.V142V,COPZ1:NM_001271736:exon7:c.G450C:p.V150V,COPZ1:NM_016057:exon7:c.G426C:p.V142V	0.890701152776699	0.10906675594144	0.000232091281861618	coatomer protein complex subunit zeta 1	FUNCTION: The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non- clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). {ECO:0000250}.; 	.	.	lymphoreticular;myocardium;ovary;umbilical cord;skin;retina;prostate;optic nerve;cochlea;endometrium;thyroid;iris;amniotic fluid;germinal center;brain;bladder;heart;cartilage;pharynx;blood;lens;skeletal muscle;breast;epididymis;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;peripheral nerve;salivary gland;developmental;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;larynx;bone;pituitary gland;testis;dura mater;artery;unclassifiable (Anatomical System);meninges;lymph node;islets of Langerhans;hypothalamus;pancreas;pia mater;lung;cornea;mesenchyma;adrenal gland;nasopharynx;placenta;hippocampus;duodenum;head and neck;kidney;stomach;aorta;cerebellum;	superior cervical ganglion;kidney;cerebellum;	0.16613	0.12378	-0.09720619	46.20193442	3.96945	0.14679	12q13.13		0.0077	0.0316	0.0178	0.0404	0	0.0004	0.0055	0.0011	0.0114	0.0317	0.0131	0	0.0345	0.0003	0.0001	0.0061	rs73316319						
12	54741838	54741838	A	-	intronic	COPZ1				0.890701152776699	0.10906675594144	0.000232091281861618	coatomer protein complex subunit zeta 1	FUNCTION: The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non- clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). {ECO:0000250}.; 	.	.	lymphoreticular;myocardium;ovary;umbilical cord;skin;retina;prostate;optic nerve;cochlea;endometrium;thyroid;iris;amniotic fluid;germinal center;brain;bladder;heart;cartilage;pharynx;blood;lens;skeletal muscle;breast;epididymis;macula lutea;visual apparatus;liver;alveolus;spleen;cervix;mammary gland;peripheral nerve;salivary gland;developmental;intestine;colon;parathyroid;fovea centralis;choroid;uterus;whole body;larynx;bone;pituitary gland;testis;dura mater;artery;unclassifiable (Anatomical System);meninges;lymph node;islets of Langerhans;hypothalamus;pancreas;pia mater;lung;cornea;mesenchyma;adrenal gland;nasopharynx;placenta;hippocampus;duodenum;head and neck;kidney;stomach;aorta;cerebellum;	superior cervical ganglion;kidney;cerebellum;	0.16613	0.12378	-0.09720619	46.20193442	3.96945	0.14679	12q13.13																								
12	56093778	56093778	G	-	intronic	ITGA7				1.80979797287063e-09	0.999585497375624	0.000414500814577502	integrin subunit alpha 7	FUNCTION: Integrin alpha-7/beta-1 is the primary laminin receptor on skeletal myoblasts and adult myofibers. During myogenic differentiation, it may induce changes in the shape and mobility of myoblasts, and facilitate their localization at laminin-rich sites of secondary fiber formation. It is involved in the maintenance of the myofibers cytoarchitecture as well as for their anchorage, viability and functional integrity. Isoform Alpha-7X2B and isoform Alpha-7X1B promote myoblast migration on laminin 1 and laminin 2/4, but isoform Alpha-7X1B is less active on laminin 1 (In vitro). Acts as Schwann cell receptor for laminin-2. Acts as a receptor of COMP and mediates its effect on vascular smooth muscle cells (VSMCs) maturation (By similarity). Required to promote contractile phenotype acquisition in differentiated airway smooth muscle (ASM) cells. {ECO:0000250, ECO:0000269|PubMed:10694445, ECO:0000269|PubMed:17641293, ECO:0000269|PubMed:9307969}.; 	DISEASE: Muscular dystrophy congenital due to integrin alpha-7 deficiency (MDCI) [MIM:613204]: A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures. {ECO:0000269|PubMed:9590299}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Isoforms containing segment A are predominantly expressed in skeletal muscle. Isoforms containing segment B are abundantly expressed in skeletal muscle, moderately in cardiac muscle, small intestine, colon, ovary and prostate and weakly in lung and testes. Isoforms containing segment X2D are expressed at low levels in fetal and adult skeletal muscle and in cardiac muscle, but are not detected in myoblasts and myotubes. In muscle fibers isoforms containing segment A and B are expressed at myotendinous and neuromuscular junctions; isoforms containing segment C are expressed at neuromuscular junctions and at extrasynaptic sites. Isoforms containing segments X1 or X2 or, at low levels, X1X2 are expressed in fetal and adult skeletal muscle (myoblasts and myotubes) and cardiac muscle. {ECO:0000269|PubMed:8626012}.; 	myocardium;medulla oblongata;ovary;sympathetic chain;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;subthalamic nucleus;optic nerve;endometrium;cerebral cortex;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;muscle;lens;skeletal muscle;lung;placenta;macula lutea;hippocampus;liver;spleen;kidney;stomach;	amygdala;olfactory bulb;adipose tissue;tongue;spinal cord;ciliary ganglion;atrioventricular node;caudate nucleus;skeletal muscle;	0.26775	0.36635	0.170781634	65.34560038	592.64062	4.93434	12q13.2																								
12	58010222	58010224	CTG	-	exonic	ARHGEF25		nonframeshift deletion	ARHGEF25:NM_001347933:exon13:c.1486_1488del:p.L498Sfs*53,ARHGEF25:NM_182947:exon14:c.1576_1578del:p.L528Sfs*53,ARHGEF25:NM_001111270:exon15:c.1693_1695del:p.L567Sfs*53	5.17606707704438e-06	0.992194775303211	0.00780004862971155	Rho guanine nucleotide exchange factor 25	FUNCTION: May play a role in actin cytoskeleton reorganization in different tissues since its activation induces formation of actin stress fibers. It works as a guanine nucleotide exchange factor for Rho family of small GTPases. Links specifically G alpha q/11- coupled receptors to RHOA activation. May be an important regulator of processes involved in axon and dendrite formation. In neurons seems to be an exchange factor primarily for RAC1. Involved in skeletal myogenesis (By similarity). {ECO:0000250, ECO:0000269|PubMed:11861769, ECO:0000269|PubMed:12547822, ECO:0000269|PubMed:15069594, ECO:0000269|PubMed:15632174, ECO:0000269|PubMed:16314529, ECO:0000269|PubMed:17606614}.; 	.	TISSUE SPECIFICITY: Isoform 1 and isoform 2 are highly expressed in excitable tissues, such as brain, heart and muscle. Also detected in kidney and liver. {ECO:0000269|PubMed:11861769, ECO:0000269|PubMed:12547822, ECO:0000269|PubMed:15069594}.; 	colon;choroid;fovea centralis;skin;retina;uterus;prostate;optic nerve;whole body;frontal lobe;bone;pituitary gland;testis;brain;spinal ganglion;unclassifiable (Anatomical System);heart;lacrimal gland;islets of Langerhans;lens;lung;placenta;macula lutea;stomach;cerebellum;	.	.	.	-0.021969881	52.14673272	191.33923	2.99965	12q13.3																								
12	80935957	80935957	-	GTGCAATAATAAGTTGCGAATTTCGACGATCGTTGAAATTCGCAACTTATTAAAGCCAAAT	exonic	PTPRQ		stopgain	PTPRQ:NM_001145026:exon19:c.3019_3020insGTGCAATAATAAGTTGCGAATTTCGACGATCGTTGAAATTCGCAACTTATTAAAGCCAAAT:p.Y1012Cfs*13	.	.	.	protein tyrosine phosphatase, receptor type Q	FUNCTION: Phosphatidylinositol phosphatase required for auditory function. May act by regulating the level of phosphatidylinositol 4,5-bisphosphate (PIP2) level in the basal region of hair bundles. Can dephosphorylate a broad range of phosphatidylinositol phosphates, including phosphatidylinositol 3,4,5-trisphosphate and most phosphatidylinositol monophosphates and diphosphates. Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring. Has low tyrosine-protein phosphatase activity; however, the relevance of such activity in vivo is unclear. Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regulates the phosphorylation state of AKT1 by suppressing the phosphatidylinositol 3,4,5-trisphosphate (PIP3) level in MSCs and preadipocyte cells. {ECO:0000269|PubMed:19351528}.; 	DISEASE: Deafness, autosomal recessive, 84A (DFNB84A) [MIM:613391]: A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction. {ECO:0000269|PubMed:20346435, ECO:0000269|PubMed:20472657}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In developing kidney, it localizes to the basal membrane of podocytes, beginning when podocyte progenitors can first be identified in the embryonic kidney (at protein level). Expressed in lung and kidney. {ECO:0000269|PubMed:12837292, ECO:0000269|PubMed:20346435}.; 	.	.	0.39566	0.10497	.	.	17963.04124	28.76351	12q21.31																								
12	81067025	81067026	AT	-	exonic	PTPRQ		frameshift deletion	PTPRQ:NM_001145026:exon40:c.6164_6165del:p.Y2057Wfs*5	.	.	.	protein tyrosine phosphatase, receptor type Q	FUNCTION: Phosphatidylinositol phosphatase required for auditory function. May act by regulating the level of phosphatidylinositol 4,5-bisphosphate (PIP2) level in the basal region of hair bundles. Can dephosphorylate a broad range of phosphatidylinositol phosphates, including phosphatidylinositol 3,4,5-trisphosphate and most phosphatidylinositol monophosphates and diphosphates. Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring. Has low tyrosine-protein phosphatase activity; however, the relevance of such activity in vivo is unclear. Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regulates the phosphorylation state of AKT1 by suppressing the phosphatidylinositol 3,4,5-trisphosphate (PIP3) level in MSCs and preadipocyte cells. {ECO:0000269|PubMed:19351528}.; 	DISEASE: Deafness, autosomal recessive, 84A (DFNB84A) [MIM:613391]: A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction. {ECO:0000269|PubMed:20346435, ECO:0000269|PubMed:20472657}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In developing kidney, it localizes to the basal membrane of podocytes, beginning when podocyte progenitors can first be identified in the embryonic kidney (at protein level). Expressed in lung and kidney. {ECO:0000269|PubMed:12837292, ECO:0000269|PubMed:20346435}.; 	.	.	0.39566	0.10497	.	.	17963.04124	28.76351	12q21.31																								
12	109883374	109883374	T	C	exonic	MYO1H		nonsynonymous SNV	MYO1H:NM_001101421:exon30:c.T3002C:p.L1001P	2.91611360098295e-17	0.365254710934844	0.634745289065156	myosin IH	FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments (By similarity). {ECO:0000250}.; 	.	.	uterus;heart;bone;skin;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.18215	.	-0.547447733	19.99882048	2516.66481	9.35299	12q24.11		0.6584	0.9349	0.5237	0.5085	0.5542	0.6571	0.6496	0.7143	0.7167	0.9316	0.5800	0.6225	0.5253	0.5530	0.6656	0.6303	rs3825393						
12	120527791	120527791	G	A	exonic	BICDL1		synonymous SNV	BICDL1:NM_207311:exon8:c.G1476A:p.R492R																12q24.23		0.0372	0.1459	0.0187	0.0299	0.0180	0.0195	0.0311	0.0691	0.0558	0.1493	0.0239	0.0430	0.0345	0.0172	0.0172	0.0204	rs2286041						
13	45515460	45515461	AA	-	intronic	NUFIP1				3.91687077980072e-06	0.82085529897725	0.17914078415197	nuclear fragile X mental retardation protein interacting protein 1	FUNCTION: Binds RNA. {ECO:0000269|PubMed:10556305}.; 	.	TISSUE SPECIFICITY: Expressed in spleen, thymus, prostate, testis, ovary, small intestine, colon, peripheral blood leukocyte, heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas. {ECO:0000269|PubMed:10556305}.; 	.	.	0.55277	.	-0.200157416	39.11299835	50.37843	1.39556	13q14.12																								
13	51819466	51819466	G	A	exonic	FAM124A		nonsynonymous SNV	FAM124A:NM_145019:exon3:c.G119A:p.R40Q	5.43000288891245e-07	0.240489773745443	0.759509683254268	family with sequence similarity 124 member A	.	.	.	unclassifiable (Anatomical System);cartilage;heart;ovary;cerebellum cortex;colon;skin;skeletal muscle;retina;uterus;lung;thyroid;placenta;visual apparatus;liver;testis;kidney;brain;stomach;aorta;	atrioventricular node;trigeminal ganglion;skin;	0.37251	0.09790	0.154398214	64.73814579	1309.33779	6.80771	13q14.3		0.0012	0.0006	0	0.0177	0	0.0005	0.0072	0.0012	0.0013	0.0006	0	0	0.0136	0.0014	0.0005	0	rs117053935						
13	51819527	51819529	CCT	-	exonic	FAM124A		nonframeshift deletion	FAM124A:NM_145019:exon3:c.180_182del:p.L61Qfs*522	5.43000288891245e-07	0.240489773745443	0.759509683254268	family with sequence similarity 124 member A	.	.	.	unclassifiable (Anatomical System);cartilage;heart;ovary;cerebellum cortex;colon;skin;skeletal muscle;retina;uterus;lung;thyroid;placenta;visual apparatus;liver;testis;kidney;brain;stomach;aorta;	atrioventricular node;trigeminal ganglion;skin;	0.37251	0.09790	0.154398214	64.73814579	1309.33779	6.80771	13q14.3																								
13	102231718	102231718	-	C	exonic	ITGBL1		frameshift insertion	ITGBL1:NM_001271754:exon4:c.245dupC:p.W84Lfs*17,ITGBL1:NM_001271755:exon4:c.521dupC:p.W176Lfs*17,ITGBL1:NM_001271756:exon4:c.389dupC:p.W132Lfs*17,ITGBL1:NM_004791:exon5:c.668dupC:p.W225Lfs*17	0.170877824203552	0.82854057783344	0.000581597963007633	integrin subunit beta like 1	.	.	TISSUE SPECIFICITY: Widely expressed in many tissues, but readily detectable only in aorta. {ECO:0000269|PubMed:10051402}.; 	.	.	0.17697	0.12974	0.64123826	83.97617363	1434.7471	7.07106	13q33.1																								
13	114156174	114156250	TTCAGGACTAAATAGTATTAAGGTAAGAACAAAATTGGATTGTTTTGGTATCTGTTTAACAGAATATAAAAAGAGAA	-	exonic	TMCO3		frameshift deletion	TMCO3:NM_001349742:exon4:c.732_753del:p.S245Lfs*8,TMCO3:NM_001349743:exon4:c.732_753del:p.S245Lfs*8,TMCO3:NM_001349745:exon4:c.732_753del:p.S245Lfs*8,TMCO3:NM_001349741:exon5:c.924_945del:p.S309Lfs*8,TMCO3:NM_001349744:exon5:c.924_945del:p.S309Lfs*8,TMCO3:NM_001349746:exon5:c.924_945del:p.S309Lfs*8,TMCO3:NM_017905:exon5:c.924_945del:p.S309Lfs*8	6.68498405104448e-10	0.411660043201141	0.588339956130361	transmembrane and coiled-coil domains 3	FUNCTION: Probable Na+/H+ antiporter. {ECO:0000250}.; 	.	.	.	.	0.09724	0.09172	-0.10469683	45.64755839	1499.02081	7.20431	13q34																								
14	25100417	25100417	C	-	exonic	GZMB		frameshift deletion	GZMB:NM_001346011:exon5:c.568delG:p.D190Tfs*39,GZMB:NM_004131:exon5:c.604delG:p.D202Tfs*39	1.78750946382579e-06	0.431109670948733	0.568888541541804	granzyme B	FUNCTION: This enzyme is necessary for target cell lysis in cell- mediated immune responses. It cleaves after Asp. Seems to be linked to an activation cascade of caspases (aspartate-specific cysteine proteases) responsible for apoptosis execution. Cleaves caspase-3, -7, -9 and 10 to give rise to active enzymes mediating apoptosis.; 	.	.	unclassifiable (Anatomical System);ovary;salivary gland;intestine;pharynx;colon;blood;skin;breast;prostate;pancreas;lung;cornea;endometrium;thyroid;placenta;visual apparatus;alveolus;liver;spleen;kidney;brain;mammary gland;bladder;stomach;	whole blood;	0.04747	0.52613	0.305084559	72.22811984	2042.02554	8.32989	14q12																								
14	39777796	39777796	-	A	intronic	MIA2				0.000208820494041296	0.908098694110289	0.09169248539567	melanoma inhibitory activity 2	FUNCTION: May play a role in the pathophysiology of liver disease and may serve as a marker of liver damage.; 	.	TISSUE SPECIFICITY: Highly expressed in liver and weakly in testis. Expression was higher in patients with severe fibrosis or inflammation and chronic hepatitis.; 	liver;kidney;	medulla oblongata;superior cervical ganglion;temporal lobe;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;parietal lobe;	0.18559	0.10293	1.133561642	92.28591649	1216.13549	6.59678	14q21.1																								
14	64656834	64656834	T	A	exonic	SYNE2		nonsynonymous SNV	SYNE2:NM_015180:exon99:c.T17917A:p.L5973I,SYNE2:NM_182914:exon99:c.T17917A:p.L5973I	1.8533519422462e-11	0.999999999981466	3.58916255415674e-33	spectrin repeat containing, nuclear envelope 2	FUNCTION: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. Component of SUN-protein- containing multivariate complexes also called LINC complexes which link the nucleoskeleton and cytoskeleton by providing versatile outer nuclear membrane attachment sites for cytoskeletal filaments. Involved in the maintenance of nuclear organization and structural integrity. Connects nuclei to the cytoskeleton by interacting with the nuclear envelope and with F-actin in the cytoplasm. Specifically, SYNE2 and SUN2 assemble in arrays of transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow during actin-dependent nuclear movement. Required for centrosome migration to the apical cell surface during early ciliogenesis. {ECO:0000269|PubMed:12118075, ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:19596800, ECO:0000269|PubMed:20724637}.; 	DISEASE: Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed, with higher level in kidney, adult and fetal liver, stomach and placenta. Weakly expressed in skeletal muscle and brain. Isoform 5 is highly expressed in pancreas, skeletal muscle and heart. {ECO:0000269|PubMed:15671068}.; 	myocardium;medulla oblongata;ovary;colon;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;larynx;bone;thyroid;iris;testis;dura mater;germinal center;brain;bladder;unclassifiable (Anatomical System);meninges;lymph node;heart;tongue;islets of Langerhans;blood;skeletal muscle;breast;pia mater;lung;cornea;nasopharynx;placenta;visual apparatus;hippocampus;hypopharynx;liver;head and neck;cervix;kidney;mammary gland;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.21106	.	3.839142661	99.63434772	10907.00643	22.66019	14q23.2																								
14	64656875	64656949	ATCAAGAGCAGCTGAGATCGATGACAAGCTCAACAAAATTAACGATCGTTGGCAACATCTTTTTGATGTCATCGG	-	exonic	SYNE2		nonframeshift deletion	SYNE2:NM_015180:exon99:c.17958_18032del:p.A5989Vfs*873,SYNE2:NM_182914:exon99:c.17958_18032del:p.A5989Vfs*895	1.8533519422462e-11	0.999999999981466	3.58916255415674e-33	spectrin repeat containing, nuclear envelope 2	FUNCTION: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. Component of SUN-protein- containing multivariate complexes also called LINC complexes which link the nucleoskeleton and cytoskeleton by providing versatile outer nuclear membrane attachment sites for cytoskeletal filaments. Involved in the maintenance of nuclear organization and structural integrity. Connects nuclei to the cytoskeleton by interacting with the nuclear envelope and with F-actin in the cytoplasm. Specifically, SYNE2 and SUN2 assemble in arrays of transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow during actin-dependent nuclear movement. Required for centrosome migration to the apical cell surface during early ciliogenesis. {ECO:0000269|PubMed:12118075, ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:19596800, ECO:0000269|PubMed:20724637}.; 	DISEASE: Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed, with higher level in kidney, adult and fetal liver, stomach and placenta. Weakly expressed in skeletal muscle and brain. Isoform 5 is highly expressed in pancreas, skeletal muscle and heart. {ECO:0000269|PubMed:15671068}.; 	myocardium;medulla oblongata;ovary;colon;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;larynx;bone;thyroid;iris;testis;dura mater;germinal center;brain;bladder;unclassifiable (Anatomical System);meninges;lymph node;heart;tongue;islets of Langerhans;blood;skeletal muscle;breast;pia mater;lung;cornea;nasopharynx;placenta;visual apparatus;hippocampus;hypopharynx;liver;head and neck;cervix;kidney;mammary gland;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.21106	.	3.839142661	99.63434772	10907.00643	22.66019	14q23.2																								
14	64656934	64656934	T	-	exonic	SYNE2		frameshift deletion	SYNE2:NM_015180:exon99:c.18017delT:p.F6007Lfs*8,SYNE2:NM_182914:exon99:c.18017delT:p.F6007Lfs*8	1.8533519422462e-11	0.999999999981466	3.58916255415674e-33	spectrin repeat containing, nuclear envelope 2	FUNCTION: Multi-isomeric modular protein which forms a linking network between organelles and the actin cytoskeleton to maintain the subcellular spatial organization. Component of SUN-protein- containing multivariate complexes also called LINC complexes which link the nucleoskeleton and cytoskeleton by providing versatile outer nuclear membrane attachment sites for cytoskeletal filaments. Involved in the maintenance of nuclear organization and structural integrity. Connects nuclei to the cytoskeleton by interacting with the nuclear envelope and with F-actin in the cytoplasm. Specifically, SYNE2 and SUN2 assemble in arrays of transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow during actin-dependent nuclear movement. Required for centrosome migration to the apical cell surface during early ciliogenesis. {ECO:0000269|PubMed:12118075, ECO:0000269|PubMed:18396275, ECO:0000269|PubMed:19596800, ECO:0000269|PubMed:20724637}.; 	DISEASE: Emery-Dreifuss muscular dystrophy 5, autosomal dominant (EDMD5) [MIM:612999]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:17761684}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Widely expressed, with higher level in kidney, adult and fetal liver, stomach and placenta. Weakly expressed in skeletal muscle and brain. Isoform 5 is highly expressed in pancreas, skeletal muscle and heart. {ECO:0000269|PubMed:15671068}.; 	myocardium;medulla oblongata;ovary;colon;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;larynx;bone;thyroid;iris;testis;dura mater;germinal center;brain;bladder;unclassifiable (Anatomical System);meninges;lymph node;heart;tongue;islets of Langerhans;blood;skeletal muscle;breast;pia mater;lung;cornea;nasopharynx;placenta;visual apparatus;hippocampus;hypopharynx;liver;head and neck;cervix;kidney;mammary gland;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.21106	.	3.839142661	99.63434772	10907.00643	22.66019	14q23.2																								
14	65268121	65268121	G	-	intronic	SPTB				0.999999747900015	2.52099984509224e-07	2.52004219585292e-22	spectrin beta, erythrocytic	FUNCTION: Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane.; 	DISEASE: Elliptocytosis 3 (EL3) [MIM:182870]: A Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. {ECO:0000269|PubMed:1975598, ECO:0000269|PubMed:7883966, ECO:0000269|PubMed:8018926, ECO:0000269|PubMed:8226774}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spherocytosis 2 (SPH2) [MIM:616649]: An autosomal dominant form of hereditary spherocytosis, a group of hematologic disorders characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. Clinical manifestations include chronic hemolytic anemia, jaundice, and splenomegaly, with variable severity. {ECO:0000269|PubMed:19538529, ECO:0000269|PubMed:8102379}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	colon;choroid;fovea centralis;skin;retina;uterus;prostate;optic nerve;frontal lobe;thyroid;bone;brain;unclassifiable (Anatomical System);heart;tongue;islets of Langerhans;muscle;lens;skeletal muscle;lung;macula lutea;liver;head and neck;spleen;peripheral nerve;cerebellum;	subthalamic nucleus;superior cervical ganglion;cerebellum peduncles;globus pallidus;atrioventricular node;caudate nucleus;pons;trigeminal ganglion;skeletal muscle;cerebellum;	0.31324	0.33019	-2.640400656	0.778485492	7634.17972	18.78025	14q23.3																								
14	68260419	68260419	-	G	exonic	ZFYVE26		frameshift insertion	ZFYVE26:NM_015346:exon14:c.2458dupC:p.H820Pfs*15	1.03844572602961e-11	0.99999998403029	1.59593255760405e-08	zinc finger FYVE-type containing 26	FUNCTION: Phosphatidylinositol 3-phosphate-binding protein required for the abcission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abcission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}.; 	DISEASE: Spastic paraplegia 15, autosomal recessive (SPG15) [MIM:270700]: A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. In some forms of the disorder, bladder symptoms (such as incontinence) may appear, or the weakness and stiffness may spread to other parts of the body. SPG15 is a complex form associated with additional neurological symptoms such as cognitive deterioration or mental retardation, axonal neuropathy, mild cerebellar signs, and, less frequently, a central hearing deficit, decreased visual acuity, or retinal degeneration. {ECO:0000269|PubMed:18394578, ECO:0000269|PubMed:19084844, ECO:0000269|PubMed:19805727}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Strongest expression in the adrenal gland, bone marrow, adult brain, fetal brain, lung, placenta, prostate, skeletal muscle, testis, thymus, and retina. Intermediate levels are detected in other structures, including the spinal cord. {ECO:0000269|PubMed:18394578}.; 	lymphoreticular;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;larynx;bone;thyroid;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;hypothalamus;blood;lens;skeletal muscle;breast;pancreas;lung;nasopharynx;placenta;macula lutea;duodenum;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;globus pallidus;atrioventricular node;pons;trigeminal ganglion;skeletal muscle;	0.08330	0.10527	-0.274087418	33.5928285	2850.19714	10.09609	14q24.1																								
14	93170993	93170993	C	T	exonic	LGMN		synonymous SNV	LGMN:NM_005606:exon13:c.G1251A:p.P417P,LGMN:NM_001008530:exon14:c.G1251A:p.P417P	0.00097489450100372	0.986740549161317	0.0122845563376795	legumain	FUNCTION: Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system. {ECO:0000250, ECO:0000269|PubMed:23776206}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Particularly abundant in kidney, heart and placenta.; 	myocardium;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;iris;brain;gall bladder;heart;cartilage;tongue;pineal body;urinary;blood;lens;skeletal muscle;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);small intestine;lacrimal gland;islets of Langerhans;pancreas;lung;mesenchyma;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	placenta;kidney;	0.18925	0.32479	-0.023789244	52.09365416	45.20813	1.29089	14q32.12		0.3563	0.2860	0.5892	0.0650	0.3908	0.4037	0.3485	0.1846	0.3578	0.2827	0.5120	0.4503	0.0660	0.3869	0.4141	0.3834	rs9791						
14	93199041	93199041	C	-	exonic	LGMN		frameshift deletion	LGMN:NM_005606:exon2:c.91delG:p.V31Wfs*2,LGMN:NM_001008530:exon3:c.91delG:p.V31Wfs*2	0.00097489450100372	0.986740549161317	0.0122845563376795	legumain	FUNCTION: Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system. {ECO:0000250, ECO:0000269|PubMed:23776206}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Particularly abundant in kidney, heart and placenta.; 	myocardium;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;iris;brain;gall bladder;heart;cartilage;tongue;pineal body;urinary;blood;lens;skeletal muscle;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);small intestine;lacrimal gland;islets of Langerhans;pancreas;lung;mesenchyma;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	placenta;kidney;	0.18925	0.32479	-0.023789244	52.09365416	45.20813	1.29089	14q32.12																								
14	93199091	93199091	C	-	exonic	LGMN		frameshift deletion	LGMN:NM_005606:exon2:c.41delG:p.G14Afs*7,LGMN:NM_001008530:exon3:c.41delG:p.G14Afs*7	0.00097489450100372	0.986740549161317	0.0122845563376795	legumain	FUNCTION: Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system. {ECO:0000250, ECO:0000269|PubMed:23776206}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Particularly abundant in kidney, heart and placenta.; 	myocardium;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;iris;brain;gall bladder;heart;cartilage;tongue;pineal body;urinary;blood;lens;skeletal muscle;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);small intestine;lacrimal gland;islets of Langerhans;pancreas;lung;mesenchyma;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	placenta;kidney;	0.18925	0.32479	-0.023789244	52.09365416	45.20813	1.29089	14q32.12																								
14	93199099	93199100	CA	-	exonic	LGMN		frameshift deletion	LGMN:NM_005606:exon2:c.32_33del:p.V11Gfs*11,LGMN:NM_001008530:exon3:c.32_33del:p.V11Gfs*11	0.00097489450100372	0.986740549161317	0.0122845563376795	legumain	FUNCTION: Has a strict specificity for hydrolysis of asparaginyl bonds. Can also cleave aspartyl bonds slowly, especially under acidic conditions. Required for normal lysosomal protein degradation in renal proximal tubules. Required for normal degradation of internalized EGFR. Plays a role in the regulation of cell proliferation via its role in EGFR degradation (By similarity). May be involved in the processing of proteins for MHC class II antigen presentation in the lysosomal/endosomal system. {ECO:0000250, ECO:0000269|PubMed:23776206}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Particularly abundant in kidney, heart and placenta.; 	myocardium;ovary;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;cochlea;thyroid;iris;brain;gall bladder;heart;cartilage;tongue;pineal body;urinary;blood;lens;skeletal muscle;epididymis;visual apparatus;macula lutea;liver;spleen;mammary gland;peripheral nerve;colon;parathyroid;choroid;fovea centralis;uterus;whole body;larynx;pituitary gland;testis;spinal ganglion;unclassifiable (Anatomical System);small intestine;lacrimal gland;islets of Langerhans;pancreas;lung;mesenchyma;nasopharynx;placenta;hippocampus;head and neck;kidney;stomach;	placenta;kidney;	0.18925	0.32479	-0.023789244	52.09365416	45.20813	1.29089	14q32.12																								
14	96777582	96777582	G	-	exonic	ATG2B		frameshift deletion	ATG2B:NM_018036:exon28:c.4033delC:p.H1345Ifs*12	8.12742750734489e-05	0.999918725707387	1.75399996560164e-11	autophagy related 2B	FUNCTION: Required for both autophagosome formation and regulation of lipid droplet morphology and dispersion. {ECO:0000269|PubMed:22219374}.; 	.	.	ovary;colon;fovea centralis;skin;retina;bone marrow;uterus;frontal lobe;endometrium;cerebral cortex;bone;testis;germinal center;brain;unclassifiable (Anatomical System);small intestine;heart;cartilage;islets of Langerhans;blood;breast;lung;adrenal gland;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	superior cervical ganglion;ciliary ganglion;atrioventricular node;skeletal muscle;	0.31648	.	0.486743222	79.3819297	1250.48072	6.67455	14q32.2																								
14	96777627	96777627	G	-	intronic	ATG2B				8.12742750734489e-05	0.999918725707387	1.75399996560164e-11	autophagy related 2B	FUNCTION: Required for both autophagosome formation and regulation of lipid droplet morphology and dispersion. {ECO:0000269|PubMed:22219374}.; 	.	.	ovary;colon;fovea centralis;skin;retina;bone marrow;uterus;frontal lobe;endometrium;cerebral cortex;bone;testis;germinal center;brain;unclassifiable (Anatomical System);small intestine;heart;cartilage;islets of Langerhans;blood;breast;lung;adrenal gland;placenta;macula lutea;visual apparatus;liver;kidney;stomach;	superior cervical ganglion;ciliary ganglion;atrioventricular node;skeletal muscle;	0.31648	.	0.486743222	79.3819297	1250.48072	6.67455	14q32.2																								
15	28412920	28412920	G	-	exonic	HERC2		frameshift deletion	HERC2:NM_004667:exon68:c.10467delC:p.S3490Qfs*10	1	3.99148696809968e-17	4.69739089143488e-51	HECT and RLD domain containing E3 ubiquitin protein ligase 2	FUNCTION: E3 ubiquitin-protein ligase that regulates ubiquitin- dependent retention of repair proteins on damaged chromosomes. Recruited to sites of DNA damage in response to ionizing radiation (IR) and facilitates the assembly of UBE2N and RNF8 promoting DNA damage-induced formation of 'Lys-63'-linked ubiquitin chains. Acts as a mediator of binding specificity between UBE2N and RNF8. Involved in the maintenance of RNF168 levels. E3 ubiquitin-protein ligase that promotes the ubiquitination and proteasomal degradation of XPA which influences the circadian oscillation of DNA excision repair activity. {ECO:0000269|PubMed:20023648, ECO:0000269|PubMed:20304803, ECO:0000269|PubMed:22508508}.; 	DISEASE: Mental retardation, autosomal recessive 38 (MRT38) [MIM:615516]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT38 is characterized by global developmental delay affecting motor, speech, adaptive, and social development. Patients manifest autistic features, aggression, self-injury, impulsivity, and distractibility. {ECO:0000269|PubMed:23065719}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cerebral cortex;endometrium;larynx;bone;thyroid;iris;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;nervous;islets of Langerhans;blood;lens;skeletal muscle;breast;pancreas;lung;cornea;adrenal gland;epididymis;nasopharynx;placenta;macula lutea;hippocampus;duodenum;hypopharynx;liver;spleen;head and neck;kidney;mammary gland;stomach;thymus;	whole brain;amygdala;medulla oblongata;thalamus;superior cervical ganglion;prefrontal cortex;caudate nucleus;pons;trigeminal ganglion;cingulate cortex;	0.24532	0.21556	-5.985628431	0.047180939	2166.06955	8.56756	15q13.1																								
15	57213283	57213283	A	G	exonic	TCF12		synonymous SNV	TCF12:NM_001322164:exon2:c.A135G:p.Q45Q,TCF12:NM_001322165:exon2:c.A135G:p.Q45Q,TCF12:NM_001322151:exon3:c.A135G:p.Q45Q,TCF12:NM_001322152:exon3:c.A135G:p.Q45Q,TCF12:NM_001322157:exon3:c.A135G:p.Q45Q,TCF12:NM_001322159:exon3:c.A135G:p.Q45Q,TCF12:NM_001322161:exon3:c.A135G:p.Q45Q,TCF12:NM_001322162:exon3:c.A135G:p.Q45Q,TCF12:NM_003205:exon3:c.A135G:p.Q45Q,TCF12:NM_207036:exon3:c.A135G:p.Q45Q,TCF12:NM_207037:exon3:c.A135G:p.Q45Q,TCF12:NM_207038:exon3:c.A135G:p.Q45Q	0.973899934245985	0.0261000138175462	5.1936469217086e-08	transcription factor 12	FUNCTION: Transcriptional regulator. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3').; 	DISEASE: Craniosynostosis 3 (CRS3) [MIM:615314]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:23354436, ECO:0000269|PubMed:25271085}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in several tissues and cell types including skeletal muscle, thymus, and a B-cell line.; 	ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;cochlea;endometrium;larynx;bone;thyroid;testis;germinal center;brain;gall bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;small intestine;islets of Langerhans;urinary;blood;lens;skeletal muscle;breast;bile duct;pancreas;lung;epididymis;placenta;macula lutea;visual apparatus;liver;cervix;spleen;head and neck;kidney;stomach;aorta;	dorsal root ganglion;uterus;amygdala;superior cervical ganglion;spinal cord;globus pallidus;ciliary ganglion;caudate nucleus;atrioventricular node;trigeminal ganglion;	0.74130	0.18974	-0.709045403	14.673272	248.01793	3.39501	15q21.3		0.0393	0.0670	0.0350	0.3007	0.0167	0.0026	0.0380	0.0446	0.0404	0.0690	0.0263	0	0.3035	0.0195	0.0031	0.0224	rs35615435	255312	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
15	72283548	72283548	-	A	exonic	MYO9A		frameshift insertion	MYO9A:NM_006901:exon11:c.1617dupT:p.G540Wfs*3	0.999991725771394	8.2742286060295e-06	3.49330660269938e-24	myosin IXA	FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Regulates Rho activity in neurons, has a role in the regulation of neuronal morphology and function (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Found to be expressed in testis and placenta, and at lower levels in all the examined tissues with the exception of liver. Isoform 5 was found in leukocytes but not in brain, retina or testis. {ECO:0000269|PubMed:10409426}.; 	smooth muscle;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;testis;germinal center;brain;unclassifiable (Anatomical System);amygdala;heart;islets of Langerhans;pharynx;blood;lens;skeletal muscle;breast;lung;cornea;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;testis;globus pallidus;ciliary ganglion;cingulate cortex;	0.76633	0.11338	-0.702137274	14.78532673	1190.95284	6.54335	15q23																								
15	74622533	74622533	A	G	exonic	CCDC33		nonsynonymous SNV	CCDC33:NM_001287181:exon2:c.A73G:p.M25V,CCDC33:NM_182791:exon2:c.A73G:p.M25V,CCDC33:NM_025055:exon12:c.A1294G:p.M432V	8.63487200520327e-09	0.97529710922535	0.0247028821397779	coiled-coil domain containing 33	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;endometrium;spleen;	superior cervical ganglion;trigeminal ganglion;	0.08776	0.08702	1.139030387	92.34489266	4456.19559	13.38048	15q24.1		0.1111	0.0261	0.0422	0.2395	0.0754	0.0942	0.1325	0.2464	0.0738	0.0274	0.0597	0.1467	0.2138	0.0668	0.0853	0.0943	rs2277603						
15	74622549	74622549	G	T	exonic	CCDC33		nonsynonymous SNV	CCDC33:NM_001287181:exon2:c.G89T:p.R30L,CCDC33:NM_182791:exon2:c.G89T:p.R30L,CCDC33:NM_025055:exon12:c.G1310T:p.R437L	8.63487200520327e-09	0.97529710922535	0.0247028821397779	coiled-coil domain containing 33	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;endometrium;spleen;	superior cervical ganglion;trigeminal ganglion;	0.08776	0.08702	1.139030387	92.34489266	4456.19559	13.38048	15q24.1		0.0365	0.0073	0.0188	0.0967	0.0117	0.0379	0.0443	0.0379	0.0257	0.0067	0.0310	0.0430	0.0866	0.0095	0.0325	0.0368	rs2277604						
15	74622696	74622697	GT	-	splicing	CCDC33				8.63487200520327e-09	0.97529710922535	0.0247028821397779	coiled-coil domain containing 33	.	.	.	unclassifiable (Anatomical System);medulla oblongata;lung;endometrium;spleen;	superior cervical ganglion;trigeminal ganglion;	0.08776	0.08702	1.139030387	92.34489266	4456.19559	13.38048	15q24.1																								
15	89417156	89417156	C	T	exonic	ACAN		nonsynonymous SNV	ACAN:NM_013227:exon17:c.C7417T:p.R2473W	0.999993944546979	6.05545301955806e-06	1.71315417297619e-15	aggrecan	FUNCTION: This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region.; 	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Restricted to cartilages. {ECO:0000269|PubMed:7524681}.; 	unclassifiable (Anatomical System);ovary;cartilage;adrenal cortex;colon;parathyroid;fovea centralis;choroid;lens;retina;uterus;optic nerve;whole body;lung;placenta;bone;macula lutea;visual apparatus;testis;head and neck;brain;stomach;	superior cervical ganglion;trachea;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.34070	0.57020	1.284310712	93.77211607	15528.89086	26.89264	15q26.1		3.34e-05	0	8.681e-05	0.0001	0	3.033e-05	0	0	9.696e-05	0.0001	0	0.0033	0	0	6.671e-05	0	rs149099819						
15	89417172	89417172	-	G	exonic	ACAN		frameshift insertion	ACAN:NM_013227:exon17:c.7434dupG:p.F2480Vfs*62	0.999993944546979	6.05545301955806e-06	1.71315417297619e-15	aggrecan	FUNCTION: This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region.; 	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Restricted to cartilages. {ECO:0000269|PubMed:7524681}.; 	unclassifiable (Anatomical System);ovary;cartilage;adrenal cortex;colon;parathyroid;fovea centralis;choroid;lens;retina;uterus;optic nerve;whole body;lung;placenta;bone;macula lutea;visual apparatus;testis;head and neck;brain;stomach;	superior cervical ganglion;trachea;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.34070	0.57020	1.284310712	93.77211607	15528.89086	26.89264	15q26.1																								
15	89417177	89417177	T	-	exonic	ACAN		frameshift deletion	ACAN:NM_013227:exon17:c.7438delT:p.F2480Lfs*89	0.999993944546979	6.05545301955806e-06	1.71315417297619e-15	aggrecan	FUNCTION: This proteoglycan is a major component of extracellular matrix of cartilagenous tissues. A major function of this protein is to resist compression in cartilage. It binds avidly to hyaluronic acid via an N-terminal globular region.; 	DISEASE: Spondyloepiphyseal dysplasia type Kimberley (SEDK) [MIM:608361]: Spondyloepiphyseal dysplasias are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. The autosomal dominant SEDK is associated with premature degenerative arthropathy. {ECO:0000269|PubMed:16080123}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spondyloepimetaphyseal dysplasia aggrecan type (SEMD- ACAN) [MIM:612813]: A bone disease characterized by severe short stature, macrocephaly, severe midface hypoplasia, short neck, barrel chest and brachydactyly. The radiological findings comprise long bones with generalized irregular epiphyses with widened metaphyses, especially at the knees, platyspondyly, and multiple cervical-vertebral clefts. {ECO:0000269|PubMed:19110214}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteochondritis dissecans short stature and early-onset osteoarthritis (OD) [MIM:165800]: A type of osteochondritis defined as a separation of cartilage and subchondral bone from the surrounding tissue, primarily affecting the knee, ankle and elbow joints. It is clinically characterized by multiple osteochondritic lesions in knees and/or hips and/or elbows, disproportionate short stature and early-onset osteoarthritis. {ECO:0000269|PubMed:20137779}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Restricted to cartilages. {ECO:0000269|PubMed:7524681}.; 	unclassifiable (Anatomical System);ovary;cartilage;adrenal cortex;colon;parathyroid;fovea centralis;choroid;lens;retina;uterus;optic nerve;whole body;lung;placenta;bone;macula lutea;visual apparatus;testis;head and neck;brain;stomach;	superior cervical ganglion;trachea;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.34070	0.57020	1.284310712	93.77211607	15528.89086	26.89264	15q26.1																								
15	101445884	101445885	AA	-	exonic	ALDH1A3		frameshift deletion	ALDH1A3:NM_001293815:exon7:c.904_905del:p.K302Rfs*25,ALDH1A3:NM_000693:exon10:c.1225_1226del:p.K409Rfs*25	0.924100685142389	0.0758809068734942	1.84079841171702e-05	aldehyde dehydrogenase 1 family member A3	FUNCTION: Recognizes as substrates free retinal and cellular retinol-binding protein-bound retinal. Seems to be the key enzyme in the formation of an RA gradient along the dorso-ventral axis during the early eye development and also in the development of the olfactory system (By similarity). {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed at low levels in many tissues and at higher levels in salivary gland, stomach, and kidney.; 	ovary;colon;parathyroid;choroid;skin;retina;uterus;prostate;atrium;whole body;synovium;gum;bone;thyroid;testis;dura mater;germinal center;brain;unclassifiable (Anatomical System);meninges;lymph node;heart;lacrimal gland;tongue;muscle;skeletal muscle;bile duct;breast;pancreas;pia mater;lung;nasopharynx;placenta;visual apparatus;liver;head and neck;cervix;kidney;mammary gland;stomach;	prostate;testis - interstitial;smooth muscle;lung;trachea;	0.25694	0.26772	-0.578583623	18.71903751	916.25719	5.88722	15q26.3																								
16	1272749	1272749	G	-	exonic	TPSG1		frameshift deletion	TPSG1:NM_012467:exon4:c.414delC:p.S139Afs*23	4.08951910541866e-06	0.215746169050367	0.784249741430527	tryptase gamma 1	.	.	TISSUE SPECIFICITY: Expressed in many tissues.; 	unclassifiable (Anatomical System);smooth muscle;ovary;tongue;islets of Langerhans;developmental;colon;fovea centralis;choroid;lens;retina;uterus;prostate;optic nerve;lung;endometrium;bone;macula lutea;liver;testis;spleen;cervix;kidney;	superior cervical ganglion;liver;caudate nucleus;	0.22731	0.31463	1.201528238	93.00542581	1738.17028	7.69533	16p13.3																								
16	1272775	1272775	C	-	exonic	TPSG1		frameshift deletion	TPSG1:NM_012467:exon4:c.388delG:p.E130Sfs*6	4.08951910541866e-06	0.215746169050367	0.784249741430527	tryptase gamma 1	.	.	TISSUE SPECIFICITY: Expressed in many tissues.; 	unclassifiable (Anatomical System);smooth muscle;ovary;tongue;islets of Langerhans;developmental;colon;fovea centralis;choroid;lens;retina;uterus;prostate;optic nerve;lung;endometrium;bone;macula lutea;liver;testis;spleen;cervix;kidney;	superior cervical ganglion;liver;caudate nucleus;	0.22731	0.31463	1.201528238	93.00542581	1738.17028	7.69533	16p13.3																								
16	1272797	1272797	G	-	exonic	TPSG1		frameshift deletion	TPSG1:NM_012467:exon4:c.366delC:p.S123Afs*13	4.08951910541866e-06	0.215746169050367	0.784249741430527	tryptase gamma 1	.	.	TISSUE SPECIFICITY: Expressed in many tissues.; 	unclassifiable (Anatomical System);smooth muscle;ovary;tongue;islets of Langerhans;developmental;colon;fovea centralis;choroid;lens;retina;uterus;prostate;optic nerve;lung;endometrium;bone;macula lutea;liver;testis;spleen;cervix;kidney;	superior cervical ganglion;liver;caudate nucleus;	0.22731	0.31463	1.201528238	93.00542581	1738.17028	7.69533	16p13.3																								
16	1273546	1273546	C	-	exonic	TPSG1		frameshift deletion	TPSG1:NM_012467:exon3:c.122delG:p.G41Vfs*44	4.08951910541866e-06	0.215746169050367	0.784249741430527	tryptase gamma 1	.	.	TISSUE SPECIFICITY: Expressed in many tissues.; 	unclassifiable (Anatomical System);smooth muscle;ovary;tongue;islets of Langerhans;developmental;colon;fovea centralis;choroid;lens;retina;uterus;prostate;optic nerve;lung;endometrium;bone;macula lutea;liver;testis;spleen;cervix;kidney;	superior cervical ganglion;liver;caudate nucleus;	0.22731	0.31463	1.201528238	93.00542581	1738.17028	7.69533	16p13.3																								
16	30018623	30018623	G	-	intronic	DOC2A				0.0185536457979363	0.961204690801942	0.0202416634001217	double C2-like domains, alpha	FUNCTION: Calcium sensor which most probably regulates fusion of vesicles with membranes. Binds calcium and phospholipids. May be involved in calcium dependent neurotransmitter release through the interaction with UNC13A. May be involved in calcium-dependent spontaneous release of neurotransmitter in absence of action potentials in neuronal cells. Regulates Ca(2+)-dependent secretory lysosome exocytosis in mast cells. {ECO:0000269|PubMed:18354201, ECO:0000269|PubMed:9736751, ECO:0000269|PubMed:9804756}.; 	.	TISSUE SPECIFICITY: Predominantly expressed in brain. Also expressed in testis. {ECO:0000269|PubMed:7826360, ECO:0000269|PubMed:8554557}.; 	unclassifiable (Anatomical System);uterus;optic nerve;whole body;frontal lobe;bone;thyroid;testis;kidney;brain;cerebellum;	amygdala;superior cervical ganglion;globus pallidus;ciliary ganglion;	0.29685	0.10952	-0.556537043	19.72753008	1428.98715	7.05864	16p11.2																								
16	57762368	57762368	C	T	exonic	DRC7		synonymous SNV	DRC7:NM_001289163:exon15:c.C2068T:p.L690L,DRC7:NM_032269:exon16:c.C2263T:p.L755L,DRC7:NM_001289162:exon17:c.C2263T:p.L755L	.	.	.	dynein regulatory complex subunit 7	FUNCTION: Key component of the nexin-dynein regulatory complex (N- DRC), essential for N-DRC integrity. Involved in the regulation of flagellar motility. {ECO:0000250|UniProtKB:A8JAM0}.; 	.	.	.	.	0.23416	0.10344	0.723780906	85.87520642	.	.	16q21																								
16	71609931	71609931	T	-	splicing	TAT	NM_000353:exon3:c.236-2A>-			0.0214384440123944	0.975114738186389	0.00344681780121647	tyrosine aminotransferase	FUNCTION: Transaminase involved in tyrosine breakdown. Converts tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction, using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has much lower affinity and transaminase activity towards phenylalanine. {ECO:0000269|PubMed:16640556, ECO:0000269|PubMed:7999802}.; 	DISEASE: Tyrosinemia 2 (TYRSN2) [MIM:276600]: An inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and oculocutaneous manifestations. Typical features include palmoplantar keratosis, painful corneal ulcers, and mental retardation. {ECO:0000269|PubMed:1357662}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	unclassifiable (Anatomical System);breast;lung;liver;testis;mammary gland;skeletal muscle;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;liver;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.37643	0.70880	-0.558357437	19.54470394	674.69759	5.18783	16q22.2																								
16	71701241	71701241	G	-	intronic	PHLPP2				0.0157973198741475	0.984202304993629	3.75132223179812e-07	PH domain and leucine rich repeat protein phosphatase 2	FUNCTION: Protein phosphatase involved in regulation of Akt and PKC signaling. Mediates dephosphorylation in the C-terminal domain hydrophobic motif of members of the AGC Ser/Thr protein kinase family; specifically acts on 'Ser-473' of AKT1, 'Ser-660' of PRKCB isoform beta-II and 'Ser-657' of PRKCA. Akt regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser- 473' of Akt triggers apoptosis and decreases cell proliferation. Also controls the phosphorylation of AKT3. Dephosphorylates STK4 on 'Thr-387' leading to STK4 activation and apoptosis (PubMed:20513427). Dephosphorylates RPS6KB1 and is involved in regulation of cap-dependent translation (PubMed:21986499). Inhibits cancer cell proliferation and may act as a tumor suppressor. Dephosphorylation of PRKCA and PRKCB leads to their destabilization and degradation. Dephosphorylates RAF1 inhibiting its kinase activity (PubMed:24530606). {ECO:0000269|PubMed:17386267, ECO:0000269|PubMed:18162466, ECO:0000269|PubMed:19079341, ECO:0000269|PubMed:20513427, ECO:0000269|PubMed:21986499, ECO:0000269|PubMed:24530606}.; 	.	TISSUE SPECIFICITY: In colorectal cancer tissue, expression is highest in the surface epithelium of normal colonic mucosa adjacent to the cancer tissue but is largely excluded from the crypt bases. Expression is lost or significantly decreased in 80% of tested tumors (at protein level). {ECO:0000269|PubMed:19079341}.; 	ovary;adrenal medulla;colon;parathyroid;skin;retina;uterus;prostate;bone;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;hypothalamus;skeletal muscle;bile duct;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;kidney;mammary gland;aorta;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;cerebellum;	0.51852	0.11202	-1.229158719	5.555555556	1578.91263	7.35263	16q22.2																								
16	77323289	77323289	C	-	exonic	ADAMTS18		frameshift deletion	ADAMTS18:NM_001326358:exon22:c.2906delG:p.G969Efs*49,ADAMTS18:NM_199355:exon22:c.3422delG:p.G1141Efs*49	3.73935058124161e-15	0.998600619877864	0.00139938012213193	ADAM metallopeptidase with thrombospondin type 1 motif 18	.	DISEASE: Microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) [MIM:615458]: A ocular syndrome characterized by microcornea and myopic chorioretinal atrophy. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. In addition to ocular findings, some patients have telecanthus and posteriorly rotated ears. {ECO:0000269|PubMed:23818446}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in fetal lung, liver, and kidney and in adult brain, prostate, submaxillary gland, and endothelium.; 	unclassifiable (Anatomical System);optic nerve;lung;heart;endometrium;placenta;macula lutea;fovea centralis;choroid;lens;brain;mammary gland;retina;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;skin;	0.23474	0.09538	-0.088332259	46.99811276	12292.96848	23.77511	16q23.1																								
16	81183335	81183335	C	T	exonic	PKD1L2		unknown	UNKNOWN	2.36605828568027e-09	0.020877048832658	0.979122948801284	polycystin 1 like 2 (gene/pseudogene)	FUNCTION: May function as an ion-channel regulator. May function as a G-protein-coupled receptor. {ECO:0000269|PubMed:15203210}.; 	.	TISSUE SPECIFICITY: Expressed in all tissues tested including brain, placenta, mammary gland, testis, lung and liver. Highest expression in skeletal muscle. Isoform 2 is expressed in heart and kidney. {ECO:0000269|PubMed:12782129}.; 	unclassifiable (Anatomical System);lymph node;lung;testis;mammary gland;skin;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;kidney;trigeminal ganglion;skin;skeletal muscle;	0.09644	0.07722	6.86111443	99.88794527	.	.	16q23.2																								
16	81183492	81183492	T	-	exonic	PKD1L2		unknown	UNKNOWN	2.36605828568027e-09	0.020877048832658	0.979122948801284	polycystin 1 like 2 (gene/pseudogene)	FUNCTION: May function as an ion-channel regulator. May function as a G-protein-coupled receptor. {ECO:0000269|PubMed:15203210}.; 	.	TISSUE SPECIFICITY: Expressed in all tissues tested including brain, placenta, mammary gland, testis, lung and liver. Highest expression in skeletal muscle. Isoform 2 is expressed in heart and kidney. {ECO:0000269|PubMed:12782129}.; 	unclassifiable (Anatomical System);lymph node;lung;testis;mammary gland;skin;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;kidney;trigeminal ganglion;skin;skeletal muscle;	0.09644	0.07722	6.86111443	99.88794527	.	.	16q23.2																								
16	83941865	83941865	G	C	exonic	MLYCD		nonsynonymous SNV	MLYCD:NM_012213:exon3:c.G776C:p.G259A	0.000280848275880868	0.789285897071259	0.21043325465286	malonyl-CoA decarboxylase	FUNCTION: Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In the fatty acid biosynthesis MCD selectively removes malonyl-CoA and thus assures that methyl-malonyl-CoA is the only chain elongating substrate for fatty acid synthase and that fatty acids with multiple methyl side chains are produced. In peroxisomes it may be involved in degrading intraperoxisomal malonyl-CoA, which is generated by the peroxisomal beta-oxidation of odd chain-length dicarboxylic fatty acids. Plays a role in the metabolic balance between glucose and lipid oxidation in muscle independent of alterations in insulin signaling. May play a role in controlling the extent of ischemic injury by promoting glucose oxidation. {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:18314420, ECO:0000269|PubMed:23482565}.; 	DISEASE: Malonyl-CoA decarboxylase deficiency (MLYCD deficiency) [MIM:248360]: Autosomal recessive disease characterized by abdominal pain, chronic constipation, episodic vomiting, metabolic acidosis and malonic aciduria. {ECO:0000269|PubMed:10417274}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in fibroblasts and hepatoblastoma cells (at protein level). Expressed strongly in heart, liver, skeletal muscle, kidney and pancreas. Expressed in myotubes. Expressed weakly in brain, placenta, spleen, thymus, testis, ovary and small intestine. {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:18314420}.; 	smooth muscle;ovary;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;blood;lens;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;	liver;	0.17570	0.17831	.	.	204.97186	3.09234	16q23.3		0.0073	0.0003	0.0003	0.0964	0	0.0002	0.0033	0.0019	0.0051	0.0002	0	0.0066	0.0920	0	0.0002	0.0020	rs77493891	101404	Deficiency_of_malonyl-CoA_decarboxylase|not_specified	MedGen:C0342793,OMIM:248360,Orphanet:ORPHA943,SNOMED_CT:124594007,SNOMED_CT:361203007|MedGen:CN169374	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
16	83941884	83941884	C	-	exonic	MLYCD		frameshift deletion	MLYCD:NM_012213:exon3:c.795delC:p.Q266Rfs*4	0.000280848275880868	0.789285897071259	0.21043325465286	malonyl-CoA decarboxylase	FUNCTION: Catalyzes the conversion of malonyl-CoA to acetyl-CoA. In the fatty acid biosynthesis MCD selectively removes malonyl-CoA and thus assures that methyl-malonyl-CoA is the only chain elongating substrate for fatty acid synthase and that fatty acids with multiple methyl side chains are produced. In peroxisomes it may be involved in degrading intraperoxisomal malonyl-CoA, which is generated by the peroxisomal beta-oxidation of odd chain-length dicarboxylic fatty acids. Plays a role in the metabolic balance between glucose and lipid oxidation in muscle independent of alterations in insulin signaling. May play a role in controlling the extent of ischemic injury by promoting glucose oxidation. {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260, ECO:0000269|PubMed:18314420, ECO:0000269|PubMed:23482565}.; 	DISEASE: Malonyl-CoA decarboxylase deficiency (MLYCD deficiency) [MIM:248360]: Autosomal recessive disease characterized by abdominal pain, chronic constipation, episodic vomiting, metabolic acidosis and malonic aciduria. {ECO:0000269|PubMed:10417274}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: Expressed in fibroblasts and hepatoblastoma cells (at protein level). Expressed strongly in heart, liver, skeletal muscle, kidney and pancreas. Expressed in myotubes. Expressed weakly in brain, placenta, spleen, thymus, testis, ovary and small intestine. {ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:18314420}.; 	smooth muscle;ovary;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);heart;cartilage;islets of Langerhans;blood;lens;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;	liver;	0.17570	0.17831	.	.	204.97186	3.09234	16q23.3																								
16	84218565	84218565	T	C	exonic	TAF1C		synonymous SNV	TAF1C:NM_001243156:exon2:c.A30G:p.A10A,TAF1C:NM_005679:exon2:c.A30G:p.A10A	3.23271531745362e-11	0.472377145903275	0.527622854064398	TATA-box binding protein associated factor, RNA polymerase I subunit C	FUNCTION: Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (preinitiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits. Recruits RNA polymerase I to the rRNA gene promoter via interaction with RRN3. {ECO:0000269|PubMed:11250903, ECO:0000269|PubMed:15970593}.; 	.	.	myocardium;ovary;sympathetic chain;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;whole body;frontal lobe;endometrium;thyroid;bone;testis;spinal ganglion;brain;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;spinal cord;adrenal cortex;blood;lens;lung;placenta;macula lutea;visual apparatus;liver;spleen;cervix;kidney;mammary gland;stomach;	fetal brain;white blood cells;pons;caudate nucleus;trigeminal ganglion;cingulate cortex;	0.24194	0.09250	0.593325282	82.46048596	1956.88534	8.14058	16q24.1		0.1662	0.2329	0.0696	0.2427	0.1644	0.1559	0.1631	0.1932	0.1715	0.2208	0.0716	0.1633	0.2410	0.1548	0.1449	0.1735	rs2230126						
16	89777747	89777747	G	T	exonic	VPS9D1		stopgain	VPS9D1:NM_004913:exon9:c.C821A:p.S274X	0.00176648362917067	0.992920971125487	0.00531254524534188	VPS9 domain containing 1	.	.	TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10231027}.; 	.	.	0.05029	.	-0.178111357	40.44585987	202.7909	3.07473	16q24.3		1.318e-05	0	0	0.0002	0	0	0	0									rs768299709						
17	8024971	8024971	G	T	exonic	HES7		nonsynonymous SNV	HES7:NM_001165967:exon4:c.C611A:p.P204Q,HES7:NM_032580:exon4:c.C596A:p.P199Q	0.7828835695289	0.210284914901363	0.00683151556973717	hes family bHLH transcription factor 7	FUNCTION: Transcriptional repressor. Represses transcription from both N box- and E box-containing promoters. May with HES1, cooperatively regulate somite formation in the presomitic mesoderm (PSM). May function as a segmentation clock, which is essential for coordinated somite segmentation (By similarity). {ECO:0000250}.; 	DISEASE: Spondylocostal dysostosis 4, autosomal recessive (SCDO4) [MIM:613686]: A rare condition of variable severity characterized by vertebral and costal anomalies. The main feature include dwarfism, vertebral fusion, hemivertebrae, posterior rib fusion, reduced rib number, and other rib malformations. {ECO:0000269|PubMed:18775957, ECO:0000269|PubMed:20087400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	bone;	.	0.27407	0.11360	.	.	14.20939	0.51375	17p13.1																								
17	8025280	8025280	A	-	exonic	HES7		frameshift deletion	HES7:NM_001165967:exon4:c.302delT:p.F101Sfs*41,HES7:NM_032580:exon4:c.287delT:p.F96Sfs*41	0.7828835695289	0.210284914901363	0.00683151556973717	hes family bHLH transcription factor 7	FUNCTION: Transcriptional repressor. Represses transcription from both N box- and E box-containing promoters. May with HES1, cooperatively regulate somite formation in the presomitic mesoderm (PSM). May function as a segmentation clock, which is essential for coordinated somite segmentation (By similarity). {ECO:0000250}.; 	DISEASE: Spondylocostal dysostosis 4, autosomal recessive (SCDO4) [MIM:613686]: A rare condition of variable severity characterized by vertebral and costal anomalies. The main feature include dwarfism, vertebral fusion, hemivertebrae, posterior rib fusion, reduced rib number, and other rib malformations. {ECO:0000269|PubMed:18775957, ECO:0000269|PubMed:20087400}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	bone;	.	0.27407	0.11360	.	.	14.20939	0.51375	17p13.1																								
17	11532835	11532835	A	G	exonic	DNAH9		synonymous SNV	DNAH9:NM_001372:exon7:c.A1452G:p.E484E	1.36586328854305e-35	0.999999244383913	7.55616087445322e-07	dynein axonemal heavy chain 9	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP.; 	.	.	unclassifiable (Anatomical System);uterus;lung;heart;hypothalamus;placenta;testis;brain;skin;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	17p12		0.3236	0.7243	0.2061	0.1451	0.3710	0.3015	0.3422	0.3159	0.4106	0.7120	0.2285	0.2815	0.1416	0.3587	0.2942	0.3272	rs9895535	390219	not_specified	MedGen:CN169374	criteria_provided,_single_submitter	Benign	
17	11532859	11532860	TC	-	exonic	DNAH9		frameshift deletion	DNAH9:NM_001372:exon7:c.1476_1477del:p.S494Rfs*15	1.36586328854305e-35	0.999999244383913	7.55616087445322e-07	dynein axonemal heavy chain 9	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP.; 	.	.	unclassifiable (Anatomical System);uterus;lung;heart;hypothalamus;placenta;testis;brain;skin;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	17p12																								
17	11532869	11532871	TCC	-	exonic	DNAH9		nonframeshift deletion	DNAH9:NM_001372:exon7:c.1486_1488del:p.S498Dfs*3989	1.36586328854305e-35	0.999999244383913	7.55616087445322e-07	dynein axonemal heavy chain 9	FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP.; 	.	.	unclassifiable (Anatomical System);uterus;lung;heart;hypothalamus;placenta;testis;brain;skin;	dorsal root ganglion;superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	0.20972	0.11901	0.45554211	78.06086341	11534.8129	23.18197	17p12																								
17	19644507	19644507	-	C	exonic	ALDH3A1		frameshift insertion	ALDH3A1:NM_001135168:exon5:c.705dupG:p.K236Efs*13,ALDH3A1:NM_001330150:exon5:c.486dupG:p.K163Efs*13,ALDH3A1:NM_000691:exon6:c.705dupG:p.K236Efs*13,ALDH3A1:NM_001135167:exon6:c.705dupG:p.K236Efs*13	1.32614029510281e-12	0.0129943681011167	0.987005631897557	aldehyde dehydrogenase 3 family member A1	FUNCTION: ALDHs play a major role in the detoxification of alcohol-derived acetaldehyde. They are involved in the metabolism of corticosteroids, biogenic amines, neurotransmitters, and lipid peroxidation. This protein preferentially oxidizes aromatic aldehyde substrates. It may play a role in the oxidation of toxic aldehydes.; 	.	TISSUE SPECIFICITY: High levels in stomach, esophagus and lung; low level in the liver and kidney.; 	unclassifiable (Anatomical System);tongue;salivary gland;colon;fovea centralis;choroid;lens;skin;retina;uterus;pancreas;optic nerve;lung;endometrium;macula lutea;visual apparatus;testis;head and neck;cervix;kidney;brain;stomach;	superior cervical ganglion;lung;trachea;tongue;temporal lobe;	0.38989	.	0.113945049	62.14319415	3022.02935	10.43597	17p11.2																								
17	26089867	26089867	T	C	exonic	NOS2		synonymous SNV	NOS2:NM_000625:exon22:c.A2757G:p.T919T	7.26084821392684e-09	0.998625922369478	0.0013740703696734	nitric oxide synthase 2	FUNCTION: Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body (PubMed:7531687, PubMed:7544004). In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on 'Cys-247' implicated in regulation of the GAIT complex activity and probably multiple targets including ANXA5, EZR, MSN and VIM (PubMed:25417112). Involved in inflammation, enhances the synthesis of proinflammatory mediators such as IL6 and IL8 (PubMed:19688109). {ECO:0000250|UniProtKB:P29477, ECO:0000269|PubMed:19688109, ECO:0000269|PubMed:25417112, ECO:0000269|PubMed:7531687, ECO:0000269|PubMed:7544004}.; 	.	TISSUE SPECIFICITY: Expressed in the liver, retina, bone cells and airway epithelial cells of the lung. Not expressed in the platelets.; 	unclassifiable (Anatomical System);breast;lung;cartilage;ovary;nasopharynx;testis;colon;blood;brain;stomach;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.17004	0.94961	-1.675620402	2.689313517	2728.58132	9.84685	17q11.2		0.7239	0.7804	0.6756	0.7451	0.6695	0.6636	0.7164	0.8307	0.6628	0.7784	0.6348	0.7433	0.6905	0.5853	0.6134	0.6194	rs1060826						
17	26092631	26092631	A	G	exonic	NOS2		synonymous SNV	NOS2:NM_000625:exon20:c.T2358C:p.G786G	7.26084821392684e-09	0.998625922369478	0.0013740703696734	nitric oxide synthase 2	FUNCTION: Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body (PubMed:7531687, PubMed:7544004). In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on 'Cys-247' implicated in regulation of the GAIT complex activity and probably multiple targets including ANXA5, EZR, MSN and VIM (PubMed:25417112). Involved in inflammation, enhances the synthesis of proinflammatory mediators such as IL6 and IL8 (PubMed:19688109). {ECO:0000250|UniProtKB:P29477, ECO:0000269|PubMed:19688109, ECO:0000269|PubMed:25417112, ECO:0000269|PubMed:7531687, ECO:0000269|PubMed:7544004}.; 	.	TISSUE SPECIFICITY: Expressed in the liver, retina, bone cells and airway epithelial cells of the lung. Not expressed in the platelets.; 	unclassifiable (Anatomical System);breast;lung;cartilage;ovary;nasopharynx;testis;colon;blood;brain;stomach;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.17004	0.94961	-1.675620402	2.689313517	2728.58132	9.84685	17q11.2		0.6637	0.7836	0.6143	0.7009	0.6064	0.6116	0.6849	0.8340	0.6641	0.7860	0.6348	0.7384	0.6925	0.5834	0.6118	0.6214	rs1060822						
17	26092677	26092677	-	C	exonic	NOS2		frameshift insertion	NOS2:NM_000625:exon20:c.2311dupG:p.E771Gfs*38	7.26084821392684e-09	0.998625922369478	0.0013740703696734	nitric oxide synthase 2	FUNCTION: Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body (PubMed:7531687, PubMed:7544004). In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on 'Cys-247' implicated in regulation of the GAIT complex activity and probably multiple targets including ANXA5, EZR, MSN and VIM (PubMed:25417112). Involved in inflammation, enhances the synthesis of proinflammatory mediators such as IL6 and IL8 (PubMed:19688109). {ECO:0000250|UniProtKB:P29477, ECO:0000269|PubMed:19688109, ECO:0000269|PubMed:25417112, ECO:0000269|PubMed:7531687, ECO:0000269|PubMed:7544004}.; 	.	TISSUE SPECIFICITY: Expressed in the liver, retina, bone cells and airway epithelial cells of the lung. Not expressed in the platelets.; 	unclassifiable (Anatomical System);breast;lung;cartilage;ovary;nasopharynx;testis;colon;blood;brain;stomach;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.17004	0.94961	-1.675620402	2.689313517	2728.58132	9.84685	17q11.2																								
17	34195739	34195739	T	C	exonic	HEATR9		nonsynonymous SNV	HEATR9:NM_001321395:exon1:c.A8G:p.Y3C,HEATR9:NM_152781:exon1:c.A8G:p.Y3C	.	.	.	HEAT repeat containing 9	.	.	.	.	.	0.05583	.	0.979225112	90.42816702	.	.	17q12		0.0264	0.0043	0.0097	0.1293	0.0366	0.0223	0.0352	0.0100	0.0247	0.0034	0.0167	0.0199	0.1097	0.0361	0.0259	0.0255	rs77630516						
17	34416537	34416537	G	A	exonic	CCL3		synonymous SNV	CCL3:NM_002983:exon2:c.C180T:p.P60P	0.145338664435048	0.778548432668519	0.0761129028964324	C-C motif chemokine ligand 3	FUNCTION: Monokine with inflammatory and chemokinetic properties. Binds to CCR1, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-alpha induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). {ECO:0000269|PubMed:8525373}.; 	.	.	lymphoreticular;smooth muscle;ovary;colon;fovea centralis;choroid;retina;prostate;optic nerve;endometrium;pineal gland;brain;unclassifiable (Anatomical System);heart;islets of Langerhans;blood;lens;pancreas;lung;adrenal gland;placenta;visual apparatus;macula lutea;liver;hypopharynx;spleen;head and neck;	.	0.13680	0.67562	0.281220278	71.07808445	149.93525	2.66962	17q12		0.2282	0.1362	0.2191	0.3491	0.1524	0.2374	0.2214	0.2225	0.2033	0.1298	0.2189	0.1689	0.3486	0.1606	0.2409	0.1947	rs1130371						
17	34416648	34416648	G	-	intronic	CCL3				0.145338664435048	0.778548432668519	0.0761129028964324	C-C motif chemokine ligand 3	FUNCTION: Monokine with inflammatory and chemokinetic properties. Binds to CCR1, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant MIP-1-alpha induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). {ECO:0000269|PubMed:8525373}.; 	.	.	lymphoreticular;smooth muscle;ovary;colon;fovea centralis;choroid;retina;prostate;optic nerve;endometrium;pineal gland;brain;unclassifiable (Anatomical System);heart;islets of Langerhans;blood;lens;pancreas;lung;adrenal gland;placenta;visual apparatus;macula lutea;liver;hypopharynx;spleen;head and neck;	.	0.13680	0.67562	0.281220278	71.07808445	149.93525	2.66962	17q12																								
17	37070685	37070789	CCTGGAGCAGCAGCAGCCTCACCACATCCCGACCAGTGCCCCGGGTGAGTGCAGGTCCTGTTGGTGCAGATGACCTGAGGCGAGGCCAGTGGGGTGGGGAGGAAG	-	exonic	LASP1		frameshift deletion	LASP1:NM_001271608:exon4:c.297_340del:p.E101Pfs*41,LASP1:NM_006148:exon5:c.465_508del:p.E157Pfs*41	0.8667394350595	0.132870173708275	0.000390391232224815	LIM and SH3 protein 1	FUNCTION: Plays an important role in the regulation of dynamic actin-based, cytoskeletal activities. Agonist-dependent changes in LASP1 phosphorylation may also serve to regulate actin-associated ion transport activities, not only in the parietal cell but also in certain other F-actin-rich secretory epithelial cell types (By similarity). {ECO:0000250}.; 	.	.	lymphoreticular;ovary;skin;bone marrow;prostate;frontal lobe;endometrium;germinal center;bladder;brain;tonsil;amygdala;heart;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;visual apparatus;liver;spleen;cervix;mammary gland;salivary gland;intestine;colon;choroid;uterus;cerebral cortex;larynx;testis;pineal gland;spinal ganglion;unclassifiable (Anatomical System);lymph node;cerebellum cortex;lacrimal gland;islets of Langerhans;muscle;bile duct;pancreas;lung;nasopharynx;placenta;duodenum;head and neck;kidney;stomach;	whole blood;	0.33295	0.11829	-0.449946534	24.00330267	12.83432	0.46825	17q12																								
17	56584600	56584602	TCA	-	exonic	MTMR4		nonframeshift deletion	MTMR4:NM_004687:exon9:c.744_746del:p.D248Efs*948	0.997305474235374	0.00269452572438795	4.02384896460670e-11	myotubularin related protein 4	FUNCTION: Dephosphorylates proteins phosphorylated on Ser, Thr, and Tyr residues and low molecular weight phosphatase substrate para-nitrophenylphosphate. Phosphorylates phosphatidylinositol 3,4,5-trisphosphate (PIP3). {ECO:0000269|PubMed:11302699}.; 	.	TISSUE SPECIFICITY: Expressed in brain, heart, kidney, spleen, liver, colon, testis, muscle, placenta, thyroid gland, pancreas, ovary, prostate, skin, peripheral blood, and bone marrow. {ECO:0000269|PubMed:11302699}.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;larynx;bone;pituitary gland;testis;germinal center;brain;pineal gland;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;cerebellum cortex;islets of Langerhans;urinary;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;lung;epididymis;nasopharynx;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;peripheral nerve;	medulla oblongata;superior cervical ganglion;cerebellum peduncles;pons;subthalamic nucleus;placenta;prefrontal cortex;testis;globus pallidus;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.58620	.	-0.551080959	19.93394669	10154.99993	21.97903	17q22																								
17	56584612	56584612	T	C	exonic	MTMR4		nonsynonymous SNV	MTMR4:NM_004687:exon9:c.A734G:p.N245S	0.997305474235374	0.00269452572438795	4.02384896460670e-11	myotubularin related protein 4	FUNCTION: Dephosphorylates proteins phosphorylated on Ser, Thr, and Tyr residues and low molecular weight phosphatase substrate para-nitrophenylphosphate. Phosphorylates phosphatidylinositol 3,4,5-trisphosphate (PIP3). {ECO:0000269|PubMed:11302699}.; 	.	TISSUE SPECIFICITY: Expressed in brain, heart, kidney, spleen, liver, colon, testis, muscle, placenta, thyroid gland, pancreas, ovary, prostate, skin, peripheral blood, and bone marrow. {ECO:0000269|PubMed:11302699}.; 	ovary;salivary gland;intestine;colon;parathyroid;skin;retina;bone marrow;uterus;prostate;whole body;frontal lobe;endometrium;larynx;bone;pituitary gland;testis;germinal center;brain;pineal gland;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;cerebellum cortex;islets of Langerhans;urinary;adrenal cortex;pharynx;blood;lens;skeletal muscle;breast;lung;epididymis;nasopharynx;placenta;visual apparatus;hippocampus;liver;spleen;head and neck;kidney;mammary gland;aorta;stomach;peripheral nerve;	medulla oblongata;superior cervical ganglion;cerebellum peduncles;pons;subthalamic nucleus;placenta;prefrontal cortex;testis;globus pallidus;trigeminal ganglion;cingulate cortex;parietal lobe;cerebellum;	0.58620	.	-0.551080959	19.93394669	10154.99993	21.97903	17q22																								
17	64023624	64023624	T	C	exonic	CEP112		nonsynonymous SNV	CEP112:NM_001302891:exon14:c.A1525G:p.K509E,CEP112:NM_001199165:exon16:c.A1651G:p.K551E	3.05841247613028e-18	0.582472354926836	0.417527645073164	centrosomal protein 112kDa	.	.	.	unclassifiable (Anatomical System);fovea centralis;choroid;lens;skin;retina;uterus;optic nerve;lung;oesophagus;bone;macula lutea;liver;testis;spleen;kidney;artery;aorta;	superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;testis;ciliary ganglion;trigeminal ganglion;	0.28474	.	-0.459259448	23.69072895	4016.49111	12.55095	17q24.1		0.5356	0.6459	0.4754	0.2150	0.6804	0.6206	0.5167	0.2971	0.5350	0.5889	0.2794	0.4430	0.1167	0.5797	0.5558	0.5164	rs17704679						
17	77073569	77073569	C	-	exonic	ENGASE		frameshift deletion	ENGASE:NM_001042573:exon2:c.204delC:p.L70Cfs*49	8.06055418663565e-21	0.00094656497022446	0.999053435029776	endo-beta-N-acetylglucosaminidase	FUNCTION: Endoglycosidase that releases N-glycans from glycoproteins by cleaving the beta-1,4-glycosidic bond in the N,N'-diacetylchitobiose core. Involved in the processing of free oligosaccharides in the cytosol. {ECO:0000269|PubMed:12114544}.; 	.	TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in thymus and spleen. {ECO:0000269|PubMed:12114544}.; 	ovary;sympathetic chain;adrenal medulla;colon;parathyroid;fovea centralis;choroid;skin;bone marrow;retina;uterus;optic nerve;endometrium;oesophagus;thyroid;bone;pituitary gland;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;heart;islets of Langerhans;muscle;blood;lens;pancreas;lung;placenta;macula lutea;liver;hypopharynx;cervix;spleen;head and neck;kidney;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	.	-0.632009432	16.78461901	2375.52075	9.04291	17q25.3																								
17	79166141	79166236	CCCACGCCTGCCTCTCCAGCTCCAGCTGCTGCTTCAGGGTATTCAGCTCCATCTGGGGGGCGGACATAAGAGGCCAGTCAGTCCCACCCCGTGCAG	-	exonic	CEP131		frameshift deletion	CEP131:NM_001009811:exon20:c.2440_2491del:p.M814Rfs*13,CEP131:NM_001319229:exon20:c.2449_2500del:p.M817Rfs*13,CEP131:NM_001319228:exon21:c.2557_2608del:p.M853Rfs*13,CEP131:NM_014984:exon21:c.2548_2599del:p.M850Rfs*13	.	.	.	centrosomal protein 131kDa	FUNCTION: Component of centriolar satellites contributing to build a complex and dynamic network required to regulate cilia/flagellum formation (PubMed:17954613). In proliferating cells, MIB1-mediated ubiquitination induces its sequestration within centriolar satellites, precluding untimely cilia formation initiation. In contrast, during normal and ultraviolet or heat shock cellular stress-induced ciliogenesis, its non-ubiquitinated form is rapidly displaced from centriolar satellites and recruited to centrosome/basal bodies in a microtubule- and p38 MAPK-dependent manner (PubMed:24121310). Acts also as a negative regulator of BBSome ciliary trafficking (PubMed:24550735). Plays a role in sperm flagellar formation; may be involved in the regulation of intraflagellar transport (IFT) and/or intramanchette (IMT) trafficking, which are important for axoneme extension and/or cargo delivery to the nascent sperm tail (By similarity). Required for optimal cell proliferation and cell cycle progression; may play a role in the regulation of genome stability and centriole duplication in non-ciliogenic cells (PubMed:22797915). Involved in centriole duplication. Required for CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). {ECO:0000250|UniProtKB:Q62036, ECO:0000269|PubMed:17954613, ECO:0000269|PubMed:22797915, ECO:0000269|PubMed:24121310, ECO:0000269|PubMed:24185901, ECO:0000269|PubMed:24550735, ECO:0000269|PubMed:26297806}.; 	.	.	.	.	0.11345	0.14275	2.688316751	98.8794527	.	.	17q25.3																								
17	79166194	79166194	-	G	splicing	CEP131	NM_001009811:exon20:c.2440-2->C;NM_014984:exon21:c.2548-2->C;NM_001319229:exon20:c.2449-2->C;NM_001319228:exon21:c.2557-2->C			.	.	.	centrosomal protein 131kDa	FUNCTION: Component of centriolar satellites contributing to build a complex and dynamic network required to regulate cilia/flagellum formation (PubMed:17954613). In proliferating cells, MIB1-mediated ubiquitination induces its sequestration within centriolar satellites, precluding untimely cilia formation initiation. In contrast, during normal and ultraviolet or heat shock cellular stress-induced ciliogenesis, its non-ubiquitinated form is rapidly displaced from centriolar satellites and recruited to centrosome/basal bodies in a microtubule- and p38 MAPK-dependent manner (PubMed:24121310). Acts also as a negative regulator of BBSome ciliary trafficking (PubMed:24550735). Plays a role in sperm flagellar formation; may be involved in the regulation of intraflagellar transport (IFT) and/or intramanchette (IMT) trafficking, which are important for axoneme extension and/or cargo delivery to the nascent sperm tail (By similarity). Required for optimal cell proliferation and cell cycle progression; may play a role in the regulation of genome stability and centriole duplication in non-ciliogenic cells (PubMed:22797915). Involved in centriole duplication. Required for CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). {ECO:0000250|UniProtKB:Q62036, ECO:0000269|PubMed:17954613, ECO:0000269|PubMed:22797915, ECO:0000269|PubMed:24121310, ECO:0000269|PubMed:24185901, ECO:0000269|PubMed:24550735, ECO:0000269|PubMed:26297806}.; 	.	.	.	.	0.11345	0.14275	2.688316751	98.8794527	.	.	17q25.3		1.332e-05	0	0	0	0	2.411e-05	0	0									rs758337262						
17	79244802	79244803	TG	-	exonic	SLC38A10		frameshift deletion	SLC38A10:NM_001037984:exon10:c.1046_1047del:p.T349Rfs*90,SLC38A10:NM_138570:exon10:c.1046_1047del:p.T349Rfs*90	4.09242180982345e-08	0.98655460568366	0.0134453533921224	solute carrier family 38 member 10	FUNCTION: Putative sodium-dependent amino acid/proton antiporter. {ECO:0000250}.; 	.	.	lymphoreticular;ovary;salivary gland;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;optic nerve;thyroid;bone;testis;brain;unclassifiable (Anatomical System);lymph node;cartilage;islets of Langerhans;muscle;lens;breast;lung;placenta;macula lutea;hippocampus;liver;cervix;head and neck;kidney;mammary gland;thymus;	thyroid;liver;	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	17q25.3																								
17	79477716	79477716	T	C	exonic	ACTG1		synonymous SNV	ACTG1:NM_001199954:exon6:c.A1128G:p.X376X,ACTG1:NM_001614:exon6:c.A1128G:p.X376X	0.218555803598304	0.773018476768944	0.00842571963275219	actin gamma 1	FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.; 	DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	myocardium;ovary;sympathetic chain;colon;parathyroid;vein;skin;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;oesophagus;gum;bone;thyroid;testis;spinal ganglion;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pineal body;muscle;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;nasopharynx;placenta;visual apparatus;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	.	0.92981	.	-1.927246174	1.910828025	13.06854	0.47567	17q25.3		0.0236	0.0998	0.0175	0.0302	0.0060	0.0151	0.0265	0.0177	0.0359	0.0973	0.0215	0.0728	0.0266	0.0026	0.0111	0.0061	rs11549223	133718	not_specified|not_provided	MedGen:CN169374|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
17	79477744	79477744	G	T	exonic	ACTG1		nonsynonymous SNV	ACTG1:NM_001199954:exon6:c.C1100A:p.P367H,ACTG1:NM_001614:exon6:c.C1100A:p.P367H	0.218555803598304	0.773018476768944	0.00842571963275219	actin gamma 1	FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.; 	DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	myocardium;ovary;sympathetic chain;colon;parathyroid;vein;skin;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;oesophagus;gum;bone;thyroid;testis;spinal ganglion;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pineal body;muscle;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;nasopharynx;placenta;visual apparatus;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	.	0.92981	.	-1.927246174	1.910828025	13.06854	0.47567	17q25.3																								
17	79477818	79477818	A	G	exonic	ACTG1		synonymous SNV	ACTG1:NM_001199954:exon6:c.T1026C:p.G342G,ACTG1:NM_001614:exon6:c.T1026C:p.G342G	0.218555803598304	0.773018476768944	0.00842571963275219	actin gamma 1	FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.; 	DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	myocardium;ovary;sympathetic chain;colon;parathyroid;vein;skin;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;oesophagus;gum;bone;thyroid;testis;spinal ganglion;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pineal body;muscle;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;nasopharynx;placenta;visual apparatus;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	.	0.92981	.	-1.927246174	1.910828025	13.06854	0.47567	17q25.3		0.0235	0.0989	0.0175	0.0301	0.0060	0.0150	0.0265	0.0177	0.0362	0.0984	0.0215	0.0728	0.0267	0.0026	0.0111	0.0051	rs1139406	133717	not_specified|not_provided	MedGen:CN169374|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
17	79477827	79477827	C	T	exonic	ACTG1		synonymous SNV	ACTG1:NM_001199954:exon6:c.G1017A:p.V339V,ACTG1:NM_001614:exon6:c.G1017A:p.V339V	0.218555803598304	0.773018476768944	0.00842571963275219	actin gamma 1	FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.; 	DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	myocardium;ovary;sympathetic chain;colon;parathyroid;vein;skin;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;oesophagus;gum;bone;thyroid;testis;spinal ganglion;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pineal body;muscle;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;nasopharynx;placenta;visual apparatus;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	.	0.92981	.	-1.927246174	1.910828025	13.06854	0.47567	17q25.3		8.255e-06	0	0	0	0.0002	0	0	0	3.23e-05	0	0	0	0	0	0	0.0010	rs111305526						
17	79477830	79477830	C	T	exonic	ACTG1		synonymous SNV	ACTG1:NM_001199954:exon6:c.G1014A:p.S338S,ACTG1:NM_001614:exon6:c.G1014A:p.S338S	0.218555803598304	0.773018476768944	0.00842571963275219	actin gamma 1	FUNCTION: Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells.; 	DISEASE: Deafness, autosomal dominant, 20 (DFNA20) [MIM:604717]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:13680526, ECO:0000269|PubMed:14684684, ECO:0000269|PubMed:16773128, ECO:0000269|PubMed:18804074, ECO:0000269|PubMed:19477959}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Baraitser-Winter syndrome 2 (BRWS2) [MIM:614583]: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss. {ECO:0000269|PubMed:22366783}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	myocardium;ovary;sympathetic chain;colon;parathyroid;vein;skin;bone marrow;uterus;prostate;frontal lobe;cochlea;endometrium;oesophagus;gum;bone;thyroid;testis;spinal ganglion;brain;pineal gland;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;tongue;islets of Langerhans;pineal body;muscle;urinary;adrenal cortex;blood;skeletal muscle;pancreas;lung;adrenal gland;nasopharynx;placenta;visual apparatus;duodenum;liver;cervix;spleen;head and neck;kidney;mammary gland;stomach;peripheral nerve;	.	0.92981	.	-1.927246174	1.910828025	13.06854	0.47567	17q25.3		0.0235	0.0990	0.0176	0.0301	0.0060	0.0150	0.0265	0.0177	0.0360	0.0977	0.0215	0.0728	0.0266	0.0026	0.0111	0.0051	rs1139807	133716	not_specified|not_provided	MedGen:CN169374|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
18	29433914	29433916	AAA	-	intronic	TRAPPC8				0.999999744151836	2.55848163729659e-07	1.55831401213203e-19	trafficking protein particle complex 8	FUNCTION: May be involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage. {ECO:0000269|PubMed:21525244}.; 	.	.	medulla oblongata;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;atrium;whole body;thyroid;bone;testis;dura mater;germinal center;brain;bladder;unclassifiable (Anatomical System);meninges;lymph node;cartilage;heart;islets of Langerhans;hypothalamus;lens;skeletal muscle;bile duct;breast;pia mater;lung;nasopharynx;trabecular meshwork;placenta;macula lutea;visual apparatus;liver;head and neck;cervix;kidney;peripheral nerve;	superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;testis;caudate nucleus;atrioventricular node;	0.14990	0.09632	0.721954055	85.86341118	3775.56161	12.03543	18q12.1																								
19	5654460	5654460	-	AG	exonic	SAFB		frameshift insertion	SAFB:NM_001320571:exon11:c.1277_1278insAG:p.A429Efs*109,SAFB:NM_001201340:exon12:c.1541_1542insAG:p.A517Efs*110,SAFB:NM_001201338:exon13:c.1748_1749insAG:p.A586Efs*110,SAFB:NM_001201339:exon13:c.1748_1749insAG:p.A586Efs*109,SAFB:NM_001320572:exon13:c.1748_1749insAG:p.A586Efs*109,SAFB:NM_002967:exon13:c.1748_1749insAG:p.A586Efs*110	0.999685074218684	0.000314925755372867	2.59430682328154e-11	scaffold attachment factor B	FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (By similarity). Can function as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription. When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). Can inhibit cell proliferation. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Expressed at high levels in the CNS and at low levels in the liver. Expressed in a wide number of breast cancer cell lines.; 	lymphoreticular;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;testis - seminiferous tubule;prefrontal cortex;ciliary ganglion;pons;trigeminal ganglion;skeletal muscle;cingulate cortex;parietal lobe;	0.20672	0.15741	-1.618506764	2.925218212	44.85677	1.28461	19p13.3																								
19	5654468	5654469	GT	-	splicing	SAFB				0.999685074218684	0.000314925755372867	2.59430682328154e-11	scaffold attachment factor B	FUNCTION: Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (By similarity). Can function as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription. When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). Can inhibit cell proliferation. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Ubiquitous. Expressed at high levels in the CNS and at low levels in the liver. Expressed in a wide number of breast cancer cell lines.; 	lymphoreticular;ovary;salivary gland;intestine;colon;parathyroid;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;thyroid;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;heart;islets of Langerhans;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;	superior cervical ganglion;testis - seminiferous tubule;prefrontal cortex;ciliary ganglion;pons;trigeminal ganglion;skeletal muscle;cingulate cortex;parietal lobe;	0.20672	0.15741	-1.618506764	2.925218212	44.85677	1.28461	19p13.3																								
19	7076418	7076418	C	A	exonic	ZNF557		synonymous SNV	ZNF557:NM_001044387:exon5:c.C147A:p.A49A,ZNF557:NM_001044388:exon5:c.C126A:p.A42A,ZNF557:NM_024341:exon5:c.C147A:p.A49A	1.50769654048194e-06	0.398872299105413	0.601126193198047	zinc finger protein 557	FUNCTION: May be involved in transcriptional regulation.; 	.	.	unclassifiable (Anatomical System);breast;lung;heart;hypothalamus;bone;thyroid;muscle;testis;kidney;germinal center;bone marrow;	superior cervical ganglion;ciliary ganglion;skeletal muscle;	0.06637	0.06391	-0.179930907	40.35739561	78.21487	1.86530	19p13.2	ID=COSM148468;OCCURENCE=1(stomach)	0.0359	0.0030	0.0828	0.2440	0.0508	0.0026	0.0341	0.0442	0.0236	0.0036	0.0752	0	0.2280	0.0510	0.0045	0.0255	rs2303796						
19	9003684	9003684	C	-	exonic	MUC16		frameshift deletion	MUC16:NM_024690:exon49:c.39956delG:p.G13319Afs*59	.	.	.	mucin 16, cell surface associated	FUNCTION: Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. {ECO:0000250}.; 	.	TISSUE SPECIFICITY: Expressed in corneal and conjunctival epithelia (at protein level). Overexpressed in ovarian carcinomas and ovarian low malignant potential (LMP) tumors as compared to the expression in normal ovarian tissue and ovarian adenomas. {ECO:0000269|PubMed:11369781, ECO:0000269|PubMed:12218296, ECO:0000269|PubMed:16384952}.; 	.	.	0.05884	.	29.75317221	100	23894.83454	31.77381	19p13.2																								
19	17049205	17049205	C	T	exonic	CPAMD8		nonsynonymous SNV	CPAMD8:NM_015692:exon23:c.G2986A:p.E996K	2.01801525841884e-14	0.999974749452667	2.52505473128029e-05	C3 and PZP like, alpha-2-macroglobulin domain containing 8	.	.	TISSUE SPECIFICITY: Highly expressed in the kidney, brain and testis and to a lower extent in heart, liver and small intestine. {ECO:0000269|PubMed:15177561}.; 	unclassifiable (Anatomical System);ovary;cartilage;fovea centralis;choroid;lens;retina;prostate;optic nerve;lung;endometrium;larynx;placenta;bone;macula lutea;visual apparatus;iris;testis;head and neck;kidney;brain;	.	0.10307	0.10452	2.440614487	98.54918613	4982.63255	14.40066	19p13.11																								
19	17049236	17049236	C	T	exonic	CPAMD8		synonymous SNV	CPAMD8:NM_015692:exon23:c.G2955A:p.A985A	2.01801525841884e-14	0.999974749452667	2.52505473128029e-05	C3 and PZP like, alpha-2-macroglobulin domain containing 8	.	.	TISSUE SPECIFICITY: Highly expressed in the kidney, brain and testis and to a lower extent in heart, liver and small intestine. {ECO:0000269|PubMed:15177561}.; 	unclassifiable (Anatomical System);ovary;cartilage;fovea centralis;choroid;lens;retina;prostate;optic nerve;lung;endometrium;larynx;placenta;bone;macula lutea;visual apparatus;iris;testis;head and neck;kidney;brain;	.	0.10307	0.10452	2.440614487	98.54918613	4982.63255	14.40066	19p13.11		1.893e-05	0.0002	0	0	0	0	0	0	3.23e-05	0	0	0	0	0	0	0.0010	rs757550356						
19	17049245	17049245	G	A	exonic	CPAMD8		synonymous SNV	CPAMD8:NM_015692:exon23:c.C2946T:p.V982V	2.01801525841884e-14	0.999974749452667	2.52505473128029e-05	C3 and PZP like, alpha-2-macroglobulin domain containing 8	.	.	TISSUE SPECIFICITY: Highly expressed in the kidney, brain and testis and to a lower extent in heart, liver and small intestine. {ECO:0000269|PubMed:15177561}.; 	unclassifiable (Anatomical System);ovary;cartilage;fovea centralis;choroid;lens;retina;prostate;optic nerve;lung;endometrium;larynx;placenta;bone;macula lutea;visual apparatus;iris;testis;head and neck;kidney;brain;	.	0.10307	0.10452	2.440614487	98.54918613	4982.63255	14.40066	19p13.11		0.0214	0.1806	0.0164	0.0389	0	0.0005	0.016	0.0163	0.0494	0.1641	0.0203	0	0.0395	0	0.0005	0.0112	rs61133226						
19	17081790	17081790	G	A	exonic	CPAMD8		synonymous SNV	CPAMD8:NM_015692:exon18:c.C2265T:p.D755D	2.01801525841884e-14	0.999974749452667	2.52505473128029e-05	C3 and PZP like, alpha-2-macroglobulin domain containing 8	.	.	TISSUE SPECIFICITY: Highly expressed in the kidney, brain and testis and to a lower extent in heart, liver and small intestine. {ECO:0000269|PubMed:15177561}.; 	unclassifiable (Anatomical System);ovary;cartilage;fovea centralis;choroid;lens;retina;prostate;optic nerve;lung;endometrium;larynx;placenta;bone;macula lutea;visual apparatus;iris;testis;head and neck;kidney;brain;	.	0.10307	0.10452	2.440614487	98.54918613	4982.63255	14.40066	19p13.11		0.0359	0.0038	0.1148	0.2505	0.0303	0.0067	0.0315	0.0075	0.0225	0.0033	0.0692	0.0099	0.2516	0.0301	0.0053	0.0153	rs74937996						
19	36549690	36549690	C	T	exonic	WDR62		synonymous SNV	WDR62:NM_001083961:exon2:c.C186T:p.L62L,WDR62:NM_173636:exon2:c.C186T:p.L62L	3.70153772737001e-13	0.994431561780598	0.00556843821903238	WD repeat domain 62	FUNCTION: Required for cerebral cortical development. Plays a role in neuronal proliferation and migration (PubMed:20890278, PubMed:20729831). Plays a role in mother-centriole-dependent centriole duplication; the function seems also to involve CEP152, CDK5RAP2 and CEP63 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). {ECO:0000269|PubMed:20729831, ECO:0000269|PubMed:20890278, ECO:0000269|PubMed:26297806}.; 	.	TISSUE SPECIFICITY: Present in fetal brain, enriched within the ventricular and subventricular zone (at protein level). In the embryonic brain it is expressed in mitotic neural precursor cells. {ECO:0000269|PubMed:20890279}.; 	unclassifiable (Anatomical System);medulla oblongata;ovary;colon;blood;fovea centralis;choroid;lens;skin;retina;bone marrow;uterus;prostate;optic nerve;lung;bone;macula lutea;visual apparatus;testis;spleen;germinal center;brain;thymus;	testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.44098	.	0.576763804	82.17740033	516.14972	4.64667	19q13.12		0.1795	0.0389	0.1451	0.1941	0.1711	0.2064	0.1847	0.1779	0.1492	0.0383	0.1563	0.2583	0.1751	0.1793	0.2014	0.1507	rs11538454	141612	Primary_autosomal_recessive_microcephaly_2|not_specified|Primary_Microcephaly_2_With_or_Without_Cortical_Malformations	MedGen:C1858535,OMIM:604317|MedGen:CN169374|MedGen:CN239163	criteria_provided,_multiple_submitters,_no_conflicts	Benign/Likely_benign	
19	39002725	39002725	A	G	exonic	RYR1		synonymous SNV	RYR1:NM_000540:exon62:c.A9186G:p.P3062P,RYR1:NM_001042723:exon62:c.A9186G:p.P3062P	1.60965844168568e-07	0.999999839034156	2.45437690799858e-26	ryanodine receptor 1	FUNCTION: Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering muscle contraction following depolarization of T-tubules. Repeated very high-level exercise increases the open probability of the channel and leads to Ca(2+) leaking into the cytoplasm. Can also mediate the release of Ca(2+) from intracellular stores in neurons, and may thereby promote prolonged Ca(2+) signaling in the brain. Required for normal embryonic development of muscle fibers and skeletal muscle. Required for normal heart morphogenesis, skin development and ossification during embryogenesis (By similarity). {ECO:0000250, ECO:0000269|PubMed:18268335}.; 	DISEASE: Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomal dominant pharmacogenetic disorder of skeletal muscle and is one of the main causes of death due to anesthesia. In susceptible people, an MH episode can be triggered by all commonly used inhalational anesthetics such as halothane and by depolarizing muscle relaxants such as succinylcholine. The clinical features of the myopathy are hyperthermia, accelerated muscle metabolism, contractures, metabolic acidosis, tachycardia and death, if not treated with the postsynaptic muscle relaxant, dantrolene. Susceptibility to MH can be determined with the 'in vitro' contracture test (IVCT): observing the magnitude of contractures induced in strips of muscle tissue by caffeine alone and halothane alone. Patients with normal response are MH normal (MHN), those with abnormal response to caffeine alone or halothane alone are MH equivocal (MHE(C) and MHE(H) respectively). {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10484775, ECO:0000269|PubMed:10612851, ECO:0000269|PubMed:10823104, ECO:0000269|PubMed:10888602, ECO:0000269|PubMed:11241852, ECO:0000269|PubMed:11389482, ECO:0000269|PubMed:11525881, ECO:0000269|PubMed:11575529, ECO:0000269|PubMed:11928716, ECO:0000269|PubMed:12059893, ECO:0000269|PubMed:12066726, ECO:0000269|PubMed:12123492, ECO:0000269|PubMed:12208234, ECO:0000269|PubMed:12411788, ECO:0000269|PubMed:12709367, ECO:0000269|PubMed:12883402, ECO:0000269|PubMed:1354642, ECO:0000269|PubMed:14732627, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:15221887, ECO:0000269|PubMed:15448513, ECO:0000269|PubMed:16163667, ECO:0000269|PubMed:1774074, ECO:0000269|PubMed:19191329, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:20681998, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24013571, ECO:0000269|PubMed:7751854, ECO:0000269|PubMed:7849712, ECO:0000269|PubMed:7881417, ECO:0000269|PubMed:8012359, ECO:0000269|PubMed:9066328, ECO:0000269|PubMed:9138151, ECO:0000269|PubMed:9389851, ECO:0000269|PubMed:9450902, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Central core disease of muscle (CCD) [MIM:117000]: Autosomal dominant congenital myopathy, but a severe autosomal recessive form also exists. Both clinical and histological variability is observed. Affected individuals typically display hypotonia and proximal muscle weakness in infancy, leading to the delay of motor milestones. The clinical course of the disorder is usually slow or nonprogressive in adulthood, and the severity of the symptoms may vary from normal to significant muscle weakness. Microscopic examination of CCD-affected skeletal muscle reveals a predominance of type I fibers containing amorphous-looking areas (cores) that do not stain with oxidative and phosphorylase histochemical techniques. {ECO:0000269|PubMed:10051009, ECO:0000269|PubMed:10097181, ECO:0000269|PubMed:11113224, ECO:0000269|PubMed:11709545, ECO:0000269|PubMed:11741831, ECO:0000269|PubMed:12112081, ECO:0000269|PubMed:12136074, ECO:0000269|PubMed:12565913, ECO:0000269|PubMed:12566385, ECO:0000269|PubMed:12937085, ECO:0000269|PubMed:14670767, ECO:0000269|PubMed:14985404, ECO:0000269|PubMed:17204054, ECO:0000269|PubMed:17226826, ECO:0000269|PubMed:18253926, ECO:0000269|PubMed:18312400, ECO:0000269|PubMed:20142353, ECO:0000269|PubMed:21674524, ECO:0000269|PubMed:23558838, ECO:0000269|PubMed:24561095, ECO:0000269|PubMed:7829078, ECO:0000269|PubMed:8220422, ECO:0000269|PubMed:8220423, ECO:0000269|PubMed:9497245}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiminicore disease with external ophthalmoplegia (MMDO) [MIM:255320]: Clinically heterogeneous neuromuscular disorder. General features include neonatal hypotonia, delayed motor development, and generalized muscle weakness and amyotrophy, which may progress slowly or remain stable. Muscle biopsy shows multiple, poorly circumscribed, short areas of sarcomere disorganization and mitochondria depletion (areas termed minicores) in most muscle fibers. Typically, no dystrophic signs, such as muscle fiber necrosis or regeneration or significant endomysial fibrosis, are present in multiminicore disease. {ECO:0000269|PubMed:12719381, ECO:0000269|PubMed:16380615}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD) [MIM:255310]: A genetically heterogeneous disorder in which there is relative hypotrophy of type 1 muscle fibers compared to type 2 fibers on skeletal muscle biopsy. However, these findings are not specific and can be found in many different myopathic and neuropathic conditions. {ECO:0000269|PubMed:20583297}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in RYR1 may be a cause of Samaritan myopathy, a congenital myopathy with benign course. Patients display severe hypotonia and respiratory distress at birth. Unlike other congenital myopathies, the health status constantly improves and patients are minimally affected at adulthood.; 	TISSUE SPECIFICITY: Skeletal muscle and brain (cerebellum and hippocampus). {ECO:0000269|PubMed:9607712}.; 	ovary;colon;fovea centralis;choroid;skin;retina;uterus;optic nerve;frontal lobe;larynx;thyroid;bone;testis;brain;unclassifiable (Anatomical System);heart;muscle;lens;skeletal muscle;pancreas;lung;epididymis;placenta;macula lutea;hippocampus;hypopharynx;head and neck;cervix;kidney;	tongue;skeletal muscle;	0.22212	.	-8.291678111	0.005897617	2142.38985	8.51518	19q13.2		0.3251	0.4402	0.4010	0.3409	0.3070	0.2613	0.3147	0.4572	0.3203	0.4374	0.3508	0.2384	0.3770	0.3012	0.2514	0.3053	rs2071089	99213	Malignant_hyperthermia_susceptibility|Myopathy,_Central_Core|Multiminicore_Disease|Neuromuscular_disease,_congenital,_with_uniform_type_1_fiber|not_specified|not_provided	MedGen:C0024591,Orphanet:ORPHA423|MedGen:C0751951,OMIM:117000,Orphanet:ORPHA597,SNOMED_CT:43152001|MedGen:C2673970|MedGen:C2674259|MedGen:CN169374|MedGen:CN517202	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
19	45001346	45001346	G	A	exonic	ZNF180		nonsynonymous SNV	ZNF180:NM_001278508:exon2:c.C122T:p.A41V,ZNF180:NM_001278509:exon2:c.C41T:p.A14V,ZNF180:NM_001288759:exon2:c.C119T:p.A40V,ZNF180:NM_001291633:exon2:c.C41T:p.A14V,ZNF180:NM_013256:exon2:c.C122T:p.A41V	7.35726181171227e-06	0.730469459591296	0.269523183146892	zinc finger protein 180	FUNCTION: May be involved in transcriptional regulation.; 	.	.	unclassifiable (Anatomical System);heart;ovary;hypothalamus;parathyroid;retina;bone marrow;prostate;whole body;lung;endometrium;bone;placenta;liver;testis;germinal center;kidney;brain;	superior cervical ganglion;	0.16058	.	1.157431179	92.60438783	5752.00612	15.73654	19q13.31		0.3291	0.2004	0.1465	0.3483	0.4966	0.3729	0.3614	0.2807	0.3278	0.2008	0.1492	0.3841	0.3377	0.4877	0.3690	0.3786	rs2571108						
19	52130488	52130488	G	A	exonic	SIGLEC5		synonymous SNV	SIGLEC5:NM_003830:exon7:c.C1296T:p.L432L	7.61333709335823e-05	0.918669676637401	0.081254189991665	sialic acid binding Ig like lectin 5	FUNCTION: Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Binds equally to alpha-2,3-linked and alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.; 	.	TISSUE SPECIFICITY: Expressed by monocytic/myeloid lineage cells. Found at high levels in peripheral blood leukocytes, spleen, bone marrow and at lower levels in lymph node, lung, appendix, placenta, pancreas and thymus. Expressed by monocytes and neutrophils but absent from leukemic cell lines representing early stages of myelomonocytic differentiation.; 	unclassifiable (Anatomical System);lung;blood;germinal center;brain;bone marrow;	superior cervical ganglion;ciliary ganglion;atrioventricular node;trigeminal ganglion;bone marrow;	0.02667	0.06874	0.554869705	81.59943383	1747.05185	7.71365	19q13.41		0.1653	0.1573	0.2002	0.6384	0.1656	0.1021	0.1644	0.1537	0.1623	0.1542	0.1487	0.0497	0.6343	0.1583	0.1208	0.1557	rs17740650						
20	18131569	18131569	T	-	exonic	KAT14		frameshift deletion	KAT14:NM_020536:exon3:c.483delT:p.L163Yfs*2																20p11.23																								
20	31890842	31890842	T	G	exonic	BPIFB1		nonsynonymous SNV	BPIFB1:NM_033197:exon11:c.T1102G:p.S368A	5.76895247746317e-07	0.868384481978954	0.131614941125798	BPI fold containing family B member 1	FUNCTION: May play a role in innate immunity in mouth, nose and lungs. Binds bacterial lipopolysaccharide (LPS) and modulates the cellular responses to LPS. {ECO:0000269|PubMed:21900486}.; 	.	TISSUE SPECIFICITY: Detected in duodenum mucosal crypts of cholera patients, near Paneth cells (at protein level). Detected in trachea, nasal septal epithelium and lung. {ECO:0000269|PubMed:21900486}.; 	lung;nasopharynx;skeletal muscle;	lung;trachea;thymus;	0.06268	0.09059	1.489991751	95.35857514	879.99138	5.77666	20q11.21																								
20	32336863	32336863	C	-	exonic	ZNF341		frameshift deletion	ZNF341:NM_001282935:exon3:c.204delC:p.P70Hfs*7,ZNF341:NM_001282933:exon4:c.474delC:p.P160Hfs*7,ZNF341:NM_032819:exon4:c.474delC:p.P160Hfs*7	0.124189156815528	0.875767745169137	4.30980153348915e-05	zinc finger protein 341	FUNCTION: May be involved in transcriptional regulation.; 	.	.	unclassifiable (Anatomical System);prostate;pancreas;lung;endometrium;visual apparatus;liver;testis;spleen;blood;kidney;mammary gland;bone marrow;	trigeminal ganglion;cerebellum;	0.12152	0.09319	-1.144569759	6.363529134	305.05398	3.71933	20q11.22																								
20	57045667	57045667	T	C	exonic	APCDD1L		synonymous SNV	APCDD1L:NM_153360:exon2:c.A186G:p.T62T,APCDD1L:NM_001304787:exon3:c.A219G:p.T73T	0.0175592164085508	0.892150808979574	0.0902899746118754	adenomatosis polyposis coli down-regulated 1-like	.	.	.	.	.	0.44207	.	0.420771676	77.15852795	1143.54286	6.44725	20q13.32		0.4982	0.5987	0.5662	0.4817	0.5553	0.4654	0.4872	0.5053	0.4577	0.5635	0.4580	0.3477	0.4407	0.4820	0.3952	0.4468	rs1980576						
20	57045728	57045728	G	T	exonic	APCDD1L		nonsynonymous SNV	APCDD1L:NM_153360:exon2:c.C125A:p.P42Q,APCDD1L:NM_001304787:exon3:c.C158A:p.P53Q	0.0175592164085508	0.892150808979574	0.0902899746118754	adenomatosis polyposis coli down-regulated 1-like	.	.	.	.	.	0.44207	.	0.420771676	77.15852795	1143.54286	6.44725	20q13.32		0.0001	0	0	0.0018	0	0	0	0	9.696e-05	0	0	0	0.0019	0	0	0	rs573179097						
20	57045765	57045765	A	G	exonic	APCDD1L		nonsynonymous SNV	APCDD1L:NM_153360:exon2:c.T88C:p.C30R,APCDD1L:NM_001304787:exon3:c.T121C:p.C41R	0.0175592164085508	0.892150808979574	0.0902899746118754	adenomatosis polyposis coli down-regulated 1-like	.	.	.	.	.	0.44207	.	0.420771676	77.15852795	1143.54286	6.44725	20q13.32		0.4632	0.5822	0.4381	0.4300	0.4362	0.4122	0.4451	0.4812	0.4575	0.5637	0.4582	0.3510	0.4414	0.4813	0.3946	0.4475	rs3946003						
20	57045770	57045770	C	-	exonic	APCDD1L		frameshift deletion	APCDD1L:NM_153360:exon2:c.83delG:p.G28Afs*46,APCDD1L:NM_001304787:exon3:c.116delG:p.G39Afs*46	0.0175592164085508	0.892150808979574	0.0902899746118754	adenomatosis polyposis coli down-regulated 1-like	.	.	.	.	.	0.44207	.	0.420771676	77.15852795	1143.54286	6.44725	20q13.32		0	0	0	0	0	0	0	0									rs751797316						
20	60485496	60485496	G	T	exonic	CDH4		stopgain	CDH4:NM_001252338:exon8:c.G1096T:p.E366X,CDH4:NM_001252339:exon8:c.G985T:p.E329X,CDH4:NM_001794:exon9:c.G1207T:p.E403X	0.966988413982154	0.0330114930297004	9.29881455927779e-08	cadherin 4	FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May play an important role in retinal development.; 	.	TISSUE SPECIFICITY: Expressed mainly in brain but also found in other tissues.; 	unclassifiable (Anatomical System);optic nerve;lung;islets of Langerhans;muscle;brain;	whole brain;dorsal root ganglion;amygdala;subthalamic nucleus;occipital lobe;prefrontal cortex;globus pallidus;ciliary ganglion;caudate nucleus;cingulate cortex;parietal lobe;	0.14101	0.14318	-2.070835943	1.615947157	232.04773	3.29334	20q13.33																								
20	60485547	60485547	C	T	exonic	CDH4		stopgain	CDH4:NM_001252338:exon8:c.C1147T:p.Q383X,CDH4:NM_001252339:exon8:c.C1036T:p.Q346X,CDH4:NM_001794:exon9:c.C1258T:p.Q420X	0.966988413982154	0.0330114930297004	9.29881455927779e-08	cadherin 4	FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May play an important role in retinal development.; 	.	TISSUE SPECIFICITY: Expressed mainly in brain but also found in other tissues.; 	unclassifiable (Anatomical System);optic nerve;lung;islets of Langerhans;muscle;brain;	whole brain;dorsal root ganglion;amygdala;subthalamic nucleus;occipital lobe;prefrontal cortex;globus pallidus;ciliary ganglion;caudate nucleus;cingulate cortex;parietal lobe;	0.14101	0.14318	-2.070835943	1.615947157	232.04773	3.29334	20q13.33	ID=COSM1681815;OCCURENCE=1(lung)																							
20	60485626	60485626	-	C	exonic	CDH4		frameshift insertion	CDH4:NM_001252338:exon8:c.1227dupC:p.V411Rfs*88,CDH4:NM_001252339:exon8:c.1116dupC:p.V374Rfs*88,CDH4:NM_001794:exon9:c.1338dupC:p.V448Rfs*88	0.966988413982154	0.0330114930297004	9.29881455927779e-08	cadherin 4	FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May play an important role in retinal development.; 	.	TISSUE SPECIFICITY: Expressed mainly in brain but also found in other tissues.; 	unclassifiable (Anatomical System);optic nerve;lung;islets of Langerhans;muscle;brain;	whole brain;dorsal root ganglion;amygdala;subthalamic nucleus;occipital lobe;prefrontal cortex;globus pallidus;ciliary ganglion;caudate nucleus;cingulate cortex;parietal lobe;	0.14101	0.14318	-2.070835943	1.615947157	232.04773	3.29334	20q13.33																								
20	60485627	60485627	C	T	exonic	CDH4		synonymous SNV	CDH4:NM_001252338:exon8:c.C1227T:p.D409D,CDH4:NM_001252339:exon8:c.C1116T:p.D372D,CDH4:NM_001794:exon9:c.C1338T:p.D446D	0.966988413982154	0.0330114930297004	9.29881455927779e-08	cadherin 4	FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May play an important role in retinal development.; 	.	TISSUE SPECIFICITY: Expressed mainly in brain but also found in other tissues.; 	unclassifiable (Anatomical System);optic nerve;lung;islets of Langerhans;muscle;brain;	whole brain;dorsal root ganglion;amygdala;subthalamic nucleus;occipital lobe;prefrontal cortex;globus pallidus;ciliary ganglion;caudate nucleus;cingulate cortex;parietal lobe;	0.14101	0.14318	-2.070835943	1.615947157	232.04773	3.29334	20q13.33		0.8515	0.5883	0.7973	0.5472	0.9123	0.9420	0.8830	0.8221	0.8151	0.5864	0.8026	0.8841	0.5594	0.9136	0.9464	0.8980	rs2427240						
20	60485648	60485648	G	-	exonic	CDH4		frameshift deletion	CDH4:NM_001252338:exon8:c.1248delG:p.V417Sfs*4,CDH4:NM_001252339:exon8:c.1137delG:p.V380Sfs*4,CDH4:NM_001794:exon9:c.1359delG:p.V454Sfs*4	0.966988413982154	0.0330114930297004	9.29881455927779e-08	cadherin 4	FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. May play an important role in retinal development.; 	.	TISSUE SPECIFICITY: Expressed mainly in brain but also found in other tissues.; 	unclassifiable (Anatomical System);optic nerve;lung;islets of Langerhans;muscle;brain;	whole brain;dorsal root ganglion;amygdala;subthalamic nucleus;occipital lobe;prefrontal cortex;globus pallidus;ciliary ganglion;caudate nucleus;cingulate cortex;parietal lobe;	0.14101	0.14318	-2.070835943	1.615947157	232.04773	3.29334	20q13.33																								
20	62045527	62045527	C	G	exonic	KCNQ2		nonsynonymous SNV	KCNQ2:NM_004518:exon12:c.G1461C:p.E487D,KCNQ2:NM_172106:exon13:c.G1491C:p.E497D,KCNQ2:NM_172108:exon13:c.G1452C:p.E484D,KCNQ2:NM_172107:exon14:c.G1545C:p.E515D	0.99935609863785	0.000643900629781664	7.32368580232038e-10	potassium voltage-gated channel subfamily Q member 2	FUNCTION: Probably important in the regulation of neuronal excitability. Associates with KCNQ3 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs. KCNQ2/KCNQ3 current is blocked by linopirdine and XE991, and activated by the anticonvulsant retigabine. Muscarinic agonist oxotremorine-M strongly suppress KCNQ2/KCNQ3 current in cells in which cloned KCNQ2/KCNQ3 channels were coexpressed with M1 muscarinic receptors.; 	DISEASE: Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]: A disorder characterized by clusters of seizures occurring in the first days of life. Most patients have spontaneous remission by 12 months of age and show normal psychomotor development. Some rare cases manifest an atypical severe phenotype associated with epileptic encephalopathy and psychomotor retardation. The disorder is distinguished from benign familial infantile seizures by an earlier age at onset. In some patients, neonatal convulsions are followed later in life by myokymia, a benign condition characterized by spontaneous involuntary contractions of skeletal muscles fiber groups that can be observed as vermiform movement of the overlying skin. Electromyography typically shows continuous motor unit activity with spontaneous oligo- and multiplet-discharges of high intraburst frequency (myokymic discharges). Some patients may have isolated myokymia. {ECO:0000269|PubMed:11175290, ECO:0000269|PubMed:11572947, ECO:0000269|PubMed:14534157, ECO:0000269|PubMed:15249611, ECO:0000269|PubMed:9425895}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 7 (EIEE7) [MIM:613720]: An autosomal dominant seizure disorder characterized by infantile onset of refractory seizures with resultant delayed neurologic development and persistent neurologic abnormalities. {ECO:0000269|PubMed:12742592, ECO:0000269|PubMed:15249611}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in areas containing neuronal cell bodies, low in spinal chord and corpus callosum. Isoform 2 is preferentially expressed in differentiated neurons. Isoform 6 is prominent in fetal brain, undifferentiated neuroblastoma cells and brain tumors. {ECO:0000269|PubMed:10781098}.; 	unclassifiable (Anatomical System);lung;frontal lobe;islets of Langerhans;macula lutea;hippocampus;visual apparatus;duodenum;testis;fovea centralis;mammary gland;brain;retina;	amygdala;superior cervical ganglion;cerebellum peduncles;hypothalamus;atrioventricular node;pons;skeletal muscle;subthalamic nucleus;fetal brain;testis - seminiferous tubule;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.49147	0.15128	-0.666770504	15.86459071	224.48708	3.24057	20q13.33		0.0025	9.812e-05	0.0002	0.0337	0	0	0.0011	0.0002	0.0023	0	0	0	0.0425	0	6.68e-05	0.0010	rs117067974	34616	Seizures|Benign_familial_neonatal_seizures_1|Early_infantile_epileptic_encephalopathy|KCNQ2-Related_Disorders|not_specified	Human_Phenotype_Ontology:HP:0001250,MedGen:C0036572|MedGen:C3149074,OMIM:121200|MedGen:C4552072,Orphanet:ORPHA1934|MedGen:CN169299|MedGen:CN169374	criteria_provided,_conflicting_interpretations	Conflicting_interpretations_of_pathogenicity	ID=CM095345;CLASS=DM;MUT=ALT;GENE=KCNQ2;STRAND=-;DNA=NM_172107.3:c.1545G>C;PROT=NP_742105.1:p.E515D;DB=rs117067974;PHEN="Epilepsy_benign_neonatal";RANKSCORE=0.31
20	62045533	62045533	G	-	exonic	KCNQ2		frameshift deletion	KCNQ2:NM_004518:exon12:c.1455delC:p.G486Efs*15,KCNQ2:NM_172106:exon13:c.1485delC:p.G496Efs*15,KCNQ2:NM_172108:exon13:c.1446delC:p.G483Efs*15,KCNQ2:NM_172107:exon14:c.1539delC:p.G514Efs*15	0.99935609863785	0.000643900629781664	7.32368580232038e-10	potassium voltage-gated channel subfamily Q member 2	FUNCTION: Probably important in the regulation of neuronal excitability. Associates with KCNQ3 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs. KCNQ2/KCNQ3 current is blocked by linopirdine and XE991, and activated by the anticonvulsant retigabine. Muscarinic agonist oxotremorine-M strongly suppress KCNQ2/KCNQ3 current in cells in which cloned KCNQ2/KCNQ3 channels were coexpressed with M1 muscarinic receptors.; 	DISEASE: Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]: A disorder characterized by clusters of seizures occurring in the first days of life. Most patients have spontaneous remission by 12 months of age and show normal psychomotor development. Some rare cases manifest an atypical severe phenotype associated with epileptic encephalopathy and psychomotor retardation. The disorder is distinguished from benign familial infantile seizures by an earlier age at onset. In some patients, neonatal convulsions are followed later in life by myokymia, a benign condition characterized by spontaneous involuntary contractions of skeletal muscles fiber groups that can be observed as vermiform movement of the overlying skin. Electromyography typically shows continuous motor unit activity with spontaneous oligo- and multiplet-discharges of high intraburst frequency (myokymic discharges). Some patients may have isolated myokymia. {ECO:0000269|PubMed:11175290, ECO:0000269|PubMed:11572947, ECO:0000269|PubMed:14534157, ECO:0000269|PubMed:15249611, ECO:0000269|PubMed:9425895}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 7 (EIEE7) [MIM:613720]: An autosomal dominant seizure disorder characterized by infantile onset of refractory seizures with resultant delayed neurologic development and persistent neurologic abnormalities. {ECO:0000269|PubMed:12742592, ECO:0000269|PubMed:15249611}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in areas containing neuronal cell bodies, low in spinal chord and corpus callosum. Isoform 2 is preferentially expressed in differentiated neurons. Isoform 6 is prominent in fetal brain, undifferentiated neuroblastoma cells and brain tumors. {ECO:0000269|PubMed:10781098}.; 	unclassifiable (Anatomical System);lung;frontal lobe;islets of Langerhans;macula lutea;hippocampus;visual apparatus;duodenum;testis;fovea centralis;mammary gland;brain;retina;	amygdala;superior cervical ganglion;cerebellum peduncles;hypothalamus;atrioventricular node;pons;skeletal muscle;subthalamic nucleus;fetal brain;testis - seminiferous tubule;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.49147	0.15128	-0.666770504	15.86459071	224.48708	3.24057	20q13.33																			410817	not_provided	MedGen:CN517202	criteria_provided,_single_submitter	Likely_pathogenic	
20	62045549	62045549	G	-	intronic	KCNQ2				0.99935609863785	0.000643900629781664	7.32368580232038e-10	potassium voltage-gated channel subfamily Q member 2	FUNCTION: Probably important in the regulation of neuronal excitability. Associates with KCNQ3 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs. KCNQ2/KCNQ3 current is blocked by linopirdine and XE991, and activated by the anticonvulsant retigabine. Muscarinic agonist oxotremorine-M strongly suppress KCNQ2/KCNQ3 current in cells in which cloned KCNQ2/KCNQ3 channels were coexpressed with M1 muscarinic receptors.; 	DISEASE: Seizures, benign familial neonatal 1 (BFNS1) [MIM:121200]: A disorder characterized by clusters of seizures occurring in the first days of life. Most patients have spontaneous remission by 12 months of age and show normal psychomotor development. Some rare cases manifest an atypical severe phenotype associated with epileptic encephalopathy and psychomotor retardation. The disorder is distinguished from benign familial infantile seizures by an earlier age at onset. In some patients, neonatal convulsions are followed later in life by myokymia, a benign condition characterized by spontaneous involuntary contractions of skeletal muscles fiber groups that can be observed as vermiform movement of the overlying skin. Electromyography typically shows continuous motor unit activity with spontaneous oligo- and multiplet-discharges of high intraburst frequency (myokymic discharges). Some patients may have isolated myokymia. {ECO:0000269|PubMed:11175290, ECO:0000269|PubMed:11572947, ECO:0000269|PubMed:14534157, ECO:0000269|PubMed:15249611, ECO:0000269|PubMed:9425895}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epileptic encephalopathy, early infantile, 7 (EIEE7) [MIM:613720]: An autosomal dominant seizure disorder characterized by infantile onset of refractory seizures with resultant delayed neurologic development and persistent neurologic abnormalities. {ECO:0000269|PubMed:12742592, ECO:0000269|PubMed:15249611}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	TISSUE SPECIFICITY: In adult and fetal brain. Highly expressed in areas containing neuronal cell bodies, low in spinal chord and corpus callosum. Isoform 2 is preferentially expressed in differentiated neurons. Isoform 6 is prominent in fetal brain, undifferentiated neuroblastoma cells and brain tumors. {ECO:0000269|PubMed:10781098}.; 	unclassifiable (Anatomical System);lung;frontal lobe;islets of Langerhans;macula lutea;hippocampus;visual apparatus;duodenum;testis;fovea centralis;mammary gland;brain;retina;	amygdala;superior cervical ganglion;cerebellum peduncles;hypothalamus;atrioventricular node;pons;skeletal muscle;subthalamic nucleus;fetal brain;testis - seminiferous tubule;prefrontal cortex;globus pallidus;ciliary ganglion;trigeminal ganglion;parietal lobe;cingulate cortex;	0.49147	0.15128	-0.666770504	15.86459071	224.48708	3.24057	20q13.33										3.24e-05	0.0001	0	0	0	0	0	0							
20	62321704	62321704	A	G	exonic	RTEL1		nonsynonymous SNV	RTEL1:NM_001283010:exon25:c.A1654G:p.S552G,RTEL1:NM_001283009:exon26:c.A2323G:p.S775G,RTEL1:NM_016434:exon26:c.A2323G:p.S775G,RTEL1:NM_032957:exon26:c.A2395G:p.S799G	0.777758475451746	0.22224152436455	1.83703998441753e-10	regulator of telomere elongation helicase 1	FUNCTION: ATP-dependent DNA helicase implicated in telomere-length regulation, DNA repair and the maintenance of genomic stability. Acts as an anti-recombinase to counteract toxic recombination and limit crossover during meiosis. Regulates meiotic recombination and crossover homeostasis by physically dissociating strand invasion events and thereby promotes noncrossover repair by meiotic synthesis dependent strand annealing (SDSA) as well as disassembly of D loop recombination intermediates. Also disassembles T loops and prevents telomere fragility by counteracting telomeric G4-DNA structures, which together ensure the dynamics and stability of the telomere. {ECO:0000255|HAMAP- Rule:MF_03065, ECO:0000269|PubMed:18957201, ECO:0000269|PubMed:23453664, ECO:0000269|PubMed:24009516}.; 	DISEASE: Dyskeratosis congenita, autosomal recessive, 5 (DKCB5) [MIM:615190]: A form of dyskeratosis congenita, a rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. DKCB5 is characterized by onset of bone marrow failure and immunodeficiency in early childhood. Most patients also have growth and developmental delay and cerebellar hypoplasia, consistent with a clinical diagnosis of Hoyeraal-Hreidarsson syndrome. {ECO:0000269|PubMed:23329068, ECO:0000269|PubMed:23453664, ECO:0000269|PubMed:23591994, ECO:0000269|PubMed:23959892, ECO:0000269|PubMed:24009516}. Note=The disease is caused by mutations affecting the gene represented in this entry. RTEL1 mutations have also been found in patients with a dyskeratosis congenita-like phenotype consisting of one feature of dyskeratosis congenita and short telomeres, in the absence of the typical DKC diagnostic triad (PubMed:23329068). {ECO:0000269|PubMed:23329068}.; DISEASE: Dyskeratosis congenita, autosomal dominant, 4 (DKCA4) [MIM:615190]: A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy. {ECO:0000269|PubMed:23329068}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Pulmonary fibrosis, and/or bone marrow failure, telomere- related, 3 (PFBMFT3) [MIM:616373]: A disease associated with shortened telomeres. Pulmonary fibrosis is the most common manifestation. Other manifestations include aplastic anemia due to bone marrow failure, hepatic fibrosis, and increased cancer risk, particularly myelodysplastic syndrome and acute myeloid leukemia. Phenotype, age at onset, and severity are determined by telomere length. {ECO:0000269|PubMed:25848748}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	.	.	.	0.16864	-2.481161548	0.949516395	1308.22688	6.80132	20q13.33																								
21	10907022	10907022	-	T	exonic	TPTE		frameshift insertion	TPTE:NM_001290224:exon19:c.1124dupA:p.N375Kfs*2,TPTE:NM_199260:exon22:c.1424dupA:p.N475Kfs*2,TPTE:NM_199259:exon23:c.1484dupA:p.N495Kfs*2,TPTE:NM_199261:exon24:c.1538dupA:p.N513Kfs*2	5.11403738742454e-31	2.41951757308982e-06	0.999997580482427	transmembrane phosphatase with tensin homology	FUNCTION: Could be involved in signal transduction.; 	.	TISSUE SPECIFICITY: Exclusively expressed in testis. {ECO:0000269|PubMed:10598804}.; 	unclassifiable (Anatomical System);lung;placenta;testis;	dorsal root ganglion;superior cervical ganglion;testis - interstitial;testis - seminiferous tubule;appendix;testis;ciliary ganglion;atrioventricular node;trigeminal ganglion;	.	0.05870	2.938206407	99.1507431	179.24136	2.90847	21p11.1																								
21	33067185	33067187	GCT	-	exonic	SCAF4		nonframeshift deletion	SCAF4:NM_001145444:exon9:c.1130_1132del:p.Q377Pfs*756,SCAF4:NM_001145445:exon10:c.1175_1177del:p.Q392Pfs*734,SCAF4:NM_020706:exon10:c.1175_1177del:p.Q392Pfs*756	0.999999693301169	3.06698830689798e-07	5.9189509665223e-18	SR-related CTD associated factor 4	FUNCTION: May act to physically and functionally link transcription and pre-mRNA processing. {ECO:0000250}.; 	.	.	myocardium;ovary;colon;choroid;retina;uterus;prostate;endometrium;thyroid;bone;testis;germinal center;brain;unclassifiable (Anatomical System);cartilage;urinary;blood;skeletal muscle;breast;pancreas;lung;placenta;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;	dorsal root ganglion;superior cervical ganglion;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;	0.76390	0.10408	-1.214341017	5.67940552	104.06406	2.20474	21q22.11																								
21	33725149	33725149	-	G	exonic	URB1		frameshift insertion	URB1:NM_014825:exon19:c.2482dupC:p.L828Pfs*11	.	.	.	URB1 ribosome biogenesis 1 homolog (S. cerevisiae)	.	.	.	.	.	0.19883	0.09434	2.699225953	98.89124794	843.19169	5.68362	21q22.11																								
21	43327856	43327856	A	G	exonic	C2CD2		synonymous SNV	C2CD2:NM_199050:exon8:c.T591C:p.F197F,C2CD2:NM_015500:exon9:c.T1056C:p.F352F	0.0600282483313238	0.939254399122531	0.000717352546144941	C2 calcium-dependent domain containing 2	.	.	.	ovary;colon;parathyroid;fovea centralis;skin;retina;uterus;prostate;optic nerve;frontal lobe;oesophagus;endometrium;bone;pituitary gland;testis;brain;bladder;unclassifiable (Anatomical System);heart;cartilage;adrenal cortex;lens;skeletal muscle;bile duct;lung;cornea;adrenal gland;nasopharynx;placenta;macula lutea;visual apparatus;liver;spleen;cervix;stomach;	adrenal gland;adrenal cortex;	0.08398	0.09255	-0.949752638	9.32413305	151.19965	2.68855	21q22.3		0.6182	0.6246	0.4610	0.5811	0.6131	0.6423	0.6144	0.6482	0.6272	0.6054	0.5419	0.6633	0.5681	0.6293	0.6486	0.6459	rs3746906						
21	45033823	45033825	CAA	-	exonic	HSF2BP		nonframeshift deletion	HSF2BP:NM_007031:exon7:c.578_580del:p.V193Afs*142	6.3650365720359e-10	0.0355309115547799	0.964469087808717	heat shock transcription factor 2 binding protein	FUNCTION: May be involved in modulating HSF2 activation in testis.; 	.	TISSUE SPECIFICITY: Testis specific.; 	unclassifiable (Anatomical System);uterus;medulla oblongata;lung;heart;bone;testis;cervix;skin;	dorsal root ganglion;testis - interstitial;superior cervical ganglion;testis - seminiferous tubule;testis;globus pallidus;ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;	0.14341	0.10134	-0.358119787	29.16371786	45.29789	1.29238	21q22.3																								
22	19882984	19882984	T	G	exonic	TXNRD2		nonsynonymous SNV	TXNRD2:NM_001282512:exon11:c.A895C:p.S299R	1.06916304756314e-08	0.758978014754118	0.241021974554252	thioredoxin reductase 2	FUNCTION: Maintains thioredoxin in a reduced state. Implicated in the defenses against oxidative stress. May play a role in redox- regulated cell signaling.; 	.	TISSUE SPECIFICITY: Highly expressed in the prostate, ovary, liver, testis, uterus, colon and small intestine. Intermediate levels in brain, skeletal muscle, heart and spleen. Low levels in placenta, pancreas, thymus and peripheral blood leukocytes. According to PubMed:10608886, high levels in kidney, whereas according to PubMed:9923614, levels are low. {ECO:0000269|PubMed:10215850, ECO:0000269|PubMed:10608886, ECO:0000269|PubMed:9923614}.; 	medulla oblongata;ovary;salivary gland;intestine;colon;fovea centralis;choroid;skin;retina;uterus;prostate;optic nerve;whole body;endometrium;larynx;bone;pituitary gland;testis;germinal center;brain;bladder;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;hypothalamus;muscle;pharynx;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;duodenum;liver;spleen;head and neck;cervix;kidney;stomach;thymus;	dorsal root ganglion;superior cervical ganglion;subthalamic nucleus;globus pallidus;ciliary ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;	0.14486	0.33725	0.626470967	83.55154518	4301.52381	13.05449	22q11.21		0.1879	0.5139	0.1389	0.0655	0.1259	0.1665	0.1778	0.2041	0.2514	0.5162	0.1256	0.1933	0.0580	0.1348	0.1572	0.2002	rs5992495	259130	not_specified|Cardiovascular_phenotype	MedGen:CN169374|MedGen:CN230736	criteria_provided,_multiple_submitters,_no_conflicts	Benign	
22	20940085	20940085	G	A	exonic	MED15		synonymous SNV	MED15:NM_001293236:exon15:c.G1869A:p.P623P,MED15:NM_001293234:exon16:c.G2031A:p.P677P,MED15:NM_001293235:exon16:c.G2004A:p.P668P,MED15:NM_001293237:exon16:c.G2004A:p.P668P,MED15:NM_015889:exon16:c.G2082A:p.P694P,MED15:NM_001003891:exon17:c.G2202A:p.P734P	0.960808622998609	0.0391913711650731	5.83631815978549e-09	mediator complex subunit 15	FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. Required for cholesterol-dependent gene regulation. Positively regulates the Nodal signaling pathway. {ECO:0000269|PubMed:12167862, ECO:0000269|PubMed:16630888, ECO:0000269|PubMed:16799563}.; 	.	TISSUE SPECIFICITY: Expressed in all tissues examined, including heart, brain, lung, spleen, thymus, pancreas, blood leukocyte and placenta. However, the level of expression varied, with highest expression in the placenta and peripheral blood and lowest in the pancreas and kidney. {ECO:0000269|PubMed:11024300}.; 	lymphoreticular;myocardium;medulla oblongata;ovary;salivary gland;colon;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;cerebral cortex;endometrium;larynx;bone;thyroid;iris;pituitary gland;testis;germinal center;spinal ganglion;brain;bladder;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;islets of Langerhans;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;kidney;mammary gland;stomach;thymus;	superior cervical ganglion;ciliary ganglion;	0.73008	0.16585	-1.464150033	3.780372729	97.67863	2.13739	22q11.21		0.0912	0.0126	0.0548	0.3901	0.0695	0.0593	0.0796	0.1465	0.0610	0.0136	0.0644	0.0894	0.3673	0.0639	0.0532	0.0724	rs2285699						
22	29630182	29630182	-	GA	exonic	EMID1		frameshift insertion	EMID1:NM_001267895:exon11:c.1017_1018insGA:p.G342Efs*42,EMID1:NM_133455:exon11:c.1023_1024insGA:p.G344Efs*42	0.0397077266512435	0.953633155806475	0.00665911754228154	EMI domain containing 1	.	.	.	unclassifiable (Anatomical System);cartilage;heart;colon;parathyroid;fovea centralis;choroid;lens;skeletal muscle;retina;uterus;breast;prostate;optic nerve;lung;endometrium;placenta;thyroid;macula lutea;spleen;kidney;brain;stomach;	thalamus;superior cervical ganglion;kidney;trigeminal ganglion;cerebellum;	0.28625	0.07814	0.885576705	89.14248644	2331.25441	8.94428	22q12.2																								
22	32000895	32000895	C	T	exonic	SFI1		nonsynonymous SNV	SFI1:NM_001258325:exon18:c.C1853T:p.A618V,SFI1:NM_001258326:exon18:c.C1772T:p.A591V,SFI1:NM_001258327:exon18:c.C1772T:p.A591V,SFI1:NM_014775:exon19:c.C1925T:p.A642V,SFI1:NM_001007467:exon20:c.C2018T:p.A673V	5.98724844744369e-25	0.219326979284339	0.780673020715661	SFI1 centrin binding protein	FUNCTION: Plays a role in the dynamic structure of centrosome- associated contractile fibers via its interaction with CETN2. {ECO:0000269|PubMed:16956364}.; 	.	.	medulla oblongata;ovary;colon;parathyroid;fovea centralis;choroid;vein;skin;retina;uterus;prostate;optic nerve;whole body;oesophagus;endometrium;larynx;bone;thyroid;iris;testis;germinal center;brain;unclassifiable (Anatomical System);lymph node;cartilage;islets of Langerhans;lens;skeletal muscle;pancreas;lung;placenta;macula lutea;visual apparatus;liver;spleen;head and neck;cervix;kidney;stomach;thymus;	.	0.19999	0.09106	0.595153166	82.52535975	7567.61517	18.66443	22q12.2																								
22	32756339	32756339	C	T	exonic	RFPL3		synonymous SNV	RFPL3:NM_001098535:exon2:c.C474T:p.D158D,RFPL3:NM_006604:exon3:c.C387T:p.D129D	0.00015844316199715	0.437571789221612	0.562269767616391	ret finger protein like 3	.	.	.	medulla oblongata;lung;macula lutea;testis;fovea centralis;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	22q12.3																								
22	32756394	32756395	TG	-	exonic	RFPL3		frameshift deletion	RFPL3:NM_001098535:exon2:c.529_530del:p.C177Wfs*83,RFPL3:NM_006604:exon3:c.442_443del:p.C148Wfs*83	0.00015844316199715	0.437571789221612	0.562269767616391	ret finger protein like 3	.	.	.	medulla oblongata;lung;macula lutea;testis;fovea centralis;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	22q12.3																								
22	32756423	32756423	G	-	exonic	RFPL3		frameshift deletion	RFPL3:NM_001098535:exon2:c.558delG:p.G187Efs*23,RFPL3:NM_006604:exon3:c.471delG:p.G158Efs*23	0.00015844316199715	0.437571789221612	0.562269767616391	ret finger protein like 3	.	.	.	medulla oblongata;lung;macula lutea;testis;fovea centralis;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	22q12.3																								
22	32756555	32756555	G	C	exonic	RFPL3		synonymous SNV	RFPL3:NM_001098535:exon2:c.G690C:p.T230T,RFPL3:NM_006604:exon3:c.G603C:p.T201T	0.00015844316199715	0.437571789221612	0.562269767616391	ret finger protein like 3	.	.	.	medulla oblongata;lung;macula lutea;testis;fovea centralis;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	22q12.3		0.1024	0.0479	0.1358	0.4800	0.0477	0.0555	0.0907	0.1267	0.0754	0.0439	0.1208	0.0728	0.4833	0.0455	0.0548	0.0665	rs136471						
22	32756604	32756604	-	T	exonic	RFPL3		frameshift insertion	RFPL3:NM_001098535:exon2:c.740dupT:p.L249Sfs*12,RFPL3:NM_006604:exon3:c.653dupT:p.L220Sfs*12	0.00015844316199715	0.437571789221612	0.562269767616391	ret finger protein like 3	.	.	.	medulla oblongata;lung;macula lutea;testis;fovea centralis;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	22q12.3																								
22	32756744	32756744	A	G	exonic	RFPL3		synonymous SNV	RFPL3:NM_001098535:exon2:c.A879G:p.Q293Q,RFPL3:NM_006604:exon3:c.A792G:p.Q264Q	0.00015844316199715	0.437571789221612	0.562269767616391	ret finger protein like 3	.	.	.	medulla oblongata;lung;macula lutea;testis;fovea centralis;	dorsal root ganglion;subthalamic nucleus;superior cervical ganglion;testis - seminiferous tubule;ciliary ganglion;atrioventricular node;pons;trigeminal ganglion;cingulate cortex;	0.04317	.	0.687150476	85.17928757	1089.79284	6.32074	22q12.3		0.4109	0.4908	0.4382	0.5356	0.3643	0.3744	0.4094	0.4443	0.5404	0.7720	0.4867	0.3758	0.5806	0.4330	0.4413	0.4548	rs2076035						
22	39148568	39148570	GCT	-	exonic	SUN2		nonframeshift deletion	SUN2:NM_001199579:exon2:c.64_66del:p.S22Gfs*717,SUN2:NM_015374:exon2:c.64_66del:p.S22Gfs*696,SUN2:NM_001199580:exon3:c.64_66del:p.S22Gfs*696	2.40833189817119e-07	0.994679312109684	0.00532044705712572	Sad1 and UNC84 domain containing 2	FUNCTION: Component of SUN-protein-containing multivariate complexes also called LINC complexes which link the nucleoskeleton and cytoskeleton by providing versatile outer nuclear membrane attachment sites for cytoskeletal filaments. Specifically, SYNE2 and SUN2 assemble in arrays of transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow during actin-dependent nuclear movement. Required for interkinetic nuclear migration (INM) and essential for nucleokinesis and centrosome-nucleus coupling during radial neuronal migration in the cerebral cortex and during glial migration. Anchors chromosome movement in the prophase of meiosis and is involved in selective gene expression of coding and non-coding RNAs needed for gametogenesis. Required for telomere attachment to nuclear envelope and gametogenesis. May also function on endocytic vesicles as a receptor for RAB5-GDP and participate in the activation of RAB5. {ECO:0000269|PubMed:18396275}.; 	.	TISSUE SPECIFICITY: Widely expressed. Highly expressed in heart, lung and muscle. Weakly expressed in fetal heart. Slightly overexpressed in some heart tissues form patients with congenital heart defects. {ECO:0000269|PubMed:10818110, ECO:0000269|PubMed:12393179}.; 	ovary;adrenal medulla;skin;bone marrow;retina;prostate;optic nerve;frontal lobe;endometrium;iris;germinal center;bladder;brain;heart;cartilage;blood;skeletal muscle;breast;macula lutea;liver;alveolus;spleen;cervix;mammary gland;peripheral nerve;colon;parathyroid;fovea centralis;uterus;whole body;oesophagus;larynx;bone;testis;unclassifiable (Anatomical System);lymph node;islets of Langerhans;hypothalamus;muscle;pancreas;lung;nasopharynx;placenta;hippocampus;hypopharynx;amnion;head and neck;kidney;stomach;thymus;cerebellum;	thalamus;	0.20389	0.11830	0.051446096	57.53715499	1473.25813	7.14983	22q13.1		6.685e-05	9.76e-05	0.0006	0	0	0	0	0									rs781129819						
22	39907940	39907940	G	A	exonic	MIEF1		nonsynonymous SNV	MIEF1:NM_001304564:exon4:c.G231A:p.M77I,MIEF1:NM_019008:exon4:c.G231A:p.M77I	0.0628938325307641	0.921465905895044	0.0156402615741921	mitochondrial elongation factor 1	FUNCTION: Mitochondrial outer membrane protein which regulates mitochondrial fission. Promotes the recruitment and association of the fission mediator dynamin-related protein 1 (DNM1L) to the mitochondrial surface independently of the mitochondrial fission FIS1 and MFF proteins. Regulates DNM1L GTPase activity and DNM1L oligomerization. Binds ADP and can also bind GDP, although with lower affinity. Does not bind CDP, UDP, ATP, AMP or GTP. Inhibits DNM1L GTPase activity in the absence of bound ADP. Requires ADP to stimulate DNM1L GTPase activity and the assembly of DNM1L into long, oligomeric tubules with a spiral pattern, as opposed to the ring-like DNM1L oligomers observed in the absence of bound ADP. Does not require ADP for its function in recruiting DNM1L. {ECO:0000269|PubMed:21508961, ECO:0000269|PubMed:21701560, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:23530241, ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:24515348}.; 	.	TISSUE SPECIFICITY: Expression is relatively high in heart, skeletal muscle, pancreas and kidney. {ECO:0000269|PubMed:21701560}.; 	.	.	0.12261	0.09986	0.420771676	77.15852795	1019.99486	6.14357	22q13.1																								
22	41605809	41605809	G	C	exonic	L3MBTL2		nonsynonymous SNV	L3MBTL2:NM_031488:exon2:c.G134C:p.S45T	0.0130280434479328	0.986911838666868	6.01178851992325e-05	l(3)mbt-like 2 (Drosophila)	FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. {ECO:0000269|PubMed:19233876}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;testis;amniotic fluid;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;muscle;lens;bile duct;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;stomach;thymus;	superior cervical ganglion;ciliary ganglion;	0.30184	0.10643	-1.172055164	6.027364945	286.32425	3.62314	22q13.2		0.0011	9.61e-05	0.0006	0.0116	0	5.993e-05	0.0011	0.0010	0.0008	0.0002	0	0	0.0130	0	0.0002	0	rs150194965						
22	41605838	41605838	-	A	exonic	L3MBTL2		frameshift insertion	L3MBTL2:NM_031488:exon2:c.164dupA:p.N56Kfs*2	0.0130280434479328	0.986911838666868	6.01178851992325e-05	l(3)mbt-like 2 (Drosophila)	FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. {ECO:0000269|PubMed:19233876}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;testis;amniotic fluid;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;muscle;lens;bile duct;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;stomach;thymus;	superior cervical ganglion;ciliary ganglion;	0.30184	0.10643	-1.172055164	6.027364945	286.32425	3.62314	22q13.2																								
22	41605874	41605874	-	C	exonic	L3MBTL2		frameshift insertion	L3MBTL2:NM_031488:exon2:c.200dupC:p.L69Afs*18	0.0130280434479328	0.986911838666868	6.01178851992325e-05	l(3)mbt-like 2 (Drosophila)	FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. {ECO:0000269|PubMed:19233876}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;testis;amniotic fluid;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;muscle;lens;bile duct;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;stomach;thymus;	superior cervical ganglion;ciliary ganglion;	0.30184	0.10643	-1.172055164	6.027364945	286.32425	3.62314	22q13.2																								
22	41605898	41605899	GG	-	exonic	L3MBTL2		frameshift deletion	L3MBTL2:NM_031488:exon2:c.223_224del:p.G75Dfs*11	0.0130280434479328	0.986911838666868	6.01178851992325e-05	l(3)mbt-like 2 (Drosophila)	FUNCTION: Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'. {ECO:0000269|PubMed:19233876}.; 	.	.	lymphoreticular;ovary;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;uterus;prostate;optic nerve;frontal lobe;endometrium;bone;testis;amniotic fluid;germinal center;spinal ganglion;brain;tonsil;unclassifiable (Anatomical System);lymph node;cartilage;heart;muscle;lens;bile duct;breast;pancreas;lung;trabecular meshwork;placenta;macula lutea;visual apparatus;hippocampus;liver;spleen;cervix;kidney;stomach;thymus;	superior cervical ganglion;ciliary ganglion;	0.30184	0.10643	-1.172055164	6.027364945	286.32425	3.62314	22q13.2																								
22	42076373	42076374	GG	-	intronic	SNU13				.	.	.	SNU13 homolog, small nuclear ribonucleoprotein (U4/U6.U5)	FUNCTION: Binds to the 5'-stem-loop of U4 snRNA and may play a role in the late stage of spliceosome assembly. The protein undergoes a conformational change upon RNA-binding. {ECO:0000269|PubMed:10545122, ECO:0000269|PubMed:17412961}.; 	.	TISSUE SPECIFICITY: Ubiquitous.; 	.	.	0.34688	.	0.035072054	56.2514744	.	.	22q13.2																								
22	50898034	50898034	G	-	exonic	SBF1		frameshift deletion	SBF1:NM_002972:exon27:c.3553delC:p.R1185Afs*140	0.690538813887376	0.30946118609264	1.99846807104168e-11	SET binding factor 1	FUNCTION: Probable pseudophosphatase. Lacks several amino acids in the catalytic pocket which renders it catalytically inactive as a phosphatase. The pocket is however sufficiently preserved to bind phosphorylated substrates, and maybe protect them from phosphatases. Inhibits myoblast differentiation in vitro and induces oncogenic transformation in fibroblasts. According to PubMed:20937701, may function as a guanine nucleotide exchange factor (GEF) activating RAB28. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. {ECO:0000269|PubMed:20937701, ECO:0000269|PubMed:9537414}.; 	DISEASE: Charcot-Marie-Tooth disease 4B3 (CMT4B3) [MIM:615284]: A recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot- Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. {ECO:0000269|PubMed:23749797}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	lymphoreticular;ovary;sympathetic chain;colon;parathyroid;fovea centralis;choroid;skin;retina;bone marrow;prostate;optic nerve;endometrium;bone;thyroid;testis;germinal center;brain;tonsil;unclassifiable (Anatomical System);amygdala;lymph node;cartilage;islets of Langerhans;hypothalamus;muscle;blood;lens;skeletal muscle;breast;pancreas;lung;placenta;macula lutea;visual apparatus;hippocampus;duodenum;hypopharynx;liver;spleen;head and neck;cervix;kidney;mammary gland;stomach;cerebellum;thymus;	whole brain;amygdala;medulla oblongata;superior cervical ganglion;testis - interstitial;caudate nucleus;pons;atrioventricular node;skeletal muscle;subthalamic nucleus;testis - seminiferous tubule;prefrontal cortex;testis;globus pallidus;trigeminal ganglion;parietal lobe;cingulate cortex;cerebellum;	0.15406	0.14540	-4.050718657	0.171030904	715.45512	5.30977	22q13.33																								
